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Abstract 
The continuous light-dark cycles caused by the rotation of the Earth around its own axis 
facilitated the evolution of circadian clocks, which have a huge impact on our daily life. 
Deregulation of the internal clock can lead to sleeping disorders, depression and various other 
health problems. Thus it is important to understand the mechanisms which allow our clock to 
tick properly. Since circadian clocks are quite conserved between species, model organisms 
such as mice can be used for basic research on the molecular clock mechanisms and its impact 
on physiology. In spite of this, not all results obtained in mice can be extrapolated directly to 
humans. 
The first aim of this thesis was to investigate whether the emergence of circadian rhythms in 
murine pups is dependent on a functional maternal clock. To elucidate this, wild-type males 
were crossed with arrhythmic Per1
Brdm1
Per2
Brdm1
 or Per2
Brdm1
Cry1
-/-
 double mutant females in 
constant darkness. The heterozygous offspring developed normal circadian rhythms although 
they were reared without any external Zeitgeber. However, their clocks were less 
synchronized to each other as compared to wild-type controls. These findings indicate that 
development of circadian rhythms does not depend on a functional circadian clock in 
maternal tissue.  
In a second part of this thesis, the role of Per1 and Rev-Erb in the circadian machinery was 
studied. Strikingly, mice mutant for these two genes showed high amplitude resetting in 
response to a brief light pulse at the end of their subjective night phase, which is rare in 
mammals. cFos was induced to comparable levels as those in wild-type mice, which indicates 
that the photosensitivity is normal in these animals. Surprisingly, the otherwise not light 
responsive gene Cry1 was also induced under these conditions. Hence, Rev-Erb and Per1 
may be part of a mechanism that evolved to prevent drastic phase shifts in mammals.  
The last part of this thesis aimed at developing a non-invasive method to measure and 
quantify human circadian clock gene expression in oral mucosa. It was demonstrated that 
PER2 was expressed in a circadian fashion in human buccal samples and that it was 
influenced by blue light in an age dependent manner. Hence this method may help shed more 
light onto the molecular mechanisms underlying disorders associated with the internal clock. 
 
Taken together, this work provides new insights into the distinct role of clock genes and the 
influence of light on the circadian oscillator. Increasing knowledge in these domains will 
allow the development of better therapeutic approaches for human circadian disorders. 
  Summary 
  3 
Zusammenfassung 
Zirkadiane Uhren entstanden als Anpassung an den immer wiederkehrenden Wechsel von 
Tag und Nacht, welcher  durch die Rotation der Erde um ihre eigene Achse hervorgerufen 
wird. Störungen der inneren Uhr können zu Depressionen, Schlafstörungen und vielen 
anderen Gesundheitsproblemen führen. Deswegen ist es wichtig zu verstehen, was es unserer 
inneren Uhr erlaubt, richtig zu funktionieren. Da zirkadiane Uhrwerke zwischen den Arten 
ziemlich konserviert sind, kann ihr molekularer Aufbau und ihr Einfluss auf die Physiologie 
in Modellorganismen wie  z.B. Mäusen untersucht werden. 
Ein erstes Ziel der vorliegenden Arbeit war es, zu untersuchen, ob es für die Entstehung von 
zirkadianen Rhythmen in jungen Mäusen eine funktionierende maternale Uhr braucht. Um 
diese Frage zu beantworten, wurden Wildtypmännchen mit arrhythmischen 
Per1
Brdm1
Per2
Brdm1
 oder Per2
Brdm1
Cry1
-/-
 doppelt mutanten Weibchen in kompletter 
Dunkelheit gekreuzt. Die heterozygoten Jungen zeigten einen normalen zirkadianen 
Rhythmus, obwohl sie in der vollständigen Abwesenheit von Zeitgebern aufgewachsen 
waren. Die Uhren innerhalb eines Wurfes waren jedoch weniger miteinander synchronisiert 
als die von Wildtypen. Diese Ergebnisse deuten an, dass die Entstehung zirkadianer 
Rhythmen nicht von einer intakten Uhr  im maternalen Gewebe abhängig ist. 
In einem zweiten Teil wurden die Funktion von Per1 und Rev-Erb innerhalb des zirkadianen 
Uhrwerks untersucht. Mäuse, welchen diese zwei Gene fehlen, zeigten eine bei Säugetieren 
sehr seltene Phasenverschiebung mit einer hohen Amplitude als Antwort auf einen Lichtpuls 
am Ende ihrer Aktivitätsphase. Da cFos in Mutanten und Wildtypen vergleichbar induziert 
wurde, scheint die Photosensitivität in diesen Tieren normal zu sein. Überraschenderweise 
wurde das ansonsten nicht auf Licht reagierende Gen Cry1 in den Mutanten induziert. Daher 
scheinen Per1 und Rev-Erb Bestandteil eines Mechanismus zu sein, welcher verhindert, 
dass die Phasenverschiebung in Säugetieren überschiesst. 
Ziel des letzen Teils war es, eine nicht-invasive Methode zu entwickeln, um die zirkadiane 
Expression von humanen Uhrengenen in der Mundschleimhaut zu messen. Es wurde gezeigt, 
dass in diesem Gewebe PER2 zirkadian transkribiert und durch blaues Licht am Abend 
induziert wird. Zudem wurde gezeigt, dass dieser Effekt altersabhängig zu sein scheint. Diese 
Ergebnisse deuten an, dass diese Methode hilfreich sein kann, um mehr über den zirkadianen 
Taktgeber im Menschen auf Ebene der Gene zu erfahren. Ausserdem könnte sie dazu 
beitragen, mehr über die molekularen Mechanismen zu lernen, welche Störungen der inneren 
Uhr hervorrufen. 
Summary 
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Zusammengefasst gewährt diese Arbeit neue Einsichten in die unterschiedlichen Aufgaben 
von Uhrengenen und den Einfluss von Licht auf die zirkadiane Uhr. Mit wachsendem Wissen 
in diesen Gebieten wird die Entwicklung von neuen Therapieansätzen zur Behandlung von 
Störungen des zirkadianen Systems im Menschen voranschreiten. 
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2 General Introduction 
 
2.1 Historical background 
Daily rhythms in animals and plants have been studied not only in recent times but also earlier 
in history. Alexander the Great's scribe Androsthenes (4
th
 century B.C.) noted that the tree 
Tamarindus indicus opens its leaves during the day and closes them at night. The first known 
experiment on biological rhythms was carried out in 1729 by the French astronomer Jean-
Jacques d'Ortous De Mairan. He observed that the leaves of the heliotrope plant Mimosa 
pudica open during the day and fold at night. The plants continued to open and fold their 
leaves regularly even when he put them in constant darkness. Thus, the daily rhythm was 
maintained even in the absence of daylight as an environmental cue. The famous Swedish 
taxonomist Carolus Linnaeus (1707-1778) even created a garden with flowers which opened 
their petals at various times so that he could tell the time of day by looking in his garden. 
Another important observation has been made by the French botanist De Candolle in 1883 
who noticed that the period length of plants placed in constant light differed slightly from the 
expected 24 hours. In the early 1900's Karl von Frisch observed that bees visited flowers only 
at specific times of the day. Together with Ingeborg Beling he trained bees to visit a nectar 
feeding station between 4 and 6 PM. The bees visited only at these times, and continued to 
visit even when the nectar was removed. This behaviour, called "Zeitgedächtnis" (memory of 
time), even continued when outside cues such as light were removed in laboratory trials. 
Although von Frisch and Beling did not know it, the bees were following an internal clock. 
The term “biological clock” was only coined in the 1950's by Gustav Kramer and Klaus 
Hoffmann who did prove its existence with their elegant bird experiments. The adjective 
circadian is taken from the Latin words circa and dies and means "around a day". Circadian 
rhythms are self-sustained biological rhythms, which persist with a period of approximately 
24 hours in organisms placed in constant conditions. In the 1950's as well, Colin Pittendrigh 
demonstrated that circadian clocks are temperature compensated, which means that clocks 
have approximately the same period length when the temperature changes within 
physiological ranges. Contrary to most metabolic activities, the period of the biological clock 
does not increase with body temperature. He concluded this from experiments on Drosophila 
pseudoobscura where he placed eggs at different temperatures and recorded their delay to 
eclosion. The flies emerged in constant darkness on schedule regardless of the temperature. In 
fact, the name Drosophila means dew-loving, referring to its tendency to eclose in the 
morning.
  General Introduction   
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2.2 Evolutionary relevance of having a clock 
Any living organism on earth is subjected to rhythmic changes of its environment. The major 
rhythms influencing the biosphere are the daily cycle caused by the earth’s rotation around its 
own axis and the seasonal cycle caused by the earth orbiting the sun. It is believed that 
circadian rhythms evolved due to these predictable rhythms and have been fine-tuned under 
selective pressure. One argument strengthening the idea that the circadian clock has emerged 
due to the organism’s adaptation to these geophysical facts is its ubiquity. Any organism 
investigated from cyanobacteria to human beings passing through fungi, insects, reptiles, fish, 
birds, mice, and so forth show circadian rhythmicity. According to Pittendrigh’s “escape-
from-light” hypothesis it is thought that the first circadian rhythms originated in the earliest 
cells to protect the replication of DNA from high ultraviolet radiation during daytime. Having 
a clock allowed to schedule light-sensitive processes to the night to protect the organism from 
deleterious photo-oxidative effects occurring during the day (Pittendrigh, 1993).  
Besides the periodic geophysical forces of the environment that influenced the evolution of 
the clock, the need to segregate incompatible metabolic processes has shaped it further. 
Fixation of nitrogen for example is unable to coexist with photosynthesis. On the other hand, 
some processes need to coincide to be of use. The availability of a receptor and the release of 
its corresponding hormone have to be synchronized to generate any endocrine effect. 
However, having an internal clock does not only provide an organism with intrinsic benefits 
but also with extrinsic advantages. For instance it is better for an animal to forage for food 
when it is available and predators are asleep or to search for individuals of the opposite sex at 
a time conducive for mating. Thus having a clock allows organisms to predict changes in the 
environment and to prepare their metabolism. Hence they do not only react to changes but 
they can anticipate them. This reduces energetic costs that would result from constant 
production of enzymes that are needed only at a certain time. Plants for example can prepare 
their photosynthetic machinery just before the light appears and thus make use of the first 
sunbeam. Although the set-up of circadian clocks varies enormously between organisms, their 
functions bear remarkable similarities. Today, the simplest known circadian clock is that of 
the prokaryotic cyanobacterium (photosynthetic eubacteria) Synechococcus elongatus who’s 
central oscillator consists of only three proteins: KaiA, KaiB and KaiC (fig. 2-1). This 
circadian oscillator is so basic that it was even reconstituted in vitro with just these three 
proteins and some ATP (Nakajima et al., 2005). Although the Kai proteins do not regulate a 
specific set of clock-controlled genes, they regulate genome wide gene expression turning on 
General Introduction 
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about two thirds of the genome in the morning and switching them off in the evening. The rest 
of the genome is activated at dusk and switched off at dawn. It is noteworthy that none of the 
Kai proteins shares homologies with any known clock gene found in any other organism so 
far.  
Fig.2-1: The cyanobacterial 
periodosome model. 
Environmental information, such as 
daylight is transduced through the 
phosphorylation and activation of 
Circadian input kinase A (CikA). 
CikA in turn phosphorylates and 
activates its predicted binding partner, 
Circadian input kinase R (CikR). 
Information is then transferred through 
protein-protein interaction to the 
receiver-like domain of the circadian-
clock protein KaiA. KaiA interacts 
with KaiC and stimulates 
autophosphorylation of KaiC, which is 
hexameric. In the phosphorylated 
state, KaiC hexamers can form a 
complex with other clock components. 
Synechococcus adaptive sensor A 
(SasA) joins the complex and is 
thereby stimulated to phosphorylate its 
predicted binding partner, 
Synechococcus adaptive sensor R 
(SasR). Phosphorylated, active SasR 
sends temporal information from the 
periodosome to the rest of the cell to activate rhythmic gene expression, either directly or indirectly. Late in the 
evening, another protein, KaiB, binds KaiC and inhibits KaiA-stimulated phosphorylation of KaiC. The complex 
then dissociates into its individual components (not shown) and ends the cycle. The molecular events that 
reactivate the cycle in constant environmental conditions have not yet been described (Bell-Pedersen et al., 
2005). 
 
2.3 Definition of the term “biological clock” 
Looking up the word “clock” in an ordinary dictionary one finds something similar to the 
following definition (www.brainyquote.com): “A machine for measuring time, indicating the 
hour and other divisions by means of hands moving on a dial plate. Its works are moved by a 
weight or a spring, and it is often so constructed as to tell the hour by the stroke of a hammer 
on a bell. It is not adapted, like the watch, to be carried on the person”. This definition 
clearly describes what we understand being a clock in our daily life. However, for scientific 
purposes more sophisticated definitions are required because well defined terms are the basis 
to describe the outcome of any experiment. In this respect, a system has to meet the following 
characteristics to be called “clock” from a biological point of view: 
1. The timing mechanism needs to be inherent.  
2. The system needs to be able to perceive information from the environment. 
  General Introduction   
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3. In order to synchronize the system to the outside, incoming signals have to be 
integrated by the timekeeping device. However, this synchronization is only possible 
within a narrow range that is close to the endogenous frequency of the system. 
4. The timing has to be sent to the receivers via one or several outputs. 
Once a system has been defined as being a clock, it has to be decided whether the system 
oscillates independently or whether it depends on the oscillations of a superior system. In the 
former case one talks about pacemakers whereas the latter are called slaves. 
Fig. 2-2: Model of the circadian system. 
The circadian system consists of three basic elements: an input pathway (yellow), an endogenous 
pacemaker generating circadian rhythms (red), and an output pathway (blue). Environmental signals, 
called Zeitgeber (German for “time giver”), are transduced to the master clock via input pathways. The 
Zeitgeber can be light, food intake, social factors, chemical or physical factors, etc. The input signals are 
received via receptors and then sent to the central pacemaker that generates oscillations. The output 
pathway finally translates the oscillation into rhythms such as genome transcription in cyanobacteria or 
sleep-wake cycles in animals. Some organisms contain more complex circadian clocks (shown as dotted 
line) that include multiple, interlocking oscillators and positive or negative feedback from clock-
controlled activities to the pacemaker and/or input components (figure modified from Gardner et al., 
2006). 
 
Definition of the term “circadian clock” 
Clocks that are found within a living organism are called “biological clocks”. Naturally 
occurring rhythms can be grouped into cycles that are shorter than a day, about a day or 
longer than a day. Short rhythms are called “ultradian” (e.g. circahoral = about an hour, 
circatidal) whereas long rhythms are called “infradian” (e.g. circalunar, circannual). The most 
exhaustively studied biological timekeeping devices are circadian clocks (fig. 2-2) that are 
distinguished from other biological oscillators by the following properties: 
1. They are self-sustained because they persist under constant conditions with a period 
(duration between the occurrence of two peaks or troughs) of about 24 hours. Kept 
under constant conditions, the rhythm starts to free-run which means that it drifts out 
of phase from the original period dictated by the environment. 
General Introduction 
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2. They can be synchronized by environmental cues - called Zeitgebers - allowing them 
to match local time. The phasing of the rhythm can be shifted by the same stimulus to 
which it entrains. 
3. They are temperature compensated meaning that their period length is stable over a 
wide range of biological temperatures. 
4. They send a timing signal to peripheral oscillators to set them to the prevailing 
Zeitgeber. 
Fig. 2-3: Tools of the trade. Each model system for circadian research offers its own means on non-invasive or 
automatic ways of recording daily rhythms. A Daily wheel-running activity of rodents occurs in constant 
darkness and is recorded in the form of an actogram. Bouts of activity are seen in black and provide information 
about the period and phase of the mammal’s clock. B The fungus Neurospora crassa produces asexual spores 
under the control of a biological clock. This process of conidiation can be measured using a specialized growth 
chamber called a race tube. C Plants show a daily rhythm of leaf movement. In Arabidopsis thaliana, rhythms of 
bioluminescence from luciferase fusions can be visualized for many days in constant light. D In the unicellular 
cyanobacterium, Synechococcus elongatus, luciferase fusions are used to monitor rhythms of promoter activity 
in high-throughput 96-well plates, allowing for saturation mutagenesis to determine components of the 
oscillator, as well as input and output pathways. E Daily flight movements of the model fly Drosophila 
melanogaster break an infrared beam in a specialized tube. The number of breaks can be monitored 
electronically to detect the circadian pattern of locomotor activity (Golden & Canales, 2003). 
 
It is important to make a clear differentiation between circadian and daily rhythms. While the 
former are endogenous rhythms with a period close to 24 hours the latter are 24-hours 
rhythms that are driven by a recurrent Zeitgeber and disappear under constant conditions.  
Circadian rhythms can be studied quite easily by manipulating the environment (e.g. light 
cycles, food access) and observing subsequently the outputs (e.g. wheel-running behaviour, 
blood pressure, hormone secretion, temperature, fluorescence).  Some organisms are rather 
  General Introduction   
  11   
well established model systems for circadian research and their rhythmic outputs can be 
studied automatically (fig. 2-3), which is quite a relief for the otherwise sleep deprived 
chronobiologist. 
 
2.4 The circadian clock in Drosophila melanogaster 
In the modern era, the studies of Pittendrigh on fruit flies have been continued by Ron 
Konopka, a graduate student in Seymour Benzer's laboratory. He performed a phenotype-
based screen of mutagen-exposed flies and isolated three period mutants in eclosion rhythm 
and locomotor activity: long (per
L
, ± 29 h), short (per
S
, ± 19 h) and arrhythmic (per
0
), which 
all mapped to a single locus, called period (per), on the X-chromosome (Konopka & Benzer, 
1971). In 1984, the same Drosophila period was the first clock gene ever isolated (Bargiello 
et al., 1984; Reddy et al., 1984) and it was shown to encode a large protein of more than 1200 
amino acids.  
Later on, it has been discovered that both PER protein and RNA are expressed rhythmically 
(Siwicki et al., 1988; Hardin et al., 1990; Zerr et al., 1990). This observation led to the 
formulation of the negative autoregulatory feedback loop model (fig. 2-4) in which PER feeds 
back on its own transcription. Nowadays the Transcription-Translation Oscillator Model 
(TTO) is still the model of choice in chronobiology. However, this gold standard starts to be 
questioned slowly since the number of observations not fitting the model increases steadily 
(Lakin-Thomas, 2006).  
 
 
 
Fig. 2-4: The negative 
autoregulatory feedback loop 
within a cell. 
Positive elements stimulate the 
transcription of clock genes. 
The translated products regulate 
the transcription of their own 
transcription negatively.  
 
 
 
For a decade, period was the only known circadian gene in animals. Only after ten more 
years, the second fly clock gene timeless (tim) was discovered (Sehgal et al., 1994) using 
genetic and biochemical screens. Tim protein and RNA levels undergo cycling similar to 
those of per. Today, a lot is known about the workings of the biological clock in the fruit fly 
Cytoplasm 
Nucleus 
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(fig. 2-5). Its negative autoregulatory feedback loop consists of a core system of four 
regulatory proteins, which create the daily rhythm of the fruit fly's clock. The cycle begins 
when the two positive elements, CLOCK (CLK) and CYCLE (CYC), bind together and 
increase the production of PER and TIM. The latter two proteins accumulate gradually over 
time and slow down their own production when they reach a critical concentration. It is of 
note, that the transcription factors CLK and CYC contain both a basic helix-loop-helix 
(bHLH) domain, which allows them to dimerize and to bind DNA. Additionally, they contain 
a PER-ARNT-SIM (PAS) dimerization domain. The CLK/CYC heterodimers activate tim and 
per transcription by binding directly to their E-box (a binding site for bHLH-PAS 
transcription factors: CACGTG) elements found in their promoters. Interestingly, Clk, but not 
cyc, RNA and protein levels cycle over a 24-h period with a phase almost opposite to that of 
PER and TIM. Drosophila genetics identified five additional circadian components, 
cryptochrome (cry), doubletime (dbt, a casein kinase I), shaggy (sgg), Par domain protein 1 
(Pdp1) and vrille (vri), which act to fine tune the simple transcriptional-translational 
feedback loop (Price et al., 1998; Blau et al., 1999; Martinek et al., 2001; Cyran et al., 2003). 
TIM-free PER protein is phosphorylated by DBT in the cytoplasm and thus marked for 
degradation. This fate can be neutralized by the dephosphorylation of PER by protein 
phosphatase 2A (PP2A; Harms et al., 2004). Thanks to these opposing activities, PER 
stability can be altered precisely. As TIM progressively accumulates, it binds the PER-DBT 
complex and blocks the phosphorylation of PER by DBT. The nuclear entry of PER/DBT and 
TIM is independent of each other (Hall, 2003) and promoted by Casein Kinase 2 (CK2; 
Allada & Meissner, 2005) and Shaggy (SGG; Harms et al., 2004), respectively. Once they 
Fig. 2-5: Model for the circadian 
clockwork in Drosophila melanogaster. 
At least two interlocked feedback loops are 
involved in generating rhythms: a negative 
autoregulatory loop of PER and TIM 
proteins on their own genes (through 
inhibition of the transcriptional activator 
CLOCK-CYCLE), and a positive effect of 
these proteins on the expression of 
CLOCK, CRY and DBT proteins regulate 
the stability of the TIM and PER proteins, 
respectively. CLOCK-CYCLE also 
regulataes clock-controlled genes (ccg), 
and hence rhythmic output (Cermakian & 
Sassone-Corsi, 2000) 
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reach the nucleus, PER/DBT and PER/DBT/TIM complexes inhibit CLK function. The direct 
hyperphosphorylation of CLK by DBT releases the CLK/CYC heterodimer from the E-box 
promoter sequences which in turn leads to reduced per and tim (as well as vri and Pdp1) 
expression (Hardin, 2005). Following light exposure at dawn, TIM protein is rapidly degraded 
by CRY, which binds to TIM after a conformational change caused by light exposure (Ceriani 
et al., 1999; Emery et al., 2000; Ashmore & Sehgal, 2003). The interaction of TIM with the 
protein JETLAG (JET) targets it for ubiquitination and subsequent degradation by the 
proteasome pathway (Koh et al., 2006). This degradation of TIM leads each day (or after a 
light pulse) to the resetting of the clock. 
Although Drosophila has been studied for many years, not all components of its molecular 
clock have been first identified in the fly. Some of them have been discovered in mammals 
and only afterwards their homologues have been found in the fly. Through the years, fruitful 
information exchange has developed between the different model organisms used, due to the 
conserved characteristic of the clocks in “higher” eukaryotes.  
Contrary to “higher” animals, the molecular oscillators found in many tissues of Drosophila 
seem to function autonomously and they can be directly reset by light (Plautz et al., 1997). 
This observation indicates that each oscillator might function as a pacemaker (reviewed in 
Bell-Pedersen et al., 2005). However, some studies indicate that the neuropeptide pigment-
dispersing factor (PDF), which is secreted in the dorsal brain with a circadian pattern, might 
mediate communication among central oscillator neurons in the brain (Peng et al., 2003; 
Stoleru et al., 2004; Grima et al., 2004). 
 
2.5 The circadian clock in zebrafish (Danio rerio) 
In the past few years, the zebrafish has become one of the most valuable lower vertebrate 
models for studying circadian clock function. It is thought that the teleost (= “perfectly boned 
fish”) circadian system might be the more ancestral vertebrate clock that became far more 
specialized in mammals due to selective pressure. There are several reasons for its “success” 
in the field. The most prominent ones are its utility in large-scale genetic screens and the 
transparency of the embryo. Furthermore, the eggs can be fertilized externally and the rapidly 
developing fish can be observed in a test tube. Hence maturation of the clock during early 
development can be studied quite easily, via in vivo imaging approaches for example. Another 
attractive property of the zebrafish is that its peripheral oscillators can be directly entrained to 
light independently of connections with the retina (Whitmore et al., 2000) as it is also the case 
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for Drosophila. It seems that peripheral oscillators in both fishes and flies have a high degree 
of autonomy. Besides light, temperature cycles are also able to entrain the fish oscillators 
since Danio rerio is poikilotherm, which means that its internal temperature varies with 
external temperature. This property makes the fish a more accessible model to study how the 
circadian timing system responds to temperature changes. Consistent with other organisms, 
the zebrafish circadian clock is temperature compensated over a 10°C range (Lahiri et al., 
2005). Last but not least most tissues and also cell lines possess functional clocks that can be 
entrained to either light or temperature cycles in vitro. 
 
2.5.1 How to measure circadian rhythms in zebrafish 
Before zebrafish could ascend to be an excellent model for circadian studies, suitable 
rhythmic output parameters had to be found. Locomotor activity and pineal melatonin 
synthesis were soon identified displaying a robust circadian rhythm. The former can be 
monitored in larval zebrafish (5-18 days old) by a computerized video image analysis system 
(Cahill et al., 1998). Larval swimming has proven to be a robust and reliable marker for 
circadian rhythms with peak activity during the day. Furthermore, the rhythm persists under 
constant conditions with an average free-running period of 25.5 hours. In contrast, measuring 
locomotor activity in adult fish turned out to be a rather bad marker due to high inter-
individual variability in cycle robustness (Hurd et al., 1998). Besides locomotor activity, 
pineal melatonin rhythms as the principal endocrine clock output turned out to be a robust 
marker. Cultured pineal glands continue to produce and secrete melatonin in vitro with a 
precise timing for one week or more (Cahill, 1996). At least in part, melatonin synthesis 
rhythm results from the control of arylalkylamine-N-acetyltransferase (AANAT) mRNA 
which encodes the rate limiting enzyme for melatonin synthesis. Two isoforms of this enzyme 
have been identified in zebrafish: AANAT1 is expressed exclusively in the retina and 
AANAT2 is expressed mainly in the pineal gland but small levels are also found in the retina. 
Measuring melatonin rhythms is a useful tool to confirm findings obtained in locomotor 
activity screens. Last but not least a third way has been developed to study the clock in fish.  
This method takes advantage of transgenic lines carrying luciferase reporter constructs 
(Kaneko & Cahill, 2005). The bioluminescence of these transgenes can be measured 
automatically using a scintillation counter. 
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2.5.2 Molecular machinery of the circadian clock in zebrafish 
From studies in mammals and Drosophila it has been known that the molecular machinery of 
the clock is quite conserved between these two phylae. Due to this, it was not a big surprise 
that homologues of Clock, Bmal, Per and Cry have been identified in zebrafish, as it is the 
case for most other vertebrates (table 2-1). However, a big difference exists between teleosts 
and mammals as the fish has more clock genes. This peculiarity of having two paralogs of 
many mammalian single-copy genes appears to be the result of a whole-genome duplication 
occurring early during evolution in the teleost lineage (Postlethwait et al., 1998).  
 
Table 2-1: Zebrafish clock gene homologues (Vallone et al., 2005) 
Gene Cloning Known functions 
Cry1a Homology Light inducible expression, blocked by protein synthesis inhibitors. Interacts 
with CLOCK-BMAL. Represses CLOCK1-BMAL3 activation by direct 
interaction in the nucleus. Does not affect CLOCK-BMAL binding to an E-
box. 
Cry1b Homology Represses CLOCK-BMAL activation. 
Cry2a Homology Represses CLOCK-BMAL activation. 
Cry2b Homology Represses CLOCK-BMAL activation. 
Cry3 Homology Does not interact with or repress CLOCK-BMAL activators. 
Cry4 Homology Does not interact with or repress CLOCK-BMAL activation. 
Clock1 Homology Interacts with BMAL and activates transcription by binding to E-boxes. 
Temperature influences strongly the amplitude of transcriptional activation 
and phosphorylation. 
Clock2 Homology Interacts with BMAL and activates transcription by binding to E-boxes. 
Temperature influences strongly the amplitude of transcriptional activation. 
Closest similarity with NPAS2. 
Clock3 Homology Interacts with BMAL and activates transcription by binding to E-boxes. 
Temperature influences strongly the amplitude of transcriptional activation. 
Bmal1 Two Hybrid with Clock Interacts with CLOCK1 and activates transcription by binding to E-boxes. 
Temperature does not influence strongly the amplitude of transcriptional 
activation. 
Bmal2 Two Hybrid with Clock Interacts with CLOCK1 and activates transcription by binding to E-boxes. 
Bmal3 Homology Interacts with CLOCK1 and activates transcription by binding to E-boxes. 
Per1 (4) Homology Clock regulated. Light acutely down-regulates expression. 
Per2 Homology Light inducible expression involves MAPK pathway and is not blocked by 
protein synthesis inhibitors. Represses CLOCK1-BMAL3 activation by 
interacting in the cytoplasm and preventing nuclear import. mRNA 
maternally inherited. Tissue specific expression during early development. 
Required for maturation of rhythmic AANAT2 expression in the pineal 
gland. 
Per3 Homology Clock regulated. Tissue specific expression during early development. 
Transcript maternally inherited. 
Rev-Erb Homology Expression during early development appears first in pineal (44-48 hours 
post fertilization [hpf]), then the retina (68-76 hpf) and finally in the optic 
tectum (96 hpf). 
 
The basics of the molecular oscillator in zebrafish appear to have much in common with the 
more extensively studied mammalian clock. However there are some small differences 
between the two that may be informative because there is evidence for specialization of clock 
gene function in fish. In accordance with many organisms, the molecular clockwork of Danio 
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rerio functions as an autoregulatory feedback loop. CLOCK-BMAL heterodimers function as 
positive elements that activate the transcription of clock genes and clock-controlled genes via 
binding to E-box motifs. The exact composition of these heterodimers changes as a function 
of time and depending on the tissue. Contrary to mammals, Bmal and Clock mRNA 
expression oscillates rhythmically peaking at the beginning of the night (fig. 2-6; Whitmore et 
al., 1998; Pando et al., 2001; Zhuang et al., 2000). Per genes oscillate in anti-phase to Bmal 
and Clock, reminiscent to the situation in mammals (Oishi et al., 1998), with Per1 peaking at 
ZT0 (Zeitgeber time 0 = lights on, ZT12 = lights off) and Per3 at ZT3. Per1 and Per3 
continue to cycle under dark-dark (DD) conditions. Per2 on the other hand, is strictly light-
dependent and does not cycle under DD (Pando et al., 2001). In mammals, all three Per genes 
are rhythmically expressed in constant conditions, and Per1 and Per2 are both light inducible 
(Shearman et al., 1997).  
 
 
 
Fig. 2-6: Expression rhythms of zebrafish clock genes.  
The approximate timing of mRNA rhythms in LD and DD is 
illustrated. The rhythm in Per2 mRNA is driven by the LD cycle, 
whereas other rhythms persist in constant darkness (LD = light 
dark cycle, open bar = light phase, black bar = dark phase, DD = 
constant darkness, hatched bar = subjective day, black bar = 
subjective night) (Cahill, 2002).  
 
 
The zebrafish clock contains six Cry genes (Kobayashi et al., 2000). Four of them show high 
sequence homology to the mammalian Cry genes (Cry1a, Cry1b, Cry2a, Cry2b), two of them 
having higher similarity to Drosophila Cry. All zebrafish Cry genes are rhythmically 
expressed but with differing expression patterns. The mRNA of Cry1a and Cry1b peak during 
daytime whereas Cry2a and Cry2b peak in the evening. This difference in peak expression 
might indicate that they are not completely redundant within the oscillator. Cry3 peaks in the 
morning in parallel with Per1/3 whereas Cry4 peaks during the day, like Cry1a/b do. Cry 
genes that are more similar to mammalian Crys have been shown to inhibit CLOCK-BMAL 
mediated transcription in vitro (Ishikawa et al., 2002; Hirayama, Fukuda et al., 2003). In 
contrast to the first set of genes, Cry3 and Cry4 are unable to suppress the potential to activate 
transcription of CLOCK-BMAL heterodimers (Ishikawa et al., 2002; Kobayashi et al., 2000; 
Hirayama, Nakamura et al., 2003). Unlike the other Per and Cry genes in zebrafish, Per2 and 
Cry1a are directly light inducible which suggest some specific regulation by the light input 
pathway (Pando et al., 2001; Hirayama et al., 2005, Cermakian et al., 2002). Interestingly, 
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neither Per2 nor Cry1a show rhythmic expression when temperature but not light is cycling 
(Lahiri et al., 2005). However, both CRY1A and PER2 act as inhibitors of the CLOCK-
BMAL heterodimers mediated transcription (Hirayama, Fukuda et al., 2003). CRY1A appears 
to interact with the heterodimers in the nucleus without affecting E-box binding whereas 
PER2 sequesters newly synthesized CLOCK-BMAL in the cytoplasm (Ishikawa et al., 2002; 
Hirayama, Fukuda et al., 2003; Hirayama, Nakamura et al., 2003).  
 
2.5.3 Light signalling to the zebrafish clock 
Recently, it has been shown that Cry1a acts as a light-signalling molecule in the zebrafish 
clock (Tamai et al., 2007) as its induction is critical for light-induced phase shifts. 
Overexpression of Cry1a in Per1-luminescent cell lines even led to a complete abolishment 
of the clock oscillations within the cells. This experiment indicates that Cry1a acts as a strong 
transcriptional repressor and as a possible light-induced repressor of clock function. 
Furthermore, Cry1a overexpression mimics exposure to constant light. It has also been shown 
that constant light conditions lead to a fall in Per1 expression and subsequent tonic repression 
of its transcription. However, Cry1a seems not to be the only actor in the light input pathway 
to the zebrafish clock as light pulses also strongly induce Per2. Interestingly, an injection of 
Per2 antisense morpholino into early-stage zebrafish embryos blocks subsequent 
synchronized rhythms in zebrafish aanat2 expression in the pineal gland (Ziv et al., 2005). 
The mechanism by which Per2 might be involved in clock resetting still remains to be 
elucidated. Another study shows that distinct mechanisms seem to be involved in the 
induction of Per2 and Cry1a by light (Hirayama et al., 2005). They demonstrate that Per2 
continues being induced in the presence of protein synthesis inhibitors whereas Cry1a light 
induction requires de novo protein synthesis (especially the synthesis of AP-1). 
 
2.5.4 Concluding remarks 
As a summary of the zebrafish molecular clock, one can say that it is in general consistent 
with the mammalian model that will be described thereafter. The most important differences 
between the two systems lie in the number of Cry genes and in the regulation of Per2. The 
fact that Clock is cycling is also worth mentioning as well as the direct light sensitivity of 
central and peripheral oscillators in the zebrafish. The presence of two classes or groups of 
Cry genes, one similar to Drosophila Cry and one similar to mammalian Crys, suggests that 
the zebrafish circadian system may share characteristics with both the Drosophila and the 
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mammalian circadian system (Pando & Sassone-Corsi, 2002). This conjecture is also 
strengthened by the fact that clock expression oscillates in Drosophila while cycle (Bmal1 
homologue) expression is constant. Exactly the opposite is true for the mammalian system 
where Clock is constitutively expressed and Bmal1 oscillates in a circadian fashion. In the 
zebrafish, both Clock and Bmal are rhythmically expressed. 
Since the work presented in this thesis focuses on the mammalian circadian system, the 
following sections will only concentrate on the circadian clock in rodents and humans. 
 
2.6 The circadian clock in mammals 
2.6.1 The circadian pacemaker resides in the brain 
As early as in 1948, Curt Richter discovered the approximate area where the principal 
circadian pacemaker is located in mammals. Performing a series of lesion experiments in the 
rat brain, he found only one area that had an effect on circadian rhythms when it was ablated. 
This region was the frontal part of the hypothalamus located at the base of the brain 
immediately above the optic chiasm. In 1972, two independent groups narrowed down this 
area to the suprachiasmatic nuclei (SCN, fig. 2-7), which consist of two clusters (Moore & 
Eichler, 1972; Stephan & Zucker, 1972). They ablated the SCN bilaterally and observed a 
loss in circadian rhythmicity of corticosterone rhythm, drinking behaviour and locomotor 
activity. Later transplantation experiments demonstrated that circadian behaviour can be 
restored in lesioned animals by SCN grafts (Lehman et al., 1987; Ralph et al., 1990; Sujino et 
al., 2003). Similar studies have been performed in a number of other mammalian species and 
they confirmed that the circadian pacemaker resides in the SCN in all mammals.  
Fig. 2-7: Localization of the 
suprachiasmatic nuclei (SCN) in the 
mouse brain. 
This coronal section of a mouse brain 
shows the position of the SCN (red) on 
top of the optic chiasm (OC, gray) on 
both sides below the third ventricle (3V). 
The enlarged panel shows the SCN 
stained with cresyl violet (adapted from 
Paxinos & Franklin, 2001). 
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2.6.2 Anatomy of the SCN and its neurotransmitter content 
In mice, each of the two “pear-shaped” suprachiasmatic nuclei contains about 10’000 neurons 
and each is 300 μm wide, 350 μm high and 600 μm long (Abrahamson & Moore, 2001). The 
SCN can be subdived into two parts: a ventrolateral (vlSCN, or core) and a dorsomedian part 
(dmSCN, or shell). Although early studies suggested that all SCN neurons were cell 
autonomous clocks (Welsh et al., 1995), recent studies demonstrated that they are not 
identical in function. The two SCN regions not only differ from the phenotypic point of view 
but also from the neuropeptides they express (fig. 2-8), their pacemaker ability and their 
response to environmental cues. Hence gene expression or firing in dorsal “shell” neurons 
peaks earlier in the day compared to ventral “core” neurons (Yamaguchi et al., 2003; Schaap 
et al., 2003). The shell mostly secretes arginine vasopressin (AVP) whereas the core 
predominantely expresses vasoactive intestinal peptide (VIP; Abrahamson & Moore, 2001) 
and gastrin-relesing peptide (GRP; Mikkelsen et al., 1991; Abrahamson & Moore, 2001). 
Interestingly, cultured SCN slices continue to secrete AVP and VIP rhythmically into the 
medium. Hence, they seem to play a crucial role in transducing signals from the SCN to the 
periphery (Gillette & Reppert, 1987; Shinohara et al., 1994).  
Besides the neuropeptides already mentioned (and several others not cited here), the 
neurotransmitter -amino butyric acid (GABA) is expressed all over the SCN (Moore & Speh, 
1993). Furthermore, some neurons in the shell are known to express glutamate (GLU; Csaki 
et al., 2000). 
 
2.6.3 Input pathways to the mammalian circadian clock 
To be able to adapt the body to the environment, the pacemaker has to receive information 
from the outside, integrate it and send it to the peripheral oscillators. Hence, the SCN are 
Fig. 2-8: Heterogeneity of the SCN. 
The left nucleus represents the subdivision of the 
SCN into a dorsomedian (dm, shell) and a 
ventrolateral (vl, core) part. The nucleus on the right 
side shows the distribution of neuropeptide and 
neurotransmitter expression in the mouse SCN. 3V, 
third ventricle; AVP, arginine vasopressin (blue); 
GABA, -amino-butyric acid (yellow); GLU, 
glutamate (purple); GRP, gastrin-releasing peptide 
(orange); OC, optic chiasm; VIP, vasoactive 
intestinal peptide (green) (picture taken from the 
thesis of Mathieu Chansard, Université Louis 
Pasteur de Strasbourg, 2007) 
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connected to a great number of afferent nervous fibers. There exist three major input 
pathways: the retinohypothalamic tract (RHT), the geniculohypothalamic tract (GHT) and the 
serotonergic input from the raphe nucleus (fig. 2-9).  
 
 
Fig. 2-9: Main afferent pathways to the 
SCN in rat. 
Orange and dark blue arrows represent 
photic and non-photic inputs respectively. 
5-HT, serotonin; DRN dorsal raphe 
nucleus; IGL, intergeniculate leaflets; 
GABA, -amino-butyric acid; GHT, 
geniculohypothalamic tract; GLU, 
Glutamate; MRN, median raphe nucleus; 
NPY, neuropeptide Y; PACAP, pituitary 
adenylate cyclase-activating peptide; RHT, 
retinohypothalamic tract; SCN, 
suprachiasmatic nuclei (adapted from the 
thesis of Mathieu Chansard, Université 
Louis Pasteur de Strasbourg, 2007). 
 
 
2.6.3.1 Photic input via the retinohypothalamic tract 
Mammals perceive external light information mainly via a subset of photosensitive retinal 
ganglion cells (pRGC; fig. 2-10) in the eye (Moore et al., 1995; Provencio et al., 1998; 
Berson et al., 2002; Sekaran et al., 2003). These cells express the photopigment melanopsin 
(a homologue of a photoreceptor in amphibian skin; Provencio et al., 2000; Gooley et al., 
2001; Lucas et al., 2001; Hattar et al., 2002; Dacey et al., 2005) and send the photic 
information directly to the SCN via the RHT (Moore & Lenn, 1972).  
 
Fig. 2-10: Light detection in the vertebrate retina. 
The rods (R) and cones (C) convey visual information 
to the ganglion cells (G) via the second order bipolar 
cells (B). At the outerplexiform layer (OPL), 
horizontal cells (H) facilitate lateral connectivity and 
feedback to the photoreceptors. At the inner plexiform 
layer (IPL) amacrine cells (A) allow lateral 
connections between bipolar and ganglion cells. The 
optic nerve is formed by the axons of all the ganglion 
cells. A subset of ganglion cells (pRGC) also detects 
light directly; for this, they require the photopigment 
melanopsin. Light, via melanopsin, activates a G-
protein cascade in the cells that depolarizes their 
membrane. These cells also receive synpatic input in 
the IPL from bipolar cells and amacrine cells. Thus 
photodetection in the retina occurs both in the outer 
and inner retina. Counter-intuitively, light passes 
through the transparent ganglion layer to reach the 
rods and cones (Foster & Hankins, 2007). 
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The monosynaptic RHT fibers end directly on the VIP expressing neurons in the ventrolateral 
part of the nucleus (Ibata et al., 1989; Tanaka et al., 1993). The molecules implicated in the 
photic signalling are the excitatory neurotransmitter GLU (Castel et al., 1993) and the 
neuropeptide pituitary adenylate cyclase-activating protein (PACAP; Hannibal et al., 1997). 
Another interesting property of the RHT is that it is implicated exclusively in conveying 
circadian information to the SCN. This is based on the fact that RHT lesions only alter photic 
entrainment without affecting vision (Johnson et al., 1988). Light is the strongest Zeitgeber 
for the SCN. Every day it resets the phase of the endogenous circadian clock and the linked 
oscillations in physiology and behaviour to exactly 24 hours. Strikingly, the effect of light on 
the SCN varies depending on the time at which it is perceived. The light response will be 
discussed later in section 2.6.7. 
 
2.6.3.2 Non-photic input via the geniculohypothalamic tract 
The second most important afferent pathway to the SCN comes from the intergeniculate 
leaflets (IGL) of the thalamus, located between the dorsal and ventral parts of the lateral 
geniculate nucleus. The IGL is connected to the retina (Hickey & Spear, 1976) and receives 
the same information as the SCN because each RGC that innervates the core region of the 
SCN also connects the IGL (Pickard, 1985; Moore & Card, 1994). The major signalling 
molecules within the IGL are the neuropeptide Y (NPY) and the neurotransmitter GABA 
(Harrington et al., 1985; Moore & Speh, 1993; Moore & Card, 1994). It has been shown that 
NPY-immunoreactive cells of the IGL project to the SCN core (VIP neurons; Card & Moore, 
1989; Morin et al., 1992; Harrington et al., 1997) where they form a dense plexus (Harrington 
et al., 1985). Based on the fact that the IGL neurons projecting to the SCN receive 
information from the same RGC than those which directly connect to the SCN, it appears that 
the IGL constitute the integration point of a complex circuit. Furthermore, the IGL obtain 
additional information from structures like the dorsal raphe nuclei (Meyer-Bernstein & Morin, 
1996). This indicates that this path allows the tight regulation of photic and non-photic 
entrainment of the circadian clock.  
 
2.6.3.3 Non-photic input via the serotonergic tract from the raphe nuclei 
The third most important afferent input pathway to the SCN comes from the median raphe 
nucleus in hamsters (Meyer-Bernstein & Morin, 1996; Leander et al., 1998) and both the 
median and the dorsal raphe nucleus in rats (Moga & Moore, 1997). These fibers end within 
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VIP-immunoreactive cells of the SCN core region (Kiss et al., 1984; Bosler & Beaudet, 1985; 
Francois-Bellan & Bosler, 1992) where the retinal afferents also end (van den Pol & 
Tsujimoto, 1985).  
An important fact is that the administration of agonists or chemical depletion of the 
serotonergic path affect locomotor activity both in LD and in DD (van Esseveldt et al., 2000). 
Due to this it is thought that the serotonergic tract participates in a non-photic regulation of 
the entrainment of the circadian clock. 
 
2.6.4 Output pathways from the mammalian circadian clock 
Once the central pacemaker in the SCN has integrated the input signal, time cues have to be 
sent to peripheral oscillators (fig. 2-11). To synchronize behavioural and physiological 
rhythms, the signals are sent to the periphery via both neuronal pathways and diffusible 
molecules. The induction of clock-controlled genes (CCGs) orchestrates action potential 
firing rate, rates of cellular metabolism, hormone release, etc. (Reppert & Weaver, 2002). 
 
2.6.4.1 Neuronal output 
The SCN innervates several brain areas mostly located within the thalamus and the 
hypothalamus. The bulk of the SCN output innervates the subparaventricular zone (SPZ) and 
the dorsomedial nucleus of the hypothalamus (DMH). The SPZ is subdivided into a ventral 
part (vSPZ), just above the SCN, and a dorsal part (dSPZ), just below the paraventricular 
nucleus (Lu et al., 2001). In addition to the anatomic discrimination of the SPZ, the two areas 
also differ in their physiological relevance. Lesions within the vSPZ disrupt the circadian 
rhythms of sleep and wakefulness, as well as locomotor activity, but have little effects on 
oscillations in body-temperature. By contrast, ablation of the dSPZ severely impairs circadian 
rhythms of body temperature whereas the sleep-wake cycle and locomotor activity remain 
unchanged (Lu et al., 2001). From these experiments it can also be concluded that direct 
projections of the SCN to the ventrolateral preoptic nucleus (VLPO) or the orexin neurons, 
which are both involved in the sleep system, are not sufficiently strong to maintain circadian 
rhythms of precited functions. It seems that the relay neurons in the SPZ are predominantly 
required to preserve them. Furthermore, the SPZ also has efferents to the VLPO and the 
orexin neurons (Chou et al., 2002; Sakurai et al., 2005; Yoshida et al., 2006; Watts et al., 
1987). However, the major output from the SPZ signals to the DMH, where the information 
received directly from the SCN is amplified (Lu et al., 2001; Deurveilher & Semba, 2005). 
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The role of the DMH seems to be the regulation of sleep and wakefulness, as well as 
locomotor activity, corticosteroid secretion and feeding (Chou et al., 2003). Moreover, lesion 
studies of the DMH implicate that its output is mainly activating. It is one of the largest 
sources of input to the VLPO and orexin neurons conveying SCN influence to the sleep-wake 
regulatory system (Chou et al., 2003; Aston-Jones et al., 2001; Chou et al., 2002; Yoshida et 
al., 2006; Thompson et al., 1996).  
 
Fig. 2-11: Physiological significance of SCN output signals: coordination of internal physiology to optimize 
performance. A The SCN (red) sends extensive projections to the paraventricular nucleus of the hypothalamus 
(green, hPVN), subparaventricular zone (pink, sPVZ), and dorsal medial hypothalamus (brown, DMH). Internal 
physiology is “primed” for food intake via the SCN  sPVZ  DMH  hPVN circuit that ultimately regulates 
synthesis and secretion of corticosterone from the adrenal cortex and glucose production in the liver. Cortical 
arousal is regulated in part via the SCN  DMH  LH circuit. The SCN is reciprocally connected with the 
arcuate nucleus (Arc). The Arc contains receptors responsive to blood-born hormones, and therefore represents a 
key feedback pathway to the SCN. The SCN also receives input from other brain areas, and thus functions as an 
integrator of both environmental and internal signals. Ach, acetylchonline; DMV, dorsal motor nucleus of vagus; 
5HT, serotonin; IML, intermediolateral column of spinal cord; LC, locus coeruleus; LH, lateral hypothalamus; 
NE, norepinephrine; Raphe, Raphe nucleus B Examples of various body rhythms controlled by the SCN. 
Melatonin is low during the day, and high at night. Corticosterone and orexin levels are coupled to the 
behavioural state of the animal, high during wakefulness and low during sleep. Note, the timing and shape of the 
waveforms are different. Distinct cell types and heterogeneity of phase within the SCN may serve to regulate the 
diverse timing of these targets. This figure and the figure legend are taken from the introductory workshop of the 
72
nd
 Cold Spring Harbor Laboratories Symposium (2007): Clocks & Rhythms (derived in part from Saper (2005) 
and Bujis (2001)). 
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The major role of the DMH seems to be the integration of clock information from the SCN 
and the SPZ for feeding, temperature, social and other cues. This allows the animals to be 
flexible enough to adapt their behavioural and physiological cycles to the environment, 
resulting in optimal survival conditions (Saper et al., 2005). Interestingly, it seems that these 
complex three-stage pathways for circadian control of sleep and other behaviours have 
evolved to allow their different control within nocturnal and diurnal animals. In both kinds, 
the SCN firing is active during the light cycle whereas the VLPO is always active during the 
sleep cycle (Sherin et al., 1996; Gaus et al., 2002). This indicates that there must be an 
intervening set of circuitry that allows the circadian output to be set at opposite phases in 
nocturnal animals and diurnal animals despite an identical clock input and sleep-control 
system (Saper et al., 2005). 
Several groups have shown that the different parts of the SCN signal to distinct regions. The 
median preoptic area (MPOA) for example receives projections from the shell of the SCN, 
while SPZ is targeted by neurons of the core SCN. Besides, both core and shell project to the 
DMH, the paraventricular nuclei of the hypothalamus (PVN) and the paraventricular thalamic 
nucleus (Watts & Swanson, 1987; Watts et al., 1987, Leak & Moore, 2001). AVP secreted 
from the PVN is primordial for the regulation of corticosterone (Buijs et al., 1998). 
Furthermore, the PVN is also crucial for the rhythmic secretion of melatonin (Simonneaux & 
Ribelayga, 2003). 
 
2.6.4.2 Humoral output 
As mentioned above, the clock output is not only assured by neuronal projections but also by 
diffusible factors. This idea was born in 1987, when graft experiments were performed on 
SCN-lesioned hamsters placed in DD (Lehman et al., 1987). The transplant was able to 
restore rhythmic locomotor activity but not photoperiodic response. Later on, other researches 
showed that luteinising hormone (LH) rhythm, oestrous cycle, corticosterone and melatonin 
rhythm could not be restored by grafts as well (Meyer-Bernstein et al., 1999). These studies 
pointed to the existence of at least one diffusible factor implicated in synchronizing the body 
to the environment. In 1996, this hypothesis was confirmed by transplanting encapsulated 
SCN into the third ventricle of SCN-lesioned hamsters thereby restoring the circadian 
locomotor activity of these animals. The semipermeable polymeric capsule used in this 
experiment prevented the natural outgrow of neurones. However diffusion of hormones or 
other factors was not impaired by this membrane (Silver et al., 1996). Similar results have 
been obtained by surgical isolation of the SCN in vivo, which disrupted the photoperiodic 
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response (e.g. gonad regression failure in hamsters in DD) but not the rhythmic locomotor 
activity (Hakim et al., 1991). During the last few years, several diffusible signalling 
molecules of the circadian clock have been identified. 
Rhythmic locomotor activity for example has been found to be inhibited by an injection of 
transforming growth factor  (TGF) into the third ventricle. Thus TGF seems to be an 
inhibitory factor for locomotor activity that is secreted by the SCN during the day. 
Furthermore, TGF mRNA is expressed rhythmically in the SCN and peaks in the middle of 
the day in the Syrian hamster. This peptide exerts its action through binding on epidermal 
growth factor receptor (EGFR) localized in the SPZ. Indeed, a mutation in this receptor leads 
to increased daytime activity in mice. However, waved-2 mutant mice (EGFR activity 
reduced by about 80-95 % compared to the wild-type; Egfr
-/-
 mutant mice are not viable) only 
display increased daytime activity compared to the wild-type under light dark cycles but show 
normal activity patterns under DD conditions  (Kramer et al., 2001). This finding raises the 
question whether TGF influences locomotor activity only under diurnal but not circadian 
conditions. 
Besides TGF, prokineticin 2 (Pk2), which is expressed in the SCN and peaks at the 
beginning of the day, is thought to be implicated in the regulation of locomotor activity. 
Similar to TGF, injecting PK2 into the third ventricle during night-time abolishes locomotor 
activity (Cheng et al., 2002). Moreover, a light pulse at night induces Pk2 mRNA in the SCN, 
which leads to a subsequent block in locomotor activity (Cheng et al., 2002; Cheng et al., 
2005). PK2 receptors are expressed in several brain regions like the PVN, the DMH and at 
high levels in the paraventricular thalamic nucleus. However, the role of PK2 in the regulation 
of locomotor activity is controversial: first of all, the PK2 receptor is absent in the SPZ 
(Cheng et al., 2002) although this region is strongly implicated in the regulation of locomotor 
activity (Lu et al., 2001). Second of all, expression levels of PK2 should be opposite in 
nocturnal versus diurnal animals if PK2 is a real inhibitor of locomotor activity. Yet this is not 
the case in the diurnal species Arvicanthis niloticus where Pk2 also peaks during the day. But 
the possibility remains that PK2 acts as an activator of locomotor activity in diurnal animals 
whereas it is an inhibitor in nocturnal species. The fact that the PK2 receptor is absent in the 
SPZ of Arvicanthis niloticus as well, somehow weakens this hypothesis (Lambert et al., 
2005). Nevertheless, Pk2 seems to be a CCG since it contains an E-box motif in its promoter, 
which allows its activation by binding of CLOCK-BMAL1 heterodimers (Cheng et al., 2002). 
Time will help us learn more about the role of PK2 within the circadian clockwork. 
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Recently, another factor inhibiting daytime locomotor activity has been identified: 
cardiotrophin-like cytokine (CLC). It is expressed in a circadian fashion within AVP neurons 
in the SCN peaking at the end of the day and its receptors are located in the third ventricle.  
Like TGF and PK2 its injection inhibits locomotor activity (Kraves & Weitz, 2006). Perhaps 
these three peptides may act together to influence locomotor activity. 
 
2.6.4.3 Peripheral oscillators and their hierarchical organization 
The current view is that most if not all cells of the body contain their own autonomous 
circadian clockwork (Balsalobre et al., 2000). This allows tissue-based and even cell-specific 
interpretation of endocrine or neuronal signals sent by the SCN. In contrast to simpler animals 
such as Drosophila and zebrafish, peripheral oscillators of mammals are organized into a 
strict hierarchy (fig. 2-12). Time cues sent by the SCN are thought to coordinate peripheral 
oscillators and to impose cellular synchrony within a given tissue. To test this hypothesis, 
organs of SCN-lesioned animals were extracted and cultured. As expected, their oscillations 
were out of phase with one another. Surprinsingly, the oscillations within a given tissue were 
nicely synchronized suggesting the presence of organ-specific synchronizers (Yoo et al., 
2004; Stratmann & Schibler, 2006). Nevertheless, the observed synchrony within a tissue 
could be a simple culture artefact because changing culture medium is sufficient to reset 
desynchronized oscillators (Yamazaki et al., 2000). Finally, Guo and colleagues (2006) 
showed that the capacity of tissues to oscillate in vitro does not implicate that they are also 
rhythmic in vivo. They studied Per1, Per2 and Bmal1 gene expression by in situ hybridization 
in SCN-lesioned versus control hamsters. Since Pers and Bmal1 oscillate 180° out of phase 
from one another, the Per:Bmal1 ratio in control animals should give a large peak during the 
course of a cycle. As expected this large peak could be observed in peripheral tissues of 
control but not SCN-lesioned animals indicating arrhythmicity among cellular oscillators. 
Summarizing this paragraph, one can say that there is much evidence for the SCN to be the 
coordinator for timing of peripheral oscillators and that it is the SCN as well that imposes 
cellular synchrony within a given tissue. 
However, this relationship between the SCN and the periphery has been shown not to be as 
linear as it had been hypothesized some time ago. Restricted feeding for example has the 
power to uncouple circadian gene expression, especially in the liver (but also in other 
peripheral tissues), from the pacemaker (Damiola et al., 2000; Stokkan et al., 2001). This 
finding implies that metabolism and circadian clocks are tightly interwoven with each other 
via complex feedback mechanisms. Depending on the situation, circadian clocks either drive 
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the periphery or metabolic parameters affect the clock. To come back to the example of 
restricted feeding it is interesting to mention that the speed and the degree to which an organ 
changes its circadian rhythm vary between organs. The complex relationship between the 
pacemaker and the periphery in this context is underlined by the fact that tissues lacking 
glucocorticoid receptors shift their phases much faster compared to tissues carrying it. 
Furthermore, tissues of adrenalectomized animals also entrain faster when feeding time and 
photoperiod are shifted to opposite phases compared to sham operated animals (Le Minh et 
al., 2001). This implicates that the clock phase is set differently in vivo by food availability 
and glucocorticoid secretion. Astonishingly, administration of glucose alone is able to shift 
clock gene expression in cultured cells suggesting that basic food metabolites could be 
sufficient to entrain peripheral oscillators (Hirota et al., 2002). Another factor that can 
strongly influence the periphery without altering the SCN is fluctuating body temperature. 
Brown and colleagues (2002) have shown that body temperature rhythms in mammals can 
sustain oscillations in peripheral clocks.  
Fig. 2-12: Hierarchical 
organization of body clocks. 
Many tissues throughout the body 
continue to cycle for a few cycles 
when isolated in vitro, however, 
the oscillations eventually 
dampen. The SCN is generally 
considered to be the primary 
organizer of peripheral body 
oscillators, functioning to 
coordinate timing between 
various tissue oscillators and to 
synchronize oscillations among 
the cell-autonomous oscillators 
within a given tissue. Importantly, 
there is a food-entrainable 
oscillator that is maintained in 
SCN-lesioned animals exposed to 
a feeding schedule. Feedback 
likely involves glucocorticoid release from the adrenal gland into the bloodstream that is then sensed in brain 
regions outside the SCN (feedback not shown). In the intact system, the food-entrainable oscillator and the SCN 
oscillate in a coordinated manner due to SCN regulation of locomotor activity, the animal will only eat when it is 
awake, timed primarily by the SCN. Dashed line represents “masking”. This figure and the figure legend are 
taken from the introductory workshop of the 72
nd
 Cold Spring Harbor Laboratories Symposium (2007): Clocks 
& Rhythms. 
 
The findings mentioned in this section can be summarized nicely citing the following 
metaphor of H. Oster (2006): “The SCN act like the conductor of an orchestra that gives the 
pace he reads from the score (e.g. the sun). The music, however, is played by the instruments, 
the peripheral oscillators controlling the physiological and the behavioural state of the 
organism.” 
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Nevertheless, before the periphery can start to play music, the incoming information has to be 
integrated by the pacemaker located in the SCN. To achieve the accuracy and reliability 
needed within an organism, the clock needs a molecular set-up that is well-engineered. The 
cogwheels of the mammalian oscillator and how they are meshed will be further detailed in 
the following paragraph. 
 
2.6.5 Molecular machinery of the circadian clock in mammals 
2.6.5.1 How everything started: chronology of clock gene discovery 
In mammals, the molecular set-up of the circadian clock is more complex and less understood 
although it shares many homologies with that of Drosophila. Deciphering of the mammalian 
clock components started in 1988 with the serendipitous discovery of the tau mutation in 
Syrian hamsters (Ralph & Menaker, 1988). This spontaneous mutation shortens the period of 
circadian locomotor rhythm dramatically: homozygous hamsters have rhythms with periods 
close to 20 hours. However, it was only in 2000 that mapping studies revealed that this 
mutation resides within casein kinase 1 (mCK1) as a C to T transversion in position 178 
(Lowrey et al., 2000). This point mutation leads to a deficiency in the ability of CK1 to 
phosphorylate its targets, including PER proteins (Dey et al., 2005). Nevertheless, recent 
studies suggest that tau is a gain-of-function mutation on specific residues within the 
sequence targeting PER proteins (Gallego & Virshup, 2007; Meng et al., 2008). After the 
discovery of the tau mutant, the field stagnated for several years. The unravelling of the 
circadian clock was continued in 1994 with the discovery of the first mammalian clock gene 
following a mutagenesis screen in mice. The gene has been named mClock (circadian 
locomotor output cycles kaput) because mice carrying a mutation in this gene lost their 
rhythmic wheel-running behaviour after two weeks in constant darkness (Vitaterna et al., 
1994). Between 1997 and 1998, scientists finally succeeded in isolating and characterizing the 
mammalian homologues of the Drosophila period genes, mPer1 (initially named Rigui), 
mPer2, and mPer3 (Sun et al., 1997; Tei et al., 1997; Zheng et al., 1999; Shearman et al., 
2000; Zheng et al., 2001; Bae et al., 2001). Several studies further attempted to identify the 
functional partner of CLOCK. In 1998, Hogenesch and colleagues discovered several binding 
partners in vitro. Due to the fact that they all carry a PAS domain, they were called “members 
of the PAS (MOP) superfamily”. 
Within the following years, many circadian clock genes were identified in mammals and 
many of them were found to have orthologues in Drosophila: mCry1 and mCry2 
(cryptochrome; van der Horst et al., 1999; Vitaterna et al., 1999), the mClock partner mBmal1 
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(brain and muscle ARNT-like 1; mMop3; orthologue to cyc; Bunger et al., 2000), mNpas2 
(mMop4; analogue of mClock; Hogenesch et al., 1998; Reick et al., 2001). Later on, mRev-
Erb (mNr1d1; Preitner et al., 2002), mRor (mNr1f1; Sato et al., 2004), mTim (Barnes et al., 
2003), and the two basic helix-loop-helix (bHLH)-PAS proteins mDEC1 (SHARP2) and 
mDEC2 (SHARP1; Honma et al., 2002; Rossner et al., 2008) have been identified as well. A 
summary of current mammalian clock genes along with their properties and mutation 
phenotypes is listed in table 2-2.  
 
Table 2-2: Mouse circadian clock and clock-related genes (adapted from: Ko & Takahashi, 2006) 
 Average CT at peak expression 
Gene SCN Periphery Allele Mutant phenotypes in DD References 
Bmal1 15-21 22-02  Bmal1
-/-
 Arrhythmic Bunger et al., 2000 
Clock Constitutive 21-03  Clock
19/19
 4 h longer period/arrhythmic Vitaterna et al., 1994 
      Clock
-/-
 0.5 h shorter period DeBruyne et al., 2006 
Per1 4-8 10-16 Per1
Brdm1
 1 h shorter period Zheng et al., 2001 
     Per1
ldc 
0.5 h shorter period Bae et al., 2001 
     Per1
-/- 
0.5 h shorter pd /arrhythmic Cermakian et al., 2001 
Per2 6-12 14-18 Per2
Brdm1
 1.5 shorter pd /arrhythmic Zheng et al., 1999 
   Per2
ldc
 Arrhythmic Bae et al., 2001 
Per3 4-9 10-14 Per3
-/-
 0-0.5 h shorter period Shearman et al., 2000 
Cry1 8-14 14-18 Cry1
-/-  a
 1 h shorter period van der Horst et al., 1999 
     Vitaterna et al., 1999 
Cry2 8-14 8-12 Cry2
-/-  a
 1 h longer period van der Horst et al., 1999 
     Thresher et al., 1998 
Rev-erb 2-6 4-10 Rev-Erb-/- 0.5 h shorter period Preitner et al., 2002 
    Disrupted photic entrainment 
Ror 6-10 arr. Staggerer 0.5 h shorter period Sato et al., 2004 
  various
b
  Disrupted photic entrainment  
Ror 4-8 18-22 Ror-/- 0.5 h longer period Andre et al., 1998 
     Sumi et al., 2002 
Ror N/Ac 16-20 Ror-/- Unknown 
  various
b
 
NPAS2 N/A
c
 0-4 NPAS2
-/-
 0.2 h shorter period Dudley et al., 2003 
Bmal2 Constitutive   n/d
e
 Hogenesch et al., 2000 
     Ikeda et al., 2000 
     Okano et al., 2001 
CK1 Constitutive Constitutive CK1tau  d 0.4 h shorter period Lowrey et al., 2000 
   CK1-/- 0.3 h longer period Meng et al., 2008 
CK1 Constitutive Constitutive Csnkl-/+ 0.5 h shorter period Xu et al., 2005 
Dec1 2 14 Dec1
-/-
 No difference in period Grechez-Cassiau et al., 2004 
   Dec1
-/- 
0.15 h longer period Nakashima et al., 2008 
   Sharp2
-/-
 No difference in period Honma et al., 2002 
     Rossner et al., 2008 
Dec2 6 14 Sharp1
-/-
 No difference in period Honma et al., 2002 
     Rossner et al., 2008 
Tim 12
f
 various n/d
e
 embryonically lethal Barnes et al., 2003 
     Li et al., 2000 
Fbxl3 n/d
e
 n/d
e
 Fbxl3
-/-
 2-3 h longer period Siepka et al., 2007 
     Busino et al., 2007 
     Godinho et al., 2007 
a
Two independent groups generated Cry1 and Cry2 null mutants and the mice showed similar phenotypes. 
b
See: Akashi & Takumi, 2005; Guillaumond et al., 2005 ; Ueda et al., 2005 
c
N/A = not detected in the SCN 
d
Hamster mutation 
e
n/d = not determined 
f
The Tim full-length transcript is rhythmically expressed in the SCN but not the short form (Barnes et al., 2003). 
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As further detailed below, the molecular clockwork in mammals is based on interlocked 
positive and negative transcriptional/translational feedback loops (TTLs) consisting partly of 
the genes mentioned above (fig. 2-13). 
 
 
 
Fig. 2-13: A network of transcriptional-translational feedback loops constitutes the mammalian circadian 
clock. Clock gene and ccg transcription is regulated via three main enhancer motifs: E-box, RRE and D-box. 
Transcription from E-boxes is mediated by CLOCK/BMAL1 heterodimers. D-box dependent transcription is 
mediated by competitive binding of activators (mainly DBP, TEF and HLF) and its repressor (E4BP4). 
Similarly, RRE mediated transcription is activated by ROR and repressed by REV-ERB. Black circles 
represent phosphorylation sites. ccg, clock-controlled gene; CK1, casein kinase 1; dbp, albumin D-element 
binding protein; D-box, DBP/E4BP4-binding element; E-box, CLOCK/BMAL1-binding element; E4bp4, E4 
promoter binding-protein 4; RRE, retinoic acid related orphan receptor response element. The picture has been 
kindly provided by Sonja Langmesser who was inspired by Ko & Takahashi (2006) and the thesis of Gabriele 
Hampp (2007). 
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2.6.5.1 The core loop 
The basis of the mammalian clockwork consists of the core loop composed by the following 
genes: mClock, mBmal1, mPer1, mPer2, mPer3, mCry1 and mCry2. 
The positive elements of the core loop are encoded by the two transcription factors CLOCK 
and BMAL1. Both of them harbour a bHLH-PAS domain, which allows DNA binding and 
heterodimerization. Once the complex has formed in the cytoplasm, the heterodimer 
translocates into the nucleus. This nuclear entry is mediated by BMAL1, which carries both 
nuclear localization signals and nuclear export signals that allow it to shuttle between the 
nucleus and the cytoplasm to promote nuclear translocation of CLOCK (Kwon et al., 2006). 
CLOCK-BMAL1 heterodimers mediate transcriptional activation of target genes that present 
E-box (consensus sequence: CACGTG) cis-regulatory enhancer tandems in their promoter 
(Gekakis et al., 1998; Hogenesch et al., 1997; Hogenesch et al., 1998; Travnickova-Bendova 
et al., 2002; Yoo et al., 2005; Nakahata et al., 2008). These positively regulated genes include 
Pers, Crys, Rev-Erb, Ror and several other clock and clock-controlled genes. It is 
noteworthy, that their mRNA transcripts accumulate in antiphase to Bmal1 mRNA (fig. 2-14). 
In the cytoplasm, PER proteins form complexes with CRYs, which then enter the nucleus. 
Once the complexes reach their destination, the CRYs inhibit the CLOCK/BMAL1 driven 
transcription, thereby establishing a negative feedback loop (Griffin et al., 1999; Jin et al., 
1999; Kume et al., 1999). The suppressed E-box driven transcription leads to a decline in 
PER and CRY protein levels which finally leads to a re-activation of CLOCK-BMAL1 driven 
transcription. Hence the next circadian cycle is re-initiated.  
 
Fig. 2-14: Members of the 
negative limb oscillate in 
antiphase to Bmal1. In 
mammals, Bmal1 mRNA peaks at 
around circadian time (CT) 18 and 
Clock is expressed constantly 
contrasting with the situation in 
Drosophila. Per1 reaches its peak 
at midday whereas Per2 and Cry1 
peak at the late day. Per3 has a 
broader peak expression all over 
the day. Cry2 and Tim seem not to 
cycle much. (Adapted from G.E. 
Duffield) 
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This basic feed-back loop allows oscillations on a 24 hour basis. It is of note that the role of 
CLOCK in the circadian clock core loop has been challenged recently because a null mutation 
in Clock does not alter rhythmic locomotor behaviour of mice in DD. These results suggest 
that NPAS2 (a CLOCK paralog) could take over the role of CLOCK in its absence in 
knockout mice (DeBruyne et al., 2006). Moreover, BMAL2 (MOP9; an analogue to BMAL1) 
has also been shown to form active heterodimers with either CLOCK or NPAS2 (Hogenesch 
et al., 2000; Ikeda et al., 2000). However, both the capacity to activate transcription and the 
extent of repression by the CRYs differ between the various heterodimers (i.e. 
CLOCK/BMAL1, CLOCK/BMAL2, NPAS2/BMAL1, NPAS2/BMAL2). This observation 
suggests that they fulfil slightly different roles within the molecular clock that may prove 
important in vivo (Dardente et al., 2007). 
 
2.6.5.2 The secondary loops 
The oscillations generated by the core loop are further modulated (e.g. amplitude, precision, 
stability) by other interlocking feedback loops. These TTLs seem to be less important for 
normal rhythm generation as knock-out mice for those genes do not prevent self-sustained 
rhythmic behaviour. Nevertheless, they add to the precision of the clockwork and they reduce 
its sensitivity to external and internal “noise”.  The so-called stabilizing loop involving the 
orphan nuclear receptors REV-ERB and ROR is probably the best characterized of these 
loops to date (fig. 2-13). Recently it has even been suggested that the nuclear receptor co-
factor and master metabolic regulator PGC-1 (peroxisome proliferator-activated PPAR co-
activator) potentiates ROR mediated activation of Bmal1 transcription. Hence, PGC-1 
could integrate the mammalian clock and the energy metabolism (Liu et al., 2007). 
 
2.6.5.2.1 The stabilizing loop 
The REV-ERB protein represses Bmal1 transcription by binding to 2 RORE (ROR [retinoic 
acid related orphan receptor] response element) sequences in the Bmal1 promoter (Preitner et 
al., 2002; Ueda et al., 2002). Besides REV-ERB, ROR too binds the RORE sequences in 
the Bmal1 promoter (Sato et al., 2004). However, in contrast to REV-ERB, ROR activates 
Bmal1 transcription (Giguere, 1999; Akashi & Takumi, 2005). Hence the two proteins 
compete for the RORE sequences thus interconnecting the positive and negative limbs of the 
clock (Guillaumond et al., 2005). Their opposing effects on Bmal1 expression is also reflected 
in vivo: Rev-erb knock-out mice (Preitner et al., 2002) show constitutively high Bmal1 
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mRNA levels whereas Staggerer mice (loss-of-function mutation of Ror; Sato et al., 2004) 
show strongly reduced Bmal1 levels. Expression of Rev-Erb in the mouse SCN oscillates in 
a circadian fashion with a peak at midday and a trough at midnight (Onishi et al., 2002; Panda 
et al., 2002b; Preitner et al., 2002; Ueda et al., 2002). Similarly, Ror peaks at midday and 
has its minimum at midnight (Sato et al., 2004). Additionally, it has been shown that 
members of ROR (,  and ) and REV-ERB ( and ) families are able to regulate Bmal1 
through ROREs in general (Guillaumond et al., 2005). Furthermore, tissue-specific molecular 
clock mechanisms could exist as Rev-Erbs appear to be rhythmically and ubiquitously 
expressed throughout the body (Guillaumond et al., 2005; Yamamoto et al., 2004) whereas 
Rors are expressed in a tissue specific manner.  
 
2.6.5.2.2 DEC1 & DEC2: an example of another interlocked loop 
Both, Dec1 and Dec2 are bHLH transcription factors which are expressed rhythmically in the 
SCN with a peak at early day/midday and a trough at midnight/late night (Honma et al., 
2002). In vitro studies have suggested that their transcription is directly activated by 
CLOCK/BMAL1 heterodimers binding to E-boxes located in their promoter (Hamaguchi et 
al., 2004; Kawamoto et al., 2004). In line with these observations it has been found that Dec1 
as well as Dec2 levels are decreased in Clock mutant mice (Butler et al., 2004). By competing 
with CLOCK/BMAL1 for binding to the E-box motifs, DEC1 and DEC2 inhibit their own 
transcription (Hamaguchi et al., 2004; Kawamoto et al., 2004). However, it might also be 
possible that this inhibition is mediated through an interaction with BMAL1 because DEC1 
and DEC2 can bind BMAL1 (Honma et al., 2002). Furthermore, PERs and CRYs have also 
been shown to inhibit Dec1 and Dec2 transcription in vitro (Hamaguchi et al., 2004; 
Kawamoto et al., 2004).  
For the time being, DEC1 and DEC2 are thought to play an important role in inhibiting 
CLOCK/BMAL1 mediated transcription as it has been observed in vitro (Honma et al., 2002; 
Hamaguchi et al., 2004; Kawamoto et al., 2004). Recently, two studies confirmed that DECs 
seem to play a role in fine tuning the regulation and robustness of the molecular clock 
(Rossner et al., 2008; Nakashima et al., 2008). 
 
2.6.5.4 Timing of the loops via CK1 
In addition to transcriptional regulation, posttranslational modifications of clock genes have 
been found to be critical in setting clock speed in mammals (Lee et al., 2001; Gallego & 
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Virshup, 2007). Reversible phosphorylation for example provides a particularly functional 
tool for the regulated formation of protein complexes, their nuclear entry, and their 
subsequent degradation. Not surprisingly, phosphorylation of PER proteins by casein kinase 
1 or the highly homologous CK1 has been shown to be crucial in determining the pace of 
the clock (Ralph & Menaker, 1988; Dey et al., 2005; Meng et al., 2008). CK1 activity can be 
inhibited through autophosphorylation of eight sites located in its C-terminus (Graves & 
Roach, 1995; Cegielska et al., 1998; Gietzen & Virshup, 1999). Conversely, CK1 kinase 
activity can be restored by the action of PP1, PP2A, PP2B (calcineurin) and PP5 which are 
able to dephosphorylate these amino acids in vitro (Cegielska et al., 1998; Lowrey et al., 
2000; Partch et al., 2006). 
Both, CK1 and CK1 are expressed constitutively in the mammalian SCN (Lowrey et al., 
2000; Takano et al., 2000; Ishida et al., 2001; Lee et al., 2001). Furthermore, they have been 
shown to interact with and phosphorylate PER1 as well as PER2 in mice (Keesler et al., 2000; 
Camacho et al., 2001) and human (Vielhaber et al., 2000; Akashi et al., 2002; Eide et al., 
2002). On the contrary, PER3 does not show any stable interactions with CK1 and is not 
translocated into the nucleus. This characteristic could explain why Per1 (Cermakian et al., 
2001) and Per2 (Zheng et al., 1999) are able to sustain molecular circadian rhythms whereas 
Per3 can’t (Lee, Weaver & Reppert, 2004). However, CK1 and CK1 do not only interact 
with PERs but also complex with CRYs (Lee et al., 2001) and CK1-mediated 
phosphorylation of BMAL1 increases its transcriptional activity (Eide et al., 2002). Recent 
studies suggest that phosphorylation of PERs can be both destabilizing and stabilizing at once 
(Partch et al., 2006; Vanselow et al., 2006). This hypothesis has been further strengthened by 
the confirmation that CK1tau is a gain of function mutation which accelerates the clock 
(Meng et al., 2008). PER (but not CRY) degradation seems to be enhanced at specific phases 
of the circadian cycle (i.e. early night) leading to asymmetric PER stability over time and 
subsequent altered phasing of physiology and behaviour. Similarly it has been shown that 
CK1 knockouts display a slightly longer period under DD. However, hamsters heterozygous 
for CK1tau still have a shorter period under DD than the wild-type controls. From this, they 
conclude that CK1 may phosphorylate PERs. Hence, wild-type CK1 seems to be partially 
redundant with CK1 in the circadian timing mechanism (Meng et al., 2008). Nevertheless, 
this issue has to be clarified in the future using CK1 knockouts. Altogether, CK1/ is 
thought to ensure a tight regulation of the timing of transcriptional repression mediated by the 
members of the negative limb. 
  General Introduction   
  35   
2.6.5.5 Multiple regulations of the molecular clock machinery 
There exist two major prejudices about mRNA and protein abundance: mRNA oscillations are 
controlled by rhythmic transcription, and the amount of mRNA reflects the amount and 
activity of its corresponding protein. These assumptions may be true for many genes but in 
general, various mechanisms interfere with mRNA as well as protein levels and activity 
(Garbarino-Pico & Green, 2007). For instance, the amount of a particular mRNA can decrease 
although its transcription increases if the speed of its degradation increases even more. Not 
surprisingly, this assertion is also true for protein abundance. The final level and activity of a 
given protein is tightly regulated at several steps from the gene to the active protein. Although 
the TTL model is well established as being the basis of the circadian clockwork, many studies 
suggest that it does not sufficiently explain the accuracy of the clock machinery (see Hastings, 
2001; Shu & Hong-Hui, 2004; Reddy et al., 2004). Due to this, it is believed that additional 
levels of regulation must be present. 
 
2.6.5.5.1 Transcriptional regulation 
Besides the E-box and RORE motifs mentioned earlier, circadian transcription can be 
regulated via cyclic adenosine-3’-5’-monophosphate (cAMP) response elements (CRE) and 
structural modifications of chromatin. CRE motifs (TGACGTCA) have been found in Per1 
(Hida et al., 2000) and Per2 promoters (Travnickova-Bendova et al., 2002). It has been 
shown that CRE motifs are important for the light-induced expression of Per1 through CREB 
(CRE binding protein; Obrietan et al., 1999; Travnickova-Bendova et al., 2002). Upon light 
stimulation CREB is phosphorylated (pCREB) and hence activated by ERK1/2. The binding 
of pCREB to CRE requires the interplay of the two co-activators CBP and p300 (Kwok et al., 
1994; Lee et al., 1996; De Cesare & Sassone-Corsi, 2000). Interestingly, it has been 
demonstrated that CRE-mediated transcription cycles rhythmically under DD conditions in 
the mouse SCN with a peak at CT2-6 and a nadir at CT18. Consistently pCREB abundance is 
cycling too in the SCN with highest expression at CT18-22 and a trough at CT10 (Obrietan et 
al., 1999). It is worth mentioning that CRE-mediated transcription seems to be independent of 
CLOCK/BMAL1 regulation (Travnickova-Bendova et al., 2002). 
Additionally to the regulation via elements embedded in the promoter, transcription can be 
influenced by changes in chromatin structure. In the nucleus, DNA is tightly packed with 
histones. Eight of these proteins, together with about 200 bp of DNA, form a basic building 
unit called nucleosome (Kornberg, 1974). The conformation of chromatin can be altered by 
various histone modifications: acetylation, phosphorylation, methylation, ubiquitylation or 
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ADP-ribosylation (Strahl & Allis, 2000). These post-translational changes lead to either 
loosening or tightening of chromatin resulting in enhanced or reduced gene transcription 
respectively. Of course, like any other gene, clock gene expression is modulated by chromatin 
structure alterations. For instance, the acetylation of the histone H3 in Per1 and Per2 
promoters displays a circadian rhythm (Etchegaray et al., 2003). Increased acetylation of H3 
and H4 has even been associated with Per1 and Per2 induction after a light pulse in the early 
subjective night (CT16; Naruse et al., 2004). Furthermore, the histone acetyltransferases 
(HAT) CBP and p300 interact rhythmically with CLOCK and BMAL1 proteins (Takahata et 
al., 2000; Etchegaray et al., 2003; Curtis et al., 2004). In 2006, CLOCK itself was identified 
to be a HAT (Doi et al., 2006). In contrast to acetylation, histone deacetylation represses gene 
transcription. CRY1-mediated repression of Per1 and Per2 transcription is associated with the 
rhythmic recruitment of the co-regulator mSIN3 and the histone deacetylases (HDAC) 1 and 
2 (Naruse et al., 2004). Likewise, CRY2 inhibits transcription by disrupting the association of 
p300 with CLOCK (Curtis et al., 2004). Moreover, REV-ERB was found to recruit HDAC3 
to the Bmal1 promoter which decreases H3 and H4 acetylation (Yin & Lazar, 2005). Besides 
acetylation, also histone methylation changes rhythmically as demonstrated on the promoters 
of Per1 (Brown et al., 2005; Etchegaray et al., 2006) and of the clock-controlled gene Dbp 
(D-element binding protein; Ripperger & Schibler, 2006). 
 
2.6.5.5.2 Post-transcriptional regulation 
Short oscillations of a few hours can be obtained by simple feedback loops (e.g., a two hour 
period for the auto-regulation of Hes1; Hirata et al., 2002) whereas longer periods like 
circadian rhythms require numerous regulatory mechanisms. Contrary to transcription, post-
transcriptional regulation of clock genes attracted relatively little attention so far. 
Nevertheless, the fate of mRNAs after transcription is crucial for proper timing of the clock 
(Harms et al., 2004). The circadian system could modulate the mRNA during nuclear 
processing (e.g. capping, splicing, polyadenylation and messenger quality control), nuclear 
export, and sorting for storage of specific localization. It is a well-known fact that the 3’-UTR 
of mRNAs plays a crucial role in determining stability, localization and translational 
efficiency of its transcripts (Grzybowska et al., 2001). Moreover, length regulation of the 
poly(A) tail, which is added to the 3’-end of mRNAs, is critical for their stability (Wilusz et 
al., 2001). Shortening of the poly(A) tail triggers decapping of the 5’-end of RNA which in 
turn initiates degradation by exonucleases (Couttet et al., 1997). To date, only few 
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mechanisms of post-transcriptional regulation have been discovered for the circadian clock 
and most of the ones that are known were unravelled only recently.  
For example, the circadian regulation of Per1 is influenced by the RNA binding protein 
LARK, which recognizes a cis element in the 3’-UTR of Per1 mRNA. Alterations in Lark 
expression lead to significant changes in circadian period in vitro (Kojima et al., 2007). A 
recent report even shows that the abnormal circadian rhythms observed in patients suffering 
from fragile X could be due to altered regulation of the clock by LARK. They suggest that in 
flies, LARK and FMRP (fragile X mental retardation protein) cooperate to post-
transcriptionally regulate target RNAs that are relevant for circadian and other biological 
functions (Sofola et al., 2008). Furthermore, a circadian regulation of vasopressin (Avp) 
mRNA poly(A) tail length was observed in the SCN with lowest transcript levels during the 
night. Interestingly, mRNA species with short poly(A) tail length is detected at this time 
(Robinson et al., 1988). In general, a long poly(A) tail stabilizes mRNA, suggesting that Avp 
mRNA decay rates are higher when the poly(A) tail is shorter. To date only one protein is 
known to alter the length of the poly(A) tail of clock gene mRNA. This deadenylase (an 
exoribonuclase specific for poly(A) tails of mRNAs) has been identified in Xenopus retina 
and was named NOCTURNIN (NOC) by virtue of its high nocturnal increase in transcript 
levels (Green & Besharse, 1996a/b). In 2003, it was shown in this frog that NOC is involved 
in circadian regulation of the stability and/or translation of mRNAs (Baggs & Green, 2003). 
As in Xenopus, the mammalian NOC is under circadian control (Wang et al., 2001; Barbot et 
al., 2002) and exhibits deadenylase activity (Garbarino-Pico et al., 2007) indicating that it 
could influence a wide range of transcripts. Besides the post-transcriptional regulations 
already mentioned, circadian variations in splicing variants seem to be important as well in 
tuning the clock. In the mouse, Presenilin2 expresses two forms that are rhythmic and a third 
one that is not (Belanger et al., 2006). However, it is not clear whether this is due to circadian 
modulation of the spliceosome machinery or the stability of the splice variant itself. 
Moreover, the full-length mRNA of Timeless is rhythmically expressed in the SCN but not its 
short transcript variant (Barnes et al., 2003).  
 
2.6.5.5.3 Post-translational regulation  
As already mentioned above, the clock’s molecular machinery relies on tightly interlocked 
TTLs. This term indicates that proper timing of clock protein activity, dimerization, nuclear 
import and export, and finally degradation are indispensable for accurate functioning. In 
mammals, the first hint for the importance of post-translational regulation within the clock 
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came from the tau mutant hamster (Ralph & Menaker, 1988). As described previously, this 
mutation is located within the CK1 gene (Lowrey et al., 2000) and leads to changes in PER 
phosphorylation levels (Lowrey et al., 2000; Takano et al., 2000; Miyazaki et al., 2004; 
Vanselow et al., 2006). It turns out that phosphorylation is crucial in setting the pace of the 
clock. Several proteins of the core loop (e.g. PER1, PER2, CLOCK, BMAL1) were found to 
display rhythmic phosphorylation levels in the liver (Lee et al., 2001 & 2004). In addition to 
the casein kinases, other kinases are involved in the clock. Glycogen synthase kinase 3 
(GSK3) was found to phosphorylate CRY2 (Harada et al., 2005), PER2 (Iitaka et al., 2005), 
and REV-ERB (Yin et al., 2006). Phosphorylation of CRY2 and PER2 promotes their 
nuclear localization. Moreover, CRY2 is marked this way for proteasomal degradation 
(Harada et al., 2005). By contrast, phosphorylated REV-ERB is stabilised and protected 
form degradation by the proteasome pathway (Yin et al., 2006). Furthermore, mitogen-
activated protein kinases (MAPK; ERK) are implicated in BMAL1 phosphorylation (Sanada 
et al., 2002) leading to a decrease in CLOCK-BMAL1-mediated transcription. More recently, 
CRY1 and CRY2 proteins were shown to be potential substrates for ERK too (Sanada et al., 
2004) resulting in a decreased ability to inhibit CLOCK-BMAL1-induced transcription. This 
could lead to a progressive release of the inhibition of transcription, which would allow 
initiating the next cycle. Hence, phosphorylation of CRY1 and CRY2 promotes gene 
transcription whereas phosphorylation of BMAL1 suppresses it. These opposite effects create 
a time-lag within the clock period. 
Recent studies emphasize the importance of positive factors’ phosphorylation in the core loop 
(i.e. CLOCK, BMAL1, NPAS2, BMAL2; Dardente et al., 2007; Kondratov et al., 2006). 
Dardente and co-workers found that dimerization through the PAS domain is required for 
phosphorylation and for subsequent transactivation to happen. Since phosphorylated forms of 
BMAL1 are predominantly found in the nucleus at the time of maximal transcriptional 
activity of CLOCK-BMAL1 it is thought that BMAL1 phosphorylation may enhance 
transactivation of E-box sites (Eide et al., 2002; Akashi et al., 2006; Cardone et al., 2005, 
Kondratov et al., 2003; Ripperger & Schibler, 2006). Altogether, it seems that 
phosphorylation of a given protein does not depend on a single, but on several kinases acting 
at different sites. Undoubtedly, phosphatases are crucial in the regulation of the clock as well 
to counteract the effects of the kinases. Protein phosphatase 1 (PP1) was found to regulate 
PER2 stability (Gallego et al., 2006) and PP5 regulates the activity of CK1 on clock proteins 
(Partch et al., 2006). 
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Since the clock tightly controls transcriptional regulation, it is only logical that protein 
degradation is in command of the circadian system. Recently, a trio of papers demonstrated 
that CRYs are targeted for degradation by the F-box E3 ubiquitin ligase FBXL3 (fig. 2-15; 
Siepka et al., 2007; Busino et al., 2007; Godinho et al., 2007). Following a mutagenesis 
screen in mice, a circadian mutant named Overtime (Ovtm) was found, which displays a long 
period of approximately 26 hours. The Ovtm mutation has been identified to cause an 
isoleucine to threonine (I364T) substitution in the Fbxl3 gene, which is a component of the 
SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligase complex (Siepka et al., 2007). 
Simultaneously, as it often happens in science, when screening mutagenized animals for 
alterations in rhythms of wheel-running activity, another group independently identified the 
same gene. Their mutated mouse displays free-running rhythms of about 27 hours in 
homozygotes. They named their mutation after hours (Afh) and found that it corresponds to a 
cystein to serine (C358S) substitution in the Fbxl3 gene (Godinho et al, 2007). Although the 
two mutations are distinct from each other, both lie in the region of FBXL3 that binds to 
CRY. Hence the interaction of these two proteins is disrupted, preventing CRY degradation, 
thereby causing lengthening of the circadian period.  
Note that another member of the F-box proteins, however, degrades PERs (Shirogane et al., 
2005). TrCP recognizes phosphorylated but not unphosphorylated targets and mediates their 
degradation. Why the same F-box protein does not degrade both CRYs and PERs remains 
unknown. It is speculated that these proteins have to be degraded at different rates or times or 
Fig. 2-15: Targeted degradation ends repression at 
night. PER and CRY proteins accumulate during the 
night and repress the CLOCK/BMAL1 heterodimeric 
transcriptional complex that controls PER and CRY 
transcription. Repression is relieved by degradation of 
PERs and CRYs; PER degradation requires 
phosphorylation by the casein kinase CK1, which 
mediates recruitment of the F-box ubiquitin ligase 
TrCP. Degradation of CRYs requires their binding to 
the F-box protein FBXL3. Accelerated degradation of 
PERs shortens the circadian period, whereas delayed 
degradation of CRYs lengthens it. Whether CRYs are 
modified posttraslationally prior to FBXL3 binding is 
unknown (taken from Virshup & Forger, 2007). 
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in different compartments (Virshup & Forger, 2007). The carefully controlled degradation of 
CRYs and PERs may influence the rate at which multimeric proteins accumulate in the 
cytoplasm as well as their disappearance from the nucleus.  
Moreover, SUMOylation of BMAL1 has been discovered in vitro and in vivo. The small 
ubiquitin-related modifier protein (SUMO) is linked reversibly on a consensus sequence 
located between the two PAS domains involved in the interaction with CLOCK. It was shown 
that CLOCK-dependent SUMOylation of BMAL1 leads to its degradation (Cardone et al., 
2005).  
 
2.6.6 Association of clock genes and photic entrainment of the SCN 
The TTLs described above can be modulated by external signals. As mentioned previously, 
the strongest Zeitgeber for the clock is light. The RHT constituted of the pRGC of the retina 
directly innervates the core SCN and provide them with light information. In the laboratory, 
experimental animals can be completely isolated from the environment. To study the internal 
period of an animal it has to be placed under constant conditions. Nocturnal rodents are 
usually placed under constant darkness (DD) with food and water ad libitum. In rare cases 
they can be kept under constant light (LL). Endogenous rhythms are monitored by wheel-
running activity, drinking behaviour, body temperature, etc. In the context of this thesis, 
wheel-running behaviour has been used exclusively. The wheel-revolutions the animal does 
are recorded by a computer and can be represented as so-called actograms (fig. 2-16).  
  
Fig. 2-16: Schematic single and 
double plotted actograms. (A) 
Wheel-running activity is plotted as 
an actogram with each horizontal 
line corresponding to one day. Black 
vertical bars plotted side-by-side 
represent the activity, i.e. number of 
wheel revolutions. The height of 
each vertical bar indicates the 
accumulated number of wheel 
revolutions for a given interval (e.g. 
5 min). The rho- and alpha-phase 
marked at the bottom of the 
actogram refer to rest and activity, respectively. The white bar at the top of the scheme depicts light (12 h) and 
the black bar corresponds to darkness (12 h). (B) To better visualize behavioural rhythms, actograms are often 
double plotted by aligning two consecutive days horizontally (e.g. day 1 left and day 2 right; Jud et al., 2005). 
 
Under both DD and LL conditions, animals are found to “free-run” with a period slightly 
different from the 24-hour day. However, exposure to either DD or LL does not have 
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equivalent effects on the timing of rest and activity. LL conditions correspond to a constant 
exposure of the clock to a potent entraining agent whereas DD represents the absence of light 
input to the pacemaker. In LL, the period follows “Aschoff’s rule”: with increased light 
intensity the period of the locomotor cycle becomes longer and the length of time spent active 
decreases in nocturnal animals (Aschoff, 1960). For diurnal animals the opposite is true: 
increasing light intensity results in a decreased period and the time spent active expands. 
 
2.6.6.1 Light pulses can provoke phase shifts in behaviour 
To better study the impact of light on the circadian system animals kept under constant 
darkness are subjected to a brief light pulse at different time points. The effect of the stimulus 
can be studied by simply analyzing actograms or tissue samples. During the subjective day 
(corresponding to estimated day time for the animal) light has little or no effect on the 
resetting of the clock. By contrast, light exposure during the subjective night is capable of 
shifting the pacemaker (Aschoff, 1969; Daan & Pittendrigh, 1976). Furthermore, it depends 
whether the light is administered during the early or late night. While the former induces a 
phase delay (the locomotor activity of the animal will start later the next day) in nocturnal 
rodents, the latter leads to phase advances (activity will start earlier the next day; Daan & 
Pittendrigh, 1976). This phenomenon can be translated into a phase response curve (PRC; fig. 
2-17), which plots the magnitude of the phase-shift as a function of the circadian phase when 
the light stimulus was applied. Another method to visualize this phenomenon is the phase 
transition curve (PTC) where the new phase of the animal is plotted versus the old phase. This 
graph does not distinguish between phase advances and delays.  
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Fig. 2-17: PRC and PTC 
(A) A light pulse (open yellow square) during the day (A) has no effect on the locomotor activity of a free-
running nocturnal rodent. On the contrary, light at the beginning (B, C) and the end (D) of the night induces 
phase delays and phase advances in locomotor activity, respectively. Plotting the magnitude of the phase shifts 
as a function of the time of the light administration allows the drawing of a PRC (adapted from Serviere & 
Lavialle, 1996). (B) The phase transition curve (PTC) plots the old phase versus the new phase. If there is no 
phase shift observed after a light pulse, the dot lies on the diagonal (e.g. CT3). If the phase is shifted, the dot lies 
next to the diagonal (Carmona-Alcocer et al., 2005: PTC of the freshwater crab). (C) Type 0 PTC of NIH3T3 
cells. Dexamethasone can reset all clock gene phases in NIH3T3 cells. NIH3T3 cells transfected with Bmal1-
luciferase were serum shocked at time 0. At the indicated circadian times (approximately every hour) parallel 
cultures were treated for 15 min with 100 nM dexamethasone. CT0 is defined as the time at which the minimal 
bioluminescence was observed. Black dots and opens squares can be considered as phase shifts measured on two 
consecutive days. For simplicity all points are plotted on both days. Note that all new phases are nearly identical 
irrespective of when cells were treated with dexamethasone. Hence the slope of the PTC is near zero, and the 
corresponding phase response curve is called type-zero PRC (taken from Nagoshi et al., 2004).  
 
However, Winfree defined two general types of PTC in phase resetting (Winfree, 1980). He 
termed the PTC for minor perturbations of the circadian system (e.g. shifts of up to six hours) 
Type 1 PTC due to the average slope of the diagonal that is close to 1. The other PTC (Type 
0) is obtained for large magnitude perturbations with a zero average slope. 
 
2.6.6.2 Phase shifts: the light-triggered signalling cascade 
As described in section 6.2.3 the SCN clock receives light signals perceived by the pRGCs by 
two pathways: directly via the RHT or indirectly via the geniculohypothalamic tract (GHT). 
The pRGCs secrete glutamate (GLU) and pituitary adenylate cyclase activating peptide 
(PACAP) as the major neurotransmitters (Hannibal, 2002). The principal signalling molecules 
liberated by the GHT are gamma-aminobutyric acid (GABA) and neuopeptide Y (NPY; 
Harrington, 1997). By contrast, the RHT releases GLU and PACAP following nocturnal light 
pulses, which initiates a signalling cascade that results in a stable shift of the TTL. GLU is 
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released at both early and late night whereas PACAP secretion seems to be mainly important 
at late night (Kawaguchi et al., 2003). The release of GLU recruits NMDA (N-methyl-D-
aspartic acid; Abe et al., 1992; Ding et al., 1994) and AMPA (alpha-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid; Schurov et al., 1999) receptors whose activation leads to 
an influx of calcium into the SCN cells. The increased calcium concentration activates the 
calcium/calmodulin-dependent kinase (CaMK), which phosphorylates the nitric oxide 
synthase (NOS; Agostino et al., 2004; Ding et al., 1994; Golombek et al., 2004). The 
subsequent raise in NO provokes phase shifts at early and late night both in vivo and in vitro 
(Ding et al., 1994). However, the mechanisms elicited by NO seem to depend on the time of 
the light pulse. In the late night (CT19), the inhibition of the cGMP-related protein kinase 
(PKG) suppresses the phase advancing effects of light and GLU in vivo (Weber et al., 1995; 
Mathur et al., 1996) and in vitro (Ding et al., 1998), respectively. From this, it can be 
concluded that NO stimulates PKG via the activation of guanylyl cyclases (GC) which 
produce cGMP that activate PKG. By contrast, inhibition of PKG at early night does not 
abrogate GLU-induced phase delays. This suggests that the NO-GC-cGMP-PKG pathway is 
not implicated in phase shifts at this time (Weber et al., 1995; Mathur et al., 1996; Ding et al., 
1998). Instead of GC, NO activates the Ras-like G protein Dexras1 (Fang et al., 2000), which 
in turn mediates the activation of the p42/44 mitogen activated protein kinase (MAPK) ERK 
(Cheng et al., 2004; Cheng et al., 2006). The up-regulation of MAPK (ERK1 & 2) 
phosphorylation leads to the activation of CREB (Obrietan et al., 1998), which launches in its 
phosphorylated (Ser133 & Ser142) form the transcription of genes carrying a CRE motif in 
their promoter (Gau et al., 2002; Ginty et al., 1993; Obrietan et al., 1999; Tischkau et al., 
1999; Travnickova-Bendova et al., 2002). In vivo, the inhibition of ERK prevents the light-
induced phase shifts, which suggests that ERK is important for coupling light signals to clock 
entrainment (Butcher et al., 2002). Furthermore, it was shown that the inhibition of ERK 
abrogates the light-, GLU- and PACAP-induced phosphorylation of mitogen- and stress-
activated protein kinase 1 (MSK1) in the SCN at both early and late night (Butcher et al., 
2005). This indicates that MSK1, which is a known regulator of CREB phosphorylation 
(Wiggin et al., 2002), is implicated in the entrainment of the clock via light as well. In the late 
night, the light pulse-triggered release of PACAP recruits PAC1 receptors. Mice lacking these 
receptors show strongly attenuated phase-advances in response to light presented at late night 
(Kawaguchi et al., 2003). Upon activation, GS-coupled PAC1 receptors signal to the MAPK 
pathway via both GS and G mediated signalling cascade. The GTP-dependent dissociation 
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of these factors activates various downstream effectors of light signalling including ERK and 
adenylyl cyclases (AC).  
In 2006, Cheng and colleagues have shown that Dexras1 seems to fulfil contrasting roles at 
early and late night respectively. While Dexras1 potentiates phase-delays in the early night, it 
reduces the magnitude of PACAP-mediated phase shifts at late night by inhibiting the 
activation of ERK via both the GS- and the G-mediated limb (Cheng et al., 2006). Hence 
Dexras1 is thought to be a key signalling molecule which confers both phase specificity and 
sensitivity to the light stimulus (fig. 2-18). 
Besides the factors mentioned above, ryaonodine receptors (RyR) are also likely to be 
involved in the photic entrainment of the clock - at least during the early night. RyR are 
integral membrane proteins associated with cellular organelles that sequester calcium (e.g. 
endoplasmatic reticulum; McPherson et al., 1991). During early night, inhibition of RyR 
prevents GLU-induced phase delays both in vivo and in vitro whereas the activation of RyR 
by caffeine induces delays (Ding et al., 1998).  
Fig. 2-18: Proposed model of Dexras1 in modulating 
photic responsiveness of the circadian clock. Photic 
effects are mediated in part by NMDA and PAC1 receptors 
expressed in the SCN. In the early night, light-induced 
activation of NMDA receptors via GLU leads to a 
nitrosylation-dependent enhancement of the guanine 
nucleotide exchange activity of Dexras1. (1) as a result, 
Dexras1 activates the MAPK pathway and promotes photic 
resetting in the early night. Light exposure in the late night 
leads to activation of GS-coupled PAC1 receptors via 
PACAP, which signal via both the GS and G limbs to 
the MAPK cascade. Dexras1 inhibits PAC1-mediated 
MAPK pathway activation by suppressing G signalling 
events (2) as well as AC (3). Dexras1 may inhibit AC 
indirectly by a receptor-independent enhancement of tonic 
Gi/o activity. In summary, light induces smaller phase 
delays in the early night and large phase advances in the 
night in dexras1
-/-
 mice. AC, adenylyl cyclase (adapted 
from Cheng et al., 2006) 
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Although a big progress can be observed in deciphering the molecules that are implicated in 
the light-mediated entrainment of the clock, many parameters remain unknown. Additional 
work will be required to further elucidate the signalling events that underlie light-induced 
phase shifts during both early and late night. 
 
2.6.6.3 Phase shifts: perturbation of the transcription/translation feedback loop 
It is known that a light pulse leads to an increase in H3 acetylation and phosphorylation 
(Crosio et al., 2000) which facilitates transcription from a given DNA region. The finding of 
CRE-mediated transcription after light administration is in line with the fact that a light pulse 
is able to induce expression of a number of clock genes within the SCN. Besides Per1 
(Shigeyoshi et al., 1997) mentioned earlier, Per2 (Sherman et al., 1997) and Dec1 (Honma et 
al., 2002) were found to be light inducible as well. However, they only respond to light during 
the subjective night but not during the subjective day. Moreover, not all of these clock genes 
are induced at the same time. Depending whether the light is administered during the 
beginning or the end of the subjective night, one sees different induction patterns. Whereas 
Per2 expression is mainly triggered by a light pulse at the beginning of the night (Yan et al., 
1999; Field et al., 2000; Yan & Okamura, 2002), Per1 (Shigeyoshi et al., 1997; Albrecht et 
al., 1997; Field et al., 2000; Yan & Silver, 2002) and Dec1 (Honma et al., 2002) are induced 
both at the beginning and the end of the night phase. This observation leads to the hypothesis 
that Per1 may be implicated in mechanisms responsible for phase advances while Per2 would 
be implicated in phase delays. This idea is supported by experiments in Per1 and Per2 mutant 
mice. It was found that Per1 mutant mice fail to advance their clock at ZT22 (late night) 
whereas Per2 mutants are unable to delay their clock upon a light pulse at ZT14 (early night; 
Albrecht et al., 2001). However, later studies challenged these findings as Per1 and Per2 
mutants were found to be still able to accomplish both phase advances and phase delays 
(Cermakian et al., 2001; Bae & Weaver, 2003; Spoelstra et al., 2004). Importantly, huge 
experimental differences exist between the studies. Albrecht and colleagues used an Aschoff 
type II protocol in which mice were subjected to a light pulse for 15 min under LD conditions 
(Aschoff, 1965). After the light pulse they were released into DD. Bae and Weaver used T 
cycle paradigms exposing mice to one hour of light per day at T = 24 hours for phase delays 
and T = 22 hours for phase advances. Under these conditions, both Per1 and Per2 mutant 
mice display phase advances as well as phase delays. Cermakian and co-workers applied an 
Aschoff type I protocol where animals were kept under DD for two to five days (Aschoff, 
1965).  Then mice were light-pulsed for 30 min at CT14 and CT20. Last but not least, 
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Spoelstra and collaborators managed to link the divergent findings of the different studies. 
They subjected their mice to 15 min light pulses under two different paradigms: first the 
animals were treated during the first cycle in DD and second under free-running conditions. 
The first experiment confirmed the findings obtained by Albrecht et al., whereas the second 
corroborated the results of the other groups. This indicates that the outcome of the experiment 
depends strongly on the “light history” the mice went through. Nevertheless, Per1 and Per2 
seem to accomplish different roles within the oscillator because they are induced in different 
SCN regions. In the early subjective night, Per1 expression following a light stimulus is 
restricted to the GRP-expressing cells of the core SCN.  Per2 on the other hand is found to be 
induced in both GRP- and AVP-immunoreactive cells which are located in both core and shell 
(Dardente et al., 2002; Yan & Silver, 2002). In the late subjective night, the induction pattern 
of Per1 changes with an initial increase in the core and a subsequent raise in the shell (Yan & 
Silver, 2002). Besides the three clock genes mentioned already Bmal1 seems to be implicated 
in the light-mediated resetting too. It was found that BMAL1 protein levels decrease after a 
light pulse at both early (CT15) and late subjective night (CT21; Tamaru et al., 2000). 
However, the attempt by another group to confirm this observation failed (von Gall et al., 
2003). 
In addition to clock genes another group of genes – the so-called immediate early genes (e.g. 
c-fos, junB, egr1) – are induced after a light pulse. These genes respond even quicker to the 
light stimulus than clock genes do. The most prominent member of this gene family is c-fos 
whose mRNA and protein levels are increased upon light perception (Aronin et al., 1990; 
Rusak et al., 1990; Kornhauser et al., 1992) through the binding of pCREB on the CRE motif 
found in its promoter (Ginty et al., 1993). Mice mutant for c-fos are able to entrain to LD 
cycles and they show a PRC to light which is comparable to the one observed for wild-types 
(Honrado et al., 1996).  
Although the use of model organisms improves people’s understanding of life and human 
diseases knowledge gained from studying them cannot be taken over one-to-one to humans. 
Hence data obtained in model organisms have to be verified in human subjects. That is why 
the next paragraph will be focused on circadian rhythms in humans. 
 
2.7 Effects of the circadian clock on the human body 
Our modern "24/7" society is a growing source of circadian stress, which leads to disruption 
in the normal programming of our behavioural and physiological rhythms. This provokes 
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reduced well-being and even illness, as observed in shift work, jet lag, psychiatric illness, 
ageing, or cardiovascular disease. Knowledge about the circadian clock in model organisms 
such as flies or mice is of use and interest for men because human beings are also subjected to 
circadian variations. Furthermore, the circadian system seems to be greatly conserved within 
organisms. Many physiological parameters in men fluctuate during the day in a circadian 
manner: melatonin levels rise during the night, body temperature raises in the morning before 
waking up and peaks in the evening before going to bed, immune system activity reaches its 
crest in the late evening and has its trough in the morning, blood pressure and heart rate are 
dropping during night, etc. The most obvious circadian rhythm in humans is the sleep-wake 
cycle. Recently, researchers have discovered that diseases also have predictable cyclic 
rhythms (e.g. asthma attacks peak at 4 AM; myocardial infarction at 9 AM; Muller, 1999) and 
that the timing of medication regimes can improve outcomes in some of them. All these 
circadian rhythms in humans even culminate in a death and accident peak in the early 
morning due to cardiovascular episodes and sleep-related accidents that take place in a 
"vulnerability window" between 1 and 6 a.m. (e.g. Chernobyl 1:23 a.m., Three-Mile Island 
4:00 a.m.).  
Dysfunctions of the circadian clock in humans are associated with physiological disorders of 
the sleep-wake cycle. For instance, there exist two inherited sleep phase disorders: familial 
advanced sleep phase syndrome (FASPS; Jones et al., 1999) and delayed sleep phase 
syndrome (DSPS). Compared to the average population, patients suffering from one of these 
disorders display an advanced or delayed sleep-wake rhythm, respectively. In some patients 
suffering from DSPS, the symptoms are self-imposed due to social influences. Shift workers 
for example stay awake late into the morning hours or students study all night long. 
Nonetheless, a length polymorphism in hPER3 within a region encoding a putative 
phosphorylation domain is linked to DSPS (Archer et al., 2003; Okawa & Uchiyama, 2007). 
Lately, it has been shown that a mis-sense mutation in hPER2 is responsible for FASPS. 
People suffering from this hereditary disease have sleep schedules that move ahead by about 4 
hours. The reason for this is that the mutated hPER2 cannot be phosphorylated by CSNKI 
(human CKI) and therefore stabilises hPER2, which in turn may phase advance the clock 
(Toh et al., 2001). In addition, it has been shown that differential phosphorylation of hPER2 
due to mutations in hCK1 and hCK1 leads to the same phenotype (Xu et al., 2005; Xu et 
al., 2007). Furthermore, Per2 seems to be a tumour suppressor because mice lacking Per2 are 
prone to cancer (Fu et al., 2002). Besides the fact that clock genes are directly implicated in 
the development of cancer, disturbances of the circadian rhythms could lead to cancer. 
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Interestingly, grafted tumours develop more rapidly in mice which are subjected to chronic jet 
lag schedules (Filipski et al., 2004). These findings will hopefully lead to a circadian timing 
of chemotherapy (Hrushesky et al., 1990; Kobayashi et al., 2002; Gholam et al., 2006; Lévi et 
al., 2008). However, a phase III clinical trial revealed that gender could largely affect the 
survival outcome of cancer patients on chronotherapeutic delivery (Giacchetti et al., 2007; 
Lévi et al., 2007). These last two findings show the potential of circadian research in finding 
cures for many diseases and sleep disorders. Especially solving sleep problems may be very 
interesting objectives to further investigate possible changes in the molecular set-up of the 
circadian clock in humans because recent findings implicate an influence of the circadian 
clock on both homeostatic (mCry; Wisor et al., 2002) and circadian regulation (mPer1/2; 
Kopp et al., 2002) of sleep. Human clock gene polymorphisms might be involved in circadian 
rhythm sleep disorders (such as delayed sleep phase insomnia). 
Another promising field for chronobiological treatment is depression: it has been 
demonstrated that sleep deprivation (increases sleep pressure), a phase shift, or an increase in 
Zeitgeber strength can improve or even cure mild depressive states (Boivin, 2000; McClung, 
2007; Wirz-Justice, 2006; Wirz-Justice & Van den Hoofdakker, 1999). Seasonal affective 
disorder (SAD) is a seasonal depressive state due to an imbalance of serotonin and dopamine 
(Lam & Levitan, 2000; Levitan, 2007; Magnusson & Boivin, 2003). Moreover, it was found 
that SAD is associated with single-nucleotide polymorphisms (SNPs) in the three circadian 
clock genes hPER2, hBMAL1 (hARNTL), and hNPAS2 (Partonen et al., 2007). SAD consists 
of two or more consecutive major depressive episodes in autumn or winter and a spontaneous 
remission in spring or summer. This sort of heritable depression can be improved by light 
therapy, where the patient is just exposed to light in order to strengthen his internal clock and 
increase dopamine and serotonin levels. To increase Zeitgeber strength is not only a useful 
treatment for SAD but also for blind patients: melatonin intake can alleviate their sleep 
problems by undertaking the task of light as a Zeitgeber (Sack et al., 2000). Even 
Schizophrenia and Alzheimer's disease patients show improvement of their health state when 
they have to follow strict rhythms of bed, food, and nap times. Exposure to very bright light in 
the day and darkness at night can also consolidate the random patterns of rest and activity in 
Alzheimer's disease patients (Volicer et al., 2001; Dowling et al., 2008). As a general rule: the 
better the entrainment the less severe the symptoms of the illness.  
Apart from the disorders described in this paragraph, numerous other disorders of the central 
nervous system (CNS) involve disrupted circadian parameters. To close this section, some of 
them are summarized in table 2-3. 
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Table 2-3: Rhythm/sleep endophenotypes in human CNS disease (taken from: Barnard & Nolan, 2008) 
Human disease or 
condition 
Disturbed rhythm/sleep endophenotype Relevant phenotypes in mouse models 
Familial advanced 
sleep phase syndrome 
(FASPS) 
 
Early sleep and wake times, shortened circadian 
rhythms 
Mice expressing human mis-sense mutations in 
Per2 or CK1 have advanced phase of activity 
in a light-dark schedule and a shortened activity 
rhythms 
Delayed sleep phase 
syndrome (DSPS) 
Extreme evening preference, delayed phase of 
activity, sleep, core body temperature, and 
melatonin 
No model 
Seasonal affective 
disorder (SAD) 
Depressive symptoms occur during shorter 
winter days 
No model 
Mood disorders 
(unipolar depression) 
and psychoses 
(schizophrenia, 
bipolar) 
Depression. Increased sleep latency, impaired 
sleep continuity, phase advance in endogenous 
circadian system relative to sleep schedule, 
phase advances in growth hormone, plasma 
melatonin, increased plasma cortisol at night, 
All major affective disorders include circadian 
phase disturbances in sleep, activity, 
temperature, and hormone levels 
No accurate mouse model. Mutants in 
serotonergic and dopaminergic systems show 
disturbances in circadian phase and/or sleep 
parameters. Clock mutant has low anxiety, 
mania, and hyperactivity. Cognitive 
disturbances in Npas2 mutant. Abnormal 
sensitization to drugs of abuse in Clock and Per 
mutants. 
Autism spectrum 
disorders (ASD) 
Longer sleep latency and greater sleep 
fragmentation. Abnormalities in circadian 
rhythm and mean concentration of plasma 
melatonin. 
Mice expressing a conditional deletion of Pten 
have a significantly longer free-running period. 
Down syndrome Reduced sleep maintenance, sleep 
fragmentation, reduction in percent REM sleep, 
sleep apnea. 
Ts65Dn mouse mutant shows increased activity 
in the light phase, a reduction in rhythm 
amplitude, and a 4-h advance in the phase 
activity. 
Smith-Magenis 
syndrome 
Inverted rhythm of melatonin secretion. 
Advanced sleep/wake phase. Nighttime 
wakening, daytime sleepiness. Reduced total 
and NREM sleep. 
Heterozygous deletion mutant mice have a 
hypoactive phenotype and a significantly 
shorter circadian period. 
Prader-Willi syndrome Sleep apnea, sleep-related and behavioural 
disturbances including daytime napping and 
excessive daytime sleepiness. 
Mice deficient for mage-like 2 gene (Magel2) 
have reduced circadian activity amplitude with 
increased daytime activity. 
Parkinson disease (PD) Sleep fragmentation, sleep apnea, REM sleep 
behaviour disorder, excessive daytime 
sleepiness. 
No recorded circadian or sleep disturbances in 
genetic mouse models. 
Huntington disease 
(HD) 
Nocturnal awakening and progressive 
disintegration of daily activity rhythms. 
R6/2 mouse transgenic line has increased 
daytime and reduced nocturnal activity. 
Progresses to a complete disintegration of 
diurnal and circadian activity rhythms. 
Alzheimer disease 
(AD) 
Fragmented sleep, increased nocturnal activity, 
and reduced daytime activity. Delayed phase in 
peak of daily activity. 
Alterations in sleep regulation and timing in 
Tg2576 and PDAPP mice. Tg2576 mice also 
have a significantly longer circadian period. 
Both TgCRND8 and APP23 mice show 
changes in daily activity profiles potentially 
analogous to those seen in AD patients. 
Aging Sleep disturbances due to earlier wake time and 
reduced sleep consolidation. Partially attributed 
to age-related reduction in amplitude and 
advance in phase of circadian rhythms. 
Aging lengthens the period and reduces the 
amplitude of circadian activity. The onset of 
daily activity is significantly delayed and the 
variability of onsets in increased. 
Prion diseases Severe sleep abnormalities, progressive loss of 
circadian rest-activity, and melatonin rhythms. 
Increased sleep fragmentation and significantly 
longer circadian period in activity in prion 
protein null mutants. 
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2.7.1 Melatonin and human chronobiology 
To date, the profiles of melatonin measured in blood and saliva, as well as its metabolite 6-
sulphatoxymelatonin (aMT6s) found in urine, are by far the best indicators of clock timing in 
humans (Klerman et al., 2002). Melatonin is synthesized rhythmically in the pineal gland 
(Latin, epiphysis cerebri, glandula pinealis) with a peak exclusively during the night (fig. 2-
19; Laakso et al., 1990 & 1994). Due to its strong nocturnal expression pattern, melatonin got 
the colloquial sobriquet “hormone of the darkness”. Since bright light suppresses the release 
of melatonin it is even called “Dracula of hormones”.  
Fig. 2-19: Synthesis of melatonin within the pineal gland. 
(A) Sagital view of a human brain showing the pineal gland and its innervations. The retinohypothalamic tract 
sends the light signals received by the eye to the SCN. The SCN project to the intermediolateral gray column in 
the spinal cord from where preganglionic neurons pass to the superior cervical ganglion (SCG). These neurones 
then project to the pineal in nervi conarii (modified from Ganong, 1997). (B) The neurotransmitter serotonin is 
the precursor of the small indoleamine melatonin. To yield the latter, serotonin is acetylated and then methylated 
within the pineal gland. The enzyme arylalkylamine N-acetyltransferase (AANAT) has been found to be rate 
limiting for melatonin synthesis. (C) All enzymes involved in melatonin synthesis and intermediate products are 
found to accumulate in a rhythmic fashion over time. Melatonin is found to peak between 2:00 and 6:00, 
irrespective of whether a person is asleep or awake in dim light. B and C are taken from Klein, 2007 (annual 
report of the division of intramural research, Eunice Kennedy Shriver national institute of child health and 
human development). 
 
In addition to its huge role in the human circadian system, melatonin is evolutionarily well 
conserved and present in most organisms, from unicellular algae to humans (Pelham et al., 
1973; Smith et al., 1976; Hardeland & Fuhrberg, 1996). In some amphibians and reptiles, 
melatonin is involved in changing skin colour. Indeed, the first indication that the pineal gland 
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contains a biologically active substance came from a work in Xenopus laevis. Application of 
bovine pineal extracts to tadpole skin provoked skin lightening mediated by the movement of 
melanosomes (melanin-containing pigment granules) with dermal melanophores (McCord & 
Allen, 1917). Many years later, the substance responsible for this skin lightening was 
identified as 5-methoxy N-acetyltryptamine and named “melatonin” (Greek, melas = black, 
tosos = labor; Lerner et al., 1958 &1959). Furthermore, it was proved that melatonin could be 
synthesized within the pineal gland (Axelrod & Weissbach, 1960; Weissbach et al., 1960 & 
1961). This finding was confirmed by pinealectomy in rats which abolishes circadian rhythms 
of melatonin (Ozaki & Lynch, 1976; Lewy et al. 1980). Later on it was found that the pineal 
gland is the main source of melatonin in rhesus monkeys (Tetsuo et al., 1982) and humans as 
well (Neuwelt & Lewy, 1983; Petterborg et al., 1991). Last but not least, a role could be 
attributed to this small neuroendocrine organ (100 mg in humans), which was discovered over 
two millennia ago by Herophilos (325-280 B.C.) who was a famous anatomist at the 
University of Alexandria in Egypt.  
In mammals, the primary role of melatonin is to convey daylength information to physiology. 
Since nighttime length differs between summer and winter, the variation in duration and 
quantity of melatonin production can be used as a seasonal marker. Hence, melatonin is 
involved in the regulation of photoperiodic functions such as reproduction, behaviour, coat 
growth or camouflage colouring in seasonal animals (Martinet & Allain, 1985; Zucker et al., 
1991). Similarly, human melatonin regulation is suggested to be influenced by seasonal 
variation of natural lighting conditions (Illnerová et al., 1985; Martikainen et al., 1985; 
Kauppila et al., 1987; Kivelä et al., 1988; Bojkowski & Arendt, 1988; Laakso et al., 1994; 
Stokkan & Reiter, 1994; Luboshitzky et al., 1998). According to current knowledge, the 
physiological role of the human pineal is mainly related to the function of melatonin, which is 
regulated by the circadian system and light-dark cycles. In addition to its role in the circadian 
system, melatonin may have effects on reproduction (reviewed by Luboshitzky & Lavie, 
1999) and immune system. Furthermore, it is known to be a potent antioxidant. This property 
could also explain why it is conserved between phylae. One hypothesis says that the living 
cells would have used melatonin to detoxify highly reactive oxygen radicals (Paietta, 1982; 
Poeggeler et al., 1993; Reiter et al., 1993; Tan et al., 1993; Tan et al., 2002). 
Assessing circadian rhythms in humans requires highly controlled conditions (constant 
routine methodology), which will be discussed in the next section. In humans, the gold 
standard to determine circadian timing is the measurement of melatonin or its metabolite 
aMT6s. Unfortunately, there exist no established guidelines on when and how the various 
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methods for sampling and analyzing melatonin should be used. This absence of well-defined 
melatonin phase markers impedes on the comparison of results obtained from different 
studies. Recently these divergences between laboratories were tackled and led to a special 
article about measuring melatonin in humans (Benloucif et al., 2008). Nonetheless, until now 
the most commonly used phase marker of the internal clock is the “dim-light melatonin onset” 
(DLMO), which indicates the start of its rise in the evening (fig. 2-20). Taking the DLMO as 
reference point has the advantage that it avoids overnight sampling (Lewy & Sack, 1989). 
Disadvantages of this practice are that it provides no information on the duration of secretion, 
peak levels, and total production. In addition, DLMO is only an approximation of the onset of 
synthesis and secretion and sometimes is even determined by visual estimate of a change in 
slope. Besides DLMO, “dim-light melatonin offset” (DLMOff) is used as a phase marker. 
 
Fig. 2-20: Illustration of the 
phase markers for melatonin 
(plasma, saliva) and 6-
sulphatoxymelatonin (aMT6s; 
urine). The markers used to 
characterize melatonin and 
aMT6s rhythms are illustrated 
diagrammatically. Area under 
the curve or total 24-h excretion 
is used to assess total secretion. 
At present, there is no standard 
definition of onset-offset (and 
hence duration). Hence, in this 
graph the DLMO can be 
defined as the sample named 
“onset/offset” or as 25 % rise in 
melatonin. Depending on which 
threshold is used, the duration 
of melatonin secretion varies 
significantly (adapted from: 
Arendt, 2005). 
 
Melatonin can be measured either in saliva or in plasma while its primary metabolite aMT6s 
is determined in the urine. The advantage of using plasma melatonin is that samples can be 
taken during sleep, whereas sampling of saliva implies disruption of sleep. Frequent saliva 
collection can even completely deprive the subject from sleep which strongly limits its 
overnight use. Blood samples on the other hand can be sampled at frequent intervals through 
the use of intravenous catheters. Disadvantages are that plasma sampling is invasive and is 
restricted due to preservation of blood volume. Moreover, the use of catheters requires trained 
medical personnel. This fact renders it almost impossible to use plasma melatonin 
assessments for field studies. To compare plasma to saliva levels it is important to keep in 
D
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mind that melatonin levels are about three times greater in blood than in saliva. Urine 
collection on the other hand yields less resolution than blood or saliva (2 to 8 hour bins) and is 
limited by ability to void. Since the overnight aMT6s excretion levels can be calculated from 
the first morning void, this method does not require any waking up of the subject. Although 
intraindividual melatonin profiles are very stable, huge interindividual differences are 
observed frequently. It is thought that these large variations are due to the size of the pineal 
gland rather than due to changes in enzymatic activity (Gomez Brunet et al., 2002). 
Surprisingly, there exist few apparently normal subjects who show no detectable melatonin 
levels in plasma at all times of day (Arendt, 2005). 
 
2.7.2 Assessing circadian rhythms in humans 
The first attempt to determine endogenous circadian rhythms in humans was undertaken 70 
years ago. In 1938, two human subjects were studied on non-24-hour sleep/wake, light/dark, 
and meal schedules. They were isolated within Kentucky’s Mammoth Cave (longest known 
cave on Earth) and hence completely shielded from any environmental time cues (Kleitman, 
1963). A 28-hour rest/activity was imposed which freed their internal clocks from the sleep-
wake cycle. Despite the forced six-days weeks, the body temperature rhythm of one subject 
persisted for one month with a near-24-hour period. The use of this so-called “forced 
desyonchrony protocol” distributed the influence of behavioural masking effects equally 
across the circadian cycle. Later on, Jürgen Aschoff and Rütger Wever questioned the results 
of this first underground cave study conducted on humans. They performed several month-
long studies to determine the average period of human circadian rhythms. Their subjects were 
isolated from the environment in underground bunkers in Germany. To shield them 
completely from the outside world, the researchers even coiled copper wire around the rooms 
in which the subjects were accommodated. By this means, they aimed to counteract natural 
electromagnetic fields. However, the results they obtained showed that humans have a free-
running activity rhythm of 25.2 hours with huge interindividual variations between subjects 
(13 to 65 hours). Moreover, they showed that the circadian period of body temperature was 
nearly 25 hours on average. Their results were confirmed later on by several studies 
conducted all over the planet (Siffre, 1964; Chouvet et al., 1974; Jouvet et al., 1974; Mills, 
1964; Siffre, 1975; Findley, 1966; Webb & Agnew, 1974; Weitzmann et al., 1981). All of 
these experimental setups allowed subjects to self-select their bedtimes and wake times and 
they could even turn on and off the lights as they wished. Hence subjects do not expose 
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themselves equally to light across the circadian cycle, as it is the case in a forced desynchrony 
protocol. It is of note that at that time it was incorrectly thought that the human circadian 
system was insensitive to light (Wever, 1970 & 1974; Aschoff, 1976). It was only in 1999 
that it turned out that the first findings obtained in 1938 were correct. In this study a 28-hour 
day of activity and rest was imposed on the subjects and during wakening times only dim 
light was allowed. Recording body temperature and hormone rhythms in 24 subjects revealed 
that the human clock ticks with an internal period of 24.18 ± 0.26 hours (Czeisler et al., 
1999). The findings of this study revealed that the major pitfall of the former studies was the 
unrestricted access to light, which continuously delayed the circadian phase of the subjects. 
Hence Kleitman’s results were finally confirmed. 
Another technique to assess human circadian rhythms is the use of “constant routine 
protocols”. Like forced desynchrony protocols, they allow to minimize the influence of 
behavioural and environmental factors which obscure (“mask”) circadian rhythms. It is now 
generally accepted that the internal clock is subjected to exogenous influences. For instance, 
core body temperature is raised by physical activity and lowered by sleep (Minors & 
Waterhouse, 1989) or secretion of insulin is widely modulated by sleep and food intake from 
the gut (Van Cauter et al., 1991). A way to reduce masking effects is to keep an individual’s 
environment and lifestyle constant, which is the basis of the various constant routine protocols 
(Mills et al., 1978; Czeisler et al., 1986). This might include constant posture (e.g. 
semirecumbant), constant wakefulness, evenly distributed food intake (e.g. snacks every two 
hours), constant temperature, and continuous dim light (e.g. < 5 lux). To keep homeostatic 
sleep pressure low, nap protocols might be used instead of continuous wakefulness. Under 
such conditions, the phase and amplitude of various endogenous circadian rhythms can be 
studied in the absence of exogenous noise. 
 
2.7.3 Entrainment of the human pacemaker to light 
Once the incorrect conclusion that the human circadian system is insensitive to light was 
disproved, a whole bunch of studies showed that the human pacemaker is nicely entrainable 
to light. Moreover, it was found that not social interaction but light is the primary circadian 
synchronizer in humans (Czeisler, 1978 & 1995; Czeisler et al., 1981; Shanahan et al., 1997; 
Czeisler & Wright, 1999; Shanahan & Czeisler, 2000; Zeitzer et al., 2000; Wright et al., 
2001; Gronfier et al., 2004 & 2007; Lockley, 2007). The resetting of the human circadian 
system depends on the phase at which the light stimulus is administered. Light exposure in the 
morning leads to phase advances whereas light exposure in the evening and early night delays 
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the clock (Honma et al., 1987; Czeisler et al., 1989; Minors et al., 1991; Khalsa et al., 2003). 
In addition to the Type 1 PRC observed after single light pulses, it was reported that multiple 
light pulses lead to a strong Type 0 resetting in humans (Czeisler et al., 1989; Shanahan et al., 
1999). Not surprisingly, the light PRC opposes the one obtained by melatonin (Lewy et al., 
1992; Zaidan et al., 1994; Lewy et al., 1998). In contrast to the PRC observed in other 
mammals, the human PRC does not exhibit a dead zone of sensitivity during the subjective 
daytime. This may indicate that the human circadian system reacts to light across all circadian 
phases (Jewett et al., 1997; Khalsa et al., 2003). Furthermore, it was shown that the response 
of the circadian pacemaker to light does not only depend on the timing but also on the 
intensity of the photic stimulus (Brainard et al., 1988; Roenneberg & Foster, 1997, Czeisler & 
Wright, 1999). So-called dose-response curves of single light pulses during the early night 
were used to assess the effect of different polychromatic light intensities (i.e. lux) on humans 
(Boivin et al., 1996; Zeitzer et al., 2000). It was found that light even as weak as candlelight 
can induce small shifts of the human circadian system (Wright et al., 2001). In addition to 
timing and intensity, the wavelength of the light plays a crucial role for its efficiency in 
resetting the clock. As detailed earlier (section 6.2.3.1) the mammalian circadian system 
receives light input via both the visual and the non-visual system. Like other mammals, 
humans are sensitive to short wavelength light (blue; Czeisler et al., 1995; Zaidi et al., 2007). 
Melatonin suppression and circadian phase resetting is achieved most efficiently after 
exposure to bright monochromatic blue light (Brainard et al., 2001; Thapan et al., 2001; 
Lockley et al., 2003). Nonetheless, humans react to long-wavelength light, which confirms 
that cones may function as circadian photoreceptors in humans (Zeitzer et al., 1997). 
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3 Aim of this thesis 
Circadian rhythms have a huge impact on our daily life. Our mental and physical conditions 
alternate between states of high activity and recuperation with a 24-hour rhythm. 
Deregulation of the internal clock can lead to sleeping disorders, depression and various other 
health problems. Thus it is important to understand the mechanisms, which allow our clock to 
tick properly. Since circadian clocks are quite conserved between species, model organisms 
such as mice can be used for basic research on the molecular clock mechanisms and its impact 
on physiology. 
 
For the last three decades, many studies have addressed the question how circadian rhythms 
emerge. Some results pointed to an important role for pre- and postnatal maternal entrainment 
(Davis et al., 1985; Reppert & Schwartz, 1986; Weaver & Reppert, 1987; Duffield & Ebling, 
1998; Viswanathan, 1999) whereas other strengthened the importance of genetic 
predisposition (Ohta et al., 2002). One objective of this thesis was to find out, which of these 
two hypotheses is true. To elucidate this, wild-type male mice were bred with arrhythmic 
Per1
Brdm1
Per2
Brdm1
 or Per2
Brdm1
Cry1
-/-
 double mutant females. Offspring born to these mice 
were heterozygous for either Per1
 
& Per2 or Per2 & Cry1. Hence they bore at least one 
functional copy of each gene and had the genetic constitution for a functional circadian clock. 
To exclude any influence of light on the females and the developing pups, matings were set-
up in constant darkness. Moreover, all manipulations on cages and animals were done using 
night vision goggles. As soon as the first signs of pregnancy were detectable, females and 
males were kept in separate cages. At six weeks of age, pups and parents were placed in 
individual wheel-running cages and wheel-revolutions were recorded. Actograms were 
analyzed to find out whether maternal entrainment is mandatory for circadian rhythms to start 
or whether genetic predisposition is sufficient. 
 
Apart from the question “what triggers the emergence of circadian rhythms in offspring”, it is 
important to understand how the different cogwheels cooperate to sustain circadian rhythms. 
The generation and subsequent analysis of animals missing one or several genes turned out to 
be a valuable tool for analyzing potential clock genes and their roles within the feedback loop. 
A second aim of this thesis was to shed some more light on the role of both Per1 and Rev-
Erb in the circadian machinery. For this we crossed Per1Brdm1 (Zheng et al., 2001) and Rev-
Erb-/- (Preitner et al., 2002) animals to obtain double mutant mice. Subsequently, the 
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animals were tested for their basic wheel-running behavior, their response to light, the 
expression of core clock genes and other parameters. 
 
Although, circadian clocks are especially well conserved between mammals, not all results 
obtained in mice can be extrapolated directly to humans. While mice are nocturnal animals, 
humans are active during the day. This difference already implies that there must be a 
difference between these two species. Better understanding of the human circadian system is 
not only of great interest for every individual but also for the industry. Apart from faulty 
equipment, weather conditions, or human error, fatigue caused by sleep deprivation 
contributes to a huge number of accidents. Every year, the costs of property damage and 
medical treatment could be diminished considerably if companies would think about the 
impact of circadian disruptions on the efficiency of their employees. Moreover a better insight 
in circadian physiological processes could decrease the amount of medicine needed and 
reduce its side effects. The same substance taken in the identical dose can provoke either a 
strong or no response depending on when it is administered (Scheving, 1976).  
 
Still nowadays, only little is known about the human molecular clock. One reason for this is 
that human tissue is hard to access due to ethical considerations. So far, studying clock gene 
expression is only possible in blood samples or biopsies (Boivin et al., 2003; Bjarnason et al., 
2001). Unfortunately, both cannot be taken endlessly from human subjects because they are 
rather invasive. Due to this limitation, the idea arose to develop a method allowing to 
chronotype human beings as minimally invasive as possible. Hence a third aim of this thesis 
was to standardize and to validate a method for measuring clock gene expression in oral 
mucosa samples. Subjects were asked to scratch the inside of their cheek using either a pipette 
tip or special brushes. In the laboratory, clock gene expression was measured within each 
sample using probe-based quantitative real-time PCR and normalized to the levels of the 
housekeeping gene GAPDH. The optimal primer and probe concentrations had to be 
determined for every gene to be analyzed (i.e. PER2, PER1, and BMAL1). Once the method 
was established, it was validated in two studies where the effect of green or blue 
monochromatic light on clock gene expression was tested. Ongoing experiments still take 
advantage of this method. 
 
In addition to the aims mentioned above, three collaborations allowed to further understand 
the role of the circadian system within the body. One study investigated the role of the fragile 
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X mental retardation gene (Fmr1) and a fragile X related gene (Fxr2) in regulating circadian 
behavioral rhythms. The role of Per2 in vascular endothelial function was investigated in a 
second study. A third one aimed at finding out more about the role of the circadian system in 
illness related fatigue. Infectious and autoimmune diseases typically lead to an increase in 
TNF- and IL-1. It was found that TNF- inhibits CLOCK-BMAL1-mediated transcription, 
which suggest that its increase impairs clock gene functions and causes fatigue. 
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4.1 Development of circadian rhythms in murine pups 
 
“Circadian rhythms in murine pups develop in absence of a functional maternal 
circadian clock.” 
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Circadian Rhythms in Murine Pups Develop
in Absence of a Functional Maternal Circadian Clock
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Abstract A genetic approach was used to investigate whether the emergence of
circadian rhythms in murine pups is dependent on a functional maternal clock.
Arrhythmic females bearing either the mPer1Brdm1/Per2Brdm1 or mPer2Brdm1/Cry1–/–
double-mutant genotype were crossed with wild-type males under constant
darkness. The heterozygous offspring have the genetic constitution for a func-
tional circadian clock. Individual pups born to arrhythmic mPer1Brdm1/Per2Brdm1
and mPer2Brdm1/Cry1–/– mothers in constant darkness without external zeitgeber
developed normal circadian rhythms, but their clocks were less synchronized
to each other compared to wild-type animals. These findings indicate that
development of circadian rhythms does not depend on a functional circadian
clock in maternal tissue, extending previous findings obtained from pups born
to SCN-lesioned mothers.
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In mammals, circadian clocks control the rhythmic
expression of numerous physiological processes
(reviewed in Hastings et al., 2003). A self-sustaining
clock mechanism is present in every individual cell
(Nagoshi et al., 2004). At the molecular level, a set of
clock genes drives recurrent rhythms in mRNA and
protein synthesis (reviewed in Reppert and Weaver,
2002; Albrecht and Eichele, 2003). The individual
cellular rhythms may then be synchronized in a tissue
via gap junctions (Long et al., 2005) and other means
of cellular communication (Pennartz et al., 2002). The
SCNs synchronize the different tissue clocks through
neuronal and endocrine outputs (Buijs and Kalsbeek,
2001) and themselves are entrainable by the daily LD
cycle through the retinohypothalamic tract, which
connects the eye with the SCN.
How circadian rhythms emerge during develop-
ment has been of interest for many years. One focus of
research has been centered on the question of whether
development of circadian rhythms in mammals is
under the influence of maternal entrainment or
whether it is genetically predisposed. Maternal
entrainment of pups to the environmental LD cycle
has been demonstrated by studying metabolism
of C14-labeled desoxyglucose in fetal rat SCN tissue
(Reppert and Schwartz, 1983). Using the same tech-
nique, Reppert and Schwartz (1984) demonstrated
that oscillating metabolic activity in the SCN is
observed as early as the 19th day of rat gestation. In
the mouse, Per1 and Per2 expression is observed in
the developing SCN on day 17 of gestation (Shearman
et al., 1997), but rhythmic expression of these genes
is not detectable until after birth (Sládek et al., 2004;
Li and Davis, 2005). Rat pups born and reared under
constant darkness display a circadian rhythm of
pineal N-acetyltransferase (NAT) that is in phase with
the circadian time of the mother, which indicates
maternal synchronization of the clock in pups
(Reppert et al., 1984). Similarly, evidence for maternal
entrainment of developing rhythms was found in
hamsters (Davis and Gorski, 1985). The role of the
maternal SCN in entrainment of the fetal clock was
investigated by SCN-lesion experiments (Reppert and
Schwartz, 1986; Davis and Gorski, 1988). These inves-
tigations showed that the fetal clock was unaffected
by maternal SCN lesion, but synchrony between pups
was altered. These experiments indicated a promi-
nent role of the maternal SCN in litter synchroniza-
tion. However, conclusions on the role of the maternal
clock on the development of the fetal circadian system
are difficult to make, for the following reasons. First,
lesions in dams have been performed at gestation day 7,
and hence, an impact of the SCN before surgery can
not be excluded. Second, removal of the SCN leaves
peripheral clocks functional while synchronization
between organs is abolished (Yoo et al., 2004).
To study the fetal circadian system in the complete
absence of a functional maternal circadian clock, we
studied the appearance of circadian wheel-running
activity in heterozygous pups derived from mPer1Brdm1/
Per2Brdm1 and mPer2Brdm1/Cry1–/– double-mutant females
crossed with wild-type males. We found that all off-
spring developed a circadian rest-activity rhythm, and
within a litter, individual phases were less synchronous
compared to the wild-type control litters. These find-
ings indicate that development of the fetal circadian
system is independent of a functional maternal clock.
MATERIALS AND METHODS
Animals
The mPer2Brdm1/Cry1–/– (Oster et al., 2002) and
mPer1Brdm1/Per2Brdm1 (Zheng et al., 2001) double-mutant
mice used in this study were generated by crossing
mPer2Brdm1 mutant mice (Zheng et al., 1999) with mCry1
knockout animals (van der Horst et al., 1999) or with
mPer1Brdm1 (Zheng et al., 2001) knockout mice, respec-
tively. Matching wild-type control animals were pro-
duced by intercrossing heterozygous animals.
Housing, Breeding, and Rearing Conditions
The mPer2Brdm1/Cry1–/– and mPer2Brdm1/Per1Brdm1
double-mutant females and the wild-type mice were
reared under a normal 12:12-h LD cycle with food and
water ad libitum. They were kept and mated in trans-
parent plastic cages (267 mm long × 207 mm wide ×
140 mm high; Techniplast Makrolon type 2 1264C001)
with a stainless-steel wire lid (Techniplast 1264C116).
To exclude any influence of time cues on the off-
spring, matings were set up under defined environ-
mental conditions and constant darkness in isolated
cabinets of our wheel-running facility (Jud et al., 2005).
All manipulations were performed using night-
vision goggles (Rigel 3200), and light sources that
could be detected with the night-vision goggles were
covered with aluminum foil prior to the experiment.
The built-in infrared illuminator of the night-vision
goggles was covered with dark paper to dampen it.
Furthermore, the time of day of routine care was ran-
domized. The mPer2Brdm1/Per1Brdm1 heterozygous pups
were produced in 3 matings. One wild-type male
was bred with 1 double-mutant female and gave
birth to 2 litters (P1 and P3, see below). Another wild-
type male was bred with 2 double-mutant females
(litters P4 and P5). The 3rd mating consisted of
1 wild-type male and 1 double-mutant female (litter
P2). The mPer2Brdm1/Cry1 heterozygous pups were
produced by 3 matings. One wild-type male and
1 double-mutant female produced litter C1. Another
wild-type male and 1 double-mutant female pro-
duced litter C2. A 3rd wild-type male was mated
with 2 double-mutant females, which resulted in
litters C3 and C4. The wild-type control animals were
produced by 3 matings, each with 1 wild-type male
and 1 wild-type female (litters W1-W3). Nestlets
(5 × 5 cm; EBECO) were placed into the cages to
encourage nesting and improve breeding. Once
double-mutant females became pregnant (deter-
mined by visual inspection) or at the latest after
2 weeks, the wild-type males were moved to a sepa-
rate cage and isolation cabinet. Females received
cotton nestlets and were left undisturbed for 2 to
3 d before and after delivery. A total of 18 wild-
type mice, 40 mPer2Brdm1/Per1Brdm1 heterozygous
mice, and 25 mPer2Brdm1/Cry1–/– heterozygous mice
were obtained (see Table 1). Pups were weaned
3 weeks after birth and kept in small groups of max-
imum 5 animals up to the age of 6 weeks in constant
darkness.
Locomotor Activity Monitoring
Starting from the 7th week of age, each of the het-
erozygous offspring was placed in an individual
running-wheel cage (Jud et al., 2005). To put mice in
running wheels directly after weaning is not recom-
mended because heat loss is greater than heat gen-
eration at that age, and pups die when kept
individually. The heterozygous pups, the mother,
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and the father were placed into the same isolation
cabinet. Activity was assessed and evaluated using
the ClockLab software package (Actimetrics). Activity
records were double plotted in threshold format for
6-min bins. Period length and rhythmicity were
assessed by χ2 periodogram analysis.
Determination of Within-Litter Synchrony
The activity onset on the 2nd day of wheel run-
ning was determined for each individual. A regres-
sion line was drawn through onsets using ClockLab
software (Actimetrics). The activity onset closest to
the point where the regression line hit time axis on
day 2 of the wheel-running experiment was defined
as onset of activity at day 2. We determined the length
of the average vector r for each litter, which repre-
sents the scatter of phases within a litter (Rayleigh test
and tables for significance; see Zar, 1999). Midnight
corresponded to 0°.
RESULTS
To study the emergence of circadian rhythms in
absence of a maternal clock, we crossed mPer1Brdm1/
Per2Brdm1 and mPer2Brdm1/Cry1–/– double-mutant females
with wild-type males in constant darkness. Because
these double-mutant females display altered clock
gene expression and no circadian rest-activity behav-
ior (Zheng et al., 2001; Oster et al., 2002), it was rea-
sonable to assume that the pups develop in the
absence of a maternal clock. The pups were conceived,
developed, and grew up in constant darkness and
were tested at the age of 6 weeks for wheel-running
activity.
We found that the wild-type control as well as the
heterozygous offspring displayed a circadian rhythm
(Fig. 1A, 1B, 1C) with a τ ± SEM of 23.93 ± 0.05 h for
wild-type offspring (N = 18) (Fig. 1M), 23.19 ± 0.05 h
for mPer1Brdm1/Per2Brdm1 heterozygous offspring (N = 40)
(Fig. 1N), and 22.98 ± 0.1 h for mPer2Brdm1/Cry1
heterozygous offspring (N = 25) (Fig. 1O). The free-
running period length of the heterozygous offspring
was significantly different from that of their wild-
type fathers (Fig. 1N, 1O) whereas this was not the
case between the wild-type offspring and their
parents (Fig. 1M). The difference in period of het-
erozygous animals to their fathers is probably caused
by difference in genotype. The mPer1Brdm1/Per2Brdm1
double-mutant female shown in Figure 1H and the
inset in Figure 1K shows an initial ultradian rhythm
of 15.2 h, which was subsequently lost. In the begin-
ning, the mPer2Brdm1/Cry1–/– double-mutant mother
shows an ultradian rhythm of 11.2 h (Fig. 1I, upper
inset in 1L), which was lost later on. It then devel-
oped another ultradian rhythm of 14.8 h before it
became arrhythmic (Fig. 1I, lower inset in 1L). In gen-
eral, we observed that all double-mutant females
periodically displayed ultradian rhythms.
Because pups are synchronized by mothers, we
determined within-litter synchrony. Results are
shown in Table 1 for wild-type (W1, 2, 3), mPer1Brdm1/
Per2Brdm1 heterozygous (P1, 2, 3, 4, 5), and mPer2Brdm1/
Cry1 heterozygous (C1, 2, 3, 4) offspring.
DISCUSSION
In mammals, mothers are in intimate contact with
their offspring to ensure their survival starting from
the day of conception. Maternally provided factors
such as carbohydrates, lipids, amino acids, and hor-
mones influence the development of the embryo.
Because many metabolic pathways in the maternal
organism are structured in a circadian fashion, the
question arises of whether the maternal circadian clock
is imposed on the embryos, leading to maternally medi-
ated circadian rhythms in the offspring. In the 1980s,
experiments investigating metabolism of C14-labeled
desoxyglucose and pineal N-acetyltransferase in
mothers and their pups indicated an influence of
the maternal circadian rhythm on their offspring
(Reppert and Schwartz, 1983; Reppert et al., 1984;
Davis and Gorski, 1985). However, the fetal clock
developed normally when the maternal SCN was
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Table 1. Within-Litter Synchrony
Litter n r p
W1 8 0.95 ***
W2 4 0.85 n.a.
W3 6 0.78 *
P1 9 0.87 ***
P2 6 0.9 **
P3 9 0.40 n.s.
P4 9 0.54 n.s.
P5 7 0.56 n.s.
C1 8 0.55 n.s.
C2 9 0.56 n.s.
C3 2 0.73 n.a.
C4 6 0.69 n.s.
NOTE: W = wild-type; P = mPer1Brdm/Per2Brdm1 heterozygous;
C = mPer2Brdm1/Cry1 heterozygous mice; n.a. = not applicable
(n too small); n.s. = not significant.
*p < 0.05; **p < 0.01; ***p < 0.001 (Rayleigh test).
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Figure 1. Representative locomotor activity records, χ2 periodograms, and free-running period length. Locomotor activity records of
wild-type (A), mPer1Brdm/Per2Brdm1 heterozygous (B), and mPer2Brdm1/Cry1 heterozygous (C) pups born and reared under DD conditions
(black bar on the top of the graph), indicating that these animals never experienced an LD cycle. (D-F) Actograms of the corresponding
wild-type fathers. Black bar, gray bar = subjective night and day, respectively. (G-I) Actograms of the corresponding mothers. (J-L) The
χ2 periodograms of the mothers; the straight line in the χ2 periodogram represents a statistical significance of p < 0.001. Periodogram (J)
corresponds to the activity plot of the wild-type mother shown in (G) (τ = 23.7 h), (K) corresponds to the activity plot shown in (H), and
(L) corresponds to the activity plot shown in (I). In (K), the big χ2 periodogram = entire period of 26 days (arrhythmic), inset upper-
left corner = days 1 to 8 (τ1 = 15.2 h, τ2 = 22.8 h, τ3 = 30.3 h). In (L), the big χ2 periodogram = entire period of 26 days, inset upper-left
corner = days 1 to 6 (τ1 = 11.2 h, τ2 = 16.9 h, τ3 = 22.5 h, τ4 = 28.1 h, τ5 = 33.7 h), inset lower-right corner = days 10 to 15 (τ1 = 14.8 h, τ2 = 22.2 h,
τ3 = 29.8 h). (M-O) Average free-running period length of the offspring compared to their parents. White bar = pups; black bar = fathers;
gray bar = mothers. Data are represented as mean ± SEM. Unpaired t test was performed to compare the free-running period length of
the pups to their wild-type parents. **p = 0.0056; ***p > 0.0001.
surgically removed at gestation day 7 (Reppert and
Schwartz, 1986; Davis and Gorski, 1988), indicating
that a functional maternal SCN is not necessary for
development of circadian rhythms in pups. Our
observations using a genetic approach confirm these
results. Female mice with mutations in mPer1/Per2
and mPer2/Cry1 genes do not display circadian
wheel-running behavior (Zheng et al., 2001; Oster
et al., 2002), and cultured fibroblasts of these double-
mutant animals display no circadian rhythmicity in
Bmal1-promoter–driven luciferase activity (Brown
et al., 2005). Because in our experimental set-up, double-
mutant females are arrhythmic before and after mating
with a wild-type male, there is most likely no influ-
ence of the maternal clock on the fertilized egg and
the developing embryos. Therefore, the observed
circadian rhythms in the heterozygous offspring
(Fig. 1) probably developed through an internal
program starting the circadian cycling of the clock.
However, we cannot exclude the possibility that the
ultradian rhythms observed in double-mutant
females might contribute to initiate circadian rhyth-
micity in their offspring.
Table 1 shows that significant within-litter syn-
chrony is observed in wild-type pups, whereas this
is not the case for most of the mutant heterozygous
litters. If circadian rhythms in the heterozygous off-
spring were triggered by external factors, the animals
within a heterozygous litter would show a good syn-
chronization of clock phase. However, this is not
observed (Table 1) except for litters P1 and P2, which
were assessed during a period of construction at our
university. It also appears that handling, occurring
for all animals within a litter at the same time, is
probably not the signal for onset of circadian clock
activity. In this context, it is important to note that
variations in τ are similar between wild-type (23.93 ±
0.05 h; Fig. 1M, white bar) and heterozygous (23.19 ±
0.05 h and 22.98 ± 0.1 h; Fig. 1N and 1O, white bars)
animals, indicating that the differences of synchrony
within a litter (Table 1) appear not to be caused by τ
variation. However, we cannot exclude this possibil-
ity. A reciprocal cross with a mutant father and a
wild-type mother might shed more light on litter
synchronization.
Taken together, we show evidence for autonomous
development of circadian rhythms in pups from
mothers with a genetic defect of the circadian clock.
Our findings are in agreement with previous observa-
tions made in SCN-lesioned animals and extend them,
allowing to propose autonomous clock development
in absence of central and peripheral maternal clocks.
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4.2 Light induced Cry1 coincides with high amplitude phase 
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Abstract 
Over time, organisms developed various strategies to adapt to their environment. The 
continuous light-dark cycles caused by the rotation of the Earth around its own axis facilitated 
the evolution of circadian clocks. These generate rhythms that persist with a period of about 
24 hours even in the absence of environmental cues. However, to tick in time, they have to 
continuously synchronize themselves to the prevailing photoperiod by appropriate phase 
shifts. In this study, we disrupted two cogwheels of the mammalian circadian oscillator, Rev-
Erb and Period1 (Per1). We found that these mice displayed robust circadian rhythms with 
significantly shorter periods under constant darkness conditions. Strikingly, they showed high 
amplitude resetting (Type 0) in response to a brief light pulse at the end of their subjective 
night phase, which is rare in mammals. cFos was induced to comparable levels as those in 
wild-type mice, which indicates that the photosensitivity is normal in the double mutant 
animals. Surprisingly, the otherwise not light responsive gene Cry1 was also induced under 
these conditions. Hence, Rev-Erb and Per1 may be part of a mechanism that evolved to 
prevent drastic phase shifts in mammals.  
 
Key words: circadian rhythm, Per1, Rev-Erb, Type 0 PRC, Cry1 induction 
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Introduction 
In mammals many physiological and behavioural parameters are subjected to daily variations. 
For instance, blood pressure, heart rate, body temperature, or sleep-wake cycles change 
considerably during the course of a day. The central circadian (Latin: “around a day”) clock, 
which governs these rhythms, is located in the suprachiasmatic nuclei (SCN) of the ventral 
hypothalamus (Stephan and Zucker 1972; Ralph, Foster et al. 1990). Since this internal 
pacemaker can tell time only approximately, it has to be reset every day by environmental 
signals. The strongest synchronizer for the endogenous clock is light, which signals directly to 
the SCN via the retinohypothalamic tract (Moore and Lenn 1972). To reset peripheral 
oscillators, rhythms generated in the SCN are sent to the rest of the body via both neuronal 
and humoral signals. 
Much of the understanding concerning the functioning of the circadian clock has come from 
extensive work done in model organisms mutant for one or several clock genes. In mammals, 
it was found that the molecular clockwork is based on cell-autonomous interlocked positive 
and negative transcriptional/translational feedback loops (TTLs; Takahashi, Hong et al. 
2008). The positive limb of the core loop is formed by the transcription factors CLOCK and 
BMAL1. Heterodimers of these proteins bind to E-box motifs in the promoters of Pers, Crys, 
Rev-Erb and other genes controlled by the clock. In the cytoplasm, the PER proteins form 
complexes with the CRYs, which then enter the nucleus. Once the complexes reach their 
destination, the CRYs inhibit the CLOCK/BMAL1 driven transcription, thereby establishing 
a negative feedback loop (Griffin, Staknis et al. 1999; Jin, Shearman et al. 1999; Kume, Zylka 
et al. 1999). The suppressed E-box driven transcription leads to a decline in PER, CRY and 
REV-ERB protein levels, which finally re-activates CLOCK-BMAL1 driven transcription. 
Due to the fall in REV-ERB, Bmal1 transcription is no longer inhibited (Preitner, Damiola 
et al. 2002; Ueda, Chen et al. 2002). Hence ROR can activate Bmal1 expression by binding 
to the now vacant retinoic acid related orphan receptor response elements (RORE) in its 
promoter (Giguere 1999; Sato, Panda et al. 2004; Akashi and Takumi 2005). 
The TTLs described above can be modulated by external signals. As mentioned previously, 
the strongest Zeitgeber (literally, “time giver” in German) for the mammalian clock is light. 
To better study the impact of light on the circadian system animals kept under constant 
darkness (DD) are subjected to a brief light pulse at different time points. During the 
subjective day, light has little or no effect on the resetting of the clock. By contrast, light 
exposure during the subjective night is capable of shifting the pacemaker. Depending on 
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whether the light is administered during the early or late subjective night, the animal either 
delays or advances its clock, respectively (Pittendrigh 1960; Aschoff 1969; Daan and 
Pittendrigh 1976).  
Several studies attempted to identify the molecular mechanisms underlying resetting in 
response to a light pulse. However, in mammals only little is understood compared to 
Drosophila and zebrafish (Lin, Song et al. 2001; Koh, Zheng et al. 2006; Tamai, Young et al. 
2007). Both Rev-Erb-/- and Per1Brdm1 single mutant mice are characterized by an aberrant 
light response during late night. Therefore we were interested in analyzing the resetting 
phenotype of double mutants. We monitored their wheel-running behaviour under constant 
conditions and established a PRC to brief light pulses. Here we show that Rev-Erb-/-
Per1
Brdm1
 double mutant mice maintain a functional circadian clock although they display a 
shorter period with reduced precision. Moreover, clock gene expression and their light 
inducibility are altered in mice deficient for both Rev-Erb and Per1. Strikingly, they show 
high amplitude resetting (Type 0) and Cry1 becomes light inducible in these mice after a light 
pulse delivered at the end of the subjective night. Hence we hypothesize that Rev-Erb and 
Per1 may participate in a mechanism that prevents drastic light responses in mammals. 
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Material & Methods 
Animals 
All animal work was performed in accordance with the guidelines of the Schweizer 
Tierschutzgesetz (TSchG, SR455, Abschnitt 2: Art. 5 + 7, Abschnitt 5: Art. 11 and Abschnitt 
6: Art.12-19). 
The Rev-Erb-/-Per1Brdm1 double mutant mice used in this study were generated by crossing 
Rev-Erb-/- (Preitner, Damiola et al. 2002) and Per1Brdm1 (Zheng, Albrecht et al. 2001) single 
mutants. Intercrossing double heterozygous animals produced matching Rev-Erb-/-, 
Per1
Brdm1
, Rev-Erb-/-Per1Brdm1 and wild-type animals. Homozygous breeding pairs were 
established using F2 offspring. To prevent genetic drift as much as possible, these matings 
were kept together as long as possible. The animals were regularly backcrossed to minimize 
epigenetic effects. The genotype of the offspring was determined by PCR. The PCR protocol 
for Rev-Erb was kindly provided by U. Schibler (Geneva, Switzerland). The following 
primers were used: 
Per1_1: 5’-ACA AAC TCA CAG AGC CCA TCC-3’ 
Per1_2: 5’-ATA TTC CTG GTT AGC TGT AGG-3’ 
Per1_3: 5’-CGC ATG CTC CAG ACT GCC TTG-3’ 
Rev-Erb_1: 5’-CAC CTT ACA CAG TAG CAC CAT GCC ATT CA-3’ 
Rev-Erb_2: 5’-AAA CCA GGC AAA GCG CCA TTC GCC ATT CA-3’ 
Rev-Erb_3: 5’-CCA GGA AGT CTA CAA GTG GCC ATG GAA GA-3’ 
The final primer concentration was 0.5 M, dNTP (Roche) concentration was 0.2 mM, and 
MgCl2 concentration was 1.5 mM for Per1 and 3.5 mM for Rev-Erb, respectively. To 
improve annealing, 12 nM or 6 nM (NH4)2SO4 was added to the reaction mix for Per1 and 
Rev-Erb, respectively. 2.5 U Taq DNA polymerase (Qiagen) were used per 50 l reaction 
for Per1 and 1.25 U per 25 l reaction for Rev-Erb. A final concentration of 0.2x Q-solution 
was used to increase PCR specificity of the Per1 reaction. An initial denaturation was done at 
94°C for 2 min. Subsequent denaturation was done at 94°C for 10 s followed by an annealing 
step of 30 s and an elongation at 72°C for 1 min. The annealing temperature was 56°C for 
Per1 and 62°C for Rev-Erb, respectively. After 34 (Per1) or 36 (Rev-Erb) cycles, the PCR 
was ended with a final extension at 72°C for 10 min. From time to time, Southern blot 
analysis was used to confirm the PCR for Per1 (Ramirez-Solis, Zheng et al. 1993; Zheng, 
Albrecht et al. 2001). 
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Locomotor activity monitoring and circadian phenotype analysis 
Mice housing and handling were performed as described earlier (Jud, Schmutz et al. 2005). 
Animals were entrained in LD 12:12h for 7-15 days before they were released into DD. 
Activity was assessed and evaluated using the ClockLab software package (Actimetrics). 
Activity records were double plotted in threshold format for 6-min bins. Period length was 
assessed by 2 periodogram analysis for days 4-10 in constant darkness. To determine light 
induced phase shifts, an Aschoff Type I protocol was used (Aschoff 1965). Animals were 
allowed to stabilize their free-running rhythm for at least 2 months prior to the light pulse. 
The circadian time (CT) at the beginning of the light pulse was calculated for every mouse 
individually. The phase response curve was established administering 15 min light pulses at 
CT0 (N [wild-type/ Rev-Erb-/-Per1Brdm1] = 8/11), CT2 (N = 11/4), CT10 (N = 8/8), CT14 (N 
= 15/8), CT18 (N = 14/15), CT20 (N = 8/10), and CT22 (N = 13/6). 
Mice subjected to experimental jet lag were entrained to LD 12:12h (e.g. lights on 7:00 – 
19:00) before the photoschedule was advanced by switching off the light 8 hours earlier than 
before (e.g. 11:00). Animals were allowed to re-entrain to the new LD cycle for about 1 
month. Once stable entrainment was achieved, the photoschedule was delayed by keeping the 
light switched on 8 hours longer (e.g. until 19:00). 
 
In situ hybridization 
To determine circadian gene expression, adult mice were first anesthetized with Attane
TM
 
Isoflurane (Provet AG) and then sacrificed on day 6 in DD. For light induction experiments, 
animals were kept in DD for about 2 months before they were exposed to a 15 min light pulse 
(400 lux) at different CTs. 45 min after the end of the light pulse, the mice were sacrificed. 
Control animals were sacrificed without prior light exposure.  
Specimen preparation and in situ hybridization were carried out as described previously 
(Albrecht, Sun et al. 1997). Briefly, the 
35
S-UTP (1250 Ci/mmol, PerkinElmer) labelled 
riboprobes were synthesized using the RNAMaxx
TM
 High Yield transcription kit (Stratagene) 
according to manufacturer’s protocol. The Bmal1 probe was made from a cDNA 
corresponding to nucleotides (nt) 654-1290 (accession no. AF015953; (Oster, Yasui et al. 
2002)), Cry1 corresponds to nt 190-771 (AB000777; (Oster, Yasui et al. 2002)), Cry2 to nt 
231-945 (AF156987), Per2 to nt 229-768 (AF036893; (Albrecht, Sun et al. 1997)), cFos to nt 
237-332 (Albrecht, Sun et al. 1997). 7 m thick paraffin sections were dewaxed, rehydrated 
and fixed in 4 % paraformaldehyde. Sections were then permeabilized using a proteinase K 
(Roche) digestion before they were fixed again and acetylated. After serial dehydration, 
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hybridization was performed over-night at 55°C in a humid chamber. Stringency washes were 
carried out at 63°C. Slides were subjected to a ribonuclease A (Sigma) digestion and then 
dehydrated in graded ethanol series. Quantification was performed by densitometric analysis 
(GS-700 or GS-800, BioRad) of autoradiography films (Amersham Hyperfilm) using the 
Quantity One software (BioRad). Data from the SCN were normalized subtracting the optical 
density measured in the lateral hypothalamus next to the SCN. For each experiment at least 3 
animals per genotype were used and 4 to 9 adjacent SCN sections per animal were analyzed. 
Relative RNA abundance values were calculated by defining the highest wild-type mean 
value of each experiment as 100 %. For statistical analysis, all normalized values obtained for 
one brain were averaged to obtain one final value per animal.  
 
Statistical analysis 
Significant differences were determined using GraphPad Prism 4 software. Depending on the 
type of data, either unpaired t-test, one- or two-way ANOVA with Bonferroni post-test were 
performed. Values were considered significantly different with p < 0.05 (*), p < 0.01 (**), or 
p < 0.001 (***).  
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Results 
Generation of Rev-Erb -/-Per1Brdm1 double mutant mice 
To better understand the in vivo function of Rev-Erb and Per1, mice double mutant for these 
two genes were generated. For this, Rev-Erb (Preitner, Damiola et al. 2002) and Per1 
(Zheng, Albrecht et al. 2001) single mutants were crossed. Double mutant offspring were 
intercrossed to produce both wild-type and mutant animals. Genotyping (supl. fig. 1) of these 
mice revealed that all genotypes were obtained at the expected Mendelian ratios (supl. fig. 
2A). Moreover, they were all morphologically indistinguishable from their wild-type 
littermates. In addition, Rev-Erb-/-Per1Brdm1 double mutants are fertile and give birth to 
normally sized litters at common intervals (supl. fig. 2B & C). 
 
Rev-Erb -/-Per1Brdm1 double mutant mice display a shorter circadian period in DD 
To study the effect of absent Rev-Erb and Per1 on locomotor activity, mice were housed 
individually and their wheel-running activity was monitored (Jud, Schmutz et al. 2005). 
Initially, animals were kept in a 12-h light:12-h dark cycle (LD 12:12h) for several days until 
they were stably entrained. Subsequently, they were released into constant darkness (DD). 
Under LD conditions, Rev-Erb-/-Per1Brdm1 double mutants displayed an activity pattern 
comparable to that of wild-type mice (supl. fig. 3). Upon release into DD, double mutants 
remained rhythmic and ran with a circadian period of 22.62 ± 0.1 h (mean ± SEM; N = 34) 
which is significantly shorter than that of the wild-type (23.86 ± 0.02 h; N = 38) and Rev-
Erb-/- (23.62 ± 0.05 h; N = 27) or Per1Brdm1 (23.35 ± 0.06 h; N = 22) single mutant mice (fig. 
1). This might indicate that the absence of these two clock genes has a cumulative effect on 
circadian period in DD. Under constant light conditions, double mutant mice display a period, 
which is comparable to the one of wild-type animals (supl. table 1). 
 
Clock gene expression levels of Rev-Erb -/-Per1Brdm1 double mutant mice are similar to 
those observed for Rev-Erb -/- single mutants 
In situ hybridization analysis was used to extend our investigations to the molecular level. 
Clock gene expression patterns in the SCN were determined on coronal brain sections of mice 
kept in DD for six days. Bmal1 mRNA accumulation in Rev-Erb-/-Per1Brdm1 double mutant 
mice was constantly high (fig. 2A). However, levels were slightly lower than those reported 
for Rev-Erb-/- single mutants (Preitner, Damiola et al. 2002). This in combination with the 
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observation that the increase in Bmal1 mRNA was significantly truncated in Per1
Brdm1
 single 
mutant mice could indicate that PER1 may activate Bmal1 expression.  
The expression of Cry1 was rhythmic with similar peak levels in all four genotypes (fig. 1B). 
By contrast, the amplitude in Cry1 mRNA accumulation was dampened in Rev-Erb-/- single 
and Rev-Erb-/-Per1Brdm1 double mutant mice due to an elevated trough at CT0. Cry2 was 
expressed at slightly higher transcript levels in Rev-Erb-/- single and Rev-Erb-/-Per1Brdm1 
double mutant mice compared to Per1
Brdm1 
single mutant and wild-type animals (fig. 1C). 
However, these differences were only statistically significant at CT0 for the double mutant 
animals compared to the wild-type. Interestingly, disruption of Per1, Rev-Erb, or both did 
not alter Per2 expression patterns (fig. 1D). To sum up, our observations confirmed the 
previous findings that disrupting Rev-Erb considerably affected the expression of Bmal1 and 
Cry1 but had only little or no consequences on Cry2 and Per2 transcript levels (Preitner, 
Damiola et al. 2002). While Bmal1 expression seemed to be less changed in Rev-Erb-/-
Per1
Brdm1
 double mutant mice compared to Rev-Erb-/- single mutants, Cry1 expression was 
unchanged between these two mutants. Nevertheless, Cry2 mRNA oscillations displayed 
bigger changes in the double than in the single mutant compared to wild-type animals. 
 
Rev-Erb -/-Per1Brdm1 double mutant mice display a Type 0 PRC and adapt faster to a 
rescheduled light/dark cycle 
The impact of the combined absence of Rev-Erb and Per1 on the photic response was 
studied by administering single 15 min light pulses to the animals according to an Aschoff 
Type I protocol (Aschoff 1965). While wild-type mice displayed the expected low amplitude 
(Type I) phase response curve (PRC), Rev-Erb-/-Per1Brdm1 double mutants showed high 
amplitude (Type 0) resetting (fig. 3A & B; Winfree 1970; Winfree 1980). For double mutant 
animals, the so-called “breakpoint” (transition from phase delays to phase advances) was 
observed between CT22 and CT24. At this time point it was not possible to distinguish 
whether the animals make huge phase advances or delays. Interestingly, some mice became 
transiently arrhythmic after a light pulse given at CT22 for some days (data not shown). The 
difference between weak and strong resetting can be visualized more clearly when data are 
plotted as a phase transition curve (PTC). Thus, the time the light pulse was given is 
compared to the time the phase is shifted to after the light pulse (i.e. “old” versus “new 
phase”). In wild-type mice, all data points were found to be close to the diagonal of the 
square, which has a slope of 1 (fig. 3C). Hence, the new phase was almost identical with the 
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old one and they displayed a so-called Type 1 resetting. By contrast, the average slope for 
Rev-Erb-/-Per1Brdm1 double mutants was close to 0 (fig. 3D). 
Due to the strong resetting phenotype of the double mutant animals we were curious to find 
out, how fast they adapt to an experimental jet lag. Hence we entrained them to LD 12:12h 
before they were subjected to an 8 h advance of the lighting schedule. Rev-Erb-/-Per1Brdm1 
double mutant mice achieved stable re-entrainment already after 4.00 ± 0.69 days (mean ± 
SEM; N= 7) while it took two times longer for wild-type animals (10.67 ± 1.26 days; N = 6; 
fig. 3E). Likewise, Rev-Erb-/-Per1Brdm1 (2.80 ± 0.20 days; N = 5) double mutants adapted 
faster to an 8 h delay in the photoschedule (fig. 3F) compared to wild-type mice (4.33 ± 0.21 
days; N = 6).  
 
Cry1 is light inducible in Rev-Erb -/-Per1Brdm1 double mutant mice 
To find an explanation for the Type 0 resetting observed in mutants lacking both Rev-Erb 
and Per1, we examined the light inducibility of some clock genes. Surprisingly, the otherwise 
not light inducible gene Cry1 was increased after a light pulse at CT22 in double mutant 
animals relative to dark controls (fig. 4A). As expected, wild-type and single mutant mice did 
not show any Cry1 induction neither at CT22 nor at CT14 (fig. 4B). In contrast to CT22, light 
did not induce Cry1 expression in Rev-Erb-/-Per1Brdm1 double mutant mice at CT14. This 
observation was in line with the finding that double mutants showed relatively normal phase 
shifts at this time point. In addition, Per2 was induced to a higher extent in double mutant 
mice compared to the three other genotypes at CT22 (fig. 4C) but not at CT14 (data not 
shown). Expression of Dec1, another known light inducible clock gene, was increased 
stronger in double mutants relative to the other genotypes at both CT14 and CT22 (data not 
shown). The signal intensity for cFos was similar between all genotypes after a light pulse at 
CT22 (fig. 4D) indicating that the light signalling pathway is not oversaturated. Hence the 
Type 0 PRC is rather elicited by changes in the circadian pacemaker (fig. 4A & C) then by a 
hypersensitivity to light (fig. 4D). 
To sum up Rev-Erb-/-Per1Brdm1 double mutant mice were fertile and morphologically 
indistinguishable from wild-type animals. Although they displayed a shorter circadian period 
in DD, their molecular oscillator seemed to be still functional. However, their response to 
brief light pulses was altered and they displayed high amplitude resetting. Interestingly, Cry1 
became light inducible if the photic signal was presented at the end of the subjective night. 
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Discussion 
Here we show that mice deficient for both Rev-Erb-/- and Per1Brdm1 displayed a dramatically 
shorter circadian period in DD compared to single mutants and wild-types (fig. 1). As 
reported previously, Rev-Erb-/- and Per1Brdm1 single mutant mice on their part exhibited 
significantly shorter circadian periods relative to wild-type animals (Zheng, Albrecht et al. 
2001; Preitner, Damiola et al. 2002). Hence the shorter period observed in the double mutants 
might indicate that the concomitant absence of these two clock genes has an additive effect on 
circadian period in DD.  
To avoid any influence of prior light exposure, we chose an Aschoff Type I protocol to study 
photic entrainment. Hence animals were kept in DD until stable entrainment was achieved 
(after about 2 month). Then they were subjected to brief light pulses at different CTs. In 
agreement with earlier studies, both, Rev-Erb-/- and Per1Brdm1 deficient animals phase 
advanced their wheel-running behaviour after a light pulse administered at the end of the 
subjective night (data not shown; Preitner, Damiola et al. 2002; Spoelstra, Albrecht et al. 
2004). In contrast to the other genotypes, Rev-Erb-/-Per1Brdm1 double mutants did show high 
amplitude resetting at the end of the night (fig. 3A-D). A similar phenotype has already been 
reported for heterozygous Clock mice, which exhibit a Type 0 PRC in response to 6-h light 
pulses (Vitaterna, Ko et al. 2006). Interestingly, light inducibility of both Per1 and Per2 was 
not affected by the Clock
+/-
 mutation. However, basal expression levels of Per genes were 
significantly blunted in both Clock homo- and heterozygous mice. In contrast to their 
observations we could not detect any dampened Per2 expression in our animals. In situ 
hybridization profiles for Per2 were completely identical between Rev-Erb-/-Per1Brdm1 
double mutant and wild-type animals (fig. 2D). Moreover, they could not detect any 
differences in light induction of either Per1 or Per2 between Clock heterozygous and wild-
type mice (Vitaterna, Ko et al. 2006). By contrast, we found that Per2 induction was stronger 
in Rev-Erb-/-Per1Brdm1 double mutants compared to wild-types (fig. 4C). These findings 
indicate that the mechanisms underlying the Type 0 PRC in Rev-Erb-/-Per1Brdm1 double 
mutant mice are different from those in Clock mutants. 
Whether Type 0 or a Type 1 resetting is exhibited depends not only on species but also on the 
strength of the stimulus. Increasing the light dose can convert a Type 1 into a Type 0 PRC. 
Other factors like genetic mutations or background light quality and/or intensity can affect the 
sensitivity of the pacemaker to the light pulse. Hence perception of stimulus strength is 
changed (Johnson 1992). Concerning the Rev-Erb-/-Per1Brdm1 double mutant mice an 
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oversaturation of the circadian system can be excluded because cFos was induced comparably 
in all genotypes at CT22 (fig. 4D). Hence it is rather unlikely that the observed Type 0 PRC is 
caused by a hypersensitivity to light. It is more likely that it is elicited by changes in the core 
clock components (fig. 4A & C). 
Surprisingly, we observed that Cry1 became light inducible in Rev-Erb-/-Per1Brdm1 double 
mutant mice by a light pulse delivered at CT22 but not at CT14 (fig. 4A & B). So far, Cry1 
was thought not to respond to light pulses at all in mammals (Okamura, Miyake et al. 1999; 
Field, Maywood et al. 2000). However, a recent study has shown that Cry1a acts as a light-
signalling molecule in the zebrafish (Danio rerio) clock (Tamai, Young et al. 2007) as its 
induction was found to be critical for light-induced phase shifts. Nonetheless, Cry1a seems 
not to be the only actor in the light input pathway to the zebrafish clock as light pulses also 
strongly induced Per2. Interestingly, we observed an induction of Per2 in our double mutants 
too (fig. 4C). In the past few years, the zebrafish became one of the most valuable lower 
vertebrate models for studying circadian clock function. It is thought that the teleost 
(= “perfectly boned fish”) circadian system might be the more ancestral vertebrate clock that 
became far more specialized in mammals due to selective pressure. Hence Rev-Erb and 
Per1 might have acquired additional features, which prevent strong resetting in mammals. 
Moreover, the circadian pacemakers in zebrafish cell lines showed high amplitude phase 
shifts in response to light pulses (Vallone, Gondi et al. 2004; Tamai, Young et al. 2007). 
Contrary to mammals, most, if not all, of the zebrafish tissues are directly light responsive 
(Whitmore, Foulkes et al. 1998; Whitmore, Foulkes et al. 2000; Yoo, Yamazaki et al. 2004) 
as it is the case for Drosophila (Vansteensel, Michel et al. 2008). It is speculated that a great 
degree of similarity exists between the observations made in cell culture and what happens in 
the whole fish (Carr, Katherine Tamai et al. 2006). This idea is strengthened by the fact that 
the heart taken from Period3-luciferase transgenic zebrafish showed a Type 0 PRC (Kaneko, 
Hernandez-Borsetti et al. 2006). However, the spleen (Kaneko, Hernandez-Borsetti et al. 
2006) and the melatonin production rhythm from cultured pineal glands showed a Type 1 
PRC (DeBruyne, Hurd et al. 2004). 
Another remarkable fact is that Cry1 has been reported to be a potentially rate-limiting factor 
in behavioural adjustments to time zone transitions in mammals (Reddy, Field et al. 2002). 
Usually, animals take longer to phase advance than to delay their clock in response to an 
acute shift in the complete lighting schedule (Takamure, Murakami et al. 1991; Yamazaki, 
Numano et al. 2000; Reddy, Field et al. 2002). Consistent with observations in rodents, 
subjective impressions of people travelling rapidly across time zones indicate that phase 
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delays are accomplished more rapidly and with fewer disturbances than phase advances. In 
contrast to phase delays, the clock cannot be advanced more than three hours per day. Hence 
the activity-rest cycle has to be advanced gradually whereas delays are completed rapidly. 
Reddy and colleagues saw that during both gradual advances and immediate delays, the shift 
of the Cry1 loop matched that for the activity-rest rhythm. Since they observed concomitant 
changes in Per2 they hypothesized that the regulation of Cry1 could be a consequence of 
altered PER2 expression. However further details about the role of Per1 and Per2 in resetting 
need to be elucidated. Finally, they concluded that the Cry1 response in the SCN might be 
sufficient to explain gradual resetting of locomotor behaviour. Moreover, they hypothesized 
that delay resetting is easier to achieve because it occurs when endogenous Cry1 levels are 
high. Interestingly, they propose that PER2 may have an effect on Cry1 expression 
independently of its proposed regulation of BMAL1 (Reddy, Field et al. 2002). 
Since Rev-Erb-/-Per1Brdm1 double mutant mice displayed Type 0 resetting we thought that 
they might adapt faster to rescheduled light/dark cycles. Indeed they adjusted their wheel-
running behaviour much faster to an advanced light/dark cycle relative to wild-types (fig. 3E). 
Furthermore, they accomplished phase delays faster than the other genotypes (fig. 3F). 
Surprisingly, unpaired t-test did not reveal a significant difference for double mutant mice 
between the two jet lag paradigms. Hence it took them about the same time to adapt to either 
advances or delays. As expected, wild-type mice took dramatically longer to adapt to a phase 
advance than to a delay (fig. 3E & F). Our findings suggest that the actual adaptation to a new 
time would be fast but is slowed down by components of the circadian clock. This is in line 
with previous findings where they demonstrate that rapid phase resetting in the liver is 
counteracted by active signalling pathways (Le Minh, Damiola et al. 2001). 
As reported in previous studies, the orphan nuclear receptor REV-ERB is able to repress 
Cry1 expression by two different ways. First, REV-ERB inhibits Bmal1 transcription, which 
indirectly represses Cry1 expression (Preitner, Damiola et al. 2002). Our in situ hybridization 
profiles for Cry1 and Bmal1 in Rev-Erb-/- single and Rev-Erb-/-Per1Brdm1 double mutant 
mice confirmed the initial finding. In the absence of Rev-Erb, Bmal1 was constantly high  
(fig. 2A) and Cry1 trough levels were less profound compared to wild-type animals (fig. 2B). 
Second REV-ERB can directly suppress Cry1 transcription by binding to RORE motifs 
located in the Cry1 promoter (Etchegaray, Lee et al. 2003). Apart from REV-ERB, 
CLOCK/BMAL1 heterodimers activate Cry1 transcription by binding to E-box motifs. 
Recently, this model has been challenged by the hypothesis that CLOCK/BMAL1 activates 
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some promoters while repressing others (Kondratov, Shamanna et al. 2006). Indeed Cry1 was 
up-regulated in Bmal1
-/- 
mice while Per1 was down-regulated (Kondratov, Shamanna et al. 
2006; Hirayama, Sahar et al. 2007). In a cell-based transient transfection approach both Cry1 
and Per1 promoters were activated by CLOCK/BMAL1 but to different extents. Cry1 was 
induced by only 2-fold from its basal expression level whereas Per1 was induced by more 
than 20-fold. However, basal levels differed quite drastically between the two genes with 
Cry1 displaying more than 15-fold higher basal levels. Adding CRY1 inhibited the 
CLOCK/BMAL1- dependent transactivation of Per1 to a level still higher than the basal 
activity. By contrast, Cry1 expression was repressed to levels about 3-fold lower than basal. 
From this they concluded that Cry1 expression is mostly regulated by transrepression and 
Per1 by transactivation (Kondratov, Shamanna et al. 2006). In addition, PER1 seems to have 
an activating effect on Bmal1 transcription because its peak level is lowered in Per1
Brdm1
 
single mutant mice (fig. 2A). Hence Cry1 transcription might be influenced by the disruption 
of both Rev-Erb and Per1 to a different degree. Moreover, the altered abundance of Cry1 
transcripts might influence its own transcription to a bigger extent in the absence of the two 
regulating genes Rev-Erb and Per1. The missregulation of Cry1 expression might then 
culminate in its light inducibility due to lacking repression. However, the mechanisms 
beneath Cry1 regulation have to be further elucidated. Likewise, it is not yet clear whether 
Cry1 induction alone leads to a Type 0 resetting in Rev-Erb-/-Per1Brdm1 double mutant mice. 
It seems that in the course of evolution complex mechanisms have been added to prevent light 
inducibility of Cry1 in mammals as compared to zebrafish or Drosophila. In conclusion, our 
results suggest that Rev-Erb and Per1 exhibit a gain of function phenotype in mammals. 
Hence disrupting them seems to lead to a loss of function, which results in strong Type 0 
resetting. 
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Figure 1: Representative wheel-running activity plots. 
(A-D) Representative locomotor activity records of wild-type (A), Rev-Erb-/- (B), Per1Brdm1 (C), and 
Rev-Erb-/-Per1Brdm1 double mutant mice (D) under both light/dark (white and grey shaded, 
respectively) and constant darkness (grey shaded) conditions. Black bars represent wheel-revolutions. 
The actograms are double-plotted with the activity of the following light/dark cycle plotted to the right 
and below the previous light/dark cycle. The white and black bar on the top of each actogram indicates 
light and darkness, respectively. (E) Average free-running period (tau) in constant darkness. Data are 
represented as mean ± SEM. Unpaired t-test was performed to compare the free-running period length 
of Rev-Erb-/- (23.62 ± 0.05 h; N = 27), Per1Brdm1 (23.35 ± 0.06 h; N = 22), and Rev-Erb-/-Per1Brdm1 
(22.62 ± 0.1 h; N = 34) mutant to wild-type (23.86 ± 0.02 h; N = 38) mice. *** p < 0.0001 . 
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Figure 2: In situ hybridization (ISH) profiles of cycling clock gene expression in the SCN of wild-
type (black line), Rev-Erb -/-Per1Brdm1 (red line), Rev-Erb -/- (green line), and Per1Brdm1 (blue line) 
mice kept in DD for 6 days. Values are double plotted and represented as mean ± SEM (N = 3). (A) 
Bmal1 expression; (B) Cry1 expression; (C) Cry2 expression; (D) Per2 expression. Two-way 
ANOVA with Bonferroni post-test was performed to determine significant differences between 
genotypes. * p < 0.05; ** p < 0.01; *** p < 0.001. 
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Figure 3:  Phase shifting responses to light pulses and rescheduled light/dark cycles. 
(A/B) Phase response curve (PRC) of wild-type (A; N = 4-15) and Rev-Erb
-/-
Per1
Brdm1
 (B; N = 8-15) 
double mutant mice to 15 min light pulses. The x-axis indicates the circadian time the light pulse was 
administered and the y-axis represents the phase shift produced by the light pulse. Each dot represents 
the phase shift of one animal. (C/D) Phase transition curve (PTC) of wild-type (C) and Rev-Erb
-/-
Per1
Brdm1
 (D) double mutant mice to 15 min light pulses.  Data of A and B are replotted to obtain C 
and D, respectively. The x-axis indicates the circadian time the light pulse was administered (old 
phase). The y-axis displays the circadian time to which locomotor activity was shifted after the light 
pulse (new phase). (E) Average time to adjust to an 8-hour advance of the light/dark (LD) cycle. Data 
are represented as mean ± SEM. Unpaired t-test was performed to compare the days until re-
entrainment of Rev-Erb-/- (12.80 ± 0.80 days; N = 5), Per1Brdm1 (5.50 ± 0.67 days; N = 6), and Rev-
Erb-/-Per1Brdm1 (4.00 ± 0.69; N = 7) mutant to wild-type (10.67 ± 1.26 days; N = 6) mice. ** p < 
0.01; *** p < 0.001 . (F) Average time to adjust to an 8-hour delay of the light/dark (LD) cycle. Data 
are represented as mean ± SEM. Unpaired t-test was performed to compare the days until re-
entrainment of Rev-Erb-/- (4.00 ± 0.55 days; N = 5), Per1Brdm1 (3.20 ± 0.37 days; N = 5), and Rev-
Erb-/-Per1Brdm1 (2.80 ± 0.20 days; N = 5) mutant to wild-type (4.33 ± 0.21 days; N = 6) mice. * p < 
0.05. 
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Figure 4: Light induced mRNA accumulation in the SCN of wild-type (black), Rev-Erb -/-
Per1
Brdm1
 (red), Rev-Erb -/- (green), and Per1Brdm1 (blue) mice. Values are represented as mean ± 
SEM. (A) Cry1 induction after a light pulse at CT22 (N = 3); (B) Cry1 induction after a light pulse at 
CT14 (N = 3); (C) Per2 induction after a light pulse at CT22 (N = 3-5); (D) cFos induction after a 
light pulse at CT22 (N = 3). Two-way ANOVA with Bonferroni post-test was performed to determine 
significant differences between genotypes. Unpaired to t-test was used to determine significant 
differences between light pulsed and dark control animals.  * p < 0.05; *** p < 0.001. 
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Supplemental data 
 
Supplemental figure 1: PCR analysis of mouse tail DNA for Rev-Erb  and Per1. 
Primers for Rev-Erb amplify a fragment of about 340 nt on the wild-type allele and of about 200 nt 
on the mutant allele. The PCR for Per1 amplifies a fragment of about 290 nt on the mutant allele and 
of about 450 nt on the wild-type allele. 
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Supplemental figure 2: Breeding statistics. 
(A) Distribution of genotypes in the F2 generation born to Rev-Erb+/-Per1+/Brdm1 double heterozygous 
parents. Black bars represent the expected Mendelian distribution while white bars display the 
observed ratios. The x-axis indicates the genotype of the F2 offspring. The percent of the total mouse 
number displaying a certain genotype is plotted on the y-axis. (B) Litter frequency of wild-type 
(white), Rev-Erb-/-Per1Brdm1 double homozygous (dark grey), and Rev-Erb+/-Per1+/Brdm1 double 
heterozygous (light grey) breeding pairs. Data are represented as mean ± SEM. On average, wild-type 
matings gave birth to a new litter every 32.22 ± 2.06 days (N = 41), Rev-Erb-/-Per1Brdm1 double 
homozygous breeding pairs every 32.12 ± 2.33 days (N = 33), and Rev-Erb/Per1 double 
heterozygous couples every 26.42 ± 1.04 days (N = 60). One-way ANOVA with Bonferroni’s multiple 
comparison was performed to compare the litter frequency of the three genotypes. * p < 0.05. (C) 
Number of pups born to wild-type (white), Rev-Erb-/-Per1Brdm1 double homozygous (dark grey), and 
Rev-Erb+/-Per1+/Brdm1 double heterozygous (light grey) breeding pairs. Data are represented as mean 
± SEM. On average, wild-type couples gave birth to 6.76 ± 0.51 pups (N = 38), Rev-Erb-/-Per1Brdm1 
double homozygous breeding pairs to 6.18 ± 0.43 pups (N = 33), and Rev-Erb/Per1 double 
heterozygous couples to 6.94 ± 0.31 pups (N = 69). One-way ANOVA with Bonferroni’s multiple 
comparison did not reveal any significant differences in litter size between the three genotypes. 
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Supplemental figure 3: Total and daytime wheel-running activity. 
(A) Total wheel-running activity of mice kept under LD 12:12 h. On average, wild-type mice make 
17’738 ± 808 wheel-revolutions per day (N = 32), Rev-Erb-/-Per1Brdm1 double mutants 16’307 ± 929 
(N = 29), Rev-Erb-/- single mutants 14’551 ± 1420 (N = 17), and Per1Brdm1 single mutants 17’718 ± 
1195 (N = 16). (B) Rest (rho) phase activity of mice kept under LD 12:12 h. Wild-type mice spend 
5.98 ± 1.18 % (N = 32) of their total activity during the day, Rev-Erb-/-Per1Brdm1 double mutants 6.74 
± 1.4 % (N = 29), Rev-Erb-/- single mutants 4.6 ± 1.4 % (N = 17), and Per1Brdm1 single mutants 6.76 ± 
2.3 % (N = 16). Data are represented as mean ± SEM. One-way ANOVA with Bonferroni’s multiple 
comparison did not reveal any significant difference between genotypes for both total and rho phase 
activity. (C) 24-h average distribution of activity for wild-type (black; N = 32), Rev-Erb-/-Per1Brdm1 
double mutant (red; N = 29), Rev-Erb-/- single mutant (green; N = 17), and Per1Brdm1 single mutant 
mice (blue; N = 15) kept in LD 12:12 h. The black and white bar on the bottom depicts the light and 
dark phase, respectively. Data are represented as mean only. The x-axis indicates the phase angle 
while the y-axis displays the activity as average counts/minute over a ten-minute interval. Statistical 
analysis did not reveal any difference between the genotypes. 
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Genotype tau in LL SEM N 
arrhythmic or 
inactive animals 
total number of 
animals analyzed 
wild-type 25.18 0.11 12 0 12 
Rev-Erb-/-Per1Brdm1 24.88 0.30 11 3 14 
Rev-Erb-/- 24.78 0.14 8 0 8 
Per1
Brdm1
 27.70 0.19 7 5 12 
 
Supplemental table 1: Average period (tau) of wild-type, Rev-Erb -/-Per1Brdm1, Rev-Erb -/-, and 
Per1
Brdm1
 mutant mice kept under constant light (LL; 400 lux). The period was calculated using the 
onsets of days 4-10 in LL. N, number of mice analyzed. 
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4.2.1 Additional data 
4.2.1.1 Light induction of Dec1, Per2 and cFos 
To further elucidate the role of altered clock gene induction in the strong Type 0 resetting we 
analyzed Dec1 induction at both CT14 and CT22. In the literature, it has been reported that 
light induces Dec1 both at the beginning and at the end of the night phase (Honma et al., 
2002). Our findings confirmed these former results as Dec1 was induced at both CT14 and 
CT22 in wild-type mice (add. fig. 1A & B). Moreover, Dec1 induction was even higher in 
Rev-Erb-/-Per1Brdm1 double mutants. However, Dec1 induction may play only a minor role in 
the high amplitude resetting because it is increased to the same extent at both time points. 
Per2 on the other hand was induced to the same level in both wild-type and Rev-Erb-/-
Per1
Brdm1 
double mutant mice at CT14 (add. fig. 1C). These findings are in line with the rather 
normal resetting observed at this time point. Moreover, cFos induction was unchanged 
between wild-type and double mutant animals at CT14 (add. fig. 1D) as well as CT22 (fig. 
4D). 
 
Additional figure 1: Light induced mRNA accumulation in the SCN of wild-type (black), Rev-
Erb -/-Per1Brdm1 (red), Rev-Erb -/- (green), and Per1Brdm1 (blue) mice. Values are represented as 
mean ± SEM. (A) Dec1 induction after a light pulse at CT14 (N = 2 for wild-type and light pulsed 
Rev-Erb-/-Per1Brdm1; N = 1 for the others). (B) Dec1 induction after a light pulse at CT22 (N = 3). 
Two-way ANOVA with Bonferroni post-test was performed to determine significant differences 
between genotypes. * p < 0.5. (C) Per2 induction after a light pulse at CT14 (N = 2 for wild-type and 
light pulsed Rev-Erb-/-Per1Brdm1; N = 1 for the others). (D) cFos induction after a light pulse at CT14 
(N = 2 for wild-type and light pulsed Rev-Erb-/-Per1Brdm1; N = 1 for the others). 
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4.2.1.2 Might misregulated Dexras1 cause the Type 0 PRC? 
Dexamethasone-induced RAS protein 1 (Dexras1) encodes a Ras-related protein, which is 
stimulated by dexamethasone (Kemppainen & Behrend, 1998). Recently, it was reported to 
fulfil contrasting roles in the resetting at early and late night, respectively. While Dexras1 
potentiates phase-delays in the early night, it reduces the magnitude of PACAP-mediated 
phase shifts at late night by inhibiting the activation of ERK via both the GS- and the G-
mediated limb (Cheng et al., 2006). Hence Dexras1 is thought to be a key signalling 
molecule, which confers both phase specificity and sensitivity to the light stimulus. 
Since our double mutant mice showed a light response, which differed at early and late night, 
we decided to study Dexras1 expression. In wild-type animals, Dexras1 was expressed 
rhythmically with a peak at CT14 (add. fig. 2A) as it has already been published (Panda et al., 
2002; Ueda et al., 2002; Takahashi et al., 2003). Identical peak levels were observed in Rev-
Erb-/- single and Rev-Erb-/-Per1Brdm1 double mutant mice. By contrast, the amplitude in 
Dexras1 mRNA accumulation was dampened in these animals due to an elevated trough at 
CT0. Interestingly, the difference in Dexras1 expression was found at the end of the night, 
where the breakpoint of the Type 0 PRC was located in the double mutant mice. 
 
 
Additional figure 2: Dexras1 expression in the SCN of wild-type (black), Rev-Erb -/-Per1Brdm1 
(red line), Rev-Erb -/- (green), and Per1Brdm1 (blue) mice. (A) In situ hybridization (ISH) profile for 
basal Dexras1 levels in wild-type (N = 2), Rev-Erb-/-Per1Brdm1 double (N = 2) and Rev-Erb-/- single 
mutant mice (N = 1). Animals were kept in constant darkness for 6 days before they were sacrificed. 
Values are represented as mean ± SEM. Two-way ANOVA with Bonferroni post-test was performed 
for statistical analysis. * p < 0.5. (B) Light induced accumulation of Dexras1 mRNA in the SCN of 
wild-type (N = 3), Rev-Erb-/-Per1Brdm1 double (N = 3-4), Per1Brdm1 single (N = 3), and Rev-Erb-/- 
single mutant mice (N = 3). Two-way ANOVA with Bonferroni post-test did not reveal any 
significant differences between genotypes. However, unpaired t-test revealed significant differences 
between genotypes with and without light pulse (wild-type p = 0.001; Rev-Erb-/-Per1Brdm1 p = 
0.0478). 
 
Since these first results looked rather promising for Dexras1 being involved in the strong 
resetting phenotype, we studied Dexras1 induction before and after a light pulse administered 
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at CT22. Surprisingly, Dexras1 seemed to be suppressed uniformly by light in all genotypes 
(add. fig. 2B). From this we concluded that Dexras1 is probably not the cause for the Type 0 
resetting observed in the Rev-Erb-/-Per1Brdm1 double mutant mice. 
Nonetheless, we examined the regulation of the Dexras1 promoter by Rev-Erb and Ror 
because it has been reported to contain a RORE motif 1.1 kbp upstream of the translation start 
site (Ueda et al., 2002; Takahashi et al., 2003). Hence we cloned a luciferase reporter 
construct containing a 1.7 kb Dexras1 5’ promoter sequence. To find the optimal cell line to 
work with, we transfected several cell lines with 0.5 or 1.0 g of either pGL3-Dexras1::luc or 
the positive control pGL2-Bmal1::luc. In parallel we added 0.0, 0.1, 0.5 or 1.0 g of the 
pSCT-Rev-Erb expression plasmid to test whether the luciferase activity decreases or not. 
Unexpectedly, the Dexras1 promoter was activated by REV-ERB in a dose dependant 
manner in all cell lines and at both promoter plasmid concentrations (e.g. add. fig. 3A & B). 
By contrast, the Bmal1 promoter was repressed by REV-ERB as expected in NIH-3T3 cells. 
However, it was activated at higher concentrations in COS-7 (add. fig. 3A), NG108-15, and 
HepG2 (data not shown) cells. This phenomenon is known as squelching and means that 
higher concentrations of inhibitor or activator interfere with normal cell function by the 
sequestration of endogenous proteins. Due to these results we decided to test lower pSCT-
Rev-Erb concentrations. Hence we transfected COS-7 and NIH3T3 cells with 0.5 g of the 
reporter construct and with very small amounts of inhibitor. Indeed, squelching of the Bmal1 
promoter started only at 0.5 g pSCT-Rev-Erb in COS-7 cells (add. fig. 3C). At lower 
concentrations luciferase activity was inhibited, as one would expect. Nonetheless, the 
Dexras1 promoter was still not repressed by REV-ERB at these lower concentrations. In 
NIH3T3 cells, the Bmal1 reporter construct was only inhibited starting at a concentration of 
0.02 g pSCT-Rev-Erb (add. fig. 3D). Moreover, the Dexras1 promoter seemed not to be 
regulated by REV-ERB at any concentration in NIH3T3 cells. Last but not least, we tested 
whether Dexras1 was activated or not by ROR in COS-7 cells. The Bmal1 reporter construct 
responded to increasing pSCT-Ror4 concentrations as expected. However, at 1.0 g 
squelching occurred again (add. fig. 3E). By contrast, the Dexras1 promoter did not respond 
to ROR at all.  
Although these transfection assays did not give any promising results, it is rather unlikely that 
Dexras1 is not regulated by REV-ERB and ROR. For instance, Dexras1 peak expression is 
down-regulated in Ror mutant mice (Sato et al., 2004) and up-regulated in Rev-Erb 
mutants (add. fig. 2A). Therefore the promoter fragment seems to be too short and a longer 
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one should be cloned because a second RORE motif is located 3.3 kbp upstream of the 
translation start site. However, we decided to abandon studying Dexras1 because of its light 
response. Nonetheless it could be interesting to continue this work within another subject. 
 
 
Additional figure 3: Opposing regulation of the Dexras1 promoter by REV-ERB  and ROR4. 
Luciferase reporter constructs containing a 1.7 kb Dexras1 5’ promoter sequence were used for 
transcriptional assays. The pGL2-Bmal1::luciferase construct was used as a positive control (provided 
by U. Schibler [Nagoshi et al., 2004]). All experiments have been done once. Duplicates are 
represented as mean ± SEM. (A/B) COS-7 (A) and NIH3T3 (B) cells were transfected with 0.5 or 1.0 
g of either pGL3-Dexras1::luc or pGL2-Bmal1::luc. Different concentrations (0.1, 0.5 and 1.0 g) of 
the pSCT1-Rev-Erb expression plasmid were added to see whether it represses transcription from the 
Dexras1 promoter. (C/D) COS-7 (C) and NIH3T3 (D) cells were transfected with 0.5 g of either 
pGL3-Dexras1::luc or pGL2-Bmal1::luc. Since higher concentrations of REV-ERB showed 
squelching, lower concentrations (0.0008, 0.004 and 0.02 g) were tested. The values where 0.0 and 
0.1 g pSCT1-Rev-Erb expression plasmid were added are represented as mean ± SEM of 2 
independent experiments (each done in duplicates). (E) COS-7 cells were transfected with 0.5  g of 
either pGL3-Dexras1::luc or pGL2-Bmal1::luc. Different concentrations (0.1-1.0 g) of the pSCT1-
Ror4 expression plasmid were added to see whether or not it activates transcription from the 
Dexras1 promoter. 
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4.2.3 Other attempts to explain the Type 0 PRC 
To decipher the molecular cause of the strong resetting phenotype observed in the Rev-Erb-/- 
Per1
Brdm1
 double mutant mice we tested the expression and light inducibility of additional 
genes. For instance, the MAP kinase phosphatase 1 (Mkp1) negatively regulates the mitogen-
activated protein kinase (MAPK)-mediated signal transduction. The MAPK pathway is 
involved in the regulation of numerous transcription factors and plays a role in certain forms 
of neuronal plasticity. Moreover, MAPK signalling is induced rapidly by photic stimulation 
during the subjective night (Obrietan et al., 1998; Butcher et al., 2002). Mkp1 expression is 
induced by stimuli that activate the MAPK pathway. Interestingly, Mkp1 was reported to be a 
light-inducible and clock-controlled gene, which shows an expression profile that is similar to 
the one of Per1. In addition, Mkp1 has a Per1-like promoter containing two cAMP responsive 
elements and an E-box (Doi et al., 2007). Our results confirmed these findings. Mkp1 
expression was rhythmic and peaked during the subjective day in both wild-type and Rev-
Erb-/- Per1Brdm1 double mutant mice (add. fig. 4A). Likewise, a brief light pulse at CT22 
induced Mkp1 (add. fig. 4B). However, there was no difference between the two genotypes. 
Hence we concluded that Mkp1 may not be involved in the observed Type 0 resetting. 
Another approach was to study the circadian expression of the two neuropeptides vasoactive 
intestinal polypeptide (VIP) and gastrin-releasing peptide (GRP), which are expressed in the 
retinorecipient core region of the SCN. Former studies reported that VIP and GRP mRNA in 
the SCN are clock-controlled in mice and peak during the middle of the subjective night. The 
supposed role of VIP is to synchronize mammalian clock neurons and to maintain their 
rhythmicity (Aton et al., 2005). However, the acute induction of Per1 by light is thought to be 
independent of VIP and its receptor VPAC2 (Maywood et al., 2007). GRP on the other hand 
is thought to be an intra-SCN light signal that activates MAPK, CREB, and Per induction 
(Gamble et al., 2007).  
We found that VIP was expressed in a circadian fashion in wild-type and especially Rev-
Erb-/- Per1Brdm1 double mutant mice (add. fig. 4C). Interestingly, VIP seemed to be light 
inducible in the double mutant animals after a light pulse at CT22 (add. fig. 4D). However, 
these results should be interpreted with caution because only one animal was analyzed per 
time point. For instance, double mutants show higher basal VIP levels at CT22 (add. fig. 4C) 
and lower levels for the dark control taken at CT23 (add. fig. 4D). Nonetheless, VIP 
expression seems to differ between the two genotypes and could be an interesting target for 
further research. By contrast, GRP expression was rather similar between wild-type and 
double mutant animals (add. fig. 4E). But again, these findings need further confirmation. 
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Additional figure 4: In situ hybridization (ISH) analysis for Mkp1, VIP and GRP. All experiments 
have been done once. Data are represented as mean ± SEM for all replicates (N  6). (A/C/E) ISH 
hybridization profiles for Mkp1 (A), VIP (C) and GRP (E) expression. The x-axis indicates circadian 
time (CT) while the y-axis displays the relative RNA abundance. (B/D) Light induced mRNA 
accumulation in the SCN of wild-type (black) and Rev-Erb-/-Per1Brdm1 double mutant mice (red) for 
Mkp1 (B) and VIP (D). The light pulse was administered at CT22.  
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4.3 The effect of blue light on the human circadian system in 
the evening 
 
“Evening exposure to blue light stimulates the expression of the clock gene 
PER2 in humans.” 
 
C. Cajochen, C. Jud, M. Münch, S. Kobialka, A. Wirz-Justice, U. Albrecht  
2006 
 
Published in Journal of Neurosciences 23(4): 1082-1086 
 
 
  
SHORT COMMUNICATION
Evening exposure to blue light stimulates the expression
of the clock gene PER2 in humans
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Abstract
We developed a non-invasive method to measure and quantify human circadian PER2 gene expression in oral mucosa samples and
show that this gene oscillates in a circadian (¼ about a day) fashion. We also have the first evidence that induction of human PER2
expression is stimulated by exposing subjects to 2 h of light in the evening. This increase inPER2 expression was statistically significant
in comparison to a non-light control condition only after light at 460 nm (blue) but not after light exposure at 550 nm (green). Our results
indicate that the non-image-forming visual system is involved in human circadian gene expression. The demonstration of a functional
circadian machinery in human buccal samples and its response to light opens the door for investigation of human circadian rhythms at the
gene level and their associated disorders.
Introduction
Our light-sensing systems’ familiar function is to collect and process
light to generate an image of the world. Although light primarily serves
vision, it is now known that it also exerts powerful non-visual effects on
a number of physiological variables in humans, among them synchron-
ization of circadian rhythms (the circa-24-h rhythms) (Lockley et al.,
2003; Warman et al., 2003), suppression of the hormone melatonin
(Brainard et al., 2001a,b; Thapan et al., 2001; Lockley et al., 2003;
Cajochen et al., 2005), an increase in cortisol and heart rate (Scheer &
Buijs, 1999; Scheer et al., 1999; Cajochen et al., 2005), and an acute
alerting response (Badia et al., 1991; Cajochen et al., 2005). In
mammals, light activates signalling pathways in a brain regionwhere the
central circadian pacemaker is located ) the suprachiasmatic nuclei
(SCN) (Klein et al., 1991) ) that coordinates the daily temporal
organization of physiology and behaviour. The molecular mechanisms
underlying circadian rhythmicity involve self-sustaining transcrip-
tional ⁄ translational feedback loops based on rhythmic expression of
the mRNA and proteins of clock components. Synchronization of the
SCN to light ultimately leads to expression of a set of clock genes,
among them Per1 and Per2 (Albrecht et al., 1997). Thus, light exposure
acutely activates expression of Per1 and Per2 in the SCN of mice
(Albrecht et al., 1997; Zylka et al., 1998; Yan et al., 1999).
Reports about circadian regulation of clock genes in humans are
rare. Two recent studies provide evidence that clock genes (PER1,
PER2, PER3 and DEC1) in human peripheral blood mononuclear cells
(Boivin et al., 2003) and human oral mucosa (PER1, CRY1 and
BMAL1) are expressed in a circadian manner (Bjarnason et al., 2001).
In the present study we aimed at developing a method to measure
circadian expression of PER2 expression in a non-invasive way via
collection of oral mucosa samples. In a second step, we tested the
hypothesis that evening light exposure induces an immediate increase
in PER2 expression in human mucosa. Furthermore, because part of
light’s non-visual effects are mediated by non-classical photoreceptors
with melanopsin acting as photopigment with a maximum sensitivity
in the ‘blue’ part of the visible electromagnetic spectrum (Lucas et al.,
1999; Melyan et al., 2005; Panda et al., 2005; Qiu et al., 2005), we
applied light in the 460 nm range and compared its effect to light at a
different wavelength (550 nm) to test to what extend the novel
photoreceptor system is involved in the regulation of PER2.
Materials and methods
Study participants
Twelve male volunteers were studied in the light study (mean age ±
SD, 25.3 ± 3.6 years), and 12 female and male volunteers in the
circadian study (28.4 ± 9.9 years). All study participants were free
from medical, psychiatric and sleep disorders, as assessed by history, a
physical examination and questionnaires. For the participants in the
light study an ophthalmological examination was carried out prior to
and after completion of the study in order to exclude volunteers with
visual impairments as well as to be certain that our light application
was not harmful. The volunteers were instructed to abstain from
excessive caffeine and alcohol consumption for 1 week before the
study. They were asked to keep a regular sleep–wake schedule
(bedtimes and waketimes within ± 30 min of self-selected target time)
during 1 week prior to their admission to the laboratory. Adherence to
this regular schedule was veriﬁed with a wrist actigraph (Cambridge
Neurotechnologies, UK) and daily sleep diaries for the participants in
the light study. All volunteers gave written informed consent. The
protocol, screening questionnaires and consent form were approved by
the Ethical Committee of Basel, Switzerland, and were in agreement
with the Declaration of Helsinki.
Study protocol
Light study
The study consisted of three arms, performed in a balanced order,
separated by a 1-week intervening period (Fig. 1). Based on the
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volunteers’ habitual bedtimes, a constant posture (CP) protocol started
10 h after usual waketime in the early evening (e.g. 18.00 h) and ended
the next day, 2 h after usual waketime (e.g. 10.00 h). Under CP
conditions, the volunteers experienced a controlled lying down episode
of 1.5 h under 2 lux, followed by a 2-h dark adaptation episode under
complete darkness (0 lux). After that, light exposurewas initiated for the
next 2 h. During this 2-h episode, the volunteers received monochro-
matic light at 460 nm, or monochromatic light at 550 nm, or no-light
(0 lux). After this, the volunteers remained awake for another 1.5-h
episode under 2 lux (polychromatic white light) before they were
allowed to sleep for 7.75 h. One study participant developed amild cold
during one of the study arms and was therefore excluded from further
analysis. To quantify PER2 expression, oral mucosa samples were
collected at 18.30 h before light exposure, at 24.00 h after light exposure
and the next morning at 10.00 h. For two study participants not enough
mucosa material was available for a reliable quantiﬁcation of PER2,
resulting in a total of nine subjects for statistical analysis.
Circadian study
The study comprised a 30-h episode, which the volunteers spent in
one of our temperature-controlled chronobiology suites. The
volunteers were allowed to read, work on a laptop and listen to
music. Ambient light levels were kept low, < 15 lux at the angle of
gaze, and meals were provided by the clinic (lunch, dinner and
breakfast). An 8-h sleep episode was scheduled according to the
volunteers’ habitual bedtime. The mucosa and the saliva samples
for melatonin were taken in 3-hourly intervals, starting 3 h after
habitual bedtime (on average at 9.00, 12.00, 15.00, 18.00, 21.00,
24.00, 3.00, 6.00, 9.00, 12.00 h). For double-plotting, the last two
data points at 9.00 and 12.00 h were omitted. In order to take the
3.00 and 6.00 h samples, volunteers had to wake up, take the
sample and go back to sleep. One subject discontinued the study
after 12 h because of difﬁculties in taking mucosa samples, and two
subjects had to be excluded because not enough mucosa material
was available for a reliable quantiﬁcation of PER2. The circadian
study was conducted 3 months after the light study was completed.
Because the experimental conditions of the subjects in the two
studies were different it is not possible to compare the PER2 data
of the two studies in their absolute dimension, as the Q-PCR
method used was based on relative measures in each experiment.
Light exposure
Monochromatic 2-h light exposure was scheduled at a circadian phase at
which polychromatic white light exposure induces robust phase delays
and alerting effects (Cajochen et al., 1992, 1998; Khalsa et al., 2003).
The monochromatic light was generated by a 300 Watt arc-ozone-free
Xenon lamp (Thermo Oriel, Spectra Physics, Statford, CT, USA),
ﬁltered by either 460 nm or 550 nm (Interference ﬁlter, ± 10 nm half-
peak bandwidth, Spectra Physics, Statford, CT, USA) and transmitted
via two glass ﬁbre bundles (L.O.T. Oriel-Suisse, Romanel-sur-Morges,
Switzerland) through the wall into the sound-proof and temperature-
controlled chronobiology suite on to the goggles, which covered the
volunteers’ eyes. The custom-built goggles (K. Haug AG, Basel,
Switzerland) consisted of two spheres (27.5 mm inner radius) coated
with white reﬂectance paint (two component polyurethan-acryl anti-
fading paint, Lachenmeier & Co. AG, Basel, Switzerland). Each sphere
was illuminated via three branches of the main ﬁbre optic cable in order
to provide constant uniform illumination. Equal photon densities
(2.8 · 1013 photons ⁄ cm2 ⁄ s) for the 460 nm and 550 nm wavelength
light were administered. This irradiance level (12.1 lW ⁄ cm2 for
460 nm and 10.05 lW ⁄ cm2 for 550 nm) was chosen according to
recently reported results onmonochromatic light on the human circadian
timing system (Lockley et al., 2003). Irradiances were measured with a
laser power meter (Laser Check, Coherent, Auburn, CA, USA) before
the beginning and at the end of each light exposure. During light
exposure as well as during the non-light condition, volunteers were
asked to keep their eyes open and to ﬁx their gaze on the middle of the
spheres. A technician checked the latter by on-line monitoring the
polysomnographic recordings and also verifying that the subjects
remained awake. The volunteer’s pupils were not dilated in order to
avoid possible repercussions of the dilation agent per se on thermoreg-
ulation, heart rate and alertness. However, we tested the effects of the
light stimulus on pupil constriction by applying monocular light
exposure (light via the goggle of the right eye) and concomitantly
measuring the pupil size on the left eye via an infrared camera. The entire
control protocol was conducted at the same time of day (evening) and
with the same light intensity in six subjects. Results from the control
experiment revealed a signiﬁcantly smaller pupil size after the short
wavelength light at 460 nm than after light at 550 nm in comparison to
the dark condition (P < 0.01), Duncan’s multiple range test performed
after a one-way anova for repeated measures with the factor ‘light
condition’ (P < 0.02; dark, 460 nm and 550 nm).
Salivary melatonin
Saliva was collected at 30-min intervals during scheduled wakeful-
ness. A direct double-antibody radioimmunoassay was used for the
melatonin assay validated by gas-chromatography-mass spectroscopy
(Bu¨hlmann Laboratories, Allschwil, Switzerland). The minimum
detectable dose of melatonin (analytical sensitivity) was determined
to be 0.2 pg ⁄mL. The functional least detectable dose using the < 20%
coefﬁcient of interassay variation criterion was below 0.65 pg ⁄mL,
and individual serum and saliva melatonin proﬁles showed excellent
parallelism (r ¼ 0.977–0.999, slopes ¼ 0.21–0.63).
Human oral mucosa collection and quantification of PER2
Human oral mucosa was collected using blue pipette tips (Treff AG,
2 mm of tissue into the tip) and then was dissolved in lysis buffer
containing b-mercaptoethanol provided in the Absolutely RNA Nano-
prepKit (Stratagene). Subsequently, the samples were frozen at)80 C.
The RNAwas isolated according to the manufacturer’s instructions of
the kit using 200 lL of lysis buffer followed by a DNase treatment of
30 min. The cDNA was generated using SuperScriptTM II Reverse
Transcriptase (Invitrogen) and poly(dT)15 primers (Roche). Subse-
quently, TaqMan quantitative real-time RT-PCR was performed using
iQ Supermix (Bio-Rad) to determineGAPDH and PER2 levels for each
sample. The following primers and probes were used:
PER2 TaqMan probe:
5¢-[FAM]ATGCCTTCAGCGATGCCAAGTT[BHQ]-3¢
PER2 sense primer:
5¢-GCATCCATATTTCACTGTAAAAGA-3¢
PER2 anti-sense primer:
5¢-AGTAAAAGAATCTGCTCCACTG-3¢
GAPDH TaqMan probe:
5¢-[FAM]AGCCTCAAGATCATCAGCAATGCC [BHQ]-3¢
GAPDH sense primer:
5¢-TGTGAACCATGAGAAGTATGAC-3¢
GAPDH anti-sense primer:
5¢-ATGAGTCCTTCCACGATACC-3¢.
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The ﬁnal primer concentration was 300 nm, ﬂuorescent oligomeric
probe concentration was 100 nm and MgCl2 concentration was 5 mm.
The ampliﬁcation was carried out at 55 C for 1 min followed by a
denaturation at 94 C for 15 s using the iCycler (Bio-Rad). After 55
cycles, DCT was determined. The samples of one subject (all time
points) in the reaction mix were applied with ﬁlter tips (Axigen) onto a
0.2 mL semiskirted thermo-fast 96-well plate (ABgene AB-0900),
which was covered with an optically clear adhesive seal sheet
(ABgene AB-1170). Additionally to the single GAPDH controls, a
dilution curve for GAPDH was run on each plate for one time point to
control for reaction efﬁciency.
GAPDH was used as standard because of its constant expression in
mucosa tissue (Pan et al., 2002) and its validation as a standard gene for
this tissue under injury and repair conditions (Warburton et al., 2005).
Data analysis
For both the circadian and the light study three reference GAPDH
values and three or four PER2 values were obtained for each mucosa
sample (triplets or quadruplets a, b, c, d). A DCT value per mucosa
sample was calculated according to the comparative CT (2
–DDCT)
method, which could be applied because the efﬁciencies of the
GAPDH and PER2 assays were optimized to be comparable (Livak &
Schmittgen, 2001). A validation assay was performed where serial
dilutions were assayed for both genes. This method minimizes the
variation in performance of the iCycler apparatus. Another advantage
of this relative quantiﬁcation compared with the absolute method is
that it corrects for variance in the efﬁciency of cDNA synthesis.
The formula below was used to calculate the DCT values:
DCT ¼ ð2GAPDHaPER2a þ 2GAPDHaPER2b þ 2GAPDHaPER2c
þ 2GAPDHbPER2a þ 2GAPDHbPER2b þ 2GAPDHbPER2c
þ 2GAPDHcPER2a þ 2GAPDHcPER2b þ 2GAPDHcPER2cÞ=9
In the case of quadruplets, the formula was changed accordingly. This
method allowed the use of parametric statistics repeated-measure
anova (ranova) with the factor ‘light condition’ and ‘time of day’.
Fig. 1. Overview of the light study protocol design. After 1.5 h under 2 lux, subjects were dark adapted for 2 h, followed by another 2 h in darkness or light
exposure at 460 nm or 550 nm (for details about the light exposures, see Materials and methods). Subsequently, subjects spent 1.5 h under 2 lux before they were
allowed to sleep for 8 h. The entire protocol was carried out under constant recumbent posture conditions in bed.
Fig. 2. (a) Twenty-four-hour proﬁle of PER2 expression in human oral mucosa (d) and of salivary melatonin levels (s). Samples were taken in 3-h intervals under
dim light conditions (< 15 lux) throughout a 30-h period (n ¼ 9, mean values ± SEM). For better visualization of the 24-h rhythms, all values were double-plotted
and PER2 values ﬁtted with a sine function. The r-value, an estimate of the goodness of ﬁt, was 0.87 with P ¼ 0.0001 for PER2. Arrows on the abscissa indicate the
timing of mucosa collection and the timing of the 2-h light exposure (yellow bar) in the experiment in (b). (b) Left-hand side: Salivary melatonin levels during 2-h
light exposure at 460 nm and 550 nm and during the control no-light condition. Right hand side: PER2 expression in oral mucosa after the 2-h light exposure (460
and 550 nm) and no-light exposure at 24.00 h and 10.00 h the next morning. Values were expressed as percentages to the value before light treatment at 18.30 h
(0 ¼ value at 18.30 h; n ¼ 9, mean values + SEM; *P < 0.05, Duncan’s multiple range test). (c) Scatter plot of the individual normalized data. After blue light at
460 nm, for most of the subjects values > 1.0 can be observed at 24 h, but also for some subjects after green light at 550 nm and for two subjects in the dark
condition. Only in the blue light condition did the values at 24.00 h differ signiﬁcantly from the 18.30 h values (paired t-test, P ¼ 0.017). For most of the subjects in
the blue light condition, the values at 10.00 h the next morning decreased, statistical analyses revealed a trend for lower values after blue light, when compared with
the green condition (paired t-test; P ¼ 0.09).
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For each subject, we expressed the transformed values relative to the
value obtained at 18.00 h in the circadian study and to the value
obtained at 18.30 h in the light study, as in the light study the sample
taken at 18.30 h was the only sample taken under the same lighting
conditions and was the closest in terms of time to the 18.00 h sample
taken in the circadian study. All P-values derived from ranovas were
based on Huynh–Feldt’s (H–F) corrected degrees of freedom, but the
original degrees of freedom are reported. For post-hoc comparisons
the Duncan’s multiple range test was used.
The time course of PER2 expression in the circadian study was
ﬁtted with a sinusoidal function comprising the fundamental oscilla-
tion (24-h component):
f ðtÞ ¼ y0 þ A sin½ð2pt=s24Þ þ c:
Data were ﬁt with a non-linear least-square ﬁtting analysis based upon
the Marquardt–Levenberg algorithm to ﬁnd the coefﬁcients (param-
eters) of the independent variable(s) that give the best ﬁt between the
equation and the data (SigmaPlot for Windows, Version 7.0,
Richmond, CA, USA, Systat Software). The goodness-of-ﬁt of each
sine ﬁt was assessed by calculating the adjusted correlation coefﬁcient
and the power, or the probability that the model correctly describes the
relationship of the variables, if there is a relationship. The statistical
package Statistica (StatSoft 2004, Statistica for Windows, Tulsa, OK,
USA, Version 6.0) was used.
Results
PER2 gene expression in the circadian study showed a clear diurnal
rhythm (Fig. 2a). The sine ﬁt to the data points yielded a good ﬁt with
a r-value of 0.87, and the power that the model correctly describes the
relationship between the variables was 0.99. Maximal PER2 gene
expression in oral mucosa, sampled in 3-h intervals throughout a 30-h
period under controlled dim lighting conditions, occurred between
12.00 and 15.00 h during the biological day, while minimal PER2
expression was found between 21.00 and 03.00 h during the
biological night, deﬁned as the period of melatonin secretion. The
circadian proﬁle of the salivary melatonin exhibited the well-known
time course (Fig. 2a), with maximal values during night-time hours
and low values during daytime. The phase and amplitude of the
melatonin curve was very similar to the one we have recently reported
(Knoblauch et al., 2003).
Figure 2b illustrates changes in PER2 expression and salivary
melatonin in the light study. A ranova with the factor ‘light
condition’ and ‘time of day’ yielded a signiﬁcant effect of ‘time of
day’ (F1,8 ¼ 8.4, P ¼ 0.020) and a signiﬁcant interaction between
‘light condition’ and ‘time of day’ (F2,16 ¼ 4.6, P ¼ 0.027). Post-hoc
comparisons revealed a signiﬁcant increase in PER2 expression after
blue light at 460 nm at 24.00 h (P ¼ 0.032), but not after green light
at 550 nm (P ¼ 0.28). The comparison between blue and green light
at this time point (24.00 h) did not reach signiﬁcance (P ¼ 0.18).
Melatonin was signiﬁcantly suppressed after blue light at 460 nm
(from 12.0 pg ⁄mL to 8.8 pg ⁄mL, P ¼ 0.021), but not after green
light at 550 nm. At this time point PER2 levels are usually near
minimal levels (Fig. 2a).
PER2 gene expression the next morning at 10.00 h no longer
differed signiﬁcantly, nor did melatonin levels. Nonetheless, a
tendency for a lower PER2 gene expression was found after blue light
at 460 nm when compared with green light at 550 nm (P ¼ 0.098).
In the scatter plot showing individual data (Fig. 2c), for most of the
subjects values > 1.0 can be observed at 24 h after blue light, but also
for some subjects after green light and for two subjects in the dark
condition. However, only in the blue light condition did the values at
24.00 h differ signiﬁcantly from the 18.30 h values (paired t-test
P ¼ 0.017). For most of the subjects in the blue light condition, the
values at 10.00 h the next morning decreased and a trend for lower
values after blue light when compared with the green light was found
(see paragraph above).
Discussion
We were able to show rhythmic expression of a clock gene PER2 in
peripheral human tissue collected non-invasively from the oral
mucosa. In addition, our ﬁndings provide the ﬁrst evidence in humans
that a circadian regulator gene, PER2, acutely responds to light.
Importantly, this response to light was clearly wavelength-dependent,
such that the increase in PER2 after light is blue-shifted relative to the
three-cone visual photopic system, supporting a role of the novel ‘non-
photic’ photoreceptors at the level of human clock gene expression.
Circadian expression of PER2 in our study peaked on average 12 h
later, during the biological day at 15.00 h, with respect to maximal
melatonin expression at 03.00 h. Although a bit later into the day, it is
in accordance with Boivin et al. (2003), who reported peak PER2
expression mostly during the habitual time of activity (around noon) in
human peripheral blood mononuclear cells.
We have evidence that the induction of PER2 is acutely
stimulated by evening light exposure in the human mucosa. Studies
in rats show that the clock of peripheral tissues, such as liver and
kidney, takes more time to adjust its phase to a shifted light–dark
cycle compared with the SCN (Yamazaki et al., 2000). In contrast,
our study indicates that oral mucosa might be a tissue that responds
rather quickly to such changes as shown by the rapid response of
the PER2 gene to light in this tissue. Whether this represents an
acute stimulation of PER2 in the central circadian clock in the SCN
can not be conclusively proven in this study. However, the light-
evoked reduction of melatonin and increase in core body tempera-
ture and heart rate published in the same subject sample (Cajochen
et al., 2005) are clear indications for non-visual circadian effects of
light, which are mediated by the SCN. Therefore, we assume that
the light effects reported here on PER2 were most likely mediated
via the circadian system. Further support for this comes from the
fact that only the short-wavelength light (i.e. blue light) evoked this
effect. It is known that the human circadian system is particularly
sensitive to non-visual effects of ocular light at short wavelengths
via novel photoreceptors (Provencio et al., 2000; Hankins & Lucas,
2002; Hattar et al., 2002; Gooley et al., 2003).
The demonstration of a functional circadian machinery in human
buccal samples and its response to the most important Zeitgeber light
suggests that this method may be useful for the investigation of human
circadian rhythms at the gene level and their associated disorders.
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4.3.1 Additional data 
PER1 and BMAL1 expression was measured in the same samples that had been used for the 
circadian study (Cajochen et al., 2006). Both PER1 and BMAL1 mRNA levels showed a clear 
diurnal rhythm as it had been reported for PER2 in the same samples (add. fig. 1). BMAL1 
expression peaked in anti-phase to PER1 and PER2. However, peak clock gene expression 
varied between subjects. PER1 was high in the morning between 9:00 and 12:00 h. Variations 
in PER2 expression were more prominent. In subjects 8 and 10 it peaked between 12:00 and 
15:00 h while it reached its summit at 6:00 h in subject 9. BMAL1 profiles of subject 8 and 10 
were rather similar with peak expression at 3:00 and 24:00 h, respectively. In subject 9, 
BMAL1 levels were highest at 18:00 h. 
 
Additional figure 1: Twenty-four hour profile for PER1, PER2, and BMAL1 expression in 
human oral mucosa of three subjects. Samples were taken in 3 h intervals under dim light 
conditions (< 15 lux) throughout a 30 h period. Values are represented as mean ± SEM for all 
replicates (N  9). 
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4.4 The effect of blue light on the human circadian system in 
the morning 
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Text 
Humans and other mammals receive light information affecting the circadian system mainly 
via a subset of non-visual intrinsically photosensitive retinal ganglion cells (ipRGC) situated 
in the inner retina (Berson et al. 2002; Moore et al. 1995; Provencio et al. 2000; Sekaran et al. 
2003). These cells express the blue-light sensitive photopigment melanopsin (Gooley et al. 
2001; Hattar et al. 2002; Lucas et al. 2001; Provencio et al. 2000) and send photic information 
directly to the SCN via the RHT (Moore and Lenn 1972). Since exposure to short-wavelength 
light has a huge impact on mood and vitality, disturbances in the ipRGC photoreception can 
lead to physiological and psychological problems (Buijs et al. 2006; Klerman 2005). For 
instance, blue light exposure acutely increases core body temperature, heart rate (Cajochen et 
al. 2005), alertness (Cajochen et al. 2005; Lockley et al. 2006) and cognition (Vandewalle et 
al. 2007). With age, the crystalline lens absorbs more light (Pokorny et al. 1987; Turner and 
Mainster 2008; Weale 1985) and the pupil area decreases (Verriest 1971; Yang et al. 2002); 
thus, blue light transmission is reduced. This could result in impaired circadian 
photoreception (Herljevic et al. 2005) and be in part responsible for the changes observed in 
the sleep-wake cycle and circadian rhythmicity in the elderly (Bliwise 1993; Duffy et al. 
1998). 
The clock genes Per1 and Per2 are differentially inducible by a nocturnal light pulse in mice 
(Albrecht et al. 1997; Yan and Silver 2002). In humans evening blue light can induce 
expression of PER2 in oral mucosa (Cajochen et al. 2006).  The aim of the present study was 
to investigate whether early morning blue light exposure is also capable of influencing PER2 
levels in human oral mucosa and in addition, whether such a change would be age-dependent.  
Eleven young (23.0 ± 2.9 years) and fifteen old (65.8 ± 5.0 years) healthy males participated 
in this study and were pupil dilated and subjected to a 2 h intermittent monochromatic light 
exposure 8.5 h after their individual dim light melatonin onset (DLMO); for protocol details 
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see Sletten et al. (in press). As the time of light administration, the portion of the light phase 
response curve was chosen where advances have been demonstrated to show the highest 
amplitude (Revell and Eastman 2005). Subjects received blue (max 456 nm) or green (max 
548 nm) light matched for photon density (6 x 10
3
 photons/cm
2
/s) on separate occasions. Oral 
mucosa was sampled at clock times equivalent to 0.5, 5.0, and 10.0 hours after light exposure 
on a baseline day and 24 hours later on the day of light exposure (Fig. 1).  
Some samples were lost from analysis as PER2 levels could not be determined in every 
sample due to insufficient amounts of mRNA (young N = 6-11; old N = 7-13; for both green 
and blue light). We found that PER2 expression levels were significantly increased in young 
subjects 10.0 h after blue, but not green, light (Fig. 2A, B). By contrast, neither blue nor green 
light had an effect on PER2 expression in oral mucosa samples of older subjects (Fig. 2C, D). 
In addition, the overall baseline amplitude of PER2 expression was lower by about 50 % in 
the elderly compared to the young – this amplitude phenomenon has been reported previously 
for circadian rhythms in temperature and sleep (Carrier et al. 1996; Monk et al. 1995).  
The effect of early morning blue light on PER2 expression is probably due to a shift of the 
baseline expression curve, because the 0.5 hour sample does not show acute PER2 mRNA 
induction (Fig. 2A, C). By contrast, blue light applied in the evening results in an acute 
induction of PER2 in human oral mucosa after 0.5 hours (Cajochen et al. 2006). This time 
dependent acute inducibility of human PER2 is in line with previous observations in mice 
where Per2 is acutely induced in the early dark phase but poorly in the late dark phase 
(Albrecht et al. 1997; Yan and Silver 2002). 
Therefore the significant difference of PER2 levels in young subjects 10 hours after the blue 
light pulse versus no light is likely due to a phase shift of the mRNA expression curve (Fig. 
2A). However, our data do not provide information about the direction of the shift. 
Nevertheless, plasma melatonin profiles from the same subjects indicate a phase advance of 
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the clock caused by early morning blue light (Sletten et al. in press). Interestingly, evening 
blue light not only causes an acute induction of PER2 in oral mucosa, but it also appears that 
PER2 levels tend to be lower compared to controls 10 hours after light administration 
(Cajochen et al. 2006), Fig. 2b). This indicates a potential phase delay due to evening blue 
light. Taken together, it appears that light has comparable effects on human PER2 mRNA 
levels as previously observed in mice. Furthermore, our results in humans indicate that ageing 
impairs light activated responses impinging on the circadian system (Fig. 2C) as previously 
observed in hamsters (Zhang et al. 1996) and humans (Herljevic et al. 2005; Sletten et al. in 
press). 
In conclusion, the current results highlight similarities in the light response of the circadian 
system between rodents and humans. In addition, our report illustrates that buccal samples are 
a valuable tool for studying the response of clock genes to light in humans. 
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Appendix (Materials & Methods) 
The study protocol was as described by Sletten et al. (in press). The collection of human oral 
mucosa and the subsequent RNA isolation, cDNA synthesis and quantitative real-time RT-
PCR for GAPDH and PER2 were performed as described previously (Cajochen et al. 2006). 
2
CT
 value per mucosa sample was calculated according to the following formula (X = gene of 
interest and a, b and c correspond to replicate 1, 2 and 3): 
2
CT 
 =  (2
GAPDHa – Xa
 + 2
GAPDHa – Xb
 + 2
GAPDHa – Xc
  
  + 2
GAPDHb – Xa
 + 2
GAPDHb – Xb
 + 2
GAPDHb – Xc
  
  + 2
GAPDHc – Xa
 + 2
GAPDHc – Xb
 + 2
GAPDHc – Xc
) / 9 
For statistical analysis, the mean 2
CT 
value was used for every subject. 
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Figure Legends 
Figure 1: Overview of the protocol design. The figure illustrates an example protocol for a 
participant maintaining a 2300-0700 h sleep schedule with light and buccal sampling timed 
according to a dim light melatonin onset (DLMO) at 2100 h. Subjects had to maintain a 
consistent, self-selected sleep schedule 7 days prior to and throughout the study. In the 
laboratory, the volunteers took part in a baseline phase assessment followed by an 
experimental light session where they were subjected to 2 h of either blue (single-hatched) or 
green (cross-hatched) light in the early morning. Oral mucosa was sampled at identical time 
points on the baseline day (between night 1 [N1] and N2) and 0.5, 5.0, and 10.0 h after the 
light administration (between N2 and N3). The entire protocol was carried out under 
controlled light levels, posture and meals.  
 
Figure 2: Age- and wavelength-dependent changes in PER2 expression in human oral 
mucosa. Young and old subjects were exposed to either 2 h of monochromatic blue (max 456 
nm) or green (max 548 nm) light. PER2 expression was measured using quantitative real-time 
PCR. Data are represented as mean ± SEM, N for each condition and time point is indicated at 
the bottom of the respective bars. Samples taken after the light pulse were compared to the 
matching baseline samples (taken between N1 and N2). * p = 0.0380 as determined by 
unpaired t-test. 
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Figure 1 
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Figure 2 
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4.4.1 Additional data 
PER1 (add. fig. 1) and BMAL1 (add. fig. 2) expression was studied in the same samples but 
the sample numbers were too low to make any definite conclusions.  
Pooling all the data irrespective of age did not reveal significant differences for all three genes 
measured (add. fig.  3). 
 
 
 
 
Additional figure 1: PER1 expression in human oral mucosa. Young (A/B; N = 3-10) and old (C/D; 
N = 7-13) subjects were exposed to either 2 h of monochromatic blue (A/C; max 456 nm) or green 
(B/D; max 548 nm) light. PER1 expression was measured using quantitative real-time PCR. Data are 
represented as mean ± SEM, N for each condition and time point is indicated at the bottom of the 
respective bars. Samples taken after the light pulse were compared to the matching baseline samples 
(taken between N1 and N2). Unpaired t-test did no reveal significant differences. 
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Supplemental figure 2: BMAL1 expression in human oral mucosa. Young (A/B; N = 3-7) and old 
(C/D; N = 3-9) subjects were exposed to either 2 h of monochromatic blue (A/C; max 456 nm) or 
green (B/D; max 548 nm) light. BMAL1 expression was measured using quantitative real-time PCR. 
Data are represented as mean ± SEM, N for each condition and time point is indicated at the top of the 
respective bars. Samples taken after the light pulse were compared to the matching baseline samples 
(taken between N1 and N2). Unpaired t-test did no reveal significant differences. 
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Supplemental figure 3: PER2, PER1, and BMAL1 expression in human oral mucosa. Subjects were 
exposed to either 2 h of monochromatic blue (A/C/E; max 456 nm) or green (B/D/F; max 548 nm) 
light. PER2 (A/B; N = 13-21), PER1 (C/D; N = 13-22), and BMAL1 (E/F; N = 6-13) expression was 
measured using quantitative real-time PCR. Data are represented as mean ± SEM, N for each 
condition and time point is indicated at the top of the respective bars. Samples taken after the light 
pulse were compared to the matching baseline samples (taken between N1 and N2). Unpaired t-test 
did no reveal significant differences. 
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5 Discussion and Perspectives 
Most interpretations that arise from the work presented here have been elaborated in the 
discussion part of the included publications. Therefore this part will try to elucidate some 
additional aspects of our results. 
 
5.1 Development of circadian rhythms in mammals 
5.1.1 Discussion 
The aim of this study was to investigate whether the emergence of circadian rhythms in 
mammals is dependent on a functional maternal clock - a question that has been of interest for 
many years. Maternal entrainment of the fetal clock has been documented in many studies 
(Reppert & Schwartz, 1983; Reppert et al., 1984; Davis & Gorski, 1985; reviewed in: 
Reppert, 1995). However, maternal influence on the circadian system of the offspring differs 
tremendously between species. In precocial species (i.e. highly developed at birth; e.g. guinea 
pigs, spiny mice and sheep), maternal entrainment ends at birth and the prevailing light-dark 
cycle becomes the strongest Zeitgeber for them. By contrast, the maternal circadian system 
continues to coordinate the timing of altricial pups (i.e. less developed at birth; e.g. humans, 
mice, rats or hamsters). In addition, other experiments have shown that the clock was 
unaffected in pups born to SCN-lesioned dams. By contrast, synchrony between pups was 
altered (Reppert & Schwartz, 1986; Davis & Gorski, 1988). 
The present study was the first one to investigate the emergence of circadian rhythms in 
offspring of genetically ablated females. It was found that heterozygous offspring born to 
Per1
Brdm1
Per2
Brdm1
 or Per2
Brdm1
Cry1
-/-
 double mutant arrhythmic females crossed with wild-
type males under constant conditions developed normal circadian wheel-running behaviour. 
However, their clocks were less synchronized to each other as compared to wild-type 
controls. These results indicate that the development of circadian clocks is genetically 
predetermined and does not depend on a functional maternal clock or prenatal Zeitgebers. 
Interestingly, similar observations were reported for Drosophila. Flies raised under constant 
darkness and temperature developed robust circadian locomotor activity but at random phases 
(Sehgal et al., 1992). Hence one can assume that circadian rhythms in humans may emerge in 
an analogous way. However, this hypothesis is difficult to prove because studies in humans 
are limited due to ethical considerations. Table 5-1 summarizes what is known about the fetal 
development of the circadian system in humans. 
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All of those who have had children can confirm that unfortunately babies do not follow 
circadian rhythms in sleep-wake cycles. This observation is rather surprising, knowing that 
circadian rhythms develop early in utero (Reppert & Schwartz, 1984; Reppert, 1992). In 
humans, the SCN become visible as early a time as 18 weeks of gestation (Reppert et al., 
1988). At about the same time (20-22 weeks), circadian rhythms in heart rate, respiration, and 
movements become apparent (De Vries et al., 1987). However, these rhythms seem to be 
driven by maternal signals that are able to cross the placenta (Honnebier et al., 1989). 
Nonetheless, strong external signals may set circadian phase in the fetal SCN as suggested by 
experiments performed in squirrel monkeys (Reppert & Schwartz, 1984). These observations 
are in line with results obtained during a construction period at our university. All of a sudden 
the otherwise not synchronized Per1
Brdm1
Per2
Brdm1
 heterozygous offspring showed marked 
within-litter synchrony for clock phase. 
 
Table 5-1: Development of the human circadian system: prenatal to postnatal (adapted from: Allen, 2000). 
Gestational age Cycle characteristics Significant features 
3-6 weeks Monkey SCN neurogenesis. Squirrel monkey, also likely for humans. 
18 weeks Human SCN detected. 
 
Fetal circadian rhythms develop. 
Melatonin labeling; likely present earlier, but not 
studied. 
Heart rate, respiration, adrenal function linked to 
mother’s cycle by melatonin, nutrients, etc. 
(circadian stimulation aids development for 
premature infants). 
End of gestation SCN show internal circadian metabolic cycle. Confirmed by studies in monkeys; unknown but 
assumed for humans. 
Birth Labor onset most likely during early morning. 
 
Most infant circadian phases match maternal 
phases. 
Linked mostly to maternal cycle; may be influenced 
by fetal cycles. 
Some infants are out of phase with their mothers, 
uncertain significance of this lack of synchrony. 
1-2 weeks Loss of most fetal circadian rhythms. No 
melatonin rhythm. Some entrainment to low-
level lights. Human SCN not fully matured. 
No clear circadian pattern of activity.  
 
Multiultradian sleep-wake cycles. 
Fetal heart rate, respiration cycles lost. No clear 
temperature cycle. Demonstrated for baboons and 
humans. 
Vasopressinergic neurons 13 % of adult levels. 
Demonstrated for baboons and humans. 
Near random alterations of sleep-wake times, mostly 
sleep. 
1-2 months Circadian activity rhythm develops. Sleep 
begins to occur more at night. 
Temperature nadir in early morning by week 4. 
3-4 months Sleep mostly at night (70 % of children). 
Ultradian pattern stabilizes. 
Melatonin production clearly present. 
One solid sleep period at night for 70 % of children.  
Midday naps begin to develop – usually 2-3 naps. 
Melatonin rhythm appears, gradually increases to 
month 6. 
 
To sum up, this study demonstrates that circadian rhythms develop autonomously and do not 
need a functional circadian clock in maternal tissue. In addition, these results are similar to 
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what has been observed in other organisms suggesting that they can be extrapolated to 
humans. The more we understand about the development of circadian rhythms in the fetus 
and the neonate the better they will be shephered from a chronobiolgical point of view. 
Alarmingly, most preterm babies face the timeless environment of the Neonatal Intensive 
Care Nursery because perinatal chronomedicine is still in the fledgling stages.  
 
5.1.1 Perspectives 
To really test whether the results obtained in mice can be extrapolated to humans one would 
have to study the development of circadian rhythms in a fetus carried by a woman who has no 
functional SCN under constant conditions. In humans, two case reports show that tumors and 
congenital lesions in the SCN region result in the loss of temperature rhythms (Schwartz et 
al., 1986) and disorganized sleep-wake patterns (Rivkees, 2001). These findings are similar to 
what has been reported in SCN-lesioned rodents (Moore & Eichler, 1972; Stephan & Zucker, 
1972). However, it will be almost impossible to find such a woman who is willing to 
participate in such an experiment during pregnancy. Moreover, ethical constraints will further 
impede on the realization of such a study. 
Alternatively, one could conduct the study in baboons or squirrel monkeys that are likely very 
close to humans. Nonetheless, experiments performed on apes are heavily contested 
nowadays too.  
 
5.2 Analysis of Rev-Erb /Per1 double mutant mice 
5.2.1 Discussion 
To better understand the interplay between Rev-Erb and Per1 within the circadian clock 
machinery we generated mice deficient for these two genes. Subsequently, the double mutant 
animals were tested for their basic wheel-running behaviour, their response to light, the 
expression of core clock genes and other parameters. We found that mice mutated for Rev-
Erb and Per1 displayed rather normal wheel-running behaviour. However, their circadian 
period in DD was dramatically shortened compared to single mutants and wild-types. 
Strikingly, administration of brief light pulses provoked high amplitude resetting in Rev-
Erb-/-Per1Brdm1 double mutant mice. Moreover, Cry1 became inducible after a light pulse 
delivered at CT22 but not CT14 in these mice. This observation is surprising because Cry1 
was thought not to respond to light pulses at all in mammals (Okamura et al., 1999; Field et 
al., 2000). By contrast, Cry1a has been identified to be a key player in light entrainment of 
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the zebrafish clock as part of a signaling pathway to the circadian pacemaker (Tamai et al., 
2007). In the past few years, Danio rerio became one of the most valuable lower vertebrate 
models for studying circadian clock function. It is thought that the teleost circadian system 
might be the more ancestral vertebrate clock that became far more specialized in mammals 
due to selective pressure. Hence Rev-Erb and Per1 might have acquired additional features, 
which prevent strong resetting in mammals. Contrary to mammals, most if not all, of the 
zebrafish tissues are directly light responsive (Whitmore et al., 1998 & 2000; Yoo et al., 
2004), as it is the case for Drosophila (Vansteensel et al., 2008). The fruit fly has one single 
cryptochrome gene that acts as a blue light photopigment by binding TIM and PER upon light 
activation. This interaction causes the subsequent degradation of the protein complexes 
(Ceriani et al., 1999; Rosato et al., 2001; Busza et al., 2004). Mutants lacking Cry were 
unable to shift their clocks in response to light (Stanewsky et al., 1998). Originally, 
cryptochromes were identified in Arabidopsis thaliana as a photoactive pigment with high 
homology to photolyases (Ahmad & Cashmore, 1993). In mammals, the role of the 
cryptochromes is less clear. Both homologs are expressed in the inner retina as well as the 
SCN (Miyamoto & Sancar; 1998; Thompson et al., 2003). They accomplish light-
independent negative regulatory functions in the transcriptional feedback loop to help to run 
the circadian clock (Kume et al., 1999; Van der Horst et al., 1999; Vitaterna et al., 1999). 
Apart from this, there is a big controversy in the field whether cryptochromes act as 
photoreceptors in mammals too. Some state that cryptochromes are not required  for 
photoentrainment mainly due to the results of one study. Okumara and co-workers (1999) 
showed that Cry1
-/-
Cry2
-/- 
double mutants were still able to reset their clock upon a light 
pulse. However, mice carrying a retinal degeneration mutation (rd; depleting rods and cones) 
and lacking both cryptochromes were no longer able to react to light. Induction of cFos was 
increased in rd/rd mutants compared to wild-types while it was drastically decreased in mice 
lacking Cry1 and Cry2. In the triple mutants, cFos induction was virtually eliminated (Selby 
et al., 2000; Van Gelder et al., 2002). Interestingly, mice lacking all visual opsins (rd/rd) and 
melanopsin (Opn4
-/-
) have lost all photoresponses. By contrast, mice deficient for melanopsin 
only showed a normal response to light (Hattar et al., 2003; Panda et al., 2002 & 2003; Ruby 
et al., 2002). However, these findings are questioned by recent studies, which demonstrated 
that the ablation of melanopsin cells altered the effects of light on circadian rhythms (Göz et 
al., 2008; Hatori et al., 2008). To summarize, these data suggest that phototransduction to the 
SCN by cryptochromes requires melanopsin or the outer retina (Partch & Sancar, 2005). 
Moreover, mice mutant for retinol-binding protein (rbp) as well as Cry1 and Cry2 kept on a 
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vitamin A-free diet have no cFos induction compared to rbp
-/-
 controls. This indicates that 
cryptochromes are required for photoreception in mice depleted of ocular retinal (Thompson 
et al., 2004). Altogether, these data strongly suggest a role for mouse cryptochromes in 
photoreception. 
Considering that we found a light inducibility of Cry1 in Rev-Erb-/- Per1Brdm1 double 
mutants, our data strengthen the idea that mammalian cryptochromes might be involved in 
light signaling. Moreover, our findings suggest that Rev-Erb and Per1 suppress Cry1 
induction. However, the mechanisms beneath Cry1 regulation have to be further elucidated. 
To better understand what is going on, it would be interesting to investigate Cry2 induction 
by light in the double mutants. In humans, CRY2 has been reported to be highly abundant in 
the inner retina. From this, it has been concluded that CRY2 could be involved in 
photoreception (Thompson et al., 2003). Another interesting attempt would be to study 
whether Rev-Erb-/-Per1Brdm1 fibroblasts become directly light sensitive, as it is the case for 
zebrafish cells. If this would be the case, Rev-Erb-/-Per1Brdm1 cells would be an attractive 
model system for studying light input to the circadian clock in mammals. These cells would 
offer an alternative to the synthetically produced photo-responsive melanopsin complemented 
NIH3T3 cells (Ukai et al., 2007). Moreover, this would further strengthen the hypothesis that 
Rev-Erb and Per1 exhibit a gain of function phenotype in mammals. All of a sudden the 
famous but discredited “light behind the knee experiment” (Campbell & Murphy, 1998) 
would make again some sense – at least if it would have been performed in subjects carrying 
mutations in Rev-Erb and Per1. 
 
5.2.2 Perspectives 
As already mentioned in the discussion part, it would be interesting to study the light 
responsiveness of Rev-Erb-/-Per1Brdm1 fibroblasts. However, before starting these 
experiments one should study the responsiveness of the cells to serum or dexamethasone. 
This experiment will tell, whether Rev-Erb-/-Per1Brdm1 fibroblasts are synchronized normally 
and whether clock genes are induced comparable to wild-type cells. Hence one can exclude 
that an eventual difference observed after light administration is just due to general 
differences in the cells. In a next step, the fibroblasts have to be exposed to light and it has to 
be tested whether clock genes are induced. If this were the case, one would have to repeat the 
experiment in the presence of a protein synthesis inhibitor (e.g. hexamide). Hence one can 
find out whether eventual RNA induction is based on de novo protein synthesis. Moreover, it 
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would be interesting to test the effect of different wavelengths (i.e. blue, green, red) on the 
cells. Last but not least, one could transfect the cells with a luciferase reporter construct and 
follow the expression of the reporter in real time in the lumicycler. Finally, one could apply 
light pulses at different phases and record the shifts. 
Another interesting approach to clarify whether Cry1 induction alone leads to the Type 0 PRC 
in animals deficient for Rev-Erb and Per1 would be to generate mice triple mutant for Cry1, 
Rev-Erb and Per1. If these mice would show normal light resetting, the importance of Cry1 
in this high amplitude resetting would be underlined. However, it is generally rather difficult 
to obtain triple mutants due to fertility problems. 
In addition, it would be important to analyze what happens within the SCN and with single 
neurons following a light pulse at CT22. It is known that only a subset of mostly ventrolateral 
SCN neurons receive retinal input and seem to shift their clocks immediately (Albus et al., 
2005). These neurons then send a synchronizing signal to the rest of the SCN neurons. In 
parallel, the SCN constantly receives feedback information from other brain areas (e.g. sleep 
centers, locomoter-associated areas). These signals can attenuate phase shifts (Vanstensel et 
al., 2003). In this context it would be interesting to study VIP in the double mutants because 
VIP is supposed to synchronize mammalian clock neurons and to maintain their rhythmicity 
(Aton et al., 2005). Indeed, preliminary results suggest that this is a good approach. We found 
that VIP was expressed in a circadian fashion in wild-type and especially Rev-Erb-/- 
Per1
Brdm1
 double mutant mice. Interestingly, VIP seemed to be light inducible in the double 
mutant animals after a light pulse at CT22. However, these results should be interpreted with 
caution because only one animal was analyzed per time point. For instance, double mutants 
show higher basal VIP levels at CT22 and lower levels for the dark control taken at CT23. 
Nonetheless, VIP expression seems to differ between the two genotypes and could be an 
interesting target for further research. 
 
5.3 The influence of light on clock gene expression in humans 
In our modern society, investigation of human circadian rhythms and their associated 
disorders is a hot topic because they represent a huge risk for health and welfare. People 
suffering from sleeping disorders, jet-lag, shift work associated disorders, or mood 
disturbances are less performing at work. Due to such disturbances of the circadian system, 
industry loses tremendous amounts of money every year. Hence, analyzing human tissue for 
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clock gene expression may be a useful tool to better understand the mechanisms underlying 
these disorders. 
For this purpose we developed a non-invasive method to measure and quantify clock gene 
expression in human oral mucosa. We demonstrated that PER1, PER2, and BMAL1 were 
expressed rhythmically in buccal cells. Interestingly, PER1 and PER2 mRNA accumulation 
occurred in anti-phase to BMAL1 expression as it has been described for rodents (Abe et al., 
1998; Albrech et al., 1997). Moreover, our findings are in accordance with Bjarnason et al. 
(2001), who reported similar expression profiles for PER1 and BMAL1 in human oral mucosa 
and skin biopsies taken under local anesthesia. Hence our results confirm the existence of a 
functional circadian machinery in human buccal cells. 
Once the accuracy of our method had been proven we tested the influence of blue light on 
PER2 expression in human mucosa. Interestingly, the effect of blue light on PER2 mRNA 
levels varied depending on the time it was perceived. Evening blue light exposure acutely 
induced PER2 expression while early morning blue light had no immediate effect. These 
findings parallel observations for Per2 in mice (Albrecht et al., 1997; Yan & Silver, 2002). In 
contrast to evening blue light, early morning blue light significantly increased PER2 mRNA 
levels 10.0 hours after the light pulse. This increase is probably due to a phase shift of the 
PER2 expression curve. However, our data do not provide information about its direction. 
The effectiveness of light administration was not only time-dependent but varied also with 
wavelength. All effects on PER2 expression were only observed after blue, but not green, 
light. Our findings indicate that the changes in PER2 mRNA levels are due to non-visual 
effects of the circadian system, which are mediated by the SCN. The spectral sensitivity of the 
response in young subjects is in accordance with multiple studies in humans assessing non-
visual light responses (Brainard et al., 2001; Thapan et al., 2001; Cajochen et al., 2005; 
Lockley et al., 2003; Revell et al., 2005 & 2006). 
Moreover, early morning blue light had no effect on PER2 expression in the elderly. These 
data support the diminished response to blue light observed in older people in both the 
subjective alerting response (Sletten et al., in press) and melatonin suppression response 
(Herljevic et al., 2005). This observation could be explained in part by the fact that, with age, 
the crystalline lens progressively transmits less light (Pokorny et al., 1987; Turner & 
Mainster, 2008; Weale, 1985). Consequently, less light information reaches the SCN.  
 
In conclusion, our findings demonstrate that human buccal samples are a valuable tool for 
studying the response of PER2 to light and clock gene rhythms. Hence, this method could 
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help shed more light onto the molecular mechanisms underlying disorders associated with the 
internal clock. Moreover, this study proves that findings obtained in rodents or other model 
organisms are of great use for the understanding of the human circadian system. Ongoing 
experiments in healthy and ill subjects still take advantage of this method. Increasing 
knowledge will allow the development of better therapeutic approaches for human circadian 
disorders caused by ageing or diseases. 
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6 Materials and Methods 
6.1 Materials 
6.1.1 Chemicals and solvents  
Product Manufacturer  Cat. Number  
ABTS SIGMA-ALDRICH A 1888 
Acetic acid (glacial) 100 % MERCK 1.00063.1000 
Acetic anhydride SIGMA-ALDRICH A 6404 
Agarose (SeaKemLE) Cambrex (BioConcept) 50004E 
Agarose Low Melting (SeaPlaque) Cambrex (BioConcept) 50101 
Ammonium acetate (GR for analysis) MERCK 1.01116.0500 
Ammonium persulfate BioRad 161-0700 
Ammonium sulfate Riedel de Haen 31119 
Ampicillin SIGMA-ALDRICH A 9518 
ATP disodium salt SIGMA-ALDRICH A 7699 
ATP--S, Sp-Isomer Roche 775 746 
Beeswax, bleached, white SIGMA-ALDRICH 243221 
BisBenzimide (Hoechst No. 33258 trihydrochloride) SIGMA-ALDRICH B 2883  
Bovine Serum Albumine, fract. V (BSA) Uptima (Interchim) UP283910  
5-Bromo-4-chloro-3-indoxyl--D-galactopyranoside  Biosynth B-7141 
Bromphenol blue SIGMA-ALDRICH B 0126  
Calciumchloride MERCK 1.02382.0500 
Calf thymus type I DNA SIGMA-ALDRICH D 1501 
Canada Balsam SIGMA-ALDRICH C 1795 
Chloroform Fluka 25690 
Coenzyme A SIGMA-ALDRICH C 3144 
Colophony Fluka 60895 
Coomassie Briliant Blue R250 Fluka 27816 
Dextransulfate SIGMA-ALDRICH D 8906 
Dimethyl sulfoxide (DMSO) Fluka 41639 
di-Potassium hydrogen phosphate trihydrate MERCK 1.05099.1000 
di-Sodium hydrogen phosphate dodecahydrate MERCK 1.06573.1000 
Dexamethasone SIGMA-ALDRICH D 4902 
Dithiothreitol (DTT) SIGMA-ALDRICH D 9779 
DL-Fluorocitric acid SIGMA-ALDRICH F 9634 
Dimethylsulfoxid (DMSO) Fluka 41639 
DNA from Herring Sperm Roche 223 646  
EDTA Fluka 03680 
EGTA Fluka 03779 
Ethanol Fluka 02860 
Ethidiumbromide  Fluka 46067 
Formaldehyde solution min. 37 % MERCK 1.04003.1000 
Formamide (for molecular biology) Fluka 47671 
Glycerol 87 % Fluka 49782 
Glycine Fluka 50046 
Goat serum SIGMA-ALDRICH G 9022 
HEPES Fluka 54461 
Herring sperm DNA SIGMA-ALDRICH D 3159 
Hydrochloric acid MERCK 1.00317.1000 
Isopropanol (anhydrous 99.8+ %) Acros Organics 149320010 
Kanamycin sulfate Fluka 60615 
Linear polyethyleneimine 25 kDa (LINPEI25) Polysciences Europe 23966-5 
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Lithium chloride Fluka 62480 
Luciferin (D) SIGMA-ALDRICH L 6882 
Magnesium chloride hexahydrate MERCK 1.05833.0250 
Magnesium sulphate anhydrous Fluka 63135 
Manganese chloride SIGMA-ALDRICH M 3634 
2-Mercaptoethanol Fluka 63690 
Methanol Fluka 65543 
Methyl salicylate Fluka 84330 
MOPS (3-Morpholinopropanesulfonic acid) Fluka 69947 
MUG SIGMA-ALDRICH M 1633 
NADP
+ 
SIGMA-ALDRICH 240-305 
NADPH SIGMA-ALDRICH N-1630 
Paraformaldehyde (granules) Electron Microscopy Sciences  19280 
Paraplast tissue embedding medium (Paraffin) McCormick
TM
(Medite) 81076100  
Paraquat CL tetrahydrate SIGMA-ALDRICH PS366 
Phenol Acros Organics 327105000 
PIPES SIGMA-ALDRICH P 1851 
Potassium chloride Fluka 60130 
Potassium dihydrogen phosphate MERCK 1.04873.1000 
Potassium hydroxide Fluka 60375 
2-Propanol Fluka 59300 
Rabbit Serum SIGMA-ALDRICH R 9133 
Rapilait (skim milk powder) Migros  
Select Agar GIBCO BRL  30391-023 
Select Peptone 140 GIBCO BRL  30392-021 
Select Yeast Extract GIBCO BRL  30393-029 
Sodium acetate MERCK 1.06268.0250 
Sodium azide Fluka 71290 
Sodium chloride  MERCK 1.06404.5000 
Sodium cyanide SIGMA-ALDRICH S 3296 
Sodium dihydrogen phosphate monohydrate GR MERCK 1.06346.0500 
Sodium dodecyl sulphate (SDS) Carl Roth GmbH & Co. 2326.2 
Sodium fluoride SIGMA-ALDRICH S 7920 
Sodium hydrogen phosphate dodecahydrate Fluka 71650 
Sodium hydroxide MERCK 1.06498.1000 
Sodium hypochlorite 13-14 % Schweizerhall 28804 
Sodium orthovanadate (Na3VO4) SIGMA-ALDRICH S 6508 
Spermidine MERCK 7904.0001 
Spermine tetrahydrochloride SIGMA-ALDRICH S 2876 
Sucrose Fluka 84105 
TEA SIGMA-ALDRICH T 1377 
TEMED Fluka 87687 
TRIS Ultra Qualität Carl Roth GmbH & Co. 5429.3 
tri-Sodium citrate dihydrate MERCK 112005.0100 
Triton-X 100 Fluka 93426 
t-RNA (from baker's yeast) Roche 109 495 
Tween-20 Fluka 95773 
Uridine-5'-triphosphate [-35S] PerkinElmer NEG-039H 
Xylene cyanole FF SIGMA-ALDRICH X 4126 
Xylene Fluka 95690 
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6.1.2 Kits and ready for use solutions   
Kit Manufacturer Cat. Number 
Absolutely RNA nanoprep Kit Stratagene 400 753 
Corticosterone 
3
H RIA Kit (rat & mouse) MP Biomedicals 07-120002 
ECL
TM
 Western Blotting Analysis System GE Healthcare (Amersham) RPN2109 
FastLane Cell cDNA Kit Qiagen 215011 
iQ SYBR Green Supermix BioRad 170-8880 
iQ Supermix BioRad 170-8862 
Megaprime DNA Labelling System GE Healthcare (Amersham) RPN1606 
Illustra
TM
 ProbeQuant
TM 
G-50 Micro Columns GE Healthcare 28-9034-08 
PureYield
TM
 Plasmid Maxiprep System Promega A2393 
QIAfilter
TM
 Plasmid Maxi Kit (25) Qiagen 12263 
QIAprep Spin Miniprep Kit (250) Qiagen 27106 
QIAquick Gel Extraction Kit (50) Qiagen 28704 
RNAMaxx
TM
 High Yield Transcription Kit Stratagene 200339 
S.N.A.P.
TM
 Gel Purification Kit Invitrogen K1999-25 
TOPO TA Cloning

 Kit Dual Promoter (with Invitrogen K4600-40 
PCR

II-TOPO

 Vector) 
TOPO

 XL PCR Cloning Kit (with  Invitrogen K4750-20 
PCR

 XL-TOPO vector) 
Premix Ex Taq
TM
 (Perfect Real Time) TaKaRa RR039 
Vectastain

 Elite

 ABC Kit (rabbit IgG) Vector Laboratories PK-6101 
Vectastain

 Elite

 ABC Kit (goat IgG) Vector Laboratories PK-6105 
Wizard

 SV Gel and PCR Clean-Up System Promega A 9281  
Solution Manufacturer Cat. Number 
Aquatex Merck 1.08562.0050 
Attane
TM
 Isoflurane ad us. vet. Provet AG QN01AB06 
BCA
TM
 Protein Assay Kit Thermo Scientific (Pierce) 23227 
Bradford Protein Assay Bio-Rad 500-0006 
Developer D-19 Kodak (SIGMA) P-5670  
Denhardt’s solution SIGMA-ALDRICH D 2532 
Fast
TM
 3,3’-Diaminobenzidine (DAB) tablet set SIGMA-ALDRICH D 4168 
Fixer Kodak (SIGMA) P 6557  
Kodak liquid emulsion NTB-2 Mandel Scientific Co. Ltd. 165 4433 
OptiPhase "HiSafe" 2 scintillation cocktail Perkin Elmer (Wallac SC/9195/21 
 Scintillation products) 1200-436 
pH 4.0 red buffer Beckman Instruments, Inc. 582517 
pH 7.0 green buffer Beckman Instruments, Inc. 582521 
pH 9.0 buffer solution (Borate) Metrohm 6.2307.120 
pH 10.0 blue buffer Beckman Instruments, Inc. 582525 
Phenol : Chloroform : Isoamyl Alcohol 25:24:1 SIGMA P 2069 
PCR Nucleotide Mix [10 mM] Roche 11 814 362 001 
Primer p(dT)15 for cDNA Synthesis Roche 10 814 270 001 
Protease inhibitor cocktail (compl., EDTA free) Roche 11 873 580 001 
QuickHyb

 Stratagene 201220 
RNA-Bee TEL-TEST, INC. (ams) CS-105B  
RNAlater Qiagen 1017980 
Ultraclear J. T. Backer 3905 
X-ray Developer LX 24 Kodak 507 0933 
X-ray Fixer AL 4 Kodak 507 1071 
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6.1.3 Radioactive chemicals 
Nucleotide Manufacturer Cat. Number 
Deoxycytidine 5’-Triphosphate [-32P] Perkin Elmer NEG513H  
Uridine 5’-(-Thio)Triphosphate [35S] Perkin Elmer NEG 039H 
 
6.1.4 Ladders and enzymes 
Ladder Manufacturer Cat. Number 
1 kb DNA Ladder New England Biolabs N3232L 
100 bp DNA Ladder New England Biolabs N3231L 
2-Log DNA Ladder New England Biolabs N3200G  
Gene Ruler
TM
 50 bp DNA Ladder Fermentas SM0378 
Gene Ruler
TM
 100 bp DNA Ladder Plus Fermentas SM0328 
Precision Plus Protein Dual Color Standard BioRad 161-0374 
Spectra
TM
 Multicolor Broad Range Protein Ladder Fermentas SM1841 
Enzyme Manufacturer Cat. Number 
Catalase [329.3 U/l] Fluka 60640 
CIP (Calf Intestinal Phosphatase) [10 U/l] New England Biolabs M0290L 
Collagenase type I SIGMA-ALDRICH C 0130  
DNase I, RNase-free [10 U/l] Roche 10 776 785 001 
Isocitrate Dehydrogenase SIGMA I-2516 
L-Lactic Dehydrogenase SIGMA L-2625 
Lysozyme Applichem A3711,0010 
M-MLV Reverse Transcriptase (Rnase H
-
) Promega M 3681 
Peroxidase SIGMA-ALDRICH P 1432 
ProofStart
TM
 DNA Polymerase Qiagen 202203 
Proteinase K Roche 1 000 144 
Restriction Enzymes New England Biolabs  
RNase A SIGMA R 5503 
RNasin Promega N211A 
SP6 RNA Polymerase [15 U/μl] Promega P108B 
SuperScript
TM
 II RNase H
-
 Reverse  Invitrogen 18064-014 
Transcriptase [200 U/μl]   
T3 RNA Polymerase [50 U/μl] Stratagene 600111-51 
T4 DNA Quick Ligase New England Biolabs M2200S 
T7 RNA Polymerase [200 U/μl| Stratagene 200339-51 
TaqDNA Polymerase Qiagen 201205 
TrypsinEDTA 10x (0.5 % with EDTA 4Na) Gibco 15400-054 
 
6.1.5 Cell lines 
Name Origin Morphology 
COS-7 Monkey African green kidney, SV40 transformed (Gluzman et al., 1981) fibroblast 
HEK293 Human embryonic kidney, Ad5 transformed (Graham et al., 1977) epithelial-like 
HEPG2 Human Caucasian liver hepatocellular carcinoma (Aden et al., 1979) epithelial-like 
HER911 Human embryonic retina, Ad5 transformed (Fallaux et al., 1996) epithelial-like  
NG108-15 Mouse neuroblastoma  x rat glioma hybrid (Banker & Goslin, 1988) neuronal 
NIH3T3 Mouse NIH Swiss embryo (Jainchill et al., 1969) fibroblasts 
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6.1.6 Cell culture products 
Product Manufacturer Cat. Number 
Amphotericine B SIGMA-ALDRICH A 2411 
Collagenase type I SIGMA-ALDRICH C 0130 
Dexamethasone SIGMA-ALDRICH D 4902 
DMEM high Glucose [4.5 g/l] Amimed (BioConcept) 1-26F01-I 
DMEM high Glucose [4.5 g/l] SIGMA-ALDRICH D6429 
DMEM high Glucose [4.5 g/l] w/o Phenol Red Amimed (BioConcept) 1-26F22-I 
FCS (Fetal Calf Serum) Amimed (BioConcept) 2-01F10-I 
Lab-Tek
 
Chamber slides
TM 
(Permanox, 8 wells) Fisher Scientific B1008Y 
L-Glutamine [200 mM] Amimed (BioConcept) 5-10K00-H 
Linear polyethyleneimine 25 kDa (LINPEI25) Polysciences Europe 23966-5 
Penicillin [10'000 IU/ml]/Streptomycin [10'000 μg/ml] Amimed (BioConcept) 4-01F00-H  
TrypsinEDTA 10x (0.5 % with EDTA 4Na) Gibco 15400-054 
 
6.1.7 Oligonucleotides 
The oligonucleotides have been ordered desalted from Microsynth. 
Name Use DNA sequence 5’3’ 
mCatalaseF ISH probe CAC CTG AAG GAC GCT CAG C 
mCatalaseR ISH probe GTA ATA GGA GAA TAC ACT ATT CTC G 
mDexras1f ISH probe CCA AGA AGA ACA GCA GCT TG 
mDexras1r ISH probe TGG CAA CAC CAA TCA CAG AC 
mDexras1  oligo annealing (antisense) CAT GGG GTA GAG GGG CC 
mDexras1  oligo annealing (sense) CCT CTA CCC 
mDexras1Pf reporter construct CTA GAT CTA GCT GAT GAG TCC 
mDexras1Pr reporter construct GGT GTA AGC ATC CTC GAA ACG 
mFxr2f ISH probe GTC AAT TCC AGT TCC CTT GCA ACC 
mFxr2r ISH probe GTC TCT TCA CCC AAC TCA ATG G 
mMkp1f ISH probe CAA CGT CTC AGC CAA TTG TCC 
mMkp1r ISH probe GAG CCT CTC CCA GAG TTA TTG C 
mPrkcaF ISH probe CCA TCA GTG GGA AGT GAT CC 
mPrkcaR ISH probe TGG TTG TGC TAT GAT GAC TG 
mRor1f full length clone AAA ACA TGG AGT CAG CT 
mRor1r full length clone TTT GTA CTC CAG ATG TTC TAG A 
mRor4f full length clone CGT AAA GGA TGT ATT TTG TGA T 
mRor4r full length clone CTC TTA CTT TCA TGT TGT ACT C 
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6.1.8 Antibodies 
Antibody Manufacturer Cat. Number 
Anti-Actin (rabbit) SIGMA-ALDRICH A5060  
Anti-BMAL1 (rabbit) U. Schibler, Geneva  
Anti-CLOCK (rabbit) U. Schibler, Geneva 
Anti-CREB (48H2; rabbit) Cell Signaling (Bioconcept) 9197  
Anti-CRY1 (rabbit) Alph Diagnostic CRY1 1-A 
Anti-CRY1 (rabbit) U. Schibler, Geneva 
Anti-HSP90/ (F-8; mouse) Santa Cruz (Labforce) SC-13119 
Anti-Mouse IgG Peroxidase Conjugate SIGMA-ALDRICH A 9044 
Anti-Phospho RNA Polymerase II (rabbit) Bethyl A300-654A 
Anti-Rabbit IgG Peroxidase Conjugate SIGMA-ALDRICH A 9169 
 
6.1.9 Bacteria and vectors used for cloning 
The E. coli TOP10 strain (provided with the TOPO TA Cloning Kit from Invitrogen) and 
HB101 strain (amplified and made competent in our laboratory) have been used for general 
cloning. Both strains were rendered competent by a chemical treatment. The genotype of the 
TOP10 strain is F
-
, mcrA, (mrr-hsdRMS-mcrBC), 80lacZM15, lacX74, recA1, 
araD139, (ara-leu)7697, galU, galK, rpsL, (StrR), endA1, nupG whereas the genotype of 
the HB101 strain is thi-1, hsdS20 (rB-, mB-), supE44, recA13, ara-14, leu B6, pro A2, lac Y1, 
rpsL20 (str
r
), xyl-5, mtl-1. 
Probes for in situ hybridization have been cloned using the pCRII-TOPO vector (TOPO TA 
Cloning

 Kit from Invitrogen) because this vector contains both, a T7 and an Sp6 RNA 
polymerase promoter allowing in vitro transcription of the insert to produce sense or anti-
sense products. This vector is supplied linearized with single 3’-thymidine overhangs and 
covalently bound topoisomerase I. Some older in situ hybridization probes have been cloned 
into the pPCR-Script Amp SK(+) vector from Stratagene. This vector carries a T3 promoter 
on one side of the insert and a T7 promoter on the other side. 
For rapid cloning of long PCR products (3 to 10 kb) the pCR

 XL-TOPO vector (TOPO

 XL 
PCR Cloning Kit from Invitrogen) has been used. Its function is based on the same principle 
than the one described for the pCR

II-TOPO

 vector.  
Luciferase reporter constructs have been cloned using the pGL3 basic vector from Promega. 
The pSCT1 vector (Dr. S. Rusconi) has been used as backbone for protein expression vectors. 
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6.1.10 Plasmids 
Plasmids used for Southern blot 
#  Name Vector Resistance How to release probe 
177 mCry1 pSP72 ampicillin release with HindIII 
178 mCry2 pCRII-TOPO ampicillin release with EcoRI 
162 mPer1 pBSK+ ampicillin release with SpeI 
161 mPer2 pBSK+ ampicillin release with SalI 
Plasmids used for transfection 
#  Name Vector Resistance Purpose 
444 mBmal1 pGL2 kanamycin promoter-luciferase construct 
370 mDexras1 pGL3 basic ampicillin promoter-luciferase construct 
226 pCMV-LacZ pSCT1 ampicillin -galactosidase expression plasmid 
332 mRev-Erb pSCT1 ampicillin full-length expression plasmid 
335 mRor4 pSCT1 ampicillin full-length expression plasmid 
Plasmids used for in situ hybridization 
#  Name Vector Resistance How to get AS or S probe 
157 mAvp pBSK ampicillin T7 AS EcoRV  T3 S HindIII 
153 mBmal1 pCR-Script SK ampicillin T7 AS NotI T3 S EcoRI 
418 mCatalase pCRII-TOPO ampicillin T7 AS BamHI Sp6 S XhoI 
419 mCatalase pCRII-TOPO ampicillin Sp6 AS XhoI T7 S BamHI 
105 mcFos pB SK- ampicillin T3 AS EcoRI T7 S SacI 
101 mClock pCR-Script SK ampicillin T7 AS XhoI T3 S NotI 
156 mCry1 pCRII-TOPO ampicillin T7 AS SpeI   Sp6 S EcoRV 
196 mCry2 pCRII-TOPO ampicillin T7 AS SpeI   Sp6 S Eco RV 
284 mDec1 pCRII-TOPO ampicillin T7 AS BamHI Sp6 S XhoI 
354 mDexras1 pCRII-TOPO ampicillin Sp6 AS XhoI T7 S BamHI 
355 mDexras1 pCRII-TOPO ampicillin T7 AS BamHI Sp6 S XhoI 
278 mFxr2 pCRII-TOPO ampicillin Sp6 AS EcoRV T7 S SpeI  
361 mMkp1 (dusp1) pCRII-TOPO ampicillin T7 AS BamHI Sp6 S XhoI 
98  mPer1 pB SK-  ampicillin T3 AS XhoI   T7 S BamHI  
104 mPer2 pCR-Script SK ampicillin T3 AS EcoRI T7 S NotI 
390 mPrkca RII-TOPO ampicillin Sp6 AS XhoI T7 S BamHI 
 
6.1.11 Mouse strains 
Clock gene mutant mice: The mutant and wild-type mice used were derived from 
intercrosses between heterozygous animals. The mPer1
Brdm1
 mutants were generated using 
embryonic stem cell technology replacing a 4.3 kb long genomic region in the mPer1 gene 
(encompassing 15 of the 23 exons) by an Hprt (hypoxanthine phosphoribosyltransferase) 
minigene (Zheng et al., 2001; fig. 6.1-1A). The mPer2
 Brdm1
 mutant mice have been generated 
using a deletion mutation that removes a major part of the PAS domain of the mPer2
Brdm1
 
gene (Zheng et al., 1999; fig. 6.1-1B). The mPer1
Brdm1
/mPer2
Brdm1
 double mutant mice have 
been generated by intercrossing mPer1
Brdm1
 and mPer2
Brdm1
 single mutant animals (Zheng et 
al., 2001). Similarly, mPer1
Brdm1
/mCry1 and mPer1
Brdm1
/mRev-Erb double mutant mice 
have been derived from mPer1
Brdm1
 and mCry1 (van der Horst et al., 1999; fig. 6.1-1C) single 
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mutants and mPer1
Brdm1
 and mRev-Erb (Preitner et al., 2002; fig. 6.1-1D) single mutants 
respectively. 
 
Fragile X mutant mice:  The different fragile X mutants (Fmr1
-/-
, Fxr2
-/-
, Fmr1
-/-
Fxr2
-/-
) and 
corresponding wild-type mice were bred and housed in the Baylor College of Medicine in 
Houston. All of them were bred on a C57BL/6 background (Spencer et al., 2006; Peier et al., 
2000; Bontekoe et al., 2002; Zhang et al., 2008). 
 
 
 Fig. 6.1-1: Targeted disruption of the Per1, Per2, Cry1 and Rev-Erb genes. 
A Genomic structure of the murine mPer1 gene, the targeting vector, and the predicted structure of 
the targeted allele. Exons are indicated by vertical black bars with the first and last exons 
numbered. WT, wild-type; R, EcoRI; Hprt, hypoxanthine phosphoribosyltransferase gene; TK, 
Herpes Simplex Virus thymidine kinase gene (Zheng et al., 2001). B Genomic structure of a 
portion of the mouse mPer2 gene, the targeting vector and the predicted structure of the targeted 
allele. H, HindIII; B, BamHI; Neo, neomycin resistance gene; HSV tk, Herpes simplex virus 
thymidine kinase gene (Zheng et al., 1999). C Physical map of the wild-type mCry1 locus, the 
targeting construct and the disrupted mCry1 locus. Exons are indicated by black filled boxes. Note 
that the use of PCR-derived genomic DNA does not allow proper exon numbering. The probe used 
for screening homologous recombinants and genotyping mice, localized external to the construct, is 
represented by a grey box. Primers used for RNA analysis by RT-long-range PCR are depicted as 
black arrowheads (van der Horst et al., 1999). D Strategy used to delete the DNA binding domain 
(DBD) of the Rev-erb allele. The cartoon displays a map of the eight Rev-erb exons on the top 
strand and the 3 terminal Tr (thyroid hormone receptor ) exons on the bottom strand. These two 
genes are oriented in opposite directions on chromosome 11 and are partially overlapping. The 
positions of the recognition sites for the following restriction endonucleases are given: BamH1 (B), 
KpnI (K), HindIII (H), EcoR1 (R1), EcoR5 (R5), and XhoI (X). Atg and tga indicate the positions 
of the initiation and termination codons, respectively. The structure of the targeting vector, in 
which part of exon 2, intron 2, exon 3, intron 3, exon 4, intron 4, and part of exon 5 have been 
replaced by a LacZ and a PGK-neo gene, is given below the Rev-erb/Tr locus (Preitner et al., 
2002). 
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6.1.12 Computer programs 
Program Use 
Adobe Acrobat Reader Reading of PDF files 
Adobe Photoshop CS3 Figures 
AxioVision 3.1 Picture taking on the Zeiss microscope 
BeaconDesigner 2.1 Primer and probe design for quantitative real-time PCR 
DNA Strider 1.4f8 DNA and protein sequence analysis 
EndNote Manage references 
GraphPad Prism 4.0a Statistical analysis 
iCycler iQ
TM
 Software 2002 qRT-PCR 
Internet Explorer, Safari Access the World Wide Web 
KC4TM v.3.4. BIO-TEK software Multidetection microplate reader (BIO-TEK) 
Matlab/Clocklab Wheel running analysis 
Microsoft Excel 2004 Work sheets 
Microsoft PowerPoint 2004 Figures / Presentations 
Microsoft Word 2004 Text processing 
Molecular Analyst Densitometric analysis (GS-700) 
Quantitiy One 1-D Densitometric analysis (GS-800) 
WinGlow Luminometer (EG & G Berthold) 
 
6.1.13 Consumer material 
All disposable plastic ware was manufactured from Eppendorf, Nunc, Millian, Falcon, 
Corning Incorporated, Axygen, BD Plastipak
TM
, TPP, Costar and Treff AG. 
Product Manufacturer Cat. Number 
Absolute QPCR Seal Axon Lab AB-1170 
Amersham Hyperfilm
TM
 MP GE Healthcare 28-9068-46 
Blotting Premium extra white (210 g/m
2
) sihl+eika 4500088517 
Cleanroom suit VWR 113-0165 
Cytobrush plus GT Medscand Medical C0105 
Filter unit 0.2 m Whatman 10 462 205 
Genescreen plus

 transfer membrane Perkin Elmer NEF988001PK 
Glass slides (Histobond, Marienfeld) Medite 85-0951-00  
Glass coverslips (24 x 55 mm) Medite 46-7155-00 
Glass coverslips (24 x 60 mm) Medite (Menzel-Glaser) 85-0191-00 
Hybond
TM
-ECL
TM
 Nitrocellulose membrane Amersham Biosciences RPN303D  
Mask VWR 114-3438 
Microvette

 100 Z Sarstedt 20.1280 
Mouse complete feed Provimi Kliba AG 3432 
Nestlests Ebeco 3097055 
PCR strip caps Axygen PCR-02CP-A 
PCR strip tubes Axygen PCR-0208-A 
Scintillation glass vials Fisher Scientific (Wheaton) 0120 916 
Shoe covers “Easy” Milian 27-298 
Stoppers with flanges (for glass test tubes) Milian AIL-123-07 
Test tube (10x75 mm, Duran, glass) GMB Glasmechanik 83613-103 
96 well PCR plates Axon Lab AB-0900 
96 MicroWell plates (white, polysorp) Nunc 436111 
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6.1.14 Appliances 
Appliance Manufacturer  Model 
Amersham Hypercassette
TM
 (8 x 10 in) GE Healthcare RPN 11649 
Balances Mettler Toledo (SUI) PBI501-S 
 Mettler Toledo (SUI) AB54-S 
Centrifuges for Eppendorf tubes Heraeus Biofuge pico 
 Hettich (GER) MIKRO 20 
Centrifuges for Falcon tubes Hermle Z383K  
 Du Pont (Sorvall) Econo Spin 
Container for liquid nitrogen CRYO Diffusion (FRA) CT120R 
Densitometer Bio-Rad GS-700 & GS-800 
DNA Thermal Cyclers Perkin Elmer (USA) Cetus 
 Biometra (GER) TGradient 
Enhancer screen Amersham 
Freezer for –20°C Liebherr comfort 
Freezer for –80°C Froilabo (FRA) CV 390 –85°C 
Heating block Eppendorf (GER) Thermomixer compact 
Heating plate with magnetic stirrer Heidolph MR-30001K 
Homogenizer Heidolph RZR 2102 control 
Homogenizer for test tubes IKA

-Werke, GmbH & Co Ultra-Turrax T8 
Hood SKAN AG Telstar BIO-II-A 
Horizontal Gel Electrophoresis system GibcoBRL (Invitrogen) Sunrise
TM
, 21069 
Hybridization ovens SHEL LAB (USA) 1012 
 SHEL LAB (USA) 1004 
iCycler iQ
TM
 BioRad 
Incubator for cells Heraeus Instruments BB 5060 
Incubator with shaker for bacteria HT Infors AG (SUI) AT 258 
Intensifying screen Amersham 
Liquid scintillation analyzer Packard Tri carb 2200CA  
Microplate Reader  Bio-Rad 3550 
Microplate Luminometer EG & G Berthold LB 96V 
Microscopes Nikkon (JAP) TMS-F 
 Zeiss Axioplan 2 imaging 
Microwave AEG Micromat 21Mini Gel 
Migration Trough COSMO BIO CO., LTD. Mupid-21 
Multi detection microplate reader BIO-TEK Synergy HT 
Night vision goggles Rigel (USA) 3200 
 Night Optics USA D-2MV 
pH-Meter  Knick 766 Calimatic 
Pipettes (10, 20, 200 and 1000 μl) Gilson Pipetman Ultra 
Pipetting assistance IBS Pipetboy acu 
 Hirschmann Laborgeräte (GER) Pipetus

-akku 
Potter THOMAS

 (USA)
 
BB 935  
Refrigerator Liebherr profi line 
Rocking platform Biometra (GER) WT 16 
IR-thermometer noncontact TFA Dostmann ScanTemp 440 
Scintillation counter Canberra Packard 
Spectrophotometer  WPA lightwave II 
Staining station Miles Tissue-Tek II 
StrataCooler Cryo Preservation Module Stratagene 400005 
Ultracentrifuge Sorvall RC-5B & RC-5C 
Ultrasonic homogenizer BioLogics, Inc. 300 V/T 
UV-lamp  Vilber Lourmat TFX-20LM 
Vortex IKA

 Works, Inc. (USA) MS1 Minishaker 
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Water baths  (for 65°C) SHEL LAB (USA) 
                     (for 37°C) GFL 
 (for 42°C) University of Fribourg (SUI) 
Western comb, spineless, 15 wells Hoefer Scientific Instruments SE 211A-15-1.5 
Western comb, spineless, 10 wells Hoefer Scientific Instruments SE 211A-10-1.5 
Western electrophoresis apparatus Hoefer Scientific Instruments SE 250 Mighty Small II 
Western 4-gel caster (10 x 8 cm) Hoefer Scientific Instruments SE 275 
Western notched alumina plate (10x8) Hoefer Scientific Instruments SE202N-10 
Western rectangular glass plates (10x8) Hoefer Scientific Instruments SE202P-10 
Western red clamps with springs Hoefer Scientific Instruments SE 252 
Western spacers Hoefer Scientific Instruments SE2119T-.1.5 
Western space saver plate Hoefer Scientific Instruments SE 217 
Western wet transfer tank BioRad Mini Trans-Blot

 Cell 
Wheel running cages Techniplast 1155M 
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6.2 Methods 
6.2.1 Animals  
6.2.1.1 Animal guidelines 
All animal work is performed in accordance with the guidelines of the Schweizer 
Tierschutzgesetz (TSchG, SR455, Abschnitt 2: Art. 5 + 7, Abschnitt 5: Art. 11 and Abschnitt 
6: Art.12-19).   
 
6.2.1.2 Mouse breeding 
Mice are kept under a 12 hours light and 12 hours dark cycle (12:12 h LD) with food and 
water ad libitum in cages covered with a filter top (Type 2 Polycarbonate Cage with top 
wiring, Tecniplast, Italy), which are stockpiled in custom made racks. Matings are set up as 
pairs of males and females according to Robertson (fig. 6.2-1). Offspring is weaned three 
weeks after birth and separated for its gender. A maximum of five mice are housed per cage. 
Genotypes are determined by PCR (mRev-Erb) or Southern blot hybridization using 
genomic DNA extracted from tail tips as described below (6.2.1.4). 
 
Fig. 6.2-1: Mating scheme according to Robertson 
Using this mating setup reduces the probability that an observed phenotype is due to paternal 
imprinting because a male and a female of every line have been used. 
 
 
6.2.1.3 Mouse activity recording  
Jud C, Schmutz I, Hampp G, Oster H, Albrecht U (2005): A guideline for analyzing 
circadian wheel-running behavior in rodents under different lighting conditions. Biological 
Procedures Online, 7:101-16 
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ABSTRACT 
 
Most behavioral experiments within circadian research are based on the analysis of locomotor activity. This paper 
introduces scientists to chronobiology by explaining the basic terminology used within the field. Furthermore, it aims 
to assist in designing, carrying out, and evaluating wheel-running experiments with rodents, particularly mice. Since 
light is an easily applicable stimulus that provokes strong effects on clock phase, the paper focuses on the application 
of different lighting conditions. 
 
 
INTRODUCTION 
 
Life of almost all organisms is governed by various 
biological rhythms that are defined as physiological and 
behavioral oscillations. These rhythms are distinguished 
by their period length (τ) with circadian (lat: circa diem, 
around a day) rhythms displaying a τ of approximately 
24 hours that evolved in adaptation to the daily rotation 
of the earth around its axis. They are found in many 
organisms from unicellular fungi and bacteria to higher 
organisms such as insects and mammals, including men. 
The bases of these oscillations are internal molecular 
clocks that maintain their rhythm even in the absence of 
external timing signals. 
 
The circadian clockwork has evolved to improve an 
organism’s adaptation to its environment and to ensure 
timed coordination of life-sustaining activities such as 
feeding, sleeping as well as the coordination of 
physiological and biochemical mechanisms. 
 
 
With the availability of manipulative in vivo techniques 
and with the rise of forward and reverse genetic 
approaches in the field of chronobiology it became 
increasingly interesting to investigate circadian 
behavioral phenotypes of wild type and mutant animals 
under different conditions. Since light is the most potent 
timing signal of the circadian system – and lighting 
conditions are relatively easy to control – this paper aims 
to provide a general guidance for testing and evaluating 
circadian wheel-running behavior under different 
lighting conditions. 
 
DEFINITIONS 
 
Actogram 
 
Circadian locomotor activity rhythms are frequently 
represented as a graph called actogram (Fig. 1A), where 
each horizontal line represents one day. Black vertical 
bars plotted side-by-side represent the activity, or 
number of wheel revolutions. The height of each vertical 
bar indicates the accumulated number of wheel 
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revolutions for a given interval (e.g. 5 min). Aligning the 
same actogram twice so that two consecutive days are 
plotted one after the other and the second day being re-
plotted in the right half of the successive line results in a 
so-called double plotted actogram (Fig. 1B). This way of 
representation often facilitates the identification of 
existing rhythms. Once the presence of a – not 
necessarily circadian – rhythm has been established, the 
chronobiologist divides the cycle into an activity (alpha) 
and a rest (rho) phase. Sometimes, scattered activity can 
be observed in the rho-phase because the animal 
interrupts its sleep for a short time. One advantage of 
recording wheel-running revolutions as compared to 
using light beam interruptions is the activity noise during 
the rest phase. Obviously, under normal light/dark 
conditions alpha- and rho-phases are at opposite times in 
regard to the 24 hours solar cycle in diurnal and 
nocturnal organisms (1). 
 
 
Fig. 1: Schematic single and double plotted actograms and masking. (A) 
Wheel-running activity is plotted as an actogram with each horizontal line 
corresponding to one day. Black vertical bars plotted side-by-side 
represent the activity, or number of wheel revolutions. The height of each 
vertical bar indicates the accumulated number of wheel revolutions for a 
given interval (e.g. 5 min). The rho- and alpha-phase marked at the 
bottom of the actogram refer to rest and activity, respectively. The white 
and black bar at the top of the scheme depicts light (12 h) and darkness 
(12 h), respectively. (B) To better visualize behavioral rhythms, actograms 
are often double plotted by aligning two consecutive days horizontally (e.g. 
day 1 left and day 2 right). (C) Schematic actogram of a nocturnal animal 
kept in very short photoperiods (LD 6:6). Since the animal is only showing 
activity during the dark phases it seems to entrain to the prevailing LD 
cycle. (D) Parallel monitoring of body temperature reveals that this 
apparent entrainment is only masking. Although the readout parameter 
“activity” seemingly adapts to the new schedule, body temperature 
continues to cycle with its free-running period length implicating that the 
circadian clock of the animal is not entrained. LD, light-dark cycle. 
Entrainment and masking 
 
Many environmental variables including light, 
temperature, humidity, food availability, and even social 
cues oscillate with a 24-hour period. Even though the 
endogenous circadian clock functions in the absence of 
external time cues, it periodically measures some of these 
environmental parameters to synchronize internal and 
external time under natural conditions to so-called 
diurnal rhythms. This mechanism of synchronization is 
called entrainment (2-6) and the environmental signal that 
can phase-set circadian clocks is called Zeitgeber (1, 5). All 
of the mentioned Zeitgebers may act as entraining agents 
although the daily 24 hour light-dark (LD) cycle is the 
most prominent one divided into a dark period or so-
called scotophase and a light period or so-called 
photophase. Furthermore, organisms can only entrain to 
synchronizers cycling with a period close to 24 hours (7) 
(see T-cycles below). If the entraining period is too short 
or too long thereby exceeding the range of entrainment the 
circadian system cannot follow the Zeitgeber anymore 
and starts to free-run (see below). Since a strong Zeitgeber 
defines the rhythm of the clockwork, time is expressed as 
Zeitgeber time (ZT). Within a lighting schedule of 12 hours 
of light and 12 hours of darkness (LD 12:12), ZT0 is 
defined as “lights on,” the beginning of the light phase, 
and ZT12 corresponds to “lights off,” the end of the light 
phase. 
 
The time difference [h] between the entraining external 
and the displayed internal rhythm, e.g. the onset of an 
animal’s activity or the peak blood concentration of an 
endocrine factor, is called phase angle difference (Ψ). True 
entrainment is characterized by a stable phase angle 
difference between two synchronized rhythms. The 
value of this phase angle, however, may vary with the 
strength of the applied Zeitgeber stimulus (e.g. the light 
intensity or its wave length). 
 
A certain rhythm may often only apparently be entrained 
to a Zeitgeber while the internal clock at the same time is 
not affected. This phenomenon is called masking (8). It 
can be observed when the Zeitgeber exerts - besides its 
influence on the clock - an additional dominant effect on 
the chosen readout parameter. One example is the 
suppressing influence of bright light on the activity of 
nocturnal rodents. In very short photoperiods (see 
below) mice seem to entrain to the dark phases, as shown 
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in the schematic drawing (Fig. 1C). The rest time during 
the light phases, however, is only a masking effect as 
revealed by parallel monitoring of the same animal’s 
body temperature (Fig. 1D). Consequently, this masking 
problem can often be overcome by changing the readout 
parameter (e.g. here temperature). 
 
Free-run 
 
Organisms kept under constant conditions by shielding 
them from external time cues display so-called free-
running or circadian rhythms that may persist 
indefinitely. The period length of these free-running 
rhythms is often no longer equal to 24 and differs from 
species to species. Therefore, time cannot be expressed in 
ZT but is expressed in circadian time (CT) units. One 
circadian cycle is divided into 24 equally sized circadian 
units (or circadian hours) with one unit being defined as 
the division of the internal period length (τ) by 24 hours. 
In nocturnal organisms and constant darkness conditions 
(DD), one circadian unit usually is less than 1 hour 
because the internal rhythm of these animals is typically 
shorter than 24 hours. Wild type mice (C57BL/6Tyrc-Brd × 
129S7) for example have an internal period length of 23.7 
± 0.1 h (9) and thus 1 CT equals 59.25 min. CT0 
designates the beginning of the subjective day (the rest 
phase in nocturnal rodents) and CT12 that of the 
subjective night (their activity phase). The same is true in 
diurnal animals only that they have their activity phase 
starting at CT0 and their rest phase at CT12, respectively. 
Since many experiments are carried out under constant 
conditions, CT calculations will be described later in the 
materials and methods section. 
 
To monitor circadian rhythms some researchers use dim 
red light instead of complete darkness. The advantage of 
using dim red light is ease of animal handling. However, 
one should keep in mind that the range of wavelengths, 
to which the visual receptors of nocturnal animals 
respond, varies from species to species. Djungarian 
hamsters, for example, have a very high photosensitivity 
to red light (10). A recent publication suggests not using 
dim red light because it can increase the circadian period 
in mice compared to constant darkness (11). Therefore, it 
is recommended to use complete darkness protocols and 
to handle the animals using night vision goggles 
equipped with an infrared beam. However, in case one 
wants to use dim red light, it is better to constantly 
illuminate the chamber rather than switching on a red 
light while checking the animals. 
Transients and aftereffects 
 
During entrainment to a new external period or after 
release into constant conditions, transient cycles (12) can 
be observed before stable entrainment to the Zeitgeber or 
free-run occurs (blue bars in Fig. 2 panels A and B). 
Those transients reflect the disequilibrium or the altered 
phase angle between the overt rhythm and the Zeitgeber 
in response to a phase shift (1). A phase shift is a change 
in the phasing of the rhythm due to a distinct external 
stimulus (e.g. a light pulse). Transient cycles should be 
excluded from the determination of the displayed 
internal period or the phase-angle difference. 
 
 
Fig. 2: Transients and Aftereffects. Transients (blue bars) can be caused 
by various treatments, such as the release of the animal into constant 
conditions (A) or a shift in the lighting regime (B). These transients usually 
persist for several days depending on the strength of the provoking signal. 
The white and black bar at the top of the scheme depicts light (12 h) and 
darkness (12 h), respectively. (C) An animal kept in constant darkness 
(DD) displays a stable free-running rhythm with a period length τ1 before it 
is subjected to a light pulse. This pulse leads to a phase shift and often 
provokes τ2, which is different from τ1, as an aftereffect. If the animal is 
left in DD long enough after this treatment, it will again display its old 
period length τ1. The red regression lines are drawn through the onsets 
before and after the light pulse to determine τ1 and τ2, respectively. The 
black bar at the top of the scheme represents constant darkness (24 h) 
conditions. DD, constant darkness; LD, light-dark cycle. 
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Even though the rhythm of a free-run can be remarkably 
precise, a certain plasticity of individual period length is 
a result of prior entrainment conditions. These so called 
aftereffects (12) can persist for several weeks and are also 
observed frequently after phase shifting stimuli (see 
below). Figure 2C shows the two different period lengths 
that can be observed before (τ1) and after (τ2) the 
stimulus. 
 
T-cycles 
 
To determine the stability range of entrainment, light 
cycles of different periods can be applied (4). Those T-
cycles (with L + D = T) have periods deviating from the 
natural 24-hour period. For example, 22 hour or 26 hour 
T-cycles (LD 11:11 and LD 13:13, respectively), may be 
used to define the limits of stable entrainment. This limit 
differs from species to species and is depending on the 
nature of the applied Zeitgeber. In order to entrain to a 22 
hour T-cycle (Fig. 3A), the organism has to constantly 
accelerate its internal rhythm whereas it decelerates its 
internal clock in response to a 26 hour T-cycle (Fig. 3E). 
This adaptation is only feasible within a close range. The 
mammalian circadian system has a plasticity of 
approximately 2 hours around its internal τ. Outside this 
critical range, entrainment is not possible anymore and 
the clock will start to free-run as indicated in Fig. 3A and 
E where the white and gray areas represent light and 
darkness, respectively. As long as the mice entrain to the 
T-cycle, they synchronize their activity onsets with 
lights-off (Fig. 3B and D). The phase-angle difference 
between lights-off and activity onset may increase with 
increasing deviation of T from the internal τ but will 
remain stable under given conditions as long as the 
animal still entrains. 
 
Photoperiods and dim light ramps 
 
Seasonal variations influencing circadian behavior can be 
simulated by applying different experimental 
photoperiods. A photoperiod is described by the ratio of 
light to darkness during a 24-hour cycle. Under 
laboratory conditions, summertime light conditions are 
typically represented by cycles of 18 hours light and 6 
hours dark or of 14 hours light and 10 hours dark (LD 
18:6 and LD 14:10, respectively), whereas winter light 
conditions are mimicked by an LD 6:18 cycle or an LD 
10:14 cycle. In photoperiod experiments the external time 
of the Zeitgeber rhythm is specified as ExT (External 
Time) with ExT12 corresponding to the middle of the 
light-phase (Fig. 4) (13, 14). 
 
Fig. 3: T-cycles. T-cycles are LD cycles with a period length other than 24 
hours (T = L + D). Mice are able to entrain to T-cycles of 23 (B) and 25 (D) 
hours but not to T-cycles of 22 (A) and of 26 (E) hours. Panel C represents 
a normal 24 hours LD 12:12 cycle. All schemes are plotted on 24 hours 
scale where the white area represents lights on and the gray area lights 
off, respectively. The white and black bar at the top of the scheme depicts 
light and darkness of the LD 12:12 cycle the animals were entrained to in 
the beginning of each panel. Each species has a distinct range of 
entrainment; the schemes here represent the range for mice. The black 
horizontal bars display the active time of the animals. LD, light–dark 
cycle; T, period or cycle time of a Zeitgeber; h, hours. 
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Fig. 4: Schematic representation of external time (ExT) in photoperiods 
and T-cycles. External time (ExT) subdivides any light-dark cycle into 24 
units using the following formula: number of hours*24/T elapsed since 
the middle of the dark period. ExT0 (= ExT24) is determined as the middle 
of the dark period. ExT12 corresponds to the middle of the light phase. 
Vertical black lines indicate the corresponding external time. Black bars 
represent the dark period whereas the white bars correspond to lights on. 
(A) Schematic representation of ExT for photoperiods. (B) Schematic 
representation of ExT for T-cycles. ExT, external time; LD, light–dark cycle; 
T, period or cycle time of a Zeitgeber; h, hours. 
 
Most laboratories use a rapid transition from light to 
dark and from dark to light and apply the same 
wavelength range and light intensity during the whole 
light period. However, this does not truly reflect natural 
lighting conditions. To more faithfully mimic the 
different sunlight conditions in a circadian context, one 
can use dim light ramps simulating dusk and dawn for 
light-dark transitions. Dim light conditions may allow a 
better understanding of daily events taking place in an 
organism in response to light. This procedure is still not 
commonly used – mainly due to technical and historical 
reasons. Moreover, the question of how much influence 
the dim light has on the establishment of circadian 
rhythmicity still remains to be answered.  
 
Phase shift 
 
A phase shift (ф) is defined as the resetting of the 
organism’s internal rhythm in response to an external 
stimulus such as nocturnal light exposure (3). Such a 
phase shift can either result in a phase advance or a phase 
delay, where the former is the exact opposite of the latter. 
To specify, this means that a phase advance shifts the 
activity onset to an earlier position in the circadian cycle, 
whereas a phase delay shifts it to a later time. As an 
example, a shift of the activity phase by 2 circadian hours 
from CT12 to CT10 represents a 2 circadian hour phase 
advance. To analyze this resetting ability, animals 
displaying a stable free-running rhythm are kept in 
constant darkness and a light pulse is administered at a 
specific CT (Fig. 5A and B). Animals having an unstable 
free-running rhythm, receive the light at a certain ZT 
before they are released into DD (Fig. 5C). An overview 
of the daily variations in an animal’s ability to shift its 
rhythm in response to a certain stimulus is given by the 
phase response curve (PRC) whose shape varies 
depending on species and stimulus (15). Figure 5D 
shows a typical light PRC of a nocturnal rodent. It can be 
divided into three parts, a phase delaying zone (CT12 to 
CT18 in Fig. 5D), a phase advancing zone (CT18 to CT2), 
and a dead zone (CT2 to CT12), where the stimulus has 
no or little effect on the activity phase. In a light PRC, 
this dead zone normally corresponds to the subjective 
day. 
 
Jet lag 
 
Traveling across several time zones and shift work 
schedules disturb the circadian clock and lead to fatigue, 
insomnia, irritability, etc. All these symptoms taken 
together are referred to as jet lag and are provoked by the 
transients generated during the resetting of the internal 
pacemaker to re-synchronize with external time. Since jet 
lag is generated artificially by our fast-living society, this 
problem is predominantly observed in humans. 
However, it can be mimicked in rodents by an abrupt 
shift in the lighting schedule (Fig. 5E). Depending on the 
amplitude of the shift, the animal needs several days to 
re-adjust to the new light regimen. In mice (and in 
human) back-shifting normally is accomplished 
considerably faster than forward-shifting of a similar 
time span, but activity read-outs are often overlaid by the 
masking influence of the new light phase (Fig. 5E, lower 
part of the actogram). For example, wild type mice need 
around 4 days to adapt to a 4 hours phase delay and 
around 6 days to adapt to a 4 hours phase advance. 
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Fig. 5: Real actograms and phase response curve (PRC). (A) Plot of mouse 
locomotor activity before and after administering a light pulse (LP) at 
CT14 provoking a phase delay. The mouse was entrained to an LD 12:12 
cycle before it was released into constant darkness (DD). The line above 
“DD” indicates the transition from LD to DD. When a stable free-running 
rhythm was established, a LP (green arrow) was administered at CT14 for 
15 min. In order to quantify the phase shift, regression lines are drawn 
through 10 activity onsets before (red) and through 6 onsets after (blue) 
the LP. The horizontal distance between them corresponds to the phase 
shift triggered by the LP. (B) Plot of mouse locomotor activity before and 
after administering a LP at CT22 provoking a phase advance. The mouse 
was entrained to LD 12:12 (not shown) and then released into DD. As 
soon as a stable free-running rhythm was established, a LP (green arrow) 
was administered at CT22 for 15 min. In order to quantify the phase shift, 
regression lines are drawn through 6 activity onsets before (red) and 
through 7 onsets after (blue) the LP. The horizontal distance between 
them corresponds to the phase shift triggered by the LP. (C) Typical 
actograms of wild-type mice subjected to an Aschoff type II protocol. Mice 
were entrained to an LD 12:12 cycle (10 days) before releasing them into 
DD. The line above “DD” indicates the transition from LD to DD. The grey 
background represents darkness. Upon release into DD, no light pulse was 
administered to the mouse in the upper panel, whereas light pulses of 15 
min were applied to the mouse at ZT14 (middle panel) and ZT 22 (lower 
panel). Regression lines (red) are drawn through the onsets of wheel-
running activity in order to calculate the phase shift. Adapted from (26). 
(D) Typical light phase response curve (PRC) for nocturnal rodents. The 
grey and black bars below the PRC indicate subjective day and night, 
respectively. The X-axis shows the circadian time (CT) at which the light 
pulse was applied whereas the Y-axis displays the observed phase shift (φ) 
[h]. Light pulses administered between CT11 and CT18 provoke a phase 
delay (negative values). Light pulses between CT19 and CT3, on the other 
hand, generate phase advances (positive values). Between CT4 and CT10, 
no phase shift can be observed (dead zone). (E) Jet lag can be mimicked 
in the lab by subjecting entrained animals to a rapid shift in the lighting 
schedule. This actogram shows the locomotor behavior of a mouse that 
was first entrained to LD 12:12 with light from 6 am to 6 pm. After 10 
days, the lighting schedule was still LD 12:12 but shifted to “lights on” at 
2 pm and “lights off” at 2 am (red star). The mouse only entrains after 
around 7 days of transition to the new LD cycle. 17 days after the first 
shift, the lighting schedule was again shifted to the original schedule (LD 
12:12 from 6 am to 6 pm; green star). (F) Panel F shows an actogram of a 
mouse subjected to a skeleton photoperiod. The mouse was first 
entrained to LD 12:12 with lights on from 7:30 am to 7:30 pm for 8 days. 
The grey background represents lights off, whereas the white area stands 
for lights on. After day 8, an asymmetrical skeleton photoperiod was 
applied with a shorter pulse in the evening (dusk) and a longer one in the 
morning (dawn). Due to the two light pulses, the mouse remains entrained 
and wheel-running activity does not differ tremendously compared to LD 
12:12. Adapted from ref. 31. LD, light-dark cycle; h, hours; DD, constant 
darkness. 
 
Skeleton photoperiods 
 
In nature, nocturnal animals are only foraging during the 
night and hiding in their burrows during the day where 
they normally do not perceive any light. The standard 
LD cycles of the laboratory therefore do only weakly 
reflect natural conditions. To overcome this and mimic 
the periodic crepuscular light exposure skeleton 
photoperiods may be used (4). 
 
Animals subjected to skeleton photoperiods are kept in 
constant darkness with two short light pulses per 
circadian cycle. In skeleton photoperiods, one 
distinguishes three parts: dawn (light), daytime (dark) 
and dusk (light). One pulse is applied at the beginning 
and one at the end of an otherwise complete photoperiod 
(e.g. one 15 min light pulse every 12 hours). The duration 
of the pulses is arbitrary (16). If the dawn- and the dusk-
pulse have the same duration, the skeleton photoperiod 
is called symmetrical. In contrast, asymmetrical skeleton 
photoperiods are determined by pulses, where one is 
longer than the other. In general, the dawn pulse is 
longer than the dusk pulse (e.g. 3 hour dawn pulse and 
30 min dusk pulse).  
 
Skeleton photoperiods – like dim light – can also be used 
to overcome the masking effects of the LD cycle on the 
activity onset phase-angle and the alpha phase (Fig. 5F). 
 
MATERIALS AND METHODS 
 
Why wheel-running? 
 
Monitoring wheel-running activity is only one of several 
possible ways to track circadian locomotor activity. 
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Compared to infrared beam or emitter-based 
measurements, wheel-running only registers voluntary 
movements. In contrast, the two other methods record all 
the movements including eating, drinking and grooming 
which increases noise levels. A mentionable advantage of 
the emitter-based measurement is that many modern 
systems allow you to easily record locomotor activity 
and certain physiological parameters such as body 
temperature or heart beat simultaneously.  
 
Wheel-running facility 
 
Circadian rhythms can be influenced by several 
environmental cues such as light, noise, vibrations, 
temperature, humidity, or pheromones. Due to this, it is 
important to perform any wheel-running experiment 
under defined environmental conditions. To achieve this, 
wheel-running experiments in our lab are carried out in 
an isolated, soundproof and air-conditioned room (17). 
 
Isolation cabinets and cages 
 
Animals are housed individually in plastic cages (280 
mm long x 105 mm wide x 125 mm high, Tecniplast 
1155M) equipped with a steel running wheel (115 mm in 
diameter, Trixie GmbH, Article No. 6083) (Fig. 6A). 
Diameter and type of the running wheel may influence 
the amount of wheel-running activity of mice (18, 19). 
The cages are provided with little bedding and one 
nestlet (5 x 5 cm; EBECO). One should take care not to 
use excessive amounts of bedding to avoid wheel 
blockage. Food and water are accessible ad libitum. Wheel 
revolutions are measured by a small magnet 
(Fehrenkemper Magnetsysteme, Article No. 
34.601300702) embedded in a plastic disk that is fitted to 
the axis of the wheel (Fig. 6B). Upon rotation of the 
wheel, the magnet opens and closes a magnetic switch 
(Reed-Relais 60; Conrad Electronic AG, No. 503835-22), 
which is fixed outside the cage. Signals are registered on 
a computer using the ClockLab data aquisitition system 
(Actimetrics).  
 
Maximally twelve of these wheel-running cages can be 
placed in a light-tight box. These isolation cabinets (Fig. 6 
panels C and D) are ventilated and contain two 
fluorescent light bulbs (Mazdafluor Symphony AZURA 
965, 18 W) mounted on the ceiling of the cabinet.  
 
Fig. 6: Wheel-running cages and isolation cabinets. (A) Individually housed 
mouse in a wheel-running cage connected via a magnetic switch to the 
system recording wheel revolutions. On each rotation of the running 
wheel, the magnetic switch is once opened and closed. (B) Detailed view 
of the magnet (upper arrow) and the magnetic switch (lower arrow). (C) 
Schematic representation of a ventilated isolation cabinet (200 x 62 cm) 
offering space for 12 wheel-running cages. The arrows represent the 
airflow through the cabinet. (D) Picture of a fully occupied isolation 
cabinet with two light bulbs at the ceiling. 
 
The lighting conditions can be adjusted via a timer 
without opening the box. In order to minimize reflection 
of light and guarantee comparable lighting conditions for 
each cage, the interior of the isolation chamber should be 
black and non-reflective. Although the isolation cabinets 
are well ventilated, the heat produced by the two light 
bulbs can’t be eliminated completely by ventilation. 
Therefore there are diurnal temperature variations of 2-
3.5°C (min. 23.5-24°C; max. 26-27°C) within the cabinets. 
However, light is a stronger and more immediate 
Zeitgeber compared to temperature and therefore the 
observed temperature variations under LD conditions 
can be neglected. Under constant lighting conditions 
temperature needs to be constant, because environmental 
temperature cycles can sustain peripheral circadian 
clocks (20). In our isolation cabinets this is the case and 
temperature remains constant after lights off (around 
22.5°C).  
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Fluorescent light bulbs and lighting regimen 
 
The choice of the correct fluorescent light bulb is a critical 
factor for wheel-running experiments. Usually, a light 
intensity of 300-400 lux at the level of the cage is chosen. 
Working with albino animals, one should keep in mind 
that they do not have any eye pigments. In this case, 
lower light intensities should be chosen in order not to 
damage their eyes. 
 
Besides the mere intensity the color temperature of the 
bulb is also important. Color temperature is a measure of 
the visual “whiteness” of the light and its unit is degrees 
Kelvin (K). Light sources described as warm have a low 
color temperature and range from red to yellow. Cold 
ones on the other hand display a high color temperature 
and range towards the blue end of the spectrum. Natural 
daylight has a temperature between 6000 and 7000 K. 
The bulb described above has a luminous flux of 1000 
lumen and a color temperature of 6500 K. 
 
Entrainment to LD 12:12 and subsequent release into 
constant darkness 
 
For standard wheel-running experiments mice should be 
between 2 and 6 months of age. Mice being younger than 
2 months could freeze to death in the well ventilated 
cabinets while older mice often show low performance 
and other age related effects both of which can influence 
the analysis of running-wheel experiments (21, 22).  
 
Additionally, it is normally preferable to use only male 
animals because in females the estrous cycle may 
influence general activity and wheel-running 
performance, which adds an additional rhythmic 
component that may complicate the evaluation. 
 
Before any experiment can take place, it is essential that 
the mice are fully adapted to the isolation cabinets, to the 
cage and the wheel. For this, animals are entrained for 2 
weeks to a standard LD cycle (e.g. LD 12:12 for mice, or 
LD 14:10 for hamsters) (Fig. 7A). After this time the 
experiments can be started.  
 
In an entrained situation, the following parameters can 
be determined: Onset phase angle, onset variation, 
duration of the activity phase (α) and the rest phase (ρ), 
the daily overall activity and the percentage of light 
phase activity. To determine τ, animals are transferred to 
constant darkness (DD) by switching off the lights in the 
isolation cabinets at ZT12 and not turning them on again 
the next day. In DD, animals begin to free-run with an 
internal period close to 24 hours. On the first 2-3 days, 
animals often display unstable period lengths. These 
transients should be excluded from the evaluation. 
 
 
Fig. 7: Adaptation time and CT diagram. (A) Linear recording of wheel-
running activity of a male wild type mouse (C57BL/6 x 129SV) under LD 
12:12 conditions. Without prior wheel-running experience mice need two 
to three weeks to fully develop their wheel-running capacity. Only after 
this initial training (and entraining) phase experimental manipulations 
should be applied (X-axis: days of experiment; Y-axis wheel revolutions; 
black and white bars indicate dark and light phases, respectively; bin size 
for activity counts is 6 min).  (B) Diagram comparing circadian time (CT) in 
degrees versus CT units. 
 
Animals should be kept in constant darkness for at least 
2 weeks. Once a stable free-running rhythm is 
established, one can determine the onset error, the length 
of the alpha and rho phases, the internal period length, 
and the overall activity (revolutions/day). The onset error 
is the average difference (in hours or minutes) of the true 
activity onsets compared to the theoretical onsets 
predicted by a least square fit regression line drawn 
through all onsets of the analyzed time span. Alpha and 
rho phase can be calculated after determination of onset 
and offset times. The batch analysis function of the 
ClockLab data analysis software (Actimetrics) allows the 
automatic determination of most of these values for a 
given set of animals. 
 
Calculation of CTs 
 
For many circadian experiments it is necessary to 
calculate the subjective phases (CT, or circadian time) of 
an animal’s rhythm. A specific CT value is calculated 
upon the individual organism’s free-running rhythm. 
For this, one needs to determine the internal period 
length (τ) and the onset of activity on the day prior to the 
day of the experiment (Day A). 
 
It is important that the organism tested displays a stable 
rhythm during the time used to calculate the period 
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length. Activity onsets should be determined for at least 
6 consecutive days and a least square fit should be used 
to calculate τ. The last onset before the day of the 
experiment is determined as CT12 (Day A). CT12 on the 
following day (Day B) is calculated as follows: 
 
CT12 Day B = CT12 Day A + τ - 24 hrs 
 
To calculate circadian hours (or units), one divides the 
internal period length by 24 (see definitions section): 
 
1 circadian hour = τ / 24 
 
To define a circadian time earlier than CT12 (CT0 to 
CT12), one has to subtract X times one circadian hour 
from the predicted CT12 Day B.  
 
CTX earlier than CT12 = CT12 Day B – X * 1 circadian hour 
 
For CTX values later than CT12 (CT13 to CT24), one has 
to add X times 1 circadian hour to CT12 Day B. 
 
CTX later than CT12 = CT12 Day B + X * 1 circadian hour 
 
Some scientists do not use circadian time but divide the 
subjective circadian day into 360 degrees. In this case 0° 
corresponds to CT0, 180°C to CT12 and 360° to CT24 
(Fig. 7B). 
 
Phase resetting by brief light pulses 
 
Aschoff type I 
 
Resetting experiments according to Aschoff type I protocol 
(23) are done with mice that display a stable free-running 
rhythm in constant darkness and do not lose circadian 
rhythmicity (24). To determine a full light phase response 
curve (PRC), pulses have to be applied subsequently at 
CTs throughout the circadian cycle. Because of the long 
dead zone of the rodent light PRC exposure times can 
normally be restricted to the subjective night. However, 
one or two time points during the subjective day should 
be considered to exclude unexpected light 
responsiveness during this time (for example in a 
transgenic mouse strain). To get a rough overview, light 
pulses are normally given only at cardinal wild-type 
PRC time points of the circadian cycle like CT10 (the end 
of the dead zone), CT14 (maximum phase delay), and 
CT22 (maximum phase advance).  
 
In this setup the circadian time has to be determined 
individually for each mouse. When kept in the described 
12 cage isolation chambers, individual animals have to 
be removed from the chamber in their cages and be 
placed under an illumination screen for the time of the 
light exposure. 
 
It is crucial, that the mice are not unnecessarily disturbed 
by changing cages or by supplying food or water for at 
least four days before and after the light pulse. As a 
standard, pulse durations of 15 min are used. After a 
light pulse mice are returned to constant darkness for 
about ten days before the next light pulse can be 
administered.  
 
For quantification of the phase shift, regression lines are 
drawn through six to ten activity onsets prior to the light 
pulse and a minimum of six onsets after the light pulse 
(Fig. 5A and B). The activity onsets of the two to three 
days following the stimulus are normally not included in 
the regression lines because the oscillator is still in 
transition. To determine the extent of the phase shift, the 
distance between the two lines is calculated on the first 
day after the light pulse. The period length of the free-
running rhythm can change slightly after a light pulse 
(see aftereffects). In this case, the regression lines drawn 
through the onsets are not in parallel. 
 
Phase advances are noted as positive values while phase 
delays result in negative phase shifts. The value of the 
phase shift depends on the species/strain and the 
experimental setup. For 129SvEvBrd/129 Ola mice one 
can expect phase delays of up to 90 min (CT14) and 
phase advances of up to 40 min (CT22) after 15 min light 
exposure (25). By pulsing all animals sitting in the same 
isolation cabinet at once, a PRC can be created (Fig. 5D). 
Retrospectively, the CT when the light pulse was 
administered is calculated for each animal. Doing so with 
many animals, one gets easily the phase shifts for each 
CT and thus can establish a PRC. 
 
Aschoff type II 
 
When working with animals that display unstable 
circadian rhythmicity in constant darkness, the 
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determination of circadian times may cause problems 
and testing phase shifts with an Aschoff type I protocol is 
not possible. In this case we suggest using the Aschoff 
type II protocol as follows (23, 26). 
 
After 2 weeks of entrainment to LD 12:12 conditions, 
mice are released into a first period of constant darkness 
during 2-3 weeks. Thereafter, mice are re-entrained to a 
LD 12:12 cycle (15 days) before release into DD for at 
least ten days. In the first day of DD (with the nocturnal 
time points starting immediately after the last “lights 
off”), the light pulse is administered at the desired time 
points. Advantages of this protocol are that the light 
pulses can be administered simultaneously to all the 
mice without any disturbance like manipulating the cage 
(see Aschoff type I protocol). 
 
For the determination of the phase shift in this protocol, 
regression lines are fitted through 6 consecutive activity 
onsets before (LD) and after the light pulse (DD). For the 
DD regressions the first day is disregarded because of 
possible transition effects. The phase shift is calculated as 
the difference between the two regression lines on the 
first day after the light pulse. Some species/strains show 
an apparent phase-shift after release into DD even 
without prior light administration. Therefore it is 
mandatory to monitor LD-DD transitions without light 
pulse and adjust the experimental data accordingly (Fig. 
5C). 
 
Jet lag 
 
In the lab, delaying the LD cycle (simulating westward 
flights) or advancing it (simulating eastward flights) can 
simulate jet lag very easily. After 10 days in the same LD 
cycle (e.g. LD 12:12, lights on from 6 am to 6 pm) the LD 
cycle is delayed (e.g. by 8 hours; LD 12:12, lights on from 
10 pm to 10 am) for 2 to 3 weeks. Since the animals 
cannot adjust their rhythm immediately to such a shift, 
some transients will be observed. After a stable 
entrainment is established, the LD cycle can again be 
advanced to the initial LD cycle (e.g. LD 12:12, lights on 
from 6 am to 6 pm), which simulates a transmeridian 
flight to the east. Sporadic jet lags have only minor 
impact on the general health state while regular jet lags 
have been shown to influence physiology, the immune 
system and may even promote cancer (27). Chronic jet 
lags can be observed in persons working predominantly 
at night, often changing their work shift, or frequently 
traveling by transmeridian flights. 
 
To assess chronic jet lag in the laboratory, mice are 
entrained to LD 12:12 for around 10 days with lights on 
at 6 am and lights off at 6 pm (Fig. 5E). After full 
entrainment is accomplished, the animals are confronted 
to chronic jet lag by advancing the LD 12:12 cycle in 
series of 8 hours every 2 days for 10 days. This means 
that the first shift changes lights on from 6 am to 2 pm, 
the second from 2 pm to 10 pm, the third from 10 pm to 6 
am, and so forth. After the 6th shift, the animals are 
released into DD for 2 days before sacrificing them at the 
desired CTs (28). Alternatively, mice can also be 
subjected to alternating advance and delay shifts to 
study chronic jet lag. Such a protocol is a more realistic 
simulation, because usually one travels to another 
continent and back home. 
 
Constant light conditions 
 
A second type of free-run condition (as opposed to DD) 
is constant light (LL). In LL, behavior in response to 
different light intensities can be tested. After a standard 
training phase in LD, one normally starts with a period 
of DD before gradually increasing the light intensity. 
Standard paradigms use 14 to 20 days per lighting 
condition. It should, however, be ensured that the 
rhythm is stabilized in a particular condition before 
applying the next level of intensity. Like in DD, onset 
error, the length of the alpha- and rho-phases, the internal 
period length, and the overall activity (revolutions/day) 
can be determined for any given light intensity. 
 
In wild type mice, the robustness of the activity rhythm 
is decreased with increasing light intensities. Besides the 
activity depressing effect of bright light exposure, the 
tonic light signaling to the SCN hampers the coupling of 
the single cell oscillators in this area and eventually 
renders the pacemaker output arrhythmic (29). In 
addition, constant light modulates the period length of 
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the circadian system with τ increasing roughly in 
proportion with the logarithm of the applied light 
intensity (“Aschoffʹs rule”) (30). 
 
APPENDIX 
 
Does constant darkness have an impact on the health 
of mice? 
 
To demonstrate that wheel-running in constant darkness 
is not harmful for mice, their state of health was daily 
monitored by gently checking them with night vision 
goggles (Rigel 3200) during their active phase as it is 
demanded and approved by the Swiss Federal Veterinay 
Office (FVO). Additionally, a small-scale study has been 
done by their request to further demonstrate this. For 
this, four females and four males with a mixed C75BL/6 x 
129S5/SvEvBrd background together with four males 
carrying a 129SvEvBrd/129 Ola background were held in 
constant darkness in an isolation cabinet as described 
above. Body weight was determined every two to three 
days for three weeks with a balance (WEDO Digi 2000, 
2000g/1g). Night vision goggles possessing an infrared 
beam were used for all manipulations because of the 
insensitivity of the rodent visual system to these longer 
wavelengths. Infrared light may act as a Zeitgeber in 
reptiles whereas it does not in rodents. 
 
Our results show that constant darkness does not have 
any negative effects on the health of mice during wheel-
running experiments. Both females and males (C75BL/6 x 
129S5/SvEvBrd) did not lose any significant weight 
during monitoring. The same is true for males carrying a 
129SvEvBrd/129 Ola background (Fig. 8A and B). A 
single male animal that lost weight within this group 
was overweight in the beginning of the experiment. It 
steadily lost weight during the first twelve days and 
stabilized it then on the same extent than his 
companions. Weighing mice is only one of many possible 
parameters to assess health status. In conclusion, this 
implicates that the exposure to constant darkness for a 
period of some weeks has no negative consequences on 
the health of mice. 
 
Fig. 8: Impact of constant darkness on weight and overall activity of wild-
type mice. (A) Weight curves of 8 littermates (males: solid lines / females: 
hatched lines) with a mixed C75BL/6 x 129S5/SvEvBrd background. Mice 
were reared in a normal LD 12:12 cycle and then transferred to constant 
darkness (DD). They were housed individually in wheel-running cages 
where food and water were accessible ad libitum. During 22 days, they 
were weighed regularly using night vision goggles. The x-axis displays the 
days spent in constant darkness whereas the y-axis displays the weight 
[g]. (B) Weight curves of 4 male mice with a 129SvEvBrd/129Ola 
background. Only one mouse (J) that was overweight in the beginning 
looses weight during monitoring. 
 
SUPPLEMENTAL INFORMATION 
 
Web resources 
 
1. http://circadiana.blogspot.com 
2. www.actimetrics.com 
3. www.amillar.org 
4. www.circadianpubcrawler.org 
5. www.cbt.virginia.edu 
6. www.epbr-society.com 
7. www.srbr.org 
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PROTOCOLS 
 
Equipment 
 
 Wheel-running facility 
 Isolation cabinets: 
 Light bulb: Mazdafluor, Symphony AZURA 965, 18 W 
 Light bulb mounting: Mazda, type: Mx204-118 (230V, 50Hz, 0.37A) 
 Fan: accessories by Monacor, Article No. 03.1670 (CF-1212, 12V=/500mA) 
 Wheel-running cages: 
 Cage: Tecniplast 1155M (280 mm long x 105 mm wide x 125 mm high) 
 Stainless steel wire lid: Tecniplast 1155M115 
 Stainless running wheel: Trixie GmbH, Article No. 6083 (diameter 115 mm) 
 Magnet: Fehrenkemper Magnetsysteme, Article No. 34.601300702 
 Magnetic switch: Reed-Relais 60, Conrad Electronic AG, No. 503835-22 
 Mouse housing: 
 Water bottles: Tecniplast ACBTO262 (260 ml, 55 x 128 mm, polycarbonate, with silicone ring) 
 Bottle caps: Tecniplast ACCP2521 
 Nestlets (5 x 5 cm): EBECO 
 Animal bedding: Schill AG Bedding type 3-4 
 Food (γ irradiated): Provimi Kliba, No. 3432 
 Computer Hardware and software [4]: 
 Microsoft Windows PC (e.g. Dell, Intel Pentium III running Windows 2000 or better) 
 Data acquisition board: National Instruments AMUX 64-T (fitted with 10-kΩ resistors) 
 RJ45 socket 
 PCI 6503 card National Instruments 
 National Instruments NI-DAQ software  
 ClockLab software package, Actimetrics 
 All components listed above can be purchased in a ready to use package from Actimetrics 
 
Methods 
 
Abbreviations 
 
LD light dark cycle (usually LD 12:12 cycles) 
DD constant darkness 
LL constant light 
ZT Zeitgeber time (ZT0 corresponds to lights on) 
CT circadian time 
 
Experimental set-up 
 
 6 mutant mice and 6 wild-type controls (2-6 months old) 
 Mutant and wild-type mice need to have the same genetic background and should be of similar age (most suitable 
are littermates) 
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Table 1: Aschoff type I 
Lighting condition Duration Measurements 
LD 12:12 10-15 days  
DD 10-15 days Period length of free-running rhythm (τ), onset error, length of activity period 
(alpha-period) 
Light pulse at CT14 15 min Phase shift 
DD 10-15 days  
Light pulse at CT22 15 min Phase shift 
DD 10-15 days  
Light pulse at CT10 15 min Phase shift 
DD 10-15 days  
LD 12:12 10-15 days Onset phase angle, onset error, rel. light phase activity, length of activity period 
 
Table 2: Aschoff type II 
Lighting condition Duration Measurements 
LD 12:12 10-15 days  
DD 10-15 days Period length, onset error, length of activity period 
LD 12:12 10-15 days Onset phase angle, onset error, rel. light phase activity, length of activity period 
Light pulse at ZT14 15 min Phase shift (compare to LD → DD without light pulse) 
DD 10-15 days  
LD 12:12 10-15 days Onset phase angle, onset error, rel. light phase activity, length of activity period 
→ compare to previous LD 12:12 
Light pulse at ZT22 15 min Phase shift (compare to LD → DD without light pulse) 
DD 10-15 days  
 
Table 3: Optional for Aschoff type I and Aschoff type II 
Lighting condition Duration Measurements 
LL (~5 lux) 10-15 days Period length, onset error, length of activity period 
LL (~50 lux) 10-15 days Period length, onset error, length of activity period 
LL (~500 lux) 10-15 days Period length, onset error, length of activity period 
Overall activity (revolutions/day) has to be monitored for every lighting condition. Above experiments should be 
done with at least 10 to 12 mice before performing statistical analysis. 
 
Formulas for CT calculations 
 
1CT = internal period length / 24 
CTX earlier than CT12 = CT12 Day B – X * 1CT  
CTY earlier than CT12 = CTX + 24 
CTX later than CT12 = CT12 Day B + X * 1CT 
CTY later than CT12 = CTX – 24 
Relative time = absolute time / 60 
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Jet lag: An example of a typical experimental setup 
 
Table 4 : Simulating a westward transmeridian flight 
Lighting condition Duration Measurements 
LD 12:12 (L 6 am to 6 pm) 10-15 days Onset phase angle, onset error, rel. light phase activity, length of activity 
period 
LD 12:12 (L 10 pm to 10 am) 2-3 weeks Onset phase angle, onset error, rel. light phase activity, length of activity 
period, time in transience 
LD 12:12 (L 6 am to 6 pm) 10-15 days Onset phase angle, onset error, rel. light phase activity, length of activity 
period 
 
Table 5 : Simulating an eastward transmeridian flight 
Lighting condition Duration Measurements 
LD 12:12 (L 6 am to 6 pm) 10-15 days Onset phase angle, onset error, rel. light phase activity, length of activity 
period 
LD 12:12 (L 10 pm to 10 am) 2-3 weeks Onset phase angle, onset error, rel. light phase activity, length of activity 
period, time in transience 
LD 12:12 (L 6 am to 6 pm) 10-15 days Onset phase angle, onset error, rel. light phase activity, length of activity 
period 
 
Table 6: Chronic jet lag: An example of a typical experimental setup (Ref: 28) 
Lighting condition Duration Measurements 
LD 12:12 (L 6 am to 6 pm) 10 days Onset phase angle, onset error, rel. light phase activity, length of activity 
period 
LD 12:12 (L 2 pm to 2 am) 2 days  
LD 12:12 (L 10 pm to 10 am) 2 days  
LD 12:12 (L 6 am to 6 pm) 2 days  
LD 12:12 (L 2 pm to 2 am) 2 days  
LD 12:12 (L 10 pm to 10 am) 2 days  
LD 12:12 (L 6 am to 6 pm) 2 days  
DD 2 days  
One should always keep in mind that jet lag can be caused by both shifting time backwards and forwards. 
 
Definitions 
 
Overall activity - Average activity bouts (revolutions/day) over the specified period (alpha- and rho-phase). 
 
Period length - Length of displayed overt rhythm. In DD, it represents the endogenous internal rhythm (τ). 
 
Onset error - Difference [h] between the onsets of activity and the constructed regression line. To achieve this, a least  
square fit regression line is plotted through the onsets of activity for the specified period. 
 
Onset phase angle - Difference [h] between an external (entraining) and an internal period of an entrained organism  
e.g. anticipated or delayed activity onset.  
 
Rel. light phase activity - Activity [%] during light phase (rho-phase in mice) relative to the overall activity. 
 
Length of activity period - Duration [h] of the alpha-phase (often given as relative value compared to the period  
length). 
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6.2.1.4 Genotyping of mice 
6.2.1.4.1 Solutions 
•  Lysis buffer (pH 8.0): 
  20 mM  Tris-HCl 
  5 mM EDTA 
 400 mM NaCl 
 1 % (w/v) SDS   
•   6 x Loading dye:  
  80 % Glycerol 100 % 
  20 % 0.5 M EDTA pH 8  
  2 mg  Bromophenol Blue 
  2 mg  Xylene Cyanole 
•  1x TE (pH 8): 
  10 mM Tris-HCl  
  1 mM EDTA  
•  Proteinase K [20 mg/ml]: 
 20 mg Proteinase K 
 1 ml ddH2O 
•  50 x TAE: 
  242 g  Tris 
  57.1 ml glacial acetic acid  
  100 ml EDTA 0.5 M pH 8.0  
  The volume is completed to 1000 ml with ddH2O. 
•  EtBr [10 mg/ml]: 
 1 g of EtBr is dissolved in 100 ml ddH2O and stored in a reaction tube wrapped with 
aluminium foil and stored in a dark place. 
•   20 x SSC (pH 7.0): 
 175.3 g NaCl 
 88.2 g tri-Na-Citrate x 2 H2O (AW: 294.1) 
 800 ml dH2O 
The pH is adjusted to 7.0 and the volume is completed to 1 l with dH2O. 
•  10 % SDS: 
  100 g  SDS  
 The powder is dissolved in a total of 1000 ml dH2O under shaking at 37°C. The solution is 
stored at RT without autoclaving. 
•  2x SSC, 0.1 % SDS: 
  100 ml  20x SSC 
  10 ml 10 % SDS  
  890 ml dH2O 
•  0.1x SSC, 0.1 % SDS: 
  5 ml  20x SSC 
  10 ml 10 % SDS  
  985 ml dH2O 
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•  Herring sperm DNA: 
 10 mg/ml herring sperm DNA is dissolved o/n and under continuous shaking in ddH2O. 
Then NaCl is added to yield a final concentration of 0.1 M. The mixture is extracted with 
the same volume of phenol:chloroform. The aqueous phase is portioned into 1 ml aliquots. 
The DNA is sheared by forcing it 12 times through a 0.5 mm needle before it is sonicated. 
The DNA is precipitated by adding double the amount of cold 100 % EtOH and pelleted 
by centrifugation at 4°C and 13000 rpm for 20 min.  
   
6.2.1.4.2 Digestion of mouse tails 
On the day of weaning, the tail tip of mice is cut using scissors and they receive an ear mark 
for later identification. The tail tip is put into a safe lock reaction tube and then digested under 
continuous rotation over-night (o/n) at 60°C in a mixture of 500 μl lysis buffer pH 8.0 and   
20 μl proteinase K [20 mg/ml]. 
 
6.2.1.4.3 Extraction of genomic DNA 
The next morning, the tube is centrifuged at RT and 13’000 rpm for 3 min to pellet the cell 
debris. The supernatant (around 450 μl) is transferred to a new tube with wide bore tips. 
Using these tips reduces shearing of the DNA. To precipitate DNA, 800 μl of 100 % EtOH is 
mixed with the supernatant. The white DNA thread is then transferred to a new tube 
containing 500 μl of 70 % EtOH to wash away salts. After discarding as much 70 % EtOH as 
possible, 500 μl of 100 % EtOH is added to remove the remaining water. Then the 100 % 
EtOH is taken out completely and the DNA is air dried at RT for 5 min, before it is dissolved 
in 50-100 μl 1x TE. If the DNA pellet can not be dissolved after a while, the tube can be left 
at RT o/n or it can be incubated on a shaker at 37°C for about 2 h. 
 
6.2.1.4.4 Genotyping by polymerase chain reaction (PCR) 
Since the PCR is a very sensitive method, small changes in the reaction mixture or in the PCR 
cycle protocol can lead to dramatic changes in PCR efficiency. This is why every gene to be 
analyzed needs a specific setup which is listed below. Once the PCR is finished, 10 l of the 
product is analyzed on a 1.5 % agarose gel. To be able to determine the length of the 
fragments, 1.5 l of 100 bp DNA ladder are loaded as well. 
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PCR-program: 
 mCry1 mPer1 mPer2 mRev-Erb  
Step 1 2 min at 94°C 2 min at 94°C 2 min at 94°C 2 min at 94°C 
Step 2: Denaturation 30 s at 94 °C 30 s at 94 °C 30 s at 94 °C 30 s at 94 °C 
Step 3: Annealing 30 s at 62°C 30 s at 56°C 30 s at 56°C 30 s at 62°C 
Step 4: Elongation 7 min at 68°C 1 min at 72°C 1 min at 72°C 1 min at 72°C 
Step 5 7 min at 68°C 10 min at 72°C 10 min at 72°C 10 min at 72°C 
Step 6  at 20°C  at 20°C  at 20°C  at 20°C 
Repeat step 2 to 4 35 cycles 34 cycles 33 cycles 36 cycles 
 
PCR-mix: 
 mCry1 mPer1 mPer2 mRev-Erb  
DNA 0.3 μg 0.3 μg 0.3 μg 0.3 μg 
10x Buffer 2.5 μl 5.0 μl 2.5 μl 2.5 μl 
(NH4)2SO4 [60 nM] 2.5 μl 10.0 μl 2.5 μl 2.5 μl 
MgCl2 1.5 μl - - 2.0 μl 
5x Q-Solution 1.25 μl 2.0 μl - - 
Primer 1 1.0 μl [25 mM] 5.0 μl [5 μM] 3.5 μl [5 μM] 2.5 μl [5 μM] 
Primer 2 1.0 μl [25 mM] 5.0 μl [5 μM] 3.5 μl [5 μM] 2.5 μl [5 μM] 
Primer 3 1.0 μl [25 mM] 5.0 μl [5 μM] 3.5 μl [5 μM] 2.5 μl [5 μM] 
Taq-polymerase [5 U/μ l] 0.25 μl 0.5 μl 0.25 μl 0.25 μl 
dNTP [10 mM] 1.0 μl 1.0 μl 0.5 μl 0.5 μl 
ddH2O x μl x μl x μl x μl 
Total 25 μl 50.0 μl 25 μl 25 μl 
 
Primers: 
mCry1 primer 1  (mCry1 new fwd): 5’-GCA TGA CCC CTC TGT CTG AT-3’ 
mCry1 primer 2 (mCry1 new KO rev): 5’-TGA ATG AAC TGC AGG ACG AG-3’ 
mCry1 primer 3 (mCry1 new WT rev2): 5’-AAC ACG CAG ATG CAG TCG-3’ 
mPer1 primer 1 (gPer1f): 5’-ACA AAC TCA CAG AGC CCA TCC-3’ 
mPer1 primer 2 (gPer1r2): 5’-ATA TTC CTG GTT AGC TGT AGG-3’ 
mPer1 primer 3 (PKG hprt rev): 5’-CGC ATG CTC CAG ACT GCC TTG-3’ 
mPer2 primer 1 (gP2f2): 5’-GCT GGT CCA GCT TCA TCA ACC-3’ 
mPer2 primer 2 (gP2r2): 5’-GAA CAC ATC CTC ATT CAA AGG-3’ 
mPer2 primer 3 (PKG hprt rev): 5’-CGC ATG CTC CAG ACT GCC TTG-3’ 
mRev-Erb primer 1 (WT29rev): 5’-CAC CTT ACA CAG TAG CAC CAT GCC ATT CA-3’ 
mRev-Erb primer 2 (LacZ29rev): 5’-AAA CCA GGC AAA GCG CCA TTC GCC ATT CA-3’ 
mRev-Erb primer 3 (comm29rev): 5’-CCA GGA AGT CTA CAA GTG GCC ATG GAA GA-3’ 
 
6.2.1.4.5 Genotyping by Southern blot 
The method is named after the British biologist Edwin Southern who invented it in 1975 
(Southern, 1975). This method allows checking for the presence of a specific DNA sequence 
in a sample via combination of agarose gel electrophoresis for size separation and subsequent 
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transfer of the DNA to a filter membrane. A labelled probe is then incubated with the 
membrane and the signal is detected by autoradiography or other methods. 
 
Electrophoresis and neutral transfer 
Before the DNA can be loaded on a 0.8 % agarose gel, 10 μg of tail tip DNA have to be 
digested o/n at 37°C, in a total volume of 50 μl, with a restriction enzyme that is specific for 
each gene. 
• mCry1: NcoI  
• mCry2 and mPer1: EcoRI 
• mPer2: BamHI 
The DNA fragments are then loaded onto the gel to separate them by size o/n at 20 V or at 65 
V during 6 to 7 hours in an electrophoresis chamber (Sunrise
TM
, GibcoBRL). Once the 
migration is finished, the gel is coloured for 10 min in EtBr (20 l EtBr in 1000 ml 1x TAE) 
to check whether the DNA bands migrated well or not. If the gel is fine, it is rinsed in dH2O 
and then incubated twice in 0.25 M HCl for 5 min. It is important to respect the incubation 
time because HCl depurinates DNA, breaking it into small pieces, which improves their 
transfer from the gel to the membrane later on. The gel is rinsed once more in dH2O, before it 
is incubated for 30 min in a mixture of 0.4 M NaOH and 0.6 M NaCl. In a next step the gel is 
incubated for 30 min in 1.5 M NaCl and 0.5 M Tris-HCl pH 7.5. After washing the gel shortly 
in dH2O it is ready for neutral transfer in a glass chamber containing 10x SSC.  
A big sheet of plotting paper is wetted in 10x SSC and the Gene Screen Plus transfer 
membrane (Perkin Elmer) is incubated for 10-15 min in 10x SSC. The big blotting paper is 
put on a platform located inside the glass chamber with its sides dipping into 10x SSC. Then 
the gel is placed upside down on a big wet plotting paper and the humidified membrane is laid 
over it. Eventually, bubbles have to be removed gently by rolling them out, before some 
sheets of dry plotting paper and several sheets of tissue paper are put on top of the stack. 
Parafilm is laid around the gel to prevent overlapping tissue paper that may touch the liquid 
from disturbing the capillary force which moves the DNA from the gel to the membrane. The 
DNA is bound to the membrane due to ion exchange interactions as the negatively charged 
DNA sticks to the positively charged membrane. The transfer is left o/n and the next morning 
the membrane is washed in 0.4 M NaOH for 1 min to denature the DNA. Before the DNA can 
be UV-cross linked to the membrane, the latter is neutralized in 0.2 M Tris-HCl pH 7.5 / 1x 
SSC for 1 min.  After cross linking, the membrane is washed several times in dH2O to remove 
ions, which could form crystals with the hybridization buffer. 
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Probe labelling and hybridization 
The Southern blot probe templates for mCry1
-/-
 (van der Horst et al., 1999), mPer1
Brdm1
 
(Zheng et al., 2001) and mPer2
Brdm1
 (Zheng et al., 1999) are as described previously. 
The probes are labelled with 
32
P-dCTP using the Megaprime DNA Labelling System kit 
(Amersham, RPN1606). 50 ng of template DNA are mixed carefully with 5 μl primer, before 
the mixture is boiled for 3 min in a water bath. Then the mixture is allowed to cool down on 
ice for 2 min. The tube is then centrifuged shortly and the following components of the kit are 
added: 
 10.0 μl labelling buffer 
 5.0 μl  32P-dCTP 
   2.0 μl  Klenow enzyme 
The mixture is incubated for 1 h at 37°C. Then the tube is centrifuged quickly and boiled for 3 
min before it is put on ice for 2 min. In order to avoid contamination with radioactive aerosols 
the contents are spun down before unincorporated nucleotides are removed with ProbeQuant 
G-50 Micro Columns (Amersham) according to the manufacturer’s instructions. 2 μl of the 
labelled probe are added to 2 ml of scintillation cocktail and counted in a scintillation counter. 
If at least 2 Mio cpm/μl are obtained, 50 μl of herring sperm DNA is added to the probe and 
the mixture is boiled for 2 min. Then the tube is cooled down on ice for 2 min. 
 
Hybridization and posthybridization 
The cross linked membrane is put into a hybridization bottle together with an appropriate 
volume (usually 10 ml) of hybridization buffer (QuickHyb, Stratagene) and incubated under 
rotation at 68°C for 20 min. Once the pre-hybridization is finished, the denatured probe is 
added directly into the hybridization bottle where it is hybridized for 1 to 1.5 hours at 68°C.  
The excess buffer is decanted and the membrane is washed three times inside the bottle with 
2x SSC containing 0.1 % SDS and then twice with 2x SSC/0.1 % SDS at RT for 20 min. 
Subsequently, the membrane is taken out of the bottle and washed twice with 0.1x SSC/0.1 % 
SDS at 62°C for 20 min in a shaking water bath. The membrane is wrapped with Saran paper 
and exposed to a film with an intensifying screen at -80°C for one to two days. Upon direct 
exposure of the film, only around 5 % of the X-ray photons will be absorbed by the film. The 
intensifying screen is a sheet of inorganic salt crystals, which emit fluorescent light when 
excited by X-ray radiation. This leads to an increase in detected photons of up to 40 %. Prior 
to development, the cassette has to be equilibrated at RT for 30 min.  
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6.2.2 Molecular biology applications 
6.2.2.1 Solutions 
•  10 x TAE: 
  48.4 g  Tris 
  11.4 ml glacial acetic acid  
  20.0 ml EDTA 0.5 M pH 8.0 
•  EtBr [10 mg/ml]: 
 1 g of EtBr is dissolved in 100 ml ddH2O and stored in a reaction tube wrapped with 
aluminium foil and stored in a dark place. 
•   6 x Loading buffer for DNA:  
  25 mg  Bromophenol Blue 
  25 mg  Xylene Cyanol 
  7.0 ml  Glycerol 
 3.0 ml ddH2O 
•  TE (pH 7.5): 
  1 ml Tris-HCl 1 M RNase free 
  0.2 ml EDTA 0.5 M RNase free 
  The volume is completed to 100 ml with ddH2O and pH is adjusted to 7.5. 
•  Amp 100 x stock [10 mg/ml]: 
 500 mg Ampicillin in 50 ml 70 % EtOH 
 The solution is conserved at –20°C. 
•  Kanamycin 1000 x stock [25 mg/ml]: 
 The powder is dissolved in ddH2O and 1 ml aliquots are conserved at –20°C. 
•  LB medium: 
 1 % NaCl 
 1 % Select Peptone 140 
 0.5 % Select Yeast extract 
 For 1 l, 10 g Peptone, 10 g NaCl and 5 g yeast extract are dissolved in 950 ml dH2O, 
adjusted to 1 l and autoclaved prior to use. It is stored at 4°C. Before use, 10 ml of 
antibiotic has to be added. 
•  LB-Amp plates: 
  1 % NaCl 
  1% Select Peptone 140 
  0.5 % Select Yeast extract 
  1.5 % Agar 
 For 1 l, 10 g NaCl, 10 g Peptone, 5 g yeast extract and 15 g agar is dissolved in 1 l dH2O 
and autoclaved prior to use. When the temperature cools down to around 50°C, 10 ml of 
100 x Amp are added before the plates are poured (25 ml/plate) next to a Bunsen burner or 
under a hood. When they have solidified, they are inverted and stored at 4°C in the dark. 
• Lysozyme stock: 
 10 mg/ml  Lysozme in dH2O  
 The solution is stored at –20°C. 
•  TE/RNase: 
 20 g/ml  RNase A (DNase free) in TE buffer 
 The solution is stored at –20°C. 
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•  TELT solution: 
  5 ml 1 M Tris-HCl, pH 7.5 
  12.5 ml 0.5 M EDTA, pH 8.0 
  10.6 g LiCl2 
  4 ml Triton-X100 
 The volume is adjusted to 100 ml with dH2O. 
•  ATP [100 mM]: 
30 mg of ATP disodium salt are dissolved in 800 μl ddH2O. The pH is adjusted to 7.0 with 
0.1 M NaOH (pH paper) and the volume is filled up to 1 ml. Small aliquots are stored at     
-20°C. 
•  DTT [1 M]: 
1.55 g DTT are dissolved in 10 ml ddH2O and 1 ml aliquots are stored at -20°C. NEVER 
autoclave DTT! 
•  10x Ligation buffer A: 
  10 mM ATP 
  100 mM DTT 
 500 μl aliquots are stored at -20°C 
•  10x Ligation buffer B: 
  500 mM Tris-HCl pH 7.5 
  100 mM MgCl2 
  2 mg/ml BSA solution 
 500 μl aliquots are stored at -20°C 
•  BSA [10 mg/ml]: 
100 mg BSA are dissolved in 10 ml ddH2O and 10 μl 1 M DTT is added to the solution.   
1 ml aliquots are stored at -20°C. 
•  10x Annealing buffer: 
  500 mM Tris-HCl pH 7.5 
  500 mM NaCl 
  100 mM MgCl2 
 
6.2.2.2 Isolation of RNA 
Many methods, such as in situ hybridization, require a plasmid containing a labelled probe 
sequence. The raw material for this insert is the mRNA extracted from mouse tissue. 
RNA isolation is carried out using RNA-Bee, which promotes the formation of complexes of 
RNA with guanidine and water molecules, and prevents hydrophilic interactions between 
DNA and proteins. Consequently, DNA and proteins do not reach the aqueous phase and can 
be removed with phenol, leaving only the RNA remaining in the aqueous phase, from which 
it can be precipitated using isopropanol. 
Mouse tissue (half a brain, piece of liver or one kidney) and 1 ml RNA-Bee are homogenised 
with a polytron in a 2 ml Eppendorf tube and put on ice. 100 μl of chloroform is added and 
the tube is vigorously shaken (not vortexed) until a milky solution forms. It is kept on ice for 
5 min. After the incubation, the suspension is centrifuged at 13'000 rpm at 4°C for 15 min. 
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The homogenate now forms two phases: the lower blue phenol-chloroform phase and the 
colourless upper aqueous phase. DNA and proteins are located in the milky interphase and 
organic phase. The aqueous layer is transferred into a fresh tube and an equal volume of 
isopropanol is added to precipitate RNA. The tube is carefully inverted several times and 
stored at 4°C for 15 min. Finally, it is centrifuged at 13'000 rpm for 15 min at 4°C. A white 
pellet should form at the bottom of the tube. After this step, the procedure can be interrupted 
and the tube kept with the pellet and isopropanol at –80°C until further use. 
If the RNA extraction was interrupted, the tube must be thawed on ice before removing the 
isopropanol. The pellet is washed once with 1 ml of 100 % ethanol by turning the tube in your 
hands. The ethanol is discarded and the pellet is briefly air-dried. The pellet is dissolved in a 
starting volume of 20 μl ddH2O.  
 
6.2.2.3  Spectrophotometric determination of nucleic acid concentration 
The determination of RNA and DNA concentrations is achieved with a spectrophotometer by 
measuring the absorbance (A) at 260 nm and 280 nm. The purity of the sample is estimated 
by the ratio of A260/A280. The ratio values for a good DNA preparation should be around 1.8: 
values that are < 1.75 indicate protein contamination and values > 1.9 indicate RNA 
contamination. A good RNA preparation optimally shows ratios of around 2. 
The following conversion values are used to calculate the nucleic acid concentrations: 
 1 A260 unit double stranded (ds) DNA   50 μg/ml 
 1 A260 unit single stranded (ss) DNA or RNA   40 μg/ml 
 1 A260 unit oligonucleotide  20 μg/ml 
The following formula is used to calculate the concentration: 
 
 
df represents the dilution factor, cf the conversion factor, c the concentration and NA260 the 
measured number of absorbance units at 260 nm. 
 
Materials and Methods 
170 
6.2.2.4 Agarose gel electrophoresis 
Electrophoresis is used to separate biological molecules such as nucleic acids or proteins 
according to their size and charge in an electrical field. Length and purity of nucleic acid 
molecules can be accurately determined by agarose (a polysaccharide isolated from seaweed) 
gel electrophoresis as each nucleotide in a nucleic acid molecule carries a negative charge on 
its phosphate group. That is why this procedure is simpler than for proteins, since there is no 
need to add the negatively charged detergent SDS that is required to make protein molecules 
move uniformly toward the positive electrode. However, agarose gel electrophoresis only 
works for large nucleic acid molecules. According to the size of the fragment, agarose is 
prepared as follows: the longer the fragment the less concentrated the gel. 1 - 2 % (w/v) 
agarose gels are used to separate DNA or RNA fragments of 200 to 20'000 bp. For molecules 
smaller than 500 bp, less porous gels are needed, such as those made from polyacrylamide. 
These nucleic acid separation methods are widely used for both analytical and preparative 
purpose. Unfortunately, nucleic acid bands on agarose or polyacrylamide gels are invisible 
unless they are stained. One method for staining them is to add ethidium bromide (EtBr) to 
the gel, which fluoresces under UV light (312 nm) when intercalated between two 
neighbouring bases in a nucleic acid helix. 
Agarose powder is dissolved in the appropriate volume of 0.5x TAE by heating it in a 
microwave until it reaches its boiling point. As soon as the solution is cooled down to 
approximately 50°C, ~0.2 μl EtBr (10 mg/ml) per 100 ml is added. After swirling the 
Erlenmeyer, the solution is poured into a horizontal electrophoretic chamber. When the gel is 
solidified, it is ready for use in a gel migration chamber. 0.5 x TAE is used as a migration 
buffer. The electrophoresis is carried out at either 50 V for around 40 min or at 100 V for ca. 
20 min. To follow the migration of the nucleic acids across the gel, the samples are mixed 
with 6 x loading dye before filling the wells. This allows the observer to stop the 
electrophoresis at the point when the bromphenol blue (and with it DNA molecules) has 
migrated the desired distance. To be able to determine the length of the fragments, at least one 
well of the gel is filled with either a 1 kb or a 100 bp DNA Ladder. 
At the end, a picture of the gel is taken with a photo documentation system and printed on 
thermal paper (MITSUBISHI, KP65HM-CE).  
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 Fig. 6.2-2: A 0.5 g of 100 bp DNA Ladder (NEB, N3231L) visualized with 
ethidium bromide staining on a 1.3% TAE agarose gel.  B 0.5 g of 1 kb DNA 
Ladder (NEB, N3232L) visualized with ethidium bromide staining on a 0.8% TAE 
agarose gel. 
 
  
6.2.2.5 RT-PCR and cloning 
The extracted mRNA (see 6.2.2.2 for 
extraction) must be transcribed into 
complementary DNA (cDNA) by reverse 
transcriptase before it can be amplified. The 
enzyme “reverse transcriptase” originates 
from retroviruses, such as the Moloney 
Murine Leukemia Virus (MMLV), and 
synthesizes a DNA chain from a RNA 
template. Single stranded (ss) cDNA 
molecules are then converted into double 
stranded (ds) DNA molecules by DNA 
polymerase. These molecules are then 
inserted into a plasmid or a virus vector and 
cloned. 
Between 1 ng – 5 μg of total RNA are used as a template for RT-PCR. First, 17 μl ddH2O, 2 
μl RNA and 4 μl oligo dT18 primer (1 μg/μl) are mixed in a nuclease-free microcentrifuge 
tube and annealed for 10 min at 70°C.  
 
A B 
Fig. 6.2-3:  Classical cDNA synthesis via 
reverse transcription – short RT-PCR. 
Materials and Methods 
172 
The tube is chilled for 2 min on ice and then the following substances are added: 
 4.0 μl DTT (0.1 M) 
 8.0 μl 5 x First-Strand Buffer 
 2.0 μl dNTPs (10 mM) 
 1.0 μl RNasin (40 U/μl) 
 2.0 μl SuperScriptTM II RNase H- Reverse Transcriptase (200 U/μl) 
 40.0 μl total volume 
The contents are gently mixed and incubated at 37°C for 1.5 h in a water bath. Then the 
mixture is heated to 95°C to inactivate the reaction and to denature the cDNA:mRNA hybrids. 
If the cDNA is not used directly for the PCR the tubes are frozen at –20°C, otherwise they are 
kept on ice. The PCR reaction is typically set up as follows: 
 2.0 μl cDNA 
 4.0 μl  MgCl2 (25 mM) 
 5.0 μl (NH4)2SO4 (60 nM) 
 5.0 μl 10 x QIAGEN PCR Buffer 
 5.0 μl 5' primer (5 μM) 
 5.0 μl 3' primer (5 μM) 
 0.5 μl Taq DNA Polymerase (5 U/μl) 
 1.0 μl dNTPs (10 mM) 
 22.5 μl ddH2O 
 50.0 μl total volume 
Ammonium sulphate is added to improve annealing of the primers. The volumes of cDNA or 
primer can vary for each set up, depending on their concentration. Final volume of 50 μl is 
obtained by completing the volume with water. 
The components are gently mixed and the PCR started with an initial heating step at 94°C for 
2 min followed by other 30 s at 94°C to separate the complementary strands (denaturation 
step). These strands are then annealed with an excess of two DNA oligonucleotides (each 
around 20 nucleotides long) that have been chemically synthesised to match sequences 
separated by several nucleotides (generally 150 to 2000). The annealed mixture is then 
incubated with DNA polymerase and the four nucleotides so that the regions of DNA 
downstream each of the two primers are selectively synthesised. The procedure of denaturing, 
annealing and extension is repeated several times. In turn, the newly synthesised fragments 
serve as templates and within a few cycles the predominant product is a single species of 
DNA fragment whose length corresponds to the distance between the two original primers. 
Annealing and extension (always at 72°C) conditions are primer and template dependent and 
have to be determined empirically for each reaction. Typically, 15 to 40 cycles are performed. 
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At the end of the PCR the quality of the amplified DNA is checked on an agarose gel as 
described in the 6.2.2.3 section. If the PCR was successful and DNA fragments of the right 
size have been amplified, then the product can be cloned into a vector for further use (e.g. 
ISH) either directly or after purification. Generally, a gel elution is required if several 
fragments are amplified by the PCR. For this the DNA fragment of interest is cut out of the 
gel using a sharp scalpel blade and transferred to a reaction tube. The DNA is then eluted 
from the gel according to the manufacturer’s instructions of the kit used for purification 
(QIAquick gel extraction kit from Qiagen; Wizard

SV Gel and PCR Clean-Up System from 
Promega; S.N.A.P.
TM
 Gel Purification Kit from Invitrogen). 
For cloning, either the TOPO TA Cloning

 Kit Dual Promoter containing the pCR

II-TOPO

 
vector or the TOPO
 
XL PCR cloning kit
 
containing the PCR

 XL-TOPO vector have been 
used (both kits are from Invitrogen). These kits take advantage of the single 3'-deoxyadenine 
overhangs that the PCR product has, by ligating them with the single 3'-deoxythymidine 
overhangs of the linearized vector using a covalently bound topoisomerase I (prevents DNA 
tangling during replication causing single-strand breaks). This enzyme from Vaccinia virus 
binds to duplex DNA at specific sites and cleaves the phosphodiester backbone after 5'-
CCCTT in one strand. The energy from the broken strand is conserved by formation of a 
covalent bond between the 3' phosphate of the cleaved strand and a tyrosyl residue (Tyr-274) 
of topoisomerase I. The phospho-tyrosyl bond between DNA and enzyme can subsequently 
be attacked by the 5'hydroxyl of the original cleaved strand, reversing the reaction and 
releasing topoisomerase I (Shuman, 1994). The kit takes advantage of the fact that the 
topoisomerase I (covalently bound to the linearized vector) reseals the break between the 
ligated vector and the PCR product.  
The cloning reaction is set up as follows:  
 1.0 μl fresh PCR product 
 3.0 μl sterile ddH2O 
 1.0 μl TOPO vector 
 5.0 μl total volume 
The reaction is gently mixed and incubated for not more than 5 min at RT (22 – 23°C) and 
then placed on ice. 2 μl of the TOPO Cloning product are added into a vial of One Shot 
Chemically Competent E. coli that have been thawn on ice just prior to use. The bacteria and 
the cloning product are mixed very carefully, without pipetting up and down, before the tube 
is incubated on ice for 5 to 30 min. The cells are heat-shocked for 30 s at 42°C without 
shaking and immediately transferred to ice where 500 μl of room temperature SOC medium 
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are added. SOC Medium is a complex cell-growth medium that ensures maximum 
transformation efficiency when used in the final step of transformation. The tube is then put at 
37°C in a water bath for 1 h. 100 μl of the transformation product is spread on a prewarmed 
LB selective plate and incubated overnight at 37°C. 
 
6.2.2.6 Isolation and purification of recombinant DNA 
Colonies obtained from the cloning procedure must first be checked to make sure that the 
desired insert is present, because bacteria that incorporate only the vector or the vector with a 
wrong insert are also resistant to ampicillin. Usually a minimum of 10 different colonies is 
tested for the insert by conducting a Miniprep. 
The day before the Miniprep is done, 5 ml of LB medium with 50 μl 100 x Amp is placed in a 
15 ml Falcon tube. For each colony to be tested, one tube has to be prepared next to a Bunsen 
burner. Each colony is picked with a pipette tip, which is then put in the Falcon tube and 
incubated o/n at 37°C with vigorous shaking (~250 rpm). Growth for more than 16 h should 
be avoided since cells may become too dense and begin to lyse causing reduced plasmid 
yields. The next day, the Miniprep is carried out with 1.5 ml of culture according to the 
protocol of the QIAprep Spin Miniprep Kit Protocol (QIAprep Miniprep Handbook 07/99, pp. 
18-19) or according to the TELT method.  
For the TELT method, 1.5 ml of cultured bacteria is centrifuged for one minute at 13000 rpm. 
The supernatant is discarded and the tube is centrifuged again to remove all residual liquid. 
The bacterial pellet is resuspended in 150 μl TELT-solution and 15 μl lysozyme solution by 
vortexing. The mixture is incubated for five minutes at room temperature before it is heated 
for two minutes at 100°C. Then the tube is chilled on ice for five minutes and centrifuged for 
30 min at 13’000 rpm at 4°C. The lysate is transferred to a new Eppendorf tube and adding of 
150 μl isopropanol precipitates the DNA. After a 5 min incubation at room temperature the 
tube is centrifuged for 10 min at 13’000 rpm at 4°C. The DNA pellet is washed once with  
750 μl 70 % EtOH and then air dried before it is dissolved in about 50 μl TE buffer. 
Alternatively, the pellet can also be dissolved in TE/RNase but has then to be incubated for 30 
min at 37°C on a shaker at 800 rpm. 
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8 μl of eluate or TELT-preparation is used for a test digestion with EcoRI, because the insert 
is flanked on both sides with this restriction site. The digestion is set up as follows: 
 8.0 μl eluted plasmid 
 2.0 μl 10 x EcoRI buffer 
 1.0 μl EcoRI (20 U/μl) 
 9.0 μl ddH2O 
 20.0 μl total volume 
The reaction is mixed carefully and incubated for 1 to 2 h at 37°C in a water bath. All 
digestions are then run on an agarose gel as described in the 6.2.2.3 section. Only clones 
containing an insert of the right length are kept. 
The harvesting of probes from positive clones is done using a Maxiprep and starts with the 
inoculation of 250 ml LB medium with 2.5 ml 100x Amp in a 500 ml Erlenmeyer with 250 μl 
of a Miniprep culture one day before the experiment starts. They are incubated o/n at 37°C 
with vigorous shaking (~180 rpm), and incubation times should not exceed 16 h. The 
following day the cells are harvested by centrifugation at 6'000 rpm for 15 min at 4°C. The 
isolation of the plasmid is completed as described in the QIAGEN

 Plasmid Purification 
Handbook (07/99, pp. 21-24) or in the Promega PureYield
TM
 Plasmid Maxiprep System 
Handbook. The eluted DNA is also tested in an EcoRI digestion (as described for the 
Miniprep) and its purity and concentration is tested using the spectrophotometer (see 4.2.1.2). 
After its completion, a portion of each plasmid is sent to Microsynth for sequencing to 
determine both the direction and contents of the insert. 
As a backup, bacteria that have been determined to carry the correct clone after sequencing 
may be stored at –80°C in a mixture of 800 μl culture medium and 200 μl 87 % glycerol. 
 
6.2.2.7 Ligation in low-melting agarose 
This method is based on the fact that the low-melting agarose can be melted at 65°C and stays 
in a liquid state at 37°C. This property allows the in agarose ligation of DNA fragments 
separated on a preparative low-melting agarose gel without further purification steps. A big 
advantage of this is that the method is less time consuming than conventional methods in 
which the DNA has to be processed before ligation (e.g. gel elution, glass bead purification, 
etc.). However, it has to be emphasized that this procedure is more risky due to the heating 
steps and the presence of ethidium bromide during the transformation. 
Digested DNA fragments are separated according to their size on a low-melting agarose gel 
of convenient percentage that has been poured on a glass plate with 1x TAE buffer containing 
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0.5 μg/ml EtBr. The reason why the gels are poured on glass plates is that it is important to 
have gel slices that are as small as possible. Approximately 0.5 pmol of digested DNA are 
loaded per well. Once the bands migrated far enough, the gel is put on saran paper to avoid 
contamination with foreign DNA, a picture is taken and the bands of interest are cut out with 
a clean scalpel blade on a UV transilluminator. It is recommended to use the long UV 
wavelength of 365 nm and to minimize the exposure time because UV destroys the DNA. The 
gel slices are transferred to a clean reaction tube and around 50 μl of ddH2O is added to 
improve melting. The tubes can be kept on ice for a while. 
Meanwhile, a heating block is set to 65°C and a second one to 37°C. Furthermore, 500 μl 
ddH2O are pre-heated to 65°C. A master ligation mix is prepared containing 7.5 μl 10x 
ligation buffer A + 7.5 μl ligation buffer B + 35 μl ddH2O per planned reaction and all 
necessary positive and negative controls. It is assumed that 10 μl of each needed DNA 
fragment in form of melted agarose and 1 μl T4 DNA ligase will be added to each reaction 
later, leading to a final DNA fragment concentration of around 0.5 fmol/μl. 
The gel slices containing the excised DNA fragments are melted in the 65°C warm heating 
block for 10 to 20 min, vortexed thoroughly, quickly spun down and kept in the heating 
block. The tubes containing the pre-pipetted ligation mix are put in the 37°C warm heating 
block and 10 μl of each DNA fragment are added where required. Since the low-melting 
agarose solidifies at ambient temperature, each pipette tip used has to be pre-warmed in the 
water-containing reaction tube at 65°C aspirating up and down before the DNA fragments can 
be pipetted. Optionally, 6 μl of solutions C0-C2 are added to the tube if oligonucleotides are 
used for the ligation (see 6.2.2.8). While keeping the tubes at 37°C, 1 μl of T4 DNA ligase is 
added to each tube at a concentration of 1 U/μl. The reaction mixtures are mixed well, quickly 
spun down and incubated at 4°C overnight. For ligations between blunt end fragments, the 
tubes are put on a floater on ice o/n, so that in the morning the tubes are floating on water. 
 
6.2.2.8 Ligation using oligonucleotide linkers 
Sometimes it is of great use to connect plasmids and DNA fragments using oligonucleotides 
of sizes up to 100 bp. For this it is important to design a sense and an antisense 
oligonucleotide that are annealed later on. The lyophilized oligonucleotides, ordered from 
Microsynth as genomic scale, are reconstituted in 1x TE in order to have a concentration of 
about 100 μM. The dilution is verified spectrophotometrically for its concentration, 
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measuring a mixture of 10 μl oligonucleotides and 490 μl 1x TE. The concentration is 
determined according to the following formula: 
c [μM = pmol/μ l] = df x 100 x A260 / N 
(with N = oligonucleotide length and df = dilution factor) 
 
100 pmol of each oligonucleotide are annealed (sense + antisense) to a final annealed oligo 
concentration of 5 pmol/μl as follows: 
 100 pmol sense oligo 
 100 pmol antisense oligo 
    x μl ddH2O (x = amount of water to complete to 20 μl) 
 2.0 μl 10x annealing buffer 
 20.0 μl total volume 
To achieve the annealing, the mixture is boiled for 1 min and cooled down to RT by leaving 
the tubes float in the water allowing a gradual temperature decrease. Eventually, the tubes can 
be left like this o/n. To obtain optimal ligation conditions, three different molar amounts (C0-
C2) of the oligonucleotide are prepared by sequential dilutions in 1x ligation mix (= 1 μl 
ligation buffer A + 1 μl ligation buffer B + 8 μl ddH2O) on ice: 
C0: 5 μl of annealed oligo [5 pmol/μl] are added to 45 μl 1x ligation mix   500 fmol/μl 
C1: 10 μl C0 + 90 μl 1x ligation mix     50 fmol/μl 
C2: 10 μl C1 + 90 μl 1x ligation mix       5 fmol/μl 
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6.2.3 Processing of human buccal cells  
Relative RNA expression of the three clock genes hPER1, hPER2 hBMAL1 and the 
housekeeping gene GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was measured in 
human oral mucosa of healthy volunteers. 
 
6.2.3.1 SOP – Sampling human oral mucosa 
Prepared by: 
Corinne Jud 
SOP – sampling human oral mucosa 
April 26, 2006 
Revised by: 
Corinne Jud 
 
January 30, 2009 
 
PURPOSE: 
To establish a standard operating procedure for sampling oral mucosa 
  
EQUIPMENT:  
1 ml blue tips (Treff AG), 0.5 ml Eppendorf tubes, -mercaptoethanol (included in Nanoprep 
Kit), Absolutely RNA
TM
 Nanoprep Kit (Stratagene), powder free gloves  
 
PROCEDURE: 
Always wear clean gloves, change them frequently and use RNase free tips (1 ml) and tubes 
(500 μl). Tips and tubes should be autoclaved and only be touched with gloves (before and 
after autoclaving!). 
1. Prepare a mixture of 0.7 μl -mercaptoethanol and 100 μl lysis buffer (both provided in 
the Absolutely RNATM Nanoprep Kit, Stratagene) for each sample you want to collect. 
Attention: The lysis buffer contains the irritant guanidine thiocyanate! The mixture 
always has to be prepared freshly and under the hood!!! 
2. The subject should neither have eaten nor drunk anything (except water) before sampling 
because otherwise the samples will be contaminated. It improves the quality of the sample 
to rinse the mouth with water and rub the inside of the cheek gently with a very soft 
toothbrush (e.g. Meridol) prior to tissue collection. 
3. The subject should wear gloves while he is collecting his mucosa samples. Pay attention 
that he never touches the tip without gloves. He should use 1 ml pipette tips (Treff AG) 
and scratch inside the cheek until a white pellet is visible.  
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4. The subject gives the tip to the technician (gloves!!!) who makes sure that the pellet is at 
least 2 mm big. Put the tip onto a pipette. Pipette up and down in the lysis buffer until the 
pellet floats in the lysis buffer. 
Attention: Watch out not to loose the tissue while you put the tip onto the pipette. Either 
put the piston down before putting the tip onto the pipette or dip the tip into the liquid 
before putting it onto the pipette! 
5. In case you don’t get enough material from one cheek, the subject can scratch the other 
cheek (use a new tip!). Put this sample in the same tube. 
6. Vortex the tube until the sample is completely dissolved. 
7. Centrifuge it shortly (not at high speed) to spin the solution down 
8. Store it at -80°C or continue to isolate the RNA 
The samples can be transported at this stag on dry ice. 
 
6.2.3.2 SOP – Processing of human oral mucosa 
Prepared by: 
Corinne Jud 
SOP – Processing human oral mucosa 
April 26, 2006 
Revised by: 
Corinne Jud 
 
November 22, 2007 
 
PURPOSE: 
To establish a standard operating procedure for processing human oral mucosa. 
  
EQUIPMENT:  
Absolutely RNA
TM
 Nanoprep Kit (Stratagene; #400753), reaction tubes, RNAse free filter 
pipette tips, Superscript
TM
 II RNAse H
-
 Reverse Transcriptase (Invitrogen; #18064-014), 
RNAsin (Promega; #N2111), oligo dT15 (Roche; #1 081 427 000 1), primer random p(dN)6 
(Roche; #1 034 731), dNTPs (Roche; #1 181 436 200 1), iQ
TM
 Supermix (BioRad; #170-
8862), MgCl2 [25 mM] (Qiagen, component of the Taq-polymerase kit), double distilled 
water, specific primers and probes (Microsynth), 96 well plate (AxonLab; #AB-0900), 
absolute QPCR seal (AxonLab; #AB-1170), iCycler (BioRad) 
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PROCEDURE: 
RNA isolation 
The RNA is isolated using the Absolutely RNA
TM
 Nanoprep Kit following the instructions in 
the manual provided by the manufacturer: 
• The tubes containing lysis buffer, -mercaptoethanol (-ME), and oral mucosa are thawed 
on ice. 
• 100 l lysis buffer and 0.7 l -ME are mixed for each sample and added to the mix. 
• 200 l of 70 % ethanol are added to the cell lysate and mixed thoroughly until the lysate 
and the ethanol are mixed well (at least for 5 s). 
• 1 min at 13’000 rpm 
• The mixture is transferred to an RNA-binding nano-spin cup that has been seated within a 
2 ml collection tube and is closed with a cap. 
• 1 min at 13’000 rpm 
• The filtrate is discarded and the spin cup reseated in the same 2 ml collection tube. 
• DNase Treatment: 
- 300 l of 1x Low-Salt Wash Buffer is added to the spin cup, which is then capped. 
- 1 min at 13’000 rpm 
- The filtrate is discarded, the tube reseated in the collection tube, capped, and 
centrifuged for 2 min at 13’000 rpm to dry the fiber matrix. 
- For each sample 12.5 l of DNase Digestion Buffer is mixed with 2.5 l of 
reconstituted DNaseI  mix gently because the DNase I is very sensitive to 
denaturation 
- 15 l of DNase solution is directly added onto the fiber matrix inside the spin cup, 
which then is capped. 
- Incubation for 30 min at 37°C 
• The Elution Buffer is pre-heated to 60°C. 
• 300 l of 1 x High-Salt Wash Buffer is added to the spin cup 
• 1 min at 13’000 rpm 
• The filtrate is discarded. 
• 300 l of 1 x Low-Salt Wash Buffer is added 
• 1 min at 13’000 rpm 
• The filtrate is discarded. 
• A second Low-Salt wash is performed using again 300 l. 
• 1 min at 13’000 rpm 
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• The filtrate is discarded. 
• 3 min at 13’000 rpm to dry the fiber matrix 
• The spin cup is transferred to a 1.5 ml safe lock Eppendorf tube. 
• 10 l of 60°C warm Elution Buffer is directly added onto the fiber matrix inside the spin 
cup. 
• Incubation for 2 min at RT 
• 13000 rpm for 5 min 
• 5 l of 60°C warm Elution Buffer is directly added onto the fiber matrix inside the spin 
cup. 
• 13’000 rpm for 5 min 
• The eluate is transferred to a 0.5 ml Eppendorf tube and stored at –80°C. 
 
cDNA Synthesis (SuperScript
TM
 II RNase H
-
 Reverse Transcriptase)  
• Reconstitute the oligo dT15 in 58 l ddH2O 
• The following substances are added to a 0.5 ml reaction tube: 
 Oligo dT15 [1g/l]   8 l 
 RNA eluate 10 l 
 dNTPs [10 mM each]   4 l 
 ddH2O 26 l 
• Mix well and incubate the tube for 5 min at 65°C 
• Chill the tube on ice 
• Collect the contents of the tube by brief centrifugation 
• Add the following substances: 
 5 x First-Strand Buffer 16 l 
 0.1 M DTT   8 l 
 RNasin [40 U/l]   4 l 
• Incubate the tube for 2 min at 42°C  
• Centrifuge briefly and then add: 
 SuperScriptTM II RT   4 l 
 total volume 80 l 
• Incubate the sample for 1 h 45 at 42°C 
• Inactivate the reaction for 10 min at 95°C 
• Store the cDNA at –20°C until further use 
Instead of the oligo dT15 one can also use random hexamer primers at a concentration of 0.1 
g/l. If one is using random primers, the reaction has to be started with a 10 min incubation 
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at 25°C because they have a lower melting point compared to the oligo dT15. Of course also 
the 2 min incubation before adding the transcriptase has to be done at 25°C instead of 42°C. 
 
Quantitative Real-time PCR 
• Things to always remember when preparing the samples: 
 Always wear powder free gloves 
 Change gloves frequently 
 Use autoclaved plastic ware only 
 Use filter tips only 
 Clean the pipettes before use (95 % alcohol or 10 % bleach; exposure to UV-light) 
 Make at least duplicates, better triplicates 
 Vortex all the samples before use 
 Vortex the master mixes before puting into the wells 
• Prepare a master mix for the primers: 
 For 8 ml GAPDH, PER2 or BMAL1 master mix: 
  MgCl2 [25 mM]   1600 l 
  ddH2O   6368 l 
  TaqMan probe [100 M]    20 l 
  Forward primer [1 mM]      6 l 
  Reverse primer [1 mM]      6 l 
Adding 8 l of this primer master mix to a final reaction volume of 20 l yields a final 
concentration of 5 mM for MgCl2, 300 nM for primers and 100 nM for TaqMan 
probe. 
 For 8 ml PER1 master mix: 
  MgCl2 [25 mM]   1600 l 
  ddH2O   6386 l 
  TaqMan probe [100 M]    10 l 
  Forward primer [1 mM]      2 l 
  Reverse primer [1 mM]      2 l 
Adding 8 l of this primer master mix to a final reaction volume of 20 l yields a final 
concentration of 5 mM for MgCl2, 100 nM for primers and 50 nM for TaqMan probe. 
• The following ingredients are mixed for each sample: 
  iQ Supermix 10.0 l 
  Primer master mix   8.0 l 
  cDNA template   2.0 l 
  total volume 20.0 l 
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• Each reaction should be done in triplicates. A positive control is done using HER911 
cDNA and GAPDH primers. A negative control without cDNA has to be done for each 
primer pair.  
• Put all the samples on a 96 well Plate (Axon Lab, #AB-0900) and seal the plate with an 
ABsolute QPCR Seal (Axon Lab, #AB-1170). 
 
The PCR-Protocol is as follows (iCycler, BioRad): 
Cycle  1: (  1X) Denature 
 Step  1:   95.0ºC for 03:00 
Cycle  2: ( 55X) Amplification 
 Step  1:   95.0ºC for 00:15 
 Step  2:   55.0ºC for 01:00 
       Data collection and real-time analysis enabled. 
Cycle  3: (  1X)  
 Step  1:   20.0ºC HOLD 
 
Primers [final concentration in reaction mix]: 
PER2 TaqMan Probe [100 nM]: 5’-[FAM]ATG CCT TCA GCG ATG CCA AGT T[BHQ]-3’ 
PER2 sense primer [300 nM]: 5’-GCA TCC ATA TTT CAC TGT AAA AGA-3’ 
PER2 anti-sense primer [300 nM]: 5’-AGT AAA AGA ATC TGC TCC ACT G-3’ 
GAPDH TaqMan Probe [100 nM]: 5’-[FAM]AGC CTC AAG ATC ATC AGC AAT GCC[BHQ]-3’ 
GAPDH sense primer [300 nM]: 5’-TGT GAA CCA TGA GAA GTA TGAC-3’ 
GAPDH anti-sense primer [300 nM]: 5’-ATG AGT CCT TCC ACG ATA CC-3’ 
PER1 TaqMan Probe [50 nM]: 5’-[FAM]TTC GGG TTA CGA AGC TCC CCG GAT AC[BHQ]-3’ 
PER1 sense primer [100 nM]: 5’-CGC CTA ACC CCG TAT GTG A-3’ 
PER1 anti-sense primer [100 nM]: 5’- CGC GTA GTG AAA ATC CTC TTG TC-3’ 
BMAL1 TaqMan Probe [100 nM]: 5’-[FAM]AAT CCT GGG CCT TCA TTG GTT CCG[BHQ]-3’ 
BMAL1 sense primer [300 nM]: 5’-CGT TTG GAC CCA AGC TTA AC-3’ 
BMAL1 anti-sense primer [300 nM]: 5’-CAC ACA GGA AGC CCT CTA GC-3’ 
 
6.2.3.4 Sampling human oral mucosa using the cytobrush 
As described under 6.2.3.1, the subject should not have eaten or drunk anything prior to 
sampling. If, however, the subject ate something, he should rinse his mouth with water and 
eventually rub the cheek with a soft toothbrush (e.g. Meridol). The oral mucosa is then 
Materials and Methods 
184 
collected by rotating the cytobrush at the same place inside the cheek for at least 30 seconds. 
It is important to apply a certain pressure while rotating the brush because otherwise not 
enough tissue will be taken. A slight sensation of burning is a good sign for the correct 
pressure. However, bleeding due to too much pressure should be avoided. 
After sampling, the brush is dipped into a 1.5 ml safe-lock Eppendorf tube containing 1 ml of 
RNAlater
®
. The stem of the brush is cut just above the brush using scissors, before it is stored 
at -80°C until further use. 
 
6.2.3.5 Processing of human oral mucosa sampled with the cytobrush 
The tube containing the cytobrush is thawn on ice and then centrifuged in a horizontally fixed 
angle rotor at 7’000 rpm for 5 min. The cytobrush is removed using small forceps and 
carefully wiped along the side of the reaction tube to collect a maximum of tissue. After a 
second centrifugation, the RNAlater
® 
is discarded paying attention not to disturb the pellet. 
The latter is washed thoroughly in 1 ml of RNAse free 1x PBS by flicking the tube. Then the 
tube is centrifuged at 13’000 rpm in a normal Eppendorf tube centrifuge for 5 min and the 
supernatant is removed. The pellet is washed twice with 50 l 1x PBS and centrifuged at 
13’000 rpm for 3 min. The remaining PBS is discarded completely, before the pellet is 
dissolved in 300 l lysis buffer containing 2.1 l -mercaptoethanol (Absolutely RNA 
Nanoprep kit, Stratagene). The suspension is mixed vigorously by vortexing until the pellet is 
completely homogenized. Lysis is allowed to take place during 10 min at RT before 300 l of 
70 % EtOH are added to the lysate. The tube is vortexed again before it is centrifuged at 
13’000 rpm for 1.5 min. The supernatant is transferred to an RNA-binding nano-spin cup that 
has been seated within a 2 ml collection tube and it is closed with a cap. Then tube is 
centrifuged at 13’000 rpm for 1 min and the filtrate is transferred again onto the RNA-binding 
nano-spin cup. This step is repeated 3 times to improve the yield of RNA bound to the matrix. 
The following steps are as described in the 6.2.3.2 section. 
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6.2.4 In Situ Hybridization 
6.2.4.1 Solutions 
All solutions – except the SSC and NTE – have to be prepared RNase free! To do this, all 
glass bottles are flamed before filling and only ddH2O is used. Gloves have to be worn at all 
times and should be changed frequently. Chemicals are directly weighed inside the bottle or 
on a piece of aluminium foil. 
•  EDTA 0.5 M (pH 8.0): 
 93.1 g EDTA x 2 H2O (AW: 372.24)  
 400 ml ddH2O 
 The pH is adjusted to 8.0 with NaOH (around 10 g NaOH pellets). The volume is made up 
to 500 ml at the end. 
•  RNase A [10 mg/ml]: 
 500 mg RNase A are dissolved in 50 ml ddH2O and stored at –20°C in 200 μl aliquots 
•  4 % PFA in 1 x PBS: 
 850 ml ddH2O 
 2 ml NaOH 1 M 
 40 g PFA 
 100 ml 10 x PBS RNase free 
The solution is stirred and heated to about 50°C. 30 drops of NaOH 10 M are added to 
dissolve the PFA. The pH is then adjusted to 7.4 and filled to 1 l. Finally, the solution is 
filtered. 
•  10x PBS (pH 7.4): 
 80.0 g NaCl 
 2.0 g KCl 
 28.5 g Na2HPO4 x 12 H2O (AW: 358.14) 
 2.0 g KH2PO4 (AW: 136.09) 
 800 ml ddH2O 
The pH is adjusted to 7.4 then the volume is filled up to 1 l. 
• TEA 1 M (pH 8.0): 
 66.3 ml TEA 
The pH is adjusted to 8.0 and the volume is filled up to 1 l with ddH2O. 
• 10x Proteinase K buffer (pH 7.6): 
 250 ml Tris-HCl 1 M pH 8.0 RNase free 
 50 ml EDTA 0.5 M pH 8.0 RNase free 
 200 ml ddH2O 
The pH is adjusted to 7.6 with concentrated HCl. 
•  Yeast tRNA [10 mg/ml]: 
 100 mg tRNA are dissolved in 10 ml ddH2O.  Once the tRNA is completely dissolved, 1 
ml aliquots are prepared in 2 ml tubes. Each aliquot is extracted twice with 1 ml of 
premixed phenol-chloroform-isoamylalcohol (SIGMA; 25:4:1 saturated with buffer). The 
aqueous phase of all tubes is transferred into a 15 ml Falcon tube and from this, 500 l 
aliquots are prepared in 2 ml tubes. Adding 1 ml 100 % EtOH and 50 l of 4 M NH4Ac to 
every aliquot precipitates the tRNA. The pellets are dissolved in 150 l ddH2O each. The 
final concentration is adjusted to 10 g/l and aliquots are stored at -80°C. 
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•  Proteinase K [4 mg/ml]: 
 40 mg of Proteinase K is dissolved in 10 ml 50 mM Tris pH 7.6 and stored at –20°C as 1 
ml aliquots. 
•  Hyb-Mix (for 
35
S-ISH): 
 50 % Formamide  
 0.3 M NaCl 
 20 mM Tris-HCl, pH 8.0  
 5 mM EDTA 
 10 % Dextransulfate 
 2x Denhardt’s solution 
 0.5 mg/ml RNA from yeast 
The Hyb-Mix has to be prepared overnight on a shaker because it doesn’t mix well 
otherwise. The 50 % dextransulfate solution should be prepared one day in advance since it 
takes a while to dissolve in ddH2O. 10 ml of 50 % dextransulfate are mixed in a 50 ml 
Falcon tube with 3 ml 5 M NaCl, 1 ml 1 M Tris-HCl pH 8.0, 0.5 ml 0.5 M EDTA pH 8.0, 
6 ml ddH2O, and 25 ml formamide on a shaker overnight. On the next day, 2.5 ml yeast 
tRNA [10 mg/ml] and 2.0 ml of 50x Denhardt’s solution are added and mixed on the 
shaker until everything is dissolved completely (± 30 min). 1 ml aliquots are prepared and 
kept at –80°C. Before using them, 10 μl of 10 M DTT (SIGMA; in ddH2O) and 10 μl of  
25 mM -S-ATP (Roche; 146 l of ddH2O are used to dissolve 2 mg of powder) are 
added. The tube is vortexed at maximum speed for at least 15 s. 
•   20 x SSC (pH 7.0): 
 175.3 g NaCl 
 88.2 g tri-Na-Citrate x 2 H2O (AW: 294.1) 
 800 ml dH2O 
The pH is adjusted to 7.0 and the volume is filled up to 1 l with dH2O. 
•  10 x NTE (pH 8.0): 
 292.2 g NaCl 
 100 ml Tris-HCl 1 M pH 8.0 RNase free 
 100 ml EDTA 0.5 M pH 8.0 RNase free 
 The pH is adjusted to 8.0 and the volume is filled up to 1 l with dH2O. 
 
 
6.2.4.2 Tissue Fixation, Embedding and Sectioning 
After dissection, the tissue is placed in a glass scintillation vial (20 ml) containing 4 % PFA in 
ice-cold PBS o/n at 4°C with gentle shaking. The water is subsequently removed from the 
tissue so that it can be embedded in paraffin, which is accomplished using the following 
dehydration steps: 30 % EtOH for 2 h, 50 % EtOH for 2 h, 70 % EtOH o/n, 100 % EtOH for 2 
h, 100 % EtOH o/n. All dehydration steps are carried out at 4°C with gentle shaking.  
This is followed by infiltrating the tissue with xylene. The 100 % EtOH is discarded and 
xylene is added while under the hood. The vial is gently shaken at RT for 1 h. The xylene is 
then replaced and the vial gently shaken for another 30 min at RT. Finally, the tissue is 
embedded in paraffin: xylene/paraffin (1:1) at 63°C for 2 h and twice paraffin at 63°C for 2 h. 
The paraffin (paraplast) wax is melted before use by placing a PET container covered with 
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aluminium foil in a warming oven at 63°C overnight. If melted paraffin is needed 
immediately, wax can be melted in a microwave for approximately 10 min. Some unmelted 
paraffin should be left in the liquid to avoid overheating. A small amount of wax is placed in 
a separate PET beaker. Around 10 min before use, an equal volume of xylene is added. 
After the final wax step, new paraffin is added, the vial gently swirled to suspend the tissue in 
the melted wax, and then quickly poured into a plastic mold. The tissue is oriented in the 
mold and any bubbles are removed with autoclaved toothpicks. If the tissue fails to pour from 
the vial, more wax can be added to the vial and the tissue repoured. The blocks are left o/n at 
RT without disruption and, once solidified, can be stored indefinitely at RT. 
To cut the paraffin blocks, excess wax is first cut from around the embedded tissue. The 
paraffin block is then mounted in the proper orientation on a wooden block by gently melting 
the surface of the wax with a lighter. In order to get wrinkle-free section ribbons, the sides of 
the wax block are cut at 90° angles. The sections are cut on a microtome under cold H2O 
vapor at a thickness of 7 μm. The angle and position of the blade has to be determined 
experimentally for each block. The section ribbons are laid on clean black paper with the dull 
side up. After several ribbons have been cut, small segments (typically three brain sections) 
from three to four different ribbons are mounted on one slide in a 45-50 °C warm water bath 
containing ddH2O. The mounted slides are kept in a slide warmer overnight at 42°C. The next 
day they are arranged in clean boxes where they can be stored indefinitely at RT. 
 
6.2.4.3 Linearization of plasmids 
To get sense or anitsense probes, the plasmid must be cut with a restriction enzyme. Usually, 
plasmids are cut either with XhoI or BamHI. The enzyme XhoI destroys the T7-promoter, 
BamHI the Sp6-promoter. If the insert contains a restriction site for one of these two 
enzymes, another restriction enzyme must be chosen (see pCR

II-TOPO-vector map). 
For each preparation, 40 μg of plasmid DNA, 6 μl enzyme buffer and 4 μl restriction enzyme 
are used. The total volume is filled to 60 μl with ddH2O and then incubated o/n at 37°C. To 
check whether the digestion is complete, a small aliquot of the reaction is run on a 1 % 
agarose gel. If the digestion is finished, the DNA is recovered from the digestion mix using a 
phenol/chloroform extraction and precipitated with ethanol. For this, 340 μl of ddH2O and 
400 μl of phenol/chloroform are added to the entire digestion mix. The tube is shaken 
vigorously and then centrifuged at 13'000 rpm for 1 min at 4°C to separate the phases. The 
aqueous upper phase is removed and placed in a new Eppendorf tube and again extracted with 
Materials and Methods 
188 
400 μl of phenol/chloroform. To precipitate the DNA from the aqueous phase, 40 μl of 4 M 
NH4Ac and 1 ml of 100 % ethanol are added. The tube is then inverted several times and kept 
at –80°C for 15 min. Afterwards, it is centrifuged at 13'000 rpm for 20 min at 4°C, the 
supernatant removed, the pellet air-dried and then resuspended in 20 μl of DEPC water. The 
concentration of the DNA is determined using the spectrophotometer (see 4.2.1.2) and then 
diluted to a concentration of 1 μg/μl. 
 
6.2.4.4 In vitro Transcription 
The following reagents of the "RNAMaxx
TM
 High Yield Transcription Kit" are put on ice and 
mixed carefully to avoid contamination with RNases (gloves, autoclaved tubes and tips): 
    x μl  DEPC water 
 6.0 μl  5 x transcription buffer 
   1.0 μl  DTT [0.75 M] 
 1.0 μl  rATP [100 mM] 
 1.0 μl  rCTP [100 mM] 
 1.0 μl  rGTP [100 mM] 
 1.0 μl  RNAse block 
 0.5 l yeast inorganic pyrophosphatase [0.75 U/l] 
 1.0 μg  linearized DNA template 
 10.0 μl  35S-rUTP [12.5 mCi/ml] 
 1.0 μl RNA polymerase (dependent on the promoter: T7, T3 or SP6) 
 30.0 l total volume 
The contents are mixed well and incubated for 3 h at 37°C in a water bath. If the Sp6 RNAse 
polymerase has been used, additional 1.5 l are added to the reaction mix after 1.5 h. After 
incubation, 2 μl of DNase I [10 U/l] are added to the tube and incubated for 15 min in a 
37°C water bath to digest the linearized plasmids composed of DNA. To precipitate the RNA, 
the following substances are added: 
 190 μl  ddH2O 
 10 μl  tRNA (10 mg/ml) 
 250 μl  NH4Ac (4 M) 
    1000 μl  100 % EtOH 
The tube is carefully inverted, put on ice for 7 min and centrifuged at 13'000 rpm for 7 min at 
4°C.  
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The supernatant is discarded and the pellet is washed with: 
 200 μl  NH4Ac (4 M) 
 200 μl  ddH2O 
    1000 μl  100 % EtOH 
The tube is carefully inverted and centrifuged at 13'000 rpm for 7 min at 4°C. During this 
time, a complete hyb-mix is prepared by adding 10 μl of 10 M DTT and 10 μl of 25 mM 
ATP--S to a 1 ml aliquot of hyb-mix. Now, the supernatant of the centrifuged tube is 
discarded and the pellet dissolved in 100 μl complete hyb-mix. 2 μl of the complete hyb-mix 
containing the probe is added to 2 ml of scintillation cocktail in a plastic scintillation vial and 
the incorporated radioactivity is then measured in a scintillation counter. 
 
6.2.4.5 Dewaxing, postfixation and hybridization of sections 
All solutions used for the prehybridization must be RNase-free. This is achieved by flaming 
all glass bottles for 10 x stock solutions and weighing salts in aluminium foils using a flamed 
spatula. The volumes are filled up approximately (standard on the bottle) with ddH2O, and the 
solutions are then autoclaved.  
Most prehybridization solutions can be reused several times if kept RNase free. The PFA 
solution can be used only twice and should be stored at 4°C. Approximately 30 min before 
starting the experiment the PFA should be removed from the refrigerator so that it can warm 
up to RT, which is important for the pH. The proteinase K and acetylation solutions must be 
made fresh each time. Care should be taken not to introduce water into the acetic anhydride 
stock because it hydrolyses to acetic acid in the presence of water. 
The slides are placed in a rack and then transferred into each solutions in the following order: 
1. 2 x ultraclear to remove paraffin for 10 min 
2. 2 x 100 % EtOH for 2 min 
3. Rehydration series in EtOH/water, starting at 95 and progressing to 80, 70, 50, 
and 30 %. The slides are agitated in each solution for 20 s 
4. 0.9 % NaCl for 5 min 
5. 1 x PBS for 5 min 
6. 4 % PFA for 20 min (this solution is re-used in step 9) 
7. Proteinase K for 5 min (20 μg/ml proteinase K in 50 mM Tris-HCl, pH 7.6, 5 
mM EDTA)  After this step, the tissue is particularly susceptible to RNases 
and should be handled from here on with extreme caution! 
8. 1 x PBS for 5 min 
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9. 4 % PFA for 20 min 
10. Acetylation in 0.1 M TEA/HCl pH 8: 600 μl of acetic anhydride is added to the 
solution as it is being stirred in a hood; after 3 min, an additional 600 μl of acetic 
anhydride is added. Total time = 10 min 
11. 1 x PBS for 5 min 
12.  0.9 % NaCl for 5 min 
13. Dehydration series of EtOH, starting at 30 and progressing to 50, 70, 80, 95, 100 
and 100 % for 20 s each. 
The slides are air-dried in a dust-free RNase-free place at RT. After drying, 2 to 6 Mio 
cpm/slide of the radioactive probe are added to the hybridization mix and thoroughly mixed. 
50 μl of this hybridization mix containing the probe are put onto each slide and spread with a 
yellow tip. The slides are carefully overlaid with a coverslip, placed in a humidified, sealed 
chamber and incubated o/n at 55°C. 
The chamber is humidified by soaking strips of Whatmann paper in 50 % formamide/5 x SSC 
and sealed with parafilm and tape. 
 
6.2.4.6 Posthybridization washes and autoradiography  
Post-hybridization washes do not need to be carried out under RNase-free conditions. The 
removal, formamide and NTE solutions are prepared the day before and put in the 
corresponding water baths so that they are equilibrated to the right temperature when used. 
The formamide solution can be used twice and is then thrown out with the removal solution 
into the radioactive liquid waste. 
The slides are placed in a rack and then transferred into each solutions in following order: 
1. Coverslip removal wash: 200 ml 5 x SSC + 350 μl ME for 30 min at 63°C  
2. 50 % formamide, 2 x SSC and 700 μlME for 30 min at 63°C 
3. 3 washes with 1 x NTE  for 10 min at 37°C 
4. Ribonuclease A in 1 x NTE for 30 min at 37°C 
5. 1 x NTE for 15 min at 37°C 
6. 50 % formamide, 2 x SSC and 700 μl ME for 30 min at 63°C (solution from step 
2 re-used)  700 μl ME is added again 
7. 2 x SSC for 15 min at RT 
8. 0.1 x SSC for 15 min 
9. Dehydration series starting at 30 and progressing to 50, 60, 80 % EtOH/0.3 M 
NH4Ac, 95 % and 2 x 100 % EtOH for 30 s each 
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After these washes, the slides are air-dried in a dust-free place and then fixed with tape onto a 
plexi-glass sheet, which is then placed inside a film cassette and exposed to a Hyperfilm
TM 
MP from Amersham pharmacia biotech for 1 to 3 days. During the exposure time, the film 
cassettes are kept in a drawer at room temperature. 
The film is developed in complete darkness as follows: 
1. Developer for 5 min 
2. Tap water for 30 s 
3. Fixer for 1 min 
4. Tap water for around 30 s 
The film is dried and can be analyzed with a densitometer. To do this, the film is put right-
side up into the densitometer and scanned. Using the program Molecular Analyst alias a 
square is drawn over the region of interest (e. g. SCN) and a measurement is taken. A square 
of the same size is made in an adjacent region to record the background. Three sections per 
slide are chosen, each from a different line. The values are finally integrated and visualized on 
a graph. 
 
6.2.4.7 Emulsion coating 
The emulsion is prepared by adding 118 ml Kodak NTB-2 emulsion to 200 ml deionized 
water in darkness using night vision goggles. Before mixing, the solutions must be warmed to 
42°C for approximately 30 min. The emulsion is aliquoted into glass scintillation vials, 
wrapped twice in aluminium foil, and put in a light-tight box at 4°C away from -radiation. 
Before coating the slides, the emulsion has to be melted in a 42°C water bath for 10 min in 
darkness. The emulsion is transferred to a slide mailer, which is also kept in the water bath. 
The slides are dipped for 4 s and then drained for 3 s using night vision goggles. The back of 
the slide is thoroughly wiped with a soft tissue in order to remove remaining emulsion, placed 
on a slide dryer rack, and then dried o/n (at least for 6 hours) in a ventilated chamber. The 
next day, the slides are placed in a black box and wrapped in aluminium foil twice. Finally, 
they are stored at 4°C for three times as long as the cronex film was exposed to them. 
 
6.2.4.8 Development and Hoechst staining 
The fixer and developer (Kodak D-19) are delivered as a powder in bags and are prepared in 
advance. For the fixer, the contents of one bag are first dissolved in 2.8 l of distilled water and 
then filled up to a final volume of 3.8 l. The developer powder is slowly added to 3.8 l of 
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52°C distilled water and stirred until dissolved. The developer is kept in a brown glass bottle 
because it is light sensitive. 
The slides are removed from the fridge and equilibrated at RT for 30 min in the darkroom 
keeping them in the sealed box. Then the slides are placed in a rack while wearing night 
vision goggles and developed as follows: 
1. Kodak D-19 developer for 2 min (not longer!) at RT 
2. Rinse in water for 30 s 
3. Kodak fixer for 5 min at RT 
4. Rinse up to 10 min in deionized (DI) water 
5. Stain with Hoechst dye 2 μg/ml in water for 2 min 
(add 20 μl of stock 20 mg/ml in DMSO to 200 ml of DI water) 
6. Rinse in DI water for 2 min 
The slides are air-dried face up at RT for at least 1 hour in a dust free place. The place where 
they are dried should be dark because the Hoechst stain is light sensitive. Once dry, the slides 
are covered with 50 μl of a solution of 5 g Canada balsam in 10 ml methyl salicylate and then 
overlaid with a coverslip. The slides are kept horizontal for at least 1 week in a dark place so 
that the mounting medium dries. The residual emulsion on the back of the dry slides can be 
removed with glacial acetic acid on a Q-tip followed by ethanol to remove the acid. 
 
6.2.4.9 Viewing and Photography 
Hoechst staining dyes cell nuclei (DNA) and thus allows determination of cell density and 
tissue morphology. It can be detected using the DAPI channel of an epifluorescence 
microscope. Silver grains deposited after exposure to the radiactive probe are detected using 
darkfield microscopy. By viewing Hoechst staining and silver grains at the same time, one 
can determine which structure is expressing the gene of interest. Since Hoechst dye may 
bleach under fluorescent light, care should be taken in order to minimize its exposure. 
Images are taken with a videocamera linked to a computer. The pictures of Hoechst staining 
and darkfield are acquired using the same settings in black and white format. It is very 
important not to change the position of the image because otherwise the images cannot be 
superimposed later. Pictures are saved as TIFF images and edited in Adobe Photoshop 5.0.  
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6.2.5 Cell culture  
 
6.2.5.1 Solutions 
• 10x TBS (pH 7.6): 
  60.5 g Tris 
  87.6 g NaCl 
  4.0 ml HCl 1 M 
 The pH is adjusted to 7.6 and the volume completed to 1 l with ddH2O. The solution is 
autoclaved before use. 
• Na2HPO4 0.5 M: 
  179 g Na2HPO4 x 12 H2O 
 The solution is filled up to 1 l with ddH2O and then autoclaved. 
• 0.25 % Trypsin /1 mM EDTA: 
  5 ml 20 x TBS 
  85 ml ddH2O 
  10 ml trypsine 2.5 % in PBS 
  120 μl Na2HPO4 0.5 M 
  200 μl EDTA 0.5 M 
 All components except trypsine and EDTA are mixed and autoclaved, before 10 ml trypsin 
2.5 % are added. To obtain a trypsin (0.25 %) / EDTA (2 mM) solution, 200 μl EDTA 0.5 
M are added. 
• DMEM-Medium: 
  1 bottle DMEM High Glucose (4.5 g/l) from Amimed 
  5 ml penicillin/streptomycin solution 
  5 ml L-glutamine 200 mM 
  50 ml HIFCS 
 Final concentrations: 1 % PEST, 1 % L-Gln, 10 % HIFCS. The medium has to be stored at 
4°C. 
•  10x PBS (pH 7.4): 
  80 g NaCl 
  2.0 g KCl 
  2.4 g KH2PO4 
  14.4 g Na2HPO4 
 The powder is dissolved in 900 ml dH2O and the pH is adjusted to 7.4. The volume is then 
filled to 1 l and the solution is autoclaved before use. 
•  Trypan blue 0.2 % (w/v): 
 0.1 g Trypan blue is dissolved in 1 x PBS and stored at 4°C. 
•  HIFCS: 
 The FCS is defrozen at room temperature before it is heat-inactivated (HI) at 56°C for 30 
min. 50 ml aliquots are stored at -20°C until further use. In order to avoid any problems 
with remaining soap traces, the FCS is always aliquoted into the same glass bottles that are 
only rinsed with ddH2O and autoclaved again before use. 
•  Trypan blue 0.2 % (w/v): 
 0.1 g Trypan blue is dissolved in 50 ml 1 x PBS and stored at 4°C. 
•  Collagenase type I [100 mg/ml]: 
 Dissolve in PBS and store 100-500 l aliquots at -20°C. 
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•  Amphotericine B [250 g/ml]: 
Dissolve in sterile water and store 0.5-1 ml aliquots at -20°C. 
•  Dexamthasone [10 mM]: 
The powder is dissolved in 100 % EtOH and stored at -20°C. 
•  Digestion medium: 
  50 l collagenase 
  100 l amphotericine B 
  200 l PEST 1000 U 
  5 ml DMEM supplemented with 10 % FCS, 1 % PEST, 1 % glutamine 
 Since collagenase is not sterile, the digestion medium has to be passed through a sterile 0.2 
m Whatman filter. Final concentrations: collagenase 1 mg/ml, amphotericine B 5 g/ml, 
pen/strep 500 U. The unusally high concentrations are necessary in the beginning to avoid 
contamination problems; however, they should not be maintained in normal culture. 
•  LINPEI25 stock solution [100 μM]: 
0.5 g LINPEI25 is dissolved in 150 ml ddH2O. After adjusting the pH to 6.5, the volume is 
filled up to 200 ml with ddH2O. Then the solution is filtered through a sterile filter (0.2 
μm) and 20-25 ml aliquots are stored at -80°C. 
•  LINPEI25 working solution [10 μM]: 
The 100 μM stock solution is diluted 1:10 in sterile ddH2O. One aliquot is stored at 4°C 
for transfections, whereas the rest is kept at -80°C. 
•  1x HBS buffer: 
  20 mM HEPES pH 7.4 
  150 mM NaCl 
 The solution is sterile filtered and stored at 4°C. 
•  Calf thymus DNA (CT): 
 100 mg CT-DNA is dissolved in 10 ml TE at 37°C. The suspension is sonicated for around 
40 seconds until the solution is nicely liquid and well homogenized. Sometimes it may 
help to increase the volume to 20 ml. The fragment sizes are checked on an agarose gel. 20 
ml of phenol are added and the tube is centrifuged at 4500 rpm and RT for 15 min. The 
aqueous phase is transferred to a new tube and extracted once more with 20 ml 
chlorophorm-phenol. Again the aqueous phase is taken and 2 ml of 3 M NaCl and 25 ml of 
100 % EtOH are added to the tube. The DNA is precipitated o/n at -20°C. The next 
morning the DNA is pelleted at 9000 rpm at RT for 15 min. The supernatant is decanted 
and the pellet is washed once with 80 % EtOH and once with 100 % EtOH. The pellet is 
then air-dried and dissolved in 50 ml TE. The amount of DNA is determined using the 
photospectrometer and adjusted to 0.5 g/l. Aliquots of 500 l are stored at -20°C. 
•  Lysis buffer: 
  50 mM Tris-HCl pH 8.0 
  10 % Glycerol 
  10 mM MgAc 
  0.2 % 10 % Triton X-100 
•  10x reaction buffer for luciferase assay: 
  250 mM Tris-HCl pH 7.5 
  10 mM ATP 
  100 mM MgAc 
  1 mg/ml BSA 
 5 ml aliquots are stored at -20°C. 
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•  Coenzyme A stock solution [20 mg/ml]: 
  100 mg coenzyme A 
  5 ml PIPES 25 mM 
 100 μl aliquots are stored at -20°C. 
•  Luciferine stock solution: 
  10 mg luciferine 
  20 ml NaOH 5 mM 
 Adjust the pH to 6.5 with HCl and fill up the volume to 35 ml with ddH2O. 1 ml aliquots 
are stored at -20°C. Since the luciferine is light sensitive, it is important to wrap the tubes 
in aluminium foil. 
•  MUG stock solution [10 mg/ml]: 
  0.5 g MUG 
  50 ml DMSO 
 The solution is stored at -20°C wrapped in aluminium foil. 
•  Luciferine injection buffer: 
  100 μl coenzyme A stock 
  1 ml luciferine stock 
  250 μl PIPES 0.5 M 
 The volume is filled up to 10 ml with ddH2O and stored at -20°C wrapped in aluminium 
foil. 
•  Reaction buffer for MUG assay: 
  100 mM Na3PO4 
  2 mM MgCl2 
 The pH is adjusted to 8.0 with HCl. 
•  Stop solution for MUG assay: 
  300 mM glycine 
  15 mM EDTA 
 The pH is adjusted to 11.5 with NaOH. 
 
6.2.5.2 Maintenance of cells 
Since mammalian cells are very sensitive to contaminations with bacteria, fungi or other 
micro-organisms, all manipulations have to be done under a hood with laminar flow.  All cells 
are cultured in high glucose (4.5 g/l) Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 5 mM L-glutamine, 1 % penicillin/streptomycin and heat inactivated fetal 
calf serum (HIFCS) in an incubator that is set to 37°C and  5% CO2. Once the cells are 
confluent, most cell lines are detached from the plate using trypsin. For this, the cells are 
washed twice with 1x PBS before a small amount of trypsin is added. The plate is gently 
rotated and the excess trypsin is aspirated. After a short incubation of around 30 seconds to 
maximum five minutes in the incubator, the cells are detached from the plate adding DMEM. 
The cell suspension is then diluted in a final volume of 10 ml DMEM for a 10 cm plate and 
incubated again until confluent. 
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Fig. 6.2-4:  
Improved Neubauer hema-
cytometer counting grid 
Since NIH108-15 cells do not adhere firmly to the plate they can be simply detached from the 
plate by vigorously pipetting up and down 1x PBS. The suspension is then centrifuged at RT 
and 1000 g for 5 min. Once the supernatant is discarded, the pellet is completely resuspended 
in DMEM and diluted for further culturing.   
 
6.2.5.3 Counting of cells using a Neubauer hemacytometer 
For some cell culture experiments it is very important to work with an exact number of cells. 
For this, the cells are counted using an improved Neubauer hemacytometer, an instrument for 
estimating the number of cells in a measured volume under the microscope. Developed 
originally for counting blood cells, these chambers are widely 
used in cell culture to determine the concentration of cells in a 
suspension. The improved Neubauer hemacytometer is a thick 
glass slide with two counting chambers, each 0.1 mm deep. 
Each chamber is divided into nine large squares delineated by 
triple white lines. The center square is further subdivided into 
25 squares. These 25 squares are again subdivided into 16 
squares. Hemacytometer cover slips must be used to ensure 
even surfaces and coverage of both counting chambers. The 
grid surface is 0.1 mm below the cover slip. Therefore the volume of fluid over one of the 1 
mm
2
 areas of the grid (they are nine in total) is 0.1 mm
3
 or 0.0001 ml. Facultatively, trypan 
blue which is the most common stain used to distinguish viable cells from non-viable cells 
can be added. Only non-viable cells absorb the dye and appear blue and asymmetrical. 
Conversely, viable cells appear clear in a bluish background. 
The procedure is as follows:  
1. 100 μl of cell suspension is mixed with 100 μl trypan blue 0.2 %. The dilution has 
to be done just prior to use since viable cells absorb trypan blue over time. This 
can affect counting and viability results. 
2. A cover glass is centered over the hemacytometer chambers. 
3. One chamber is filled with 10 μl of the cell dilution. The solution will pass under 
the cover glass by capillary action. If the solution spreads into the two lateral 
grooves adjoining the grid table, the hemacytometer has to be cleaned and the 
application has to be repeated. The same has to be done if there are any bubbles in 
the solution covering the grid table. 
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4. The hemacytometer is placed on the stage of an inverted microscope (Nikkon, 
TMS-F) and the focus is adjusted. 
5. The white cells are counted in at least 3 squares using a hand-held counter. All the 
cells that touch the boundary of the area are counted on two sides, but not on the 
other two sides. 
6. The number of cells per ml and the total number of cells is determined using the 
following calculations:  
 
 
 
 
The dilution factor is 2, the # of counted squares 3, and the volume of original cell 
suspension 5 ml. 
7. The total cell suspension is diluted to 10'000 cells / 50 μl.  
8. 50 μl of this dilution are applied to each well of a 96 well culture plate. For each 
genotype three plates are prepared (6 in total). 
9. 100 μl of DMEM are added to each well to get a total volume of 150 μl per well. 
The cells are incubated 1-2 days at 37°C and 5 % CO2 to become confluent.  
 
6.2.5.4 Preparation of mouse embryonic fibroblasts (MEFs)  
6.2.5.4.1 Isolation of embryos and preparation of fibroblasts 
Approximately two weeks before the embryos of a mouse can be harvested, the mating needs 
to be set up and must be checked to see if the female is pregnant. The morning of a successful 
copulation, one may see a white plaque at the back of the female and from this morning on, it 
will take about twelve days for the embryos to be ready. However, the form of the belly 
should also be checked to see whether it changes shape or not. If the belly becomes rounder 
on the sides, it is a good indication of pregnancy. 
Before the female is killed, two Petri dishes, each with 1 x TBS are prepared under the hood. 
One of the dishes is left in the hood and the other is placed next to where the mouse will be 
sacrificed. The pregnant female is killed by cervical dislocation, the belly opened with 
scissors, and the womb transferred to the Petri dish. The dish is transported under the hood 
because the next steps must be carried out in a sterile environment.  
factor dilution10
counted squares #
counted cells of #
  cells/ml
4 ••=
suspension cell original of  vol. cells/ml  cells total •=
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First, the embryos are taken out of the womb. Their anatomy is compared to that in pictures 
from the book, "The Atlas of Mouse Development" (M. H. Kaufman) to determine at which 
embryonic stage they were. They are then dissected by cutting off the head and by removing 
the liver in TBS. After this, they are moved to a fresh Petri dish containing 1 x TBS, where 
they are cut into small pieces and then placed in a 2 ml syringe (without a needle). Four 
embryos are pressed through the syringe into a small cell culture bottle, given 5 ml of trypsin-
EDTA (2 mM), and the bottle is then incubated at 37°C for 30 min to disintegrate the tissue 
structure. When the embryos become viscous, 20 ml of medium (DMEM high glucose: 10 % 
FCS, 1 % PEST, 1 % L-Gln) are added to stop the reaction. After the embryos have been 
resuspended in the medium, the mixture is transferred to a 50 ml Falcon tube and centrifuged 
for 5 min at 3'000 rpm to precipitate the fibroblasts. The supernatant is discarded and the cells 
are resuspended in 20 ml of medium and plated in two 10 cm plates. The fibroblasts are 
incubated o/n at 37°C and 5 % CO2. 
 
 
6.2.5.4.2 Splitting of fibroblasts 1 day after isolation (100 % confluent) 
The Petri dishes are removed from the incubator, the old medium transferred to a 50 ml 
Falcon tube using a 25 ml sterile pipette, and then centrifuged for 5 min at 3'000 rpm. The 
supernatant is collected into a new 50 ml Falcon tube. During the centrifugation, the 
fibroblasts are split as follows: 
1. 2 washes with 5 ml 1 x PBS 
2. 1 ml of trypsin-EDTA (1 mM) for 1 min at 37°C 
3. addition of 10 ml medium with a 10 ml pipette 
 the cells are loosened from the bottom of the dish by pipetting them up and  
     down vigorously  
4. 10 new Petri dishes are prepared out of one by moving 1 ml of the new medium 
containing the fibroblasts to each one of them 
5. 8 ml of new medium is added to each one of the new plates 
6. 1 ml of the old medium is added to each one of the new plates 
It is very important to add some of the old medium to each new Petri dish because it contains 
factors that accelerate the growth of the fibroblasts. The plates are incubated until they are 
confluent (usually 2-3 days) at 37°C and 5 % CO2. 
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6.2.5.4.3 Freezing of fibroblasts 
Fibroblasts can be frozen as soon as they are confluent. To do this, 1 ml FCS/DMSO (10 %) 
is prepared in advance for each plate. For 10 ml of solution, 1 ml DMSO is mixed with 9 ml 
of FCS and chilled on ice. It is very important that this solution is ice cold because the DMSO 
will otherwise form crystals that will destroy the cells. To slowly cool down the fibroblasts, a 
freezing box (StrataCooler

 Cryo Preservation Module, Stratagene, catalog #400005) is put at 
–20°C. 
The plates are taken out of the incubator, washed twice with 5 ml 1 x PBS, and treated with 1 
ml trypsin-EDTA (2 mM) for 1 min at 37°C. The reaction is stopped by adding 5 ml of 
medium. The fibroblasts are resuspended and moved to a 50 ml Falcon tube. Unfortunately, it 
is not possible to trypsinate all of the dishes simultaneously because the fibroblasts quickly 
readhere to the bottom of the dish after medium is added. Typically only four plates are 
treated at the same time. The entire medium containing the fibroblasts from these four dishes 
is collected in the same Falcon tube and centrifuged at 3'000 rpm for 5 min. The supernatant 
is discarded and the cells resuspended in 4 ml ice cold FCS-DMSO (10 %) and aliquoted into 
cryovials (1 ml each). The tubes are put into the pre-cooled freezing box and kept at –80°C 
overnight. The next day the fibroblasts are transferred into liquid nitrogen for long-term 
storage. 
 
6.2.5.4.4 Thawing of fibroblasts 
The cryovials are taken out of the liquid nitrogen, thawed at RT, and then 1 ml of warm 
medium (37°C) is added to each vial. After this, the cells are transferred to a 50 ml falcon 
tube containing 10 ml of warm medium and are then centrifuged at RT for 5 min at 3000 rpm. 
The supernatant is discarded, the cells resuspended in 10 ml medium and again centrifuged at 
RT for 5 min at 3000 rpm. The supernatant is again discarded and the cells are plated in 10 ml 
medium per plate. The Petri dishes are incubated o/n at 37°C and 5 % CO2. If they are 
confluent the next day, they can be used for experiments, if not, the medium containing the 
dead cells is removed and they are washed twice with 1 x TBS. Then 10 ml new medium is 
added and they are incubated again until they are confluent. 
 
6.2.5.5 Preparation of mouse dermal fibroblasts (MDFs) 
Before the mouse is sacrificed, scissors and forceps have to be sterilized (70 % EtOH and 
flaming) and a falcon containing 10 ml of normal medium has to be put on ice (it is important 
to use the Amimed medium). The mouse is anesthetized with isoflurane and sacrificed by 
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cervical dislocation. The head of the mouse is sprayed with 70 % ethanol before the top parts 
of the ears are cut and put into the ice-cold medium. Alternatively, one can also use skin from 
the back. For this, the hairs have to be pulled out and the skin has to be sterilized by spraying 
70 % EtOH. Then pieces of about 1 cm
2
 are cut taking as little connective tissue and 
subcutaneous fat as possible. Under the hood, for each piece of tissue, a Petri dish containing 
5 ml of digestion medium is prepared. In this medium, the tissue is cut into as small pieces as 
possible using a scalpel blade and left o/n in an incubator. The next day, the cell suspension is 
passed through a narrowed sterile glass Pasteur pipette (not more than 10 times) before it is 
centrifuged at 4000 rpm and RT for 10 min. The supernatant is discarded and the pellet is 
resuspended in 3 ml of DMEM supplemented with 20 % HIFCS, 1 % PEST, 1 % L-Gln 
before it is transferred to one well of a six-well plate. Once they are confluent, the cells are 
split and diluted in 20 % HIFCS / DMEM after trypsinization during three passages. It should 
be avoided to split them higher than 1:4 because they need to be in close contact to each 
other. One six-well split onto a 5 cm dish corresponds to a dilution of about 1:1.5 and a 5 cm 
dish split onto a 10 cm dish corresponds to about 1:3. After three passages, the cells can be 
transferred to a 10 cm dish and the HIFCS can be reduced to 10 %. Cells enter in crisis after 
about 6 to 7 passages but will continue to grow and eventually immortalize. MDFs can be 
frozen the same way as MEFs. 
If bacterial contaminations are found in the cultures while the cells are still in six-well plates 
in spite of the antibiotics, immediately aspire the medium and fill the well with 70 % EtOH or 
Sekusept solution. Leave a few minutes at RT and aspire. Put the plate back into the 
incubator. If fungi are found, add 5 g/ml amphotericine B to the medium until the cells are 
split, and keep them in medium supplemented with 2.5 g/ml amphotericine B for the next 
passage. 
 
6.2.5.5.1 Thawing of MDFs 
The MDFs are thawed in a 37°C water bath until only a small piece of ice is left. Then the 
tube is sprayed with 70 % EtOH and wiped. The cells are transferred carefully into a 15 ml 
Falcon tube and 9 ml of normal medium is added slowly drop by drop before the tube is 
centrifuged at 4000 rpm for 5 min. The pellet is resuspended in 2 ml of DMEM and put into 
one well of a six-well plate. After one day, the medium has to be changed and the cells are 
split as soon as they are confluent. 
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6.2.5.5.2 Immortalizing of MDFs 
Since primary cells reach their senescence after a limited number of population doublings one 
has to either re-establish fresh cultures from explanted tissue or to immortalize the cells. The 
MDFs immortalize spontaneously at low frequencies by passing through replicative 
senescence after around 20 passages. However, it is important to note that these 
spontaneously immortalized cells have unstable genotypes and are host to numerous genetic 
mutations compared to cells that are immortalized via viral transformation or through the 
expression of the telomerase reverse transcriptase protein. Although the process of viral 
transformation is relatively simple and reliable, these cells may also become genetically 
unstable and might lose the properties of primary cells. 
The primary MDFs are defrozen as described above and then immortalized by successive 
transfer (Todaro and Green, 1963). Briefly, they are cultured in tissue culture flasks (75 cm
2
) 
to decrease the contamination risk and split as soon as they are confluent. After six to seven 
passages they start to enter crisis and divide very slowly. During this time the medium has to 
be changed twice a week and the cells have to be detached from time to time with trypsine 
and put back 1:1 into a new flask. As soon as the cells look better again and divide faster they 
have to be split very carefully and should only be diluted 1:2 or 1:3. After around 20 passages 
they are immortalized and aliquots can be frozen and stored in liquid nitrogen as described 
above.  
 
6.2.5.6 Synchronization of cells via dexamethasone shock  
Since the master clock is missing in mammalian cell culture, all the cells in a culture dish are 
ticking according to their own internal rhythm. However, for some experiments it is important 
that their clocks all tick synchronously. This synchronization can be achieved by various 
methods such as a serum or a dexamethasone shock. 
For the dexamethasone shock, the old medium has to be removed from the plate and replaced 
by new medium containing 100 nM dexamethasone (t = 0). For this, 0.1 l of the 10 mM 
stock solution are added to 10 ml of fresh medium. The plate is put back into the incubator for 
20 min. Then the cells are washed twice with serum-free medium before normal medium is 
added. The cells are now synchronized and can be put back into the incubator for some time 
depending on the phase of the gene or protein of interest. At its peak expression time or at 
regular intervals the cells are harvested and processed for either RNA or protein extraction. 
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One should always keep one control sample in which no dexamethasone has been 
administered. 
 
6.2.5.7 Transfection of cells using linear polyethylenimine (LINPEI25) 
Contrary to branched polyethylenimines, linear polyethylenimines contain only secondary 
amines. However, the characteristic of all polyethylenimines is that they have a high cationic-
charge density, which makes them an excellent condensing agent with the negatively charged 
DNA. The linear polyethylenimine with a molecular weight of 25 kDa (LINPEI25) is an 
effective “proton sponge”. Once the DNA/LINPEI25 complex enters the cell, the DNA is 
protected from lysosomal degradation due to its interaction with LINPEI25. Many cell lines 
can be transfected at high efficiencies with LINPEI25 because of its low toxicity for the cells. 
Another advantage of LINPEI25 is that the presence of serum does not interfere with 
transfection efficiency. 
 
6.2.5.7.1 Preparation of cells for co-transfection 
About one day prior to transfection, cells were transferred from a 10 cm plate to a 6-well 
plate with 2 ml medium per well. Each cell line needs a different dilution: 
• Cos-7 & NIH/3T3 cells   1:4 
• HEK293 cells   1:3 
• NG108-15 & HEPG2 cells   1:2.5 
NG108-15 cells were transfected at a confluence of 60-80 % whereas the other cell lines were 
transfected at 80 % confluence. 
 
6.2.5.7.2 Preparation of the LINPEI25/DNA complex 
Since the number of negative charges of the DNA phosphate groups and the number of 
positive charges of the LINPEI25 nitrogens depends on the pH of the solution it is easier to 
take into account the nitrogen molarity (N) on the phosphate molarity (P) ratio (N/P). In order 
to get optimal results, the amount of LINPEI25 used has to be calculated according to the 
following formula: 
No. of equivalents = 15.44 x amount of DNA [μg] 
One equivalent corresponds to the quantity of 10 μM LINPEI25 [μl] required to match the 
nitrogen content to phosphate contained in the DNA. The LINPEI25/DNA complex is 
prepared in 1x HBS buffer to a total volume of 200 μl. Each transfection mix contains 0.05 
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μg of CMV-lacZ DNA as transfection efficiency control, different amounts of promoter-
luciferase construct DNA, and different amounts of protein expression plasmid DNA. 
Besides, calf thymus DNA and empty expression vector (pSCT1) is added to each mix to 
equilibrate for the maximal amount of DNA or expression plasmid used within the 
experiment. Furthermore, a negative control consisting of only calf thymus DNA has to be 
included in every experiment. Finally, the appropriate amount of LINPEI25 is pipetted to 
each tube. The mixture has to be vortexed immediately after the addition of the LINPEI25 for 
a few seconds before it is incubated at RT for 20 to 30 min. The incubation time influences 
the size of the complex and thus is important for transfection efficiency. After the incubation, 
the mixture is added gently drop by drop to the cells and the 6-well plate is gently rocked to 
evenly distribute the complexes within the medium. The cells are kept in the incubator for 6 
hours. Then the medium is aspirated and replaced with 2 ml fresh medium. The cells are 
incubated again for 18-30 hours before they are harvested as described below. Alternatively, 
one can use 13 or less equivalents of 10 μM LINPEI25 and incubated the cells for 24-36 
hours without changing the medium after the transfection. 
 
6.2.5.7.1 Cell harvesting 
24-36 hours after transfection, the medium is aspirated from the culture dish and adherent 
cells are rinsed twice with 1 ml 1x PBS. Then they are harvested in 1 ml 1x TBS/5 mM 
EDTA, transferred into a reaction tube and pelleted via a 1 min centrifugation at 9000 rpm 
and 4°C. Since NG108-15 cells are not really adherent to the plate, they can be harvested 
simply by detaching them from the plate with 1 ml 1x PBS without prior washing. Then they 
are centrifuged directly at 9000 rpm for 1 min and the pellet is washed once in 1x PBS.  The 
supernatant is discarded and the pellet is resuspended by pipetting up and down in around 50-
80 μl of lysis buffer depending on the pellet size. The tube is immediately put on ice for at 
least 5 min and then centrifuged at 9000 rpm and 4°C for 5 min. The lysate is transferred into 
a 96-well plate kept on ice and either assessed directly or stored at -20°C for up to one week. 
 
6.2.5.7.2 Luciferase assay 
The luciferase assay is carried out according to the manufacturer’s instructions described in 
the manual “Luciferase Assay System” from Promega (Technical Bulletin 281). 10 μl of cell 
lysate are assayed in duplicates on a 96-well plate (NUNC
TM
 Brand Product) for the activity 
of the translated luciferase promoter construct. 100 μl of 1x reaction buffer is added to each 
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well and 100 μl of luciferine injection buffer is directly injected into each well by the 
luminometer, which measures the generated bioluminescence of each well for 10 seconds. 
 
6.2.5.7.3 MUG assay 
The measured luciferase activity of the promoter construct has to be normalized to the 
transfection efficiency of the experiment by determining the -galactosidase activity of the 
co-transfected lacZ expression plasmid. MUG (4-methylumbelliferone b-D-
galactopyranoside) is used as a substrate for -galactosidase because it fluoresces upon 
hydrolysis by the enzyme. The hydrolysis product of MUG, 4-methylumbelliferone (MUB), 
has an excitation peak at 372 nm with a fluorescence emission peak at 445 nm. 
For the assay, a mixture of 1.45 ml MUG stock solution and 13 ml MUG reaction buffer has 
to be pre-warmed to 37°C (MUG solution). Depending on the cell line used, the protein 
extracts have to be more or less diluted in lysis buffer. 10 μl duplicates of the diluted extract 
are pipetted onto a NUNC
TM
 Brand Product 96-well plate that is placed on ice. 140 μl of the 
pre-warmed MUG solution are added to each well, before the plate is wrapped in aluminium 
foil and incubated at 37°C for 20 to 60 min depending on the cell line. Once the incubation 
time is over, 100 μl of MUG stop solution are added to each well and the fluorescence is read 
using the flurimeter (Multidetection microplate reader, BIO-TEK). The following endpoint 
protocol parameters are used: 
• Excitation: 360/40 
• Emission:460/40 
• Optic position: Top 
• Sensitivity: 30 
• Plate type: 96 well 
• Reading direction: horizontal 
• Shaking: NO 
• Temperature control: NO 
The luciferase activity is then normalized dividing it by its corresponding -galactosidase 
activity. Furthermore, the data can be expressed as fold induction normalizing it relative to the 
empty reporter plasmid. 
 
6.2.5.8 RNA isolation from cells 
The medium is aspirtated from the plate and the cells are washed twice with cold 1x PBS 
before they are lysed in RNAbee (2 ml RNAbee are added to a 10 cm plate and 1 ml to a 
5 cm plate). Once the cells are completely detached, the plates can be either stored at -80°C 
or the lysate can be transferred to a reaction tube. 100 μl of chloroform are added to 1 ml of 
RNAbee before the tube is incubated on ice for at least 5 min. After the incubation, the 
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suspension is centrifuged at 13'000 rpm and 4°C for 15 min. The homogenate now forms two 
phases: the lower blue phenol-chloroform phase and the colourless upper aqueous phase. 
DNA and proteins are located in the interphase and organic phase. The aqueous layer is 
transferred into a fresh tube and an equal volume of isopropanol is added to this to precipitate 
the RNA. The tube is carefully inverted several times and stored at -20°C for 15 min. Then 
the DNA is pelleted at 13'000 rpm and 4°C for 20 min. The pellet is washed once with 75 % 
ethanol by turning the tube in your hands. The ethanol is discarded and the pellet is dissolved 
in DEPC-H2O. The same volume of 0.4 M sodiumacetate/0.2 % SDS is added at room 
temperature. Then the mixture is extracted with one volume of chlorophorm-phenol. The 
aqueous layer is transferred to a new reaction tube and two volumes of 100 % ethanol are 
added. DNA precipitation is enhanced by an incubation of 20 min at -20°C. The tube is then 
centrifuged at 13’000 rpm and 4°C for 20 min. The pellet is washed once in 75 % and once in 
100 % ethanol before it is air-dried and dissolved in DEPC-H2O. 
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6.2.6 Protein methods  
4.2.6.1 Cell fractionation for cytoplasmic and nuclear protein extracts 
4.2.6.1.1 Solutions 
• Buffer A (hypotone): for 50 ml: 
 10 mM  Hepes-KOH, pH 7.9 10.00 ml of a 0.05 M stock 
 1.5 mM  MgCl2 75.00 l of 1 M stock 
 10 mM  KCl 166.70 l of a 3 M stock 
   ddH2O fill up to 50 ml 
 0.5 mM  DTT 1.00 l/ml 
   protease inhibitors 10.00 l/ml* 
 0.5 M  NaF   10.00 l/ml 
 200 mM  Na3VO4 1.00 l/ml 
 
• Buffer B (hypertone): for 10 ml: 
 20 mM  Hepes-KOH, pH 7.9 4.00 ml of a 0.05 M stock 
 25 %   Glycerol 2.94 ml of 87 % glycerol 
 0.42 M  NaCl 0.84 ml of a 5 M stock 
 1.5 mM  MgCl2 15.00 l of a 1 M stock 
 0.2 mM  EDTA 4.00 l of a 0.5 M stock 
   ddH2O  fill up to 10 ml 
 0.5 mM  DTT 1.00 l/ml 
   protease inhibitors 10.00 l/ml* 
 0.5 M  NaF 10.00 l/ml 
 200 mM  Na3VO4 1.00 l/ml 
 
*: of a solution of one complete EDTA-free protease inhibitor tablet (Roche) dissolved in 
500 l ddH2O 
• Sucrose solution: 
 2.4 M Sucrose 
 10 mM Hepes-KOH, pH 7.6 
 15 mM KCl 
 0.5 mM spermidine 
 0.15 mM spermine 
 
6.2.6.1.2 SCN fractionation 
The animals are anesthetized using isoflurane and then sacrificed at the desired time point. 
The SCN region (fig. 6.2-5A) is extracted using two tweezers with ultra fine precision tips 
(e.g. Dumont tweezers #5) and frozen immediately in liquid nitrogen. Before homogenization, 
four samples are pooled in one tube and 280 l (70 l / animal) of buffer A containing 
protease inhibitors are added. The tissues are then homogenized thoroughly using an 
Eppendorf fitting pestle-homogenizer (fig. 6.2-5B) keeping tubes on ice at all times. The 
homogenate is then incubated on ice for 30 min, flicking the tubes from time to time.  After 
adding NP40 substitute to 0.3% (diluted from a 10 % v/v stock), the mixture is forced 10 
dilute 1:4 
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times through a 25 G needle on ice and incubated again on ice for 
another 30 min. Once the hypotonic lysis is finished, the tubes are 
vortexed for 10 s and then centrifuged at 1200 g (3600 rpm in an 
Eppendorf centrifuge) for 5 min at 4°C. The supernatant is 
transferred carefully to a fresh tube in order not to disturb the pellet 
because otherwise the cytosolic fraction could be contaminated 
with nuclei. The pellet is resuspended in 140 l of buffer A 
containing 0.3 % NP40 substitute and the mixture is overlaid onto 
800 l of 0.6 M sucrose buffer. The tube is centrifuged for 2 min at 
10’000 rpm and 4°C. The supernatant is discarded and the pellet is 
suspended again in 140 l of buffer A containing 0.3 % NP40 
substitute. After another centrifugation of 10’000 rpm for 6 min at 
4°C, the pellet is suspended in 200 l of buffer A (without NP40 
substitute). The nuclei are pelleted in a microfuge at 3600 rpm and 
4°C for 3 min. After having discarded the supernatant, 200 l of buffer A (without NP40 
substitute) are added to the pellet and the mixture is incubated on ice for 5 min before it is 
centrifuged at 3600 rpm and 4°C for 5 min. The purified nuclei are then lysed hypertonically 
in 55 l of buffer B (13.75 l / animal) at 4°C in rotating wheel during 30 min. The tube is 
then centrifuged at 13’000 rpm and 4°C for 15 min and the supernatant is taken as the nuclear 
fraction. The protein concentration is measured using the Bradford assay from BioRad. Two 
distinct standard curves have to be done for the cytoplasmic and the nuclear fraction, each 
containing the same volume of buffer A or B that has been used to extract samples. 
 
6.2.6.2 Determination of protein concentrations according to Bradford 
Although protein assays don’t tell us anything about the kind of proteins present in a sample, 
they are important to determine the total amount of proteins in a sample. A good protein assay 
should be specific, sensitive, and fast. Unfortunately, the perfect protein assay does not exist.  
Due to this, one test has to be chosen over another for ease of use or specific scientific 
limitations (e.g. interferences). Nowadays, the most commonly used protein assays are the 
Bradford and bicinchoninic acid (BCA) assays.  
An advantage of the Bradford assay is that it is fast and easy to do and the variability between 
proteins is small. Furthermore, ready to use Bradford reagents can be bought from many 
companies (e.g. BioRad). Its principle is based on the observation that the maximum 
absorbance for an acidic solution of Coomassie Brilliant Blue G-250 shifts from 465 to 595 
nm when binding to proteins occurs. Disadvantages of this assay are that Coomassie Blue 
Fig. 6.2-5:  A Ventral view 
of a mouse brain and 
marked SCN region  
B Eppendorf fitting pestle-
homogenizer 
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does not bind some specific proteins (e.g. trypsin) and that the Bradford reagent is acidic, 
which precipitates some proteins. Additionally, some detergents like Triton X-100, SDS or 
Chap interfere with the assay. 
In parallel to each protein determination a standard curve has to be prepared. A concentration 
range should be used that produces an A595 that does not exceed 1.0 A units in the assay. The 
standard curve is prepared using 1, 2, 5, 7, 10 and 12 g BSA. All samples have to be mixed 
well and incubated at room temperature for 10 to 20 min before measuring the absorption at 
595 nm. For more details see the manufacturer’s manual (BioRad). The reaction mixtures are 
pipetted as follows:  
BSA standard curve samples 
x μl of BSA [1 μg/μl] y μl of fraction 
1200-x μl dH2O 1200-y μl dH2O 
300 μl Bradford reagent  300 μl Bradford reagent 
It is important to add the Bradford reagent to all tubes in parallel at the end. 
 
6.2.6.3 Western blot 
6.2.6.3.1 Solutions 
• 10 % Ammoniumpersulfate (APS): 
  1 g APS 
  10 ml ddH2O 
 The solution can be stored for several months at 4°C. If the gels do not solidify anymore as 
they should, a fresh APS solution should be prepared.  
• 20 % SDS: 
  100 g SDS 
  350 ml ddH2O 
 Once the SDS is dissolved, the solution is filled up to 500 ml with ddH2O and stored at RT. 
• 4x Upper solution: 
  15.14 g Tris [final concentration (f.c.)  0.5 M] 
  5 ml 20 % SDS stock 
 The pH is adjusted to 6.8 and the volume completed to 250 ml. The solution is stored at 
RT. 
• 4x Lower solution: 
  45.42 g Tris [f.c.  1.5 M] 
  5 ml 20 % SDS stock 
 The pH is adjusted to 8.8 and the volume completed to 250 ml. The solution is stored at 
RT. 
• 10x Running buffer: 
  30 g Tris [f.c.  0.248 M] 
  144 g Glycin [f.c.  1.918 M] 
  800 ml ddH2O 
 The volume is adjusted to 1 l and the solution is stored at RT. 
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• 1x Running buffer: 
  100 ml 10x running buffer 
  5 ml 20 % SDS  stock 
  800 ml ddH2O 
 The volume is adjusted to 1 l and the solution is stored at RT. 
• 4x Loading buffer: 
  2 ml 20 % SDS  stock [f.c.  4 %] 
  3.6 ml water-free glycerol [f.c.  36 %] 
  400 l -mercaptoethanol [f.c.  4 %] 
  4 ml 4x upper solution, pH 6.8 [f.c. Tris  0.2 M] 
 The solution is stored at RT. 
• 10x PBS pH 7.4: 
  2 g KH2PO4 [f.c.  14.7 mM] 
  2 g KCl [f.c.  26.8 mM] 
  80 g NaCl [f.c.  1.37 mM] 
  14.2 g Na2HPO4 x 2H2O [f.c.  79.7 mM] 
  800 ml ddH2O 
 The pH is adjusted to 7.4 and the volume completed to 1000 ml with ddH2O. 
• Transfer buffer for wet transfer: 
  1 vol 10x running buffer 
  2 vol methanol (technical grade) 
  7 vol dH2O 
 For a better transfer, 5 ml of the 20 % SDS stock can be added to 1000 ml of transfer 
buffer. The solution has to be stored at 4°C. 
• 10x TBS pH 7.5: 
  121.14 g Tris 
  87.66 g NaCl   
  800 ml ddH2O 
 The pH is adjusted to 7.5 and the volume completed to 1000 ml with ddH2O. 
• 1x TBS-Tween-20: 
  100 ml 10x TBS pH 7.5 
  1 ml Tween

-20   
  900 ml ddH2O 
 Store at 4°C. 
• 5 % (w/v) milk-TBS -Tween-20: 
  25 ml 10x TBS pH 7.5 
  0.25 ml Tween

-20 
  12.5 g Rapilait milk powder  
  200 ml ddH2O 
 The volume is adjusted to 250 ml with ddH2O and the solution is stored at 4°C. 
 
 
6.2.6.4.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE is a technique that is widely used to separate proteins according to their 
electrophoretic mobility, which depends on the length of the polypeptide chain, 
posttranslational modifications, protein folding, charge and other factors. The polyacrylamide 
gel can be prepared with a wide range of average pore sizes, which are determined by both the 
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total amount of acrylamide present and the amount of cross-linker present in the gel. Pore size 
increases with decreasing amount of polyacrylamide. The gel is composed of two layers: a 
stacking gel on the top, which concentrates the proteins at a thin starting zone (Kohlrausch 
reaction), and a resolving gel at the bottom, which separates the proteins according to their 
size and charge. The former is a large pore gel containing usually around 4-5 % 
polyacrylamide, whereas the latter is a small pore gel containing 4-30 % polyacrylamide. 
The polyacrylamide gel is usually casted in a multiple gel caster as described in the 
manufacturers manual (SE 275, Hoefer Scientific Instuments). For each gel being prepared, 
one glass plate, one aluminium plate, two spacers and 1 comb have to be cleaned with 70 % 
EtOH before the gel sandwich is assembled within the gel caster. Then, the resolving gel is 
mixed according to table 6.2-1, poured into the gel caster to 2.5 cm below the top of the 
rectangular glass plate and overlayed with isopropanol. Once the gel solidified, the 
isopropanol is decanted and the gels are washed with dH2O before the stacking gel mixture is 
poured on top of the resolving gel. The comb is inserted and the gel allowed to polymerize. 
Once the gel has solidified, the comb is removed and the gel is cleaned with dH2O. The gel is 
then put into the electrophoresis apparatus (SE 250 Mighty Small II, complete, Hoefer 
Scientific Instruments). The chambers are filled with 1x running buffer and then the denatured 
proteins are loaded into the wells. At least one lane of the gel is loaded with a molecular 
weight marker. An electric current of 100 V and about 30 mA is applied for the first 2 cm of 
the gel until the proteins leave the stacking gel. The voltage is then increased to 180 V until 
the bromphenol blue band of the loading buffer has run out of the gel. 
Table 6.2-1:         
Resolving gel composition for 10 ml (amounts indicated in ml):    
Protein size in kDa       25-200 15-100 10-70 12-45 4-40 
Gel in % 5 6 7.5 8 10 12.5 15 20 
Lower Sol. (4x) 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 
Acrylamide Stock 40 % 1.25 1.50 1.88 2.00 2.50 3.13 3.75 5.00 
ddH2O 6.10 5.90 5.50 5.40 4.90 4.30 3.60 2.40 
10 % APS 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
TEMED 0.008 0.008 0.008 0.008 0.008 0.008 0.008 0.008 
         
Stacking gel composition for 4 ml:       
Gel in % 4 5       
Upper Sol. (4x) 1.0 ml 1.0 ml       
Acrylamide Stock 40 % 0.4 ml 0.5 ml       
ddH2O 2.6 ml 2.5 ml       
10 % APS 30.0 l 30.0 l       
TEMED 5.0 l 5.0 l       
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6.2.6.4.2 Wet transfer 
Once the electrophoresis is finished, the gel sandwich is disassembled and the stacking gel is 
cut off before the resolving gel is equilibrated in ice-cold transfer buffer (containing 0.1 % 
SDS) for 15 min. Besides the gel, a nitrocellulose membrane (6 x 8 cm), 4 Whatman papers 
(7 x 9 cm) and two fibre pads have to be soaked in ice-cold transfer buffer for 15 min. The gel 
holder cassette is placed on a clean 
surface with the black side down and 
the sandwich is assembled on the black 
side of the gel holder cassette as shown 
in fig. 6.2-6. It is important to gently 
roll out any air bubbles from the 
sandwich using a glass tube or a small 
Falcon tube. The cassette is firmly 
closed, locked with the white latch and 
placed in the module, which is then 
placed inside the tank. After adding a 
small magnetic stirrer (helps to 
maintain even buffer temperature and 
ion distribution in the tank) and the 
frozen Bio-Ice cooling unit, the tank is 
filled complete with ice-cold transfer 
buffer and an electric current of 300 mA and 120 V is applied for 2 h 30 min. Upon 
completion of the run, the blotting sandwich is disassembled and the membrane is either put 
into TBS-Tween o/n at 4°C or blocked in 5 % (w/v) milk-TBS-Tween for 1 h at RT. 
 
6.2.6.4.3 Blocking of the membrane and labeling of the target protein 
Before the 1
st
 antibody can be applied to the membrane, the latter has to be blocked for non-
specific binding, which is achieved by placing the membrane in a solution of diluted protein 
(either BSA or non-fat milk). These proteins attach to the membrane in vacant place (i.e. 
without target protein) leaving no space for the antibody to bind elsewhere. Hence the “noise” 
of the Western blot can be reduced and this leads to clearer results and may even eliminate 
false positives. 
Fig. 6.2-6: Mini Trans-Blot Cell description and 
assembly of parts (BioRad manual, catalog numbers 
170-3930 or 170-3935). 
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Usually, the membrane is blocked with 5 % (w/v) milk-TBS-Tween under gentle agitation for 
1 h at RT before the 1
st
 antibody is added. The optimal antibody concentration has to be 
determined by titration. The blocked membranes have been incubated with the following 1
st
 
antibody working dilutions in 5 % (w/v) milk-TBS-Tween at RT for 2 h or o/n at 4°C: 
• ACTIN 1:2500 produced in rabbit 
• BMAL1  1:1000 produced in rabbit  
• CLOCK  1:1000 produced in rabbit 
• CRY1  1:1000 produced in rabbit 
• HSP90  1:2000 produced in mouse 
• POLII  1:1000 produced in rabbit 
Once the incubation is finished the membrane has to be rinsed twice quickly with 5 % (w/v) 
milk-TBS-Tween and has then to be washed two times with 5 % (w/v) milk-TBS-Tween for 5 
min at RT on a shaker to remove unbound antibody. After rinsing, the membrane is exposed 
to the secondary antibody diluted in TBS-Tween at RT for one to two hours at the following 
concentrations: 
• Anti-mouse 1:5000 
• Anti-rabbit 1:7500 
The secondary antibody is linked to horseradish peroxidase, which allows detection of the 
target protein as described in the next paragraph. Then the membrane is rinsed twice quickly 
with TBS-Tween and shaken twice in TBS-Tween at RT for 10 min. 
 
6.2.6.4.4 Chemiluminescent detection of the target protein 
The chemoluminescent detection of the target protein depends on incubation of the Western 
blot with luminol as a substrate, which will glow when exposed to horseradish peroxidase 
bound to the secondary antibody (fig. 6.2-7). The generated light is then detected by exposing 
the membrane to a film and the image is analysed by densitometry. 
After the unbound secondary antibody is washed away, the excess wash buffer is drained 
from the membrane. A transparent plastic pocket is cut open on one side and taped into a film 
cassette. The membrane is then placed protein side up on the open plastic pocket. An equal 
volume of detection solution 1 is mixed with detection solution 2 (ECL
TM
 Western blotting 
analysis system, GE Healthcare) and applied onto the membrane, which is incubated for 2 
min or less at RT before the excess detection reagent is drained by puting the edge of the 
membrane in contact with a tissue.  The sheet protector is then closed and eventually air-
bubbles are smoothed out before an X-ray film sheet (Amersham Hyperfilm
TM
 MP, GE 
Healthcare) is placed on top of the membrane and exposed for about 30 seconds. The film is 
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removed and replaced by a new one while the first piece is immediately developed. Based on 
the appearance of the first film the duration of the second exposure is estimated. 
 
 
6.2.6.4 Corticosterone RIA 
6.2.6.4.1 Blood sampling from the tail tip 
Some cotton wool is put in a tight box (e.g. empty pipette box) and 1  Pasteur pipettes of 
isoflurane (Attane
TM
 Isoflurane, Provet, ATC vet code: QN01AB06) are put on the cotton 
wool. The mouse is carefully put into the box, paying attention that is doesn’t get wet with 
isoflurane. The mouse is left in the box until it loses consciousness. Monitoring the speed of 
breathing validates the deepness of anesthesia.  
In order to assure that the mouse remains anesthetized during blood sampling a special 
container is fabricated out of a plastic beaker (fig. 6.2-8). Some air holes are drilled into the 
bottom of the beaker and a double bottom (plastic of disposable pipette rack) is inserted and 
fixed with some wire. Cotton is put between the two bottoms. The beaker is fixed on a surface 
(lower part of a pipettip box). Some isoflurane can now be added on the cotton using a 
Pasteur pipette. 
Fig. 6.2-8: Container to keep 
mouse anesthetized  
A Front view of the container.  
B Back view of the container. 
Fig. 6.2-7: Principles of ECL 
Western blotting. The membrane is 
soaked briefly in the detection reagent. 
This elicits a peroxidase-catalyzed 
oxidation of luminol and subsequently 
enhanced chemiluminescence (ECL), 
where the HRP labeled protein is 
bound to the antigen on the membrane. 
The resulting light is detcted on a film 
in minutes, or often seconds. [Product 
Booklet RPN 2109, GE Healthcare] 
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As soon as the mouse is anesthetized deeply enough, it is taken out of the box and laid with 
its back on a table with the head inside the beaker. Inserting the mouse deeper into the beaker 
or taking it out of it can control the deepness of anesthesia. A small horizontal incision is 
made on the ventral part of the tail over the vessels 0.5 to 2 cm from the tail base using a 
scalpel blade. The blood is collected using a Microvette

 100 (Sarstedt, cat. #: 20.1280) for 
serum preparation. The tubes are kept on ice until they are centrifuged at 6000 rpm and 4°C 
for 10 min. The supernatant (serum) is kept at -20°C until further use. 
 
6.2.6.4.2 Tube restraint 
To check for the influence of stress on the mouse, corticosterone is determined before and 
after a 10 min tube restraint. Mice were individually housed for at least 1 day before blood 
sample collection. 
50 ml Falcon tubes are used as restraining tubes. 3 air holes are drilled on the conical part 
distributed at equal distances. One additional hole is made on the head of the tube. 
Blood is collected once prior to the tube restraint and once 30 min after the end of the 10 min 
restraint. 
 
6.2.6.4.3 Corticosterone determination 
Corticosterone levels are determined using the “Corticosterone 
3
H RIA Kit (rats & mice)” of 
MP Biomedicals (cat #: 07-120002) and according to the manufacturers instructions with a 
few exceptions: 
• 3 l of serum are diluted in 1.5 ml of steroid diluent 
• Incubation for around 3 h at 4°C 
• 4 ml of scintillation cocktail are used 
 
6.2.6.5 Immuncytochemistry 
Immuncytochemistry allows the in situ detection of specific proteins in fixed cells. It is 
important to always include a negative control without the primary antibody to avoid any 
false positive interpretation of the results. Furthermore, one should include a positive control 
(e.g. actin) to assure that the assay is functional.  
For the assay, 10’000 cells are cultured in 400 μl medium per well of an 8-well LabTek 
chamber slide o/n in an incubator. The next day, the medium is aspirated and the cells are 
fixed in 4% PFA for 15 min. Then the cell membranes are permeabilized incubating them in 
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0.1 % triton X-100/1x PBS for 2 min. The cells are washed once shortly and twice for 5 min 
with 1x PBS before the endogenous peroxidases are blocked with 0.06 % H2O2/MeOH for 30 
min at RT. After washing the cells twice shortly with PBS, the cells are blocked for 
unspecific antibody binding incubating them with 5 % serum for 30 min at RT. It is important 
to use the serum from the animal in which the second antibody was produced. Then the cells 
are washed once shortly and twice for 5 min in 1x PBS. The first antibody is added together 
with 2 % serum in 1x PBS and incubated o/n at 4°C. The appropriate amount of the first 
antibody has to be determined for each antibody by preparing a dilution series (e.g. 1:100, 
1:250 and 1:500). 
The next morning, the cells are washed again once shortly and twice for 5 min in 1x PBS 
before the secondary antibody is added in a dilution of 1:200 in 1x PBS for 45 min at RT. 
During this incubation time, the AB-complex of the Vectastain
®
 ABC kit has to be prepared 
diluting equal amounts of solution A and B (1:50) in 1x PBS (e.g. 80 μl A + 80 μl B + 3840 
μl PBS). The principle of this kit is that the unlabeled primary antibody is recognized by a 
biotinylated secondary antibody. The biotin of the latter is then bound by a preformed Avidin 
and Biotinylated horseradish peroxidase macromolecular Complex which remains stable for 
several hours after formation. Since avidin has an extraordinarily high binding affinity for 
biotin their binding is essentially irreversible. 
The cells are washed once more as described above with PBS and then the AB-complex is 
added for 45 min at RT. In the mean time the DAB (3,3’-diaminobenzidine) reagent has to be 
prepared dissolving one urea and one DAB tablet in 1 ml of ddH2O. DAB is widely used in 
immunhistology because it is a precipitating substrate for peroxidase. The intense brown-
black stain that is produced is resistant to alcohol and can be coverslipped in the traditional 
manner and thus be stored for future reference. Once the incubation is finished, the cells are 
washed once shortly and twice for 5 min in 1x PBS. The DAB is added for some seconds to a 
few minutes and the reaction is stopped by adding ddH2O as soon as a nice color development 
can be observed. Then the cells are washed three times with ddH2O before the gasket is 
removed from the chamber slide by smoothly lifting it away. Excess water is gently removed 
using tissue paper and a glass coverslip is mounted on the slide using two drops of Aquatex. 
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A absorbance unit 
Amp ampicillin 
arnt aryl hydrocarbon receptor nuclear translocator protein 
ATP adenosintriphosphate 
av average 
AW atomic weight 
Bmal1 brain-muscle Arnt-like protein 1 
bp base pair 
BSA bovine serum albumin 
CaMK Ca
2+
–calmodulin-dependent kinase 
cAMP cyclic adenosinmonophosphate 
ccg clock controlled gene 
cDNA complementary DNA  
cGKII cGMP-dependent protein kinase II (also known as PKGII) 
cGMP cyclic guanosinmonophosphate 
Ci curie 
CKI casein kinase I 
clk clock 
CNS central nervous system 
cpm counts per minute 
CRE cAMP-responsive element 
CREB cAMP-responsive element binding protein 
cry cryptochrome 
CT circadian time 
CT threshold cycle 
cyc cycle 
dbt doubletime 
ddH2O bi-distilled water  
DEPC diethyl pyrocarbonate  
dH2O distilled water 
DI deionized 
DMEM Dulbecco's modified Eagle's medium 
DMSO dimethyl sulfoxide  
DNA desoxyribonucleic acid 
DNase desoxyribonuclease 
dNTP 2'-desoxynucleotide-5'-triphosphate 
ds double stranded 
DTT dithiothreitol 
E. coli Escherichia coli 
EDTA ethylen-diamine-tetra-acetic acid 
e.g. exempli gratia (Latin: “for example”) 
et al. et alteri (Latin: “and others”) 
EtBr ethidium bromide 
EtOH ethanol  
FAM carboxyfluorescein (phosphoramidite) 
FASPS familial advanced sleep phase syndrome 
FCS fetal calf serum 
Fmr1 fragile X mental retardation 1 gene 
Fxr1 fragile X mental retardation, autosomal homologue 1 
Fxr2 fragile X mental retardation, autosomal homologue 2 
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g gram 
GAPDH glycerol-3-phosphate
 
dehydrogenase  
h hour 
Hprt hypoxanthine phosphribosyltransferase 
Hyb-mix hybridization mix 
i.e. id est (Latin: “that is”) 
ISH in situ hybridization 
kb kilo bases 
KO knockout 
LB Luria-Bertani  
L-Glu L-glutamine  
m milli: prefix denoting 10
-3 
M molar (mol/l) 
MAPK mitogen-activated peptide kinase 
ME 2-mercaptoethanol 
MEFs mouse embryonic fibroblasts 
MDFs mouse dermal fibroblasts 
mg milligram 
min minute 
Mio million  
mM millimolar 
MMLV Moloney murine leukemia virus 
MOPS 3-morpholinopropanesulfonic acid 
mRNA messenger RNA 
mRNP messenger ribonucleoprotein 
mU milliunit (mU = nmol/min) 
n nano: prefix denoting 10
-9 
NBT nitro blue tetrazolium  
NEB NEW ENGLAND BioLabs inc. 
neg. negative 
ng nanogram 
NH4Ac ammonium acetate  
Npas2 neuronal PAS domain protein 2 (also known as Mop4) 
NTE sodium chloride TRIS EDTA 
OD optic density 
O/N overnight 
PAC pas-associated c-terminal domain  
PAS per-arnt-sim dimerization domain 
PB phosphate buffer 
PBS phosphate buffered saline 
PCR polymerase chain reaction  
Per1 period circadian protein 1 
Per2 period circadian protein 2 
PET polyethylene  
PFA paraformaldehyde 
pH Neg. logarithm of the hydrogen ion concentration in moles per 
liter. p refers to power of 10 and H to hydrogen. 
PKA cAMP-activated protein kinase 
PKC protein kinase C 
PEST penicillin / streptomycin 
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PRC phase response curve 
PTC phase transition curve 
qRT quantitative real-time 
Ref. reference 
RHT retinohypothalamic tract 
RIA radio immune assay 
RNA ribonucleic acid 
RNase ribonuclease 
ROR retinoid acid related orphan receptor 
RORE ROR response element 
rpm rotations per minute 
RT room temperature 
RT reverse transcription 
s second 
SAD seasonal affective disorder 
SCN suprachiasmatic nucleus 
SD standard deviation 
SDS sodium dodecyl sulfate 
SEM standard error of the mean 
Sgg shaggy 
sim single-minded protein 
SOP standard operating procedure 
ss single stranded 
SSC sodium saline citrate 
TAE TRIS - acetic acid - EDTA 
Taq Thermophilus aquaticus 
TBS TRIS buffered saline 
TE TRIS-EDTA 
TEA triethanolamine 
tim timeless 
TP time point 
TRIS tris-(hydroxymethyl)-aminomethane 
U Unit (U = μmol/min) 
UTP  uridinetriphosphate 
UV ultraviolet 
V volt 
VIP vasointestinal active peptide 
VIS visible light 
vri vrille 
v/v volume per volume 
WT wild-type 
w/v weight per volume 
ZT Zeitgeber (German: “time giver”) time  
μ micro: prefix denoting 10-6 
μg microgram 
μl microliter 
μmole micromole 
°C Celsius degree centigrades 
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ARTICLE
Fragile X-Related Proteins Regulate
Mammalian Circadian Behavioral Rhythms
Jing Zhang,1 Zhe Fang,1 Corinne Jud,2 Mariska J. Vansteensel,3 Krista Kaasik,4 Cheng Chi Lee,4
Urs Albrecht,2 Filippo Tamanini,5 Johanna H. Meijer,3 Ben A. Oostra,6 and David L. Nelson1,*
Fragile X syndrome results from the absence of the fragile Xmental retardation 1 (FMR1) gene product (FMRP). FMR1 has two paralogs in
vertebrates: fragile X related gene 1 and 2 (FXR1 and FXR2). Here we show that Fmr1/Fxr2 double knockout (KO) and Fmr1 KO/Fxr2 het-
erozygous animals exhibit a loss of rhythmic activity in a light:dark (LD) cycle, and that Fmr1 or Fxr2 KO mice display a shorter free-
running period of locomotor activity in total darkness (DD). Molecular analysis and in vitro electrophysiological studies suggest
essentially normal function of cells in the suprachiasmatic nucleus (SCN) in Fmr1/Fxr2 double KO mice. However, the cyclical patterns
of abundance of several core clock component messenger (m) RNAs are altered in the livers of double KO mice. Furthermore, FXR2P
alone or FMRP and FXR2P together can increase PER1- or PER2-mediated BMAL1-Neuronal PAS2 (NPAS2) transcriptional activity in
a dose-dependent manner. These data collectively demonstrate that FMR1 and FXR2 are required for the presence of rhythmic circadian
behavior in mammals and suggest that this role may be relevant to sleep and other behavioral alterations observed in fragile X patients.
Introduction
Fragile X syndrome (FXS [MIM #300624]) is the most com-
mon form of inherited mental retardation, with an esti-
matedprevalenceof 1 in4000males and1 in8000 females.1
Typical fragile X patients display physical and behavioral
abnormalities, suchas a long,narrowface, large ears,macro-
orchidism, cognitive impairment, hyperactivity, and autis-
tic behaviors.2 The common form of this syndrome is
caused by an expansion mutation of a CGG triplet repeat
in the 50 UTR of the FMR1 gene, which transcriptionally
silences the gene and leads to loss of FMRP.3 FMRP is an
RNA-binding protein that associates with translating poly-
ribosomes.4–6 Fmr1mRNA and FMRP are expressed ubiqui-
tously, particularly the brain and testes.7
FMRP (MIM *309550), FXR1P (MIM *600819), and
FXR2P (MIM *605339) compose a small family of RNA-
binding proteins (fragile X-related protein family; FXR
family).8,9 These three proteins share >60% amino acid
identity and are able to form homo- and heterotypic inter-
actions with each other.9,10 It has been postulated that the
presence of FXR1P and FXR2P could partially compensate
for the loss of FMRP in the fragile X syndrome. Drosophila
has a single gene, Drosophila FMR1 (dfmr1) or Drosophila
Fmr1-related gene (dfxr), whose product shares sequence
identity and biochemical properties with the fragile X-
related protein family.11 To unravel the molecular and cel-
lular bases of fragile X syndrome and to explore therapeu-
tic strategies, bothDrosophila andmousemodels have been
produced. We and others tested dfmr loss-of-function flies
and found altered circadian behavior without detectable
alteration in central clock components.12,13 The disturbed
activity-rest cycle of the fly, together with the observed
sleep disorders in fragile X patients,2,14 led us to investigate
circadian behavior in mice with viable mutations in mem-
bers of the FXR family.15,16
In this study, we demonstrate that mice lacking FMRP or
FXR2P display a shorter free-running period of locomotor
activity in total darkness. In the absence of both proteins,
completely arrhythmic activity was observed in animals
maintained in a light:dark cycle. This arrhythmic pheno-
type is unique among circadian defects described in mouse
models to date. Interestingly, in the absence of FMRP/
FXR2P, the cyclical patterns of abundance of several core
clock component mRNAs are altered in the liver, which
contains a major peripheral clock. By using an in vitro
luciferase transfection assay, we observed that FXR2P alone
or FMRP and FXR2P together can increase PER1- or
PER2-mediated BMAL1-NPAS2 transcriptional activity in
a dose-dependent manner. These data collectively demon-
strate that FMR1 and FXR2 are required for the presence of
behavioral circadian rhythms and indicate that this role
may be relevant to the behavioral alterations observed in
fragile X patients.
Material and Methods
Locomotor Assays
All experiments were performed with male C57BLl/6J mice of the
following genotypes: Fmr1 KO, Fxr2 KO, Fmr1/Fxr2 double KO,
Fmr1 KO/Fxr2 heterozygous, and their nonmutant littermates as
controls (6- to 10-month-old). Animals were individually housed
in standard cages equipped with running wheels within venti-
lated, light-tight chambers with time-controlled lighting.
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Experimental animals were continuously provided with food and
water. Wheel-running activity was recorded by a computer data-
acquisition system (Chronobiology kit, Stanford Software Sys-
tems). Animals were maintained on a 12:12 light/dark cycle for
2 weeks and then were transferred to constant darkness for at least
2 weeks. The raw activity data can be visualized and analyzed with
a c2 periodogram (Chronobiology kit). The data were plotted in
double plot activity histograms. The free-running period, t, and
total activity were analyzed with the Chronobiology kit.
In Situ Hybridization
Adult wild-type (6- to 10-month-old), Fmr1 mutant, Fxr2 mutant,
and Fmr1/Fxr2 double mutant mice were maintained in 12:12 LD
cycle for 2 weeks and then released into DD. At 36th, 42nd, 48th,
and 54th hour in the constant darkness, the mice were sacrificed
for the experiments. Specimen preparation and in situ hybridiza-
tion were carried out as described previously.17 In brief, the
[35S]UTP (1250 Ci/mmol, PerkinElmer)-labeled riboprobes were
synthesized with the RNAMaxx High Yield transcription kit (Stra-
tagene) according to manufacturer’s protocol. The mBmal1 probe
was made from a cDNA corresponding to nucleotides (nt) 654–
1290 (accession number AF015953), mCry1 corresponds to nt
190–771 (AB000777), mPer1 to nt 620–1164 (AF022992), and
mPer2 to nt 229–768 (AF036893). 7 mm thick paraffin sections
were dewaxed, rehydrated, and fixed in 4% paraformaldehyde.
Sections were then permeabilized with a proteinase K (Roche)
digestion before they were fixed again and acetylated. After serial
dehydration, hybridization was performed overnight at 55!C in
a humid chamber. Stringency washes were carried out at 63!C.
Slides were subjected to a ribonuclease A (Sigma) digestion and
then dehydrated in graded ethanol series. Quantification was per-
formed by densitometric analysis (GS-700 or GS-800, BioRad) of
autoradiography films (Amersham Hyperfilm) with the Quantity
One software (BioRad). Data from the SCN were normalized by
subtracting the optical density measured in the lateral hypothala-
mus next to the SCN. For each experiment, 2 animals per genotype
were used and 4 to 9 adjacent SCN sections per animal were ana-
lyzed. Relative RNA abundance values were calculated by defining
the highest wild-typemean value of each experiment as 100%. For
statistical analysis, two-way ANOVA with Bonferroni post-test
(GraphPad Prism software) was performed.
In Vitro Electrophysiology
The multiunit electrical activity rhythms of SCN neurons were re-
corded as described previously.18 In short, brains of WT, Fmr1 KO,
and Fmr1/Fxr2 double KO mice were rapidly dissected from the
skull at the same Zeitgeber times (1.7 hr to 2.4 hr after lights
on). Coronal hypothalamic slices that contained the SCN were
sectioned and transferred to an interface chamber. Slices were
oxygenated with humidified 95% O2/5% CO2 and perfused with
artificial cerebrospinal fluid (ACSF) at 35!C. We used one slice
per animal and attempted simultaneous recordings of multiunit
neuronal activity from the dorsal and ventral SCN with two
stationary electrodes.
Northern Blot Analysis
Liver total RNA was isolated by guanidinium isothiocyanate ex-
traction and CsCl centrifugation19 from adult wild-type (6- to
10-month-old), Fmr1mutant, Fxr2mutant, and Fmr1/Fxr2 double
mutant mice. These animals were maintained in 12:12 LD cycle
for 2 weeks and then released into DD for at least 24 hr. For all
northern blot analyses, 25 mg of total RNA was separated on
1.2% agarose-formaldehyde gels and transferred to nylon mem-
branes. The UV crosslinked membranes were hybridized with
32P-labeled cDNA probes for Bmal1, Clock, Per1, Per2, Cry1,
Npas2, andActin according to the instructions of themanufacturer
(BD Biosciences). To calculate relative RNA abundance, optical
densities of Bmal1, Clock, Per1, Per2, Cry1, andNpas2 hybridization
were divided by densities from Actin hybridization to the same
blot. Normalized values were then averaged for the blots prepared
from different sets of RNA samples.
Real-Time PCR
The same RNA isolated for northern blot analysis was also used for
real-time PCR analysis. To prepare cDNA, 1–3 mg total RNA was re-
verse-transcribed with random primers at a final concentration of
3 mM MgCl2, 75 mM KCl, and 50 mM Tris-HCl (pH 8.3), 1 mM
each of dNTPs, 10 units of RNase inhibitor, and 100 units of Super-
script II Rnase H"reverse transcriptase (Invitrogen). The reaction
mixture was incubated at 37!C for 60 min. Real-time PCR was
performed with the ABI PRISM 7000 Sequence Detector System
(SDS) (Applied Biosystems) and MicroAmp optical 96-well plates
(Applied Biosystems). Gene expression assays were performed
with commercially available Pre-made TaqMan Gene Expression
assays for eight genes. The specific Pre-made TaqMan Gene Ex-
pression assays used in this study were: Bmal1 (Applied Biosys-
tems, Assay ID: Mm00500226_m1), Clock (Mm00455950_m1),
Per1 (Mm00501813_m1), Per2 (Mm00478113_m1), Cry1
(Mm00514392_m1), and Npas2 (Mm00500848_m1). Eukaryotic
18S rRNA (Applied Biosystems 4333760T) was used as endogenous
control. The thermocycling profile for all PCR reactions began
with 1 cycle of 2min at 50!C and 10min at 95!C andwas followed
by 40 cycles of 15 s at 95!C and 1 min at 60!C. All samples were
run in triplicate.
Dual Luciferase Reporter Assays
Transient transfection was carried out with the Lipofectamine2000
reagent (Invitrogen) according to the manufacturer’s instructions.
In brief, 1 3 105 HeLa cells were seeded in each well of a 24-well
tissue culture plate. The cells were incubated until 85%–90% con-
fluence. Cells in each well were transfected with 10 ng of the
mPer1-luc or 40 ngmPer2-luc reporter construct. Expression vectors
for BMAL1, CLOCK, NPAS2, PER1, PER2, CRY1, FMR1, and FXR2
were cotransfected respectively. The renilla luciferase reporter
pRL-TK plasmid (Promega) was cotransfected as an internal con-
trol. The pcDNA3.1 (Invitrogen) vector was used to bring the total
amount of plasmid DNA to 0.8 mg/well. Transfection was done
with Lipofectamine2000 reagent. After transfection for 18 hr, cells
were collected and lysed and the firefly and renilla luciferase activ-
ity were measured with Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s instructions with
a TD-20e luminometer (Turner designs).
Results
Fmr1 or Fxr2 KO Mice Display a Shorter Free-Running
Period of Locomotor Activity in DD
To determine whether mutations in the fragile X-related
protein family alter circadian behavior, we measured the
circadian wheel-running activity of Fmr1 knockout (Fmr1
KO) mice, Fxr2 knockout (Fxr2 KO) mice, and of their
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wild-type (WT) littermates individually in circadian activ-
ity-monitoring chambers. Mice were initially maintained
in a 12 hr light:12 hr dark (12:12 LD) cycle for 2 weeks to
establish entrainment. After release in constant darkness
(DD), the WT animals showed a free-running period (tau
or t) of slightly less than 24 hr (t ¼ 23.885 0.05; n ¼ 12)
(Figure 1A). Fmr1 and Fxr2 knockout mice displayed signif-
icantly shorter circadian periods than their WT littermates
in DD (t¼ 23.715 0.06, p < 0.01; n¼ 18; and t¼ 23.565
0.05, p < 0.01; n¼ 28; respectively) (Figures 1B and 1C; for
all tau values, see Figure S1A available online). These find-
ings suggest that FMRP and FXR2P affect the period length
of the circadian system. Under LD conditions, Fmr1 and
Fxr2 knockout mice were entrained by light (Figures 1B
and 1C), suggesting that a deficiency in either gene alone
does not produce a detectable loss of entrainment of loco-
motor activity.
Fmr1/Fxr2 Double KO and Fmr1 KO/Fxr2
Heterozygous Mice Exhibit a Loss of Rhythmic
Activity in Both LD and DD
Because Fmr1 knockout mice express FXR2P at normal
levels (and vice versa), functional redundancy may blur
phenotypic outcomes in single KO animals. It was of in-
terest, therefore, to examine Fmr1/Fxr2 double knockout
mice, which are viable and do not exhibit major physical
defects.20 Unexpectedly, the locomotor activity patterns
of these double mutant animals not only exhibited a strik-
ing and complete loss of circadian rhythm in constant
darkness but were also arrhythmic under LD cycles (Figures
F igure 1. Representat ive Locomotor Act ivi ty Records of Wild-Type, Fmr1 KO, Fxr2 KO, and Fmr1 /Fxr2 Double KO Mice
(A) Representative locomotor activity records of WT mice.
(B) Representative locomotor activity records of Fmr1 KO mice.
(C) Representative locomotor activity records of Fxr2 KO mice.
(D–F) Representative locomotor activity records of Fmr1/Fxr2 double KO mice. Activity records are double-plotted, so that 48 hr is shown
on each horizontal trace with a 24 hr day presented both beneath and to the right of the preceding day. Times of activity are indicated by
black vertical marks. All records show activity in wheel running activity during exposure to a 12:12 light/dark cycle and after release into
constant darkness (as indicated by the LD/DD in the margin). The slope of the line (in red) aligned with the points of onset of activity on
a 24 hr scale plot reflects the period length in DD. The open and dark rectangles at the top of the figure indicate the LD cycle during
entrainment.
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1D–1F, n ¼ 12; for more samples from double KOmice un-
der LD conditions, see Figures S2A–S2D). Chi-square perio-
dogram analysis in LD for double knockout mice showed
no measurable circadian rhythm (Figures S2E–S2H). Inter-
estingly, Fmr1 knockout mice that were heterozygous for
the Fxr2 mutation (n ¼ 8) also demonstrated wheel-
running patterns that were largely comparable to double-
knockout mice (Figures S2I–S2P), with weakly cyclical
activity in LD that does not appear to be synchronized to
the 24 hr period. Apparently, in the absence of FMR1,
half normal levels of FXR2 are inadequate to establish en-
trainment in the LD cycle. Because the average levels of
wheel-running activity did not differ significantly (p >
0.05 by one-way ANOVA) among the four genotypes in
DD (wheel rotations per day for WT, Fmr1, Fxr2, and dou-
ble knockout mice are 26,512 5 2,898; 27,924 5 2,378;
26,735 5 1,836; and 23,980 5 2,798, respectively), the
absence of a circadian rhythm cannot be explained by
a change in total activity.
Our behavioral experiments demonstrate that disrup-
tion of either of the two fragile X mental retardation genes
results in alterations of circadian period, and combined
disruption of both results in arrhythmicity in behavior.
Light and visual perception in double KO mice are
normal20 and no abnormalities could be detected in the
eyes of these animals by histology (data not shown). These
results indicate that FXRPs function in the mammalian
circadian clock or act downstream in the control of
activity.
Molecular Analysis and In Vitro Electrophysiological
Studies Suggest Normal SCN Function
in the Fmr1/Fxr2 Double KO Mice
To investigate whether the behavioral differences between
the three knockout strains and their WT littermates might
be due to a defect in the central circadian pacemaker, we
examined clock gene expression in the suprachiasmatic
nucleus (SCN) of the brain. Figure 2 illustrates expression
of clock gene mRNAs (Per1, Per2, Bmal1, and Cry1) in the
mouse SCN by in situ hybridization. The expression of
Per1, Per2, Bmal1, and Cry1 was rhythmic in the SCN
over 24 hr in constant darkness (Figure 2). Significant
quantitative differences were observed between genotypes.
For example, Fmr1/Fxr2 double knockout animals showed
an increased level of Cry1 expression at CT12, which coin-
cides with the predicted time of light off (Figure 2D). None-
theless, the overall pattern of clock gene expression in the
SCN appears unchanged between animals of different ge-
notypes. We also investigated the electrical activity of the
SCN pacemaker of WT, Fmr1 KO (n ¼ 6), and Fmr1/Fxr2
double KO (n ¼ 7) mice. Electrical activity is controlled
by the core clock and serves as a major output signal of
the SCN. We found that the SCN electrical activity shows
high amplitude circadian rhythmicity in WT (data not
F igure 2. Expression Analysis of Wild-Type, Fmr1 KO, Fxr2 KO, and Fmr1/Fxr2 Double KO under DD Condit ions in SCN
In situ hybridization results for brains isolated from WT and the three knockout genotypes sacrificed at four different time points for Per1
(A), Per2 (B), Bmal1 (C), and Cry1 (D) mRNA levels of Per1, Per2, Bmal1, and Cry1 were quantified and normalized. Graphs illustrate
the relative transcript level of these four genes. The largest value of WT is normalized to 100%. Error bars indicate the SEM. *p < 0.05,
**p < 0.01, ***p < 0.001. CT, circadian time.
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shown), Fmr1 KO (Figure 3A), and Fmr1/Fxr2 double KO
(Figures 3B–3D) mice, with no significant differences in
peak time (p > 0.2). Preparation of slices 12 hr out of phase
from Fmr1/Fxr2 double KO animals results in similar peak
time (data not shown). Our molecular and in vitro electro-
physiological data suggest that the SCN pacemaker is in-
tact in knockout animals and that behavioral differences
observed between wild-type and Fmr1 KO, Fxr2 KO, and
Fmr1/Fxr2 double KO animals are unlikely to result from
a deficiency in the SCN but could be caused by a deficiency
downstream of the SCN pacemaker.
The Cyclical Patterns of Abundance of Several Core
Clock Component mRNAs Are Altered in the Liver
of Double KO Mice
When we examined the mRNA levels in the liver, which is
probably the best described peripheral clock in mammals,
we observed a substantial change in clock gene expression
in knockout animals. Expression of Bmal1 in the livers of
double knockout mice is decreased at CT0 (Figures 4A,
4B, and 5A; Figures S3A and S3G). Compared to WT mice,
mPer1 expression in the liver of Fxr2 and Fmr1/Fxr2 double
mutants is significantly increased at CT6 (p < 0.01 for both
genotypes, Figures 4A, 4B, and 5C; Figures S3C and S3G). It
is also notable that the distributions of levels of mPer1 ex-
pression are much wider at CT6 and CT12 in the liver of
Fxr2 and Fmr1/Fxr2 double knockout mice (Figure 5C;
Figure S3C). mPer2 expression in the liver peaks approxi-
mately 6 hr earlier in Fmr1/Fxr2 double mutants compared
to Fmr1 knockout or WT animals (Figures 4A, 4B, and 5D;
Figures S3D and S3G). Similar to mPer1, the variations of
mPer2 expression levels at CT6 in the liver of Fxr2 and
Fmr1/Fxr2 double knockout mice are much more broad
than those in WT animals (Figure 5D; Figure S3D). The ex-
pression of Cry1 is significantly increased at CT12 in the
F igure 3. Representat ive Recordings of SCN Electrical
Act ivi ty in Fmr1 KO and Fmr1/Fxr2 Double KO Mice
(A) Representative recordings of SCN electrical activity in Fmr1
KO mice.
(B–D) Representative recordings of SCN electrical activity in
Fmr1/Fxr2 double KO mice. The electrical activity traces are
individual examples of neuronal ensemble recordings. The
open and dark rectangles at the top of the figure indicate the
LD cycle to which the animals were entrained before slice prep-
aration, and time is indicated on the x axis. The electrical
activity is counted per 10 s and presented on the y axis.
MUA, multiunit electrical activity.
livers of both double and either of the single KO mice
(Figures 4A, 4B, and 5E; Figures S3E and S3G). Clock,
which does not cycle in WT animals, was not signifi-
cantly altered in the livers of the mutants (Figures 4A,
4B, and 5B; Figures S3B and S3G).
Npas2, a transcription factor that is highly similar to
Clock, heterodimerizes with Bmal1 and activates Per
transcription.21,22 BecauseClock expressionwas indistin-
guishable between WT and mutants, we tested the expres-
sion of Npas2 transcript in the liver (Npas2 expression can-
not be detected by in situ hybridization in the SCN). Npas2
expression in Fmr1 mutants is similar to that in WT. How-
ever, Npas2 expression in Fxr2mutants is slightly increased
at CT18 and significantly decreased at CT0. In double mu-
tants, Npas2 expression peaks at CT18, whereas it peaks at
CT0 in WT controls (Figures 4A, 4B, and 5F; Figures S3F
and S3G). This indicates that in the absence of Fxr2, Npas2
expression is altered and that Fmr1 has an additive effect
on Npas2 cycling. These data suggest that the loss of FMRP,
FXR2P, or both affects peripheral circadian clock function.
FXR2P Alone or FMRP and FXR2P Together Can
Increase PER1- or PER2-Mediated BMAL1-NPAS2
Transcriptional Activity in a Dose-Dependent Manner
Todeterminewhether FMRPandFXR2Pcandirectly regulate
clock gene expression, we performed a luciferase reporter
assay in HeLa cell transfection assays. Initial studies showed
that addition of mPER2 enhanced BMAL1-NPAS2-depen-
dent transcription from either mPer1 or mPer2 promoter as
previouslydescribed.23CoexpressionofFXR2Por the combi-
nation of FMRP and FXR2P together significantly enhanced
the mPER2-induced BMAL1-NPAS2 transcriptional activ-
ity from both promoters (Figures 6A and 6B). Similarly,
mPER1-induced BMAL1-NPAS2 transcription from the
mPer1 promoter is further activated by FXR2P or FMRP and
FXR2P together (Figure 6C). Furthermore, this effect on tran-
scriptional stimulationwas dependent on the dose of FXRPs
(Figures S5A and S5B), which agrees with the observations
that FMRP functions in a dose-dependent manner in flies,
mice, and human patients.13,24,25 However, coexpression
of FMRP or FXR2P or both together was not found to influ-
ence CRY1 repression of BMAL1-NPAS2 stimulation (Figures
S4A and S4B). Interestingly, similar transfection studies with
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BMAL1-CLOCK showed no stimulation by either FMRP or
FXR2P or by both together (data not shown). Our data indi-
cate that FMRP and FXR2P have direct influence on themo-
lecular clock feedback loop and that these effects are medi-
ated by the BMAL1-NPAS2 rather than the BMAL1-CLOCK
complex. Based on these findings and on our observations
F igure 4. Expression Analysis of Wild-Type, Fmr1 KO, Fxr2 KO, and Fmr1 /Fxr2 Double KO Mice under DD Condit ions in Liver
(A) Northern blotting results on liver tissues of WT and three different knockout mouse genotypes sacrificed at four different time points.
The probes are indicated on the right. Rehybridization of the same filter with an actin probe was used to control for loading and RNA
integrity. Representative results are shown from one out of four sets of WT, three sets of Fmr1 KO, four sets of Fxr2 KO, and five sets
of Fmr1/Fxr2 double KO mice. Each set of animals represents an independent experiment.
(B) RNA levels of Bmal1, Clock, Per1, Per2, Cry1, and Npas2 were quantified and normalized in reference to actin mRNA levels. The largest
value of WT is normalized to 100%. Graphs illustrate the relative transcript level of these six genes. Error bars indicate the SEM. *p < 0.05,
**p < 0.01.
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that Npas2 expression is altered significantly in the livers of
Fxrmutant animals, we propose thatNPAS2 plays an impor-
tant role in the effects of the fragile X gene family on periph-
eral circadian oscillators and behavioral activity patterns.
Discussion
Circadian rhythmicity is a fundamental biological phe-
nomenon in living organisms. Among animals, the fruit
F igure 5. Expression Analysis of Four Sets of Wild-Type, Three Sets of Fmr1 KO, Four Sets of Fxr2 KO, and F ive Sets of Fmr1 /Fxr2
Double KO Mice under DD Condit ions in Liver
RNA levels of Bmal1 (A), Clock (B), Per1 (C), Per2 (D), Cry1 (E), and Npas2 (F) were quantified and normalized in reference to actin mRNA
levels. The data on relative mRNA abundance were averaged across different time points. Error bars indicate the SEM.
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fly and the mouse have provided the most information on
themechanism of central circadian pacemakers. These spe-
cies’ clocks share conserved gene products, although there
are significant differences between the explanatory models
for maintenance of rhythmicity.26 In the fly, loss-of-func-
tion mutations of the dfmr gene have been shown to alter
circadian behavior without detectably affecting the func-
tion of the central pacemaker, suggesting a role for dfmr
in circadian output.12,13 In the mouse, CLOCK, BMAL1,
PER, and CRYare core components of the circadian oscilla-
tory mechanisms. The active CLOCK-BMAL1 complex
drives expression of numerous genes including PER and
CRY, whereas PER and CRY repress CLOCK-BMAL1 tran-
scriptional activities and therefore form a feedback regula-
tion loop.27,28 Regulation of CLOCK-BMAL1 activity is
central to the mammalian clock. The appropriate delay be-
tween the activation and repression of transcription main-
tains the daily oscillations of clock proteins and gives the
clock a ~24 hr period.29 Here, we report a function for the
Fmr1 and Fxr2 genes in circadian behavior and clock gene
expression in the liver ofmice. Thedramatic circadianactiv-
ity phenotype found in Fmr1/Fxr2 double KO mice is
unprecedented, demonstrating a significant role of those
genes in clock function or output. The alterations to clock
genemRNAs in the liver, butnot in themaster clock, suggest
that FMRP and FXR2P are acting downstream of the circa-
dian pacemaker in mammals. CLOCK and NPAS2 have
been shown to have partially redundant functions in the
SCN, with CLOCK having a dominant role.30 Our transfec-
tion data would suggest that the FXR proteins exert effects
on NPAS2/BMAL1 complex rather than CLOCK/BMAL1.
Thus, it is not surprising that the SCN is less affected than
the liver in Fxr mutant animals. The differences between
the SCN and liver of Fxrmutant mice suggest examination
of the roles of FMRP and FXR2P in mice with mutations in
Clock and/or Npas2. Intriguingly, animals lacking both
Clock and Npas2 show rhythmic activity in LD,30 whereas
Fmr1/Fxr2 double knockouts are arrhythmic.
It is worth while to note that in addition to FMRP and
FXR2P, FXR1P, another member of FMR1 gene family, may
play a compensatory role in the absence of Fmr1, Fxr2, or in
Fmr1/Fxr2doubleknockoutmice.Becauseof theearlypostna-
tal death of Fxr1 knockoutmice, a conditional Fxr1 knockout
model was produced.31 These mice exhibit muscle defects,
but the generation of Fmr1/Fxr1/Fxr2 triple mutant mice
should providemore information onpotential functional in-
teractions in circadian clock regulation andmay offer amore
direct comparison to the Drosophila loss-of-function model,
where a single FMR1-like protein may perform many of the
functions distributed among the three mammalian genes.
The neural connections between the SCN and other parts
of the nervous system are important for the control of
F igure 6. Upregulat ion of BMAL1-NPAS2-Mediated Transcrip-
t ion by FMR1 and FXR2 in the Presence of mPER1 or mPER2
(A) Upregulation of BMAL1-NPAS2-mediated transcription on
mPer1 promoter by FMR1 and FXR2 in the presence of mPER2.
(B) Upregulation of BMAL1-NPAS2-mediated transcription on
mPer2 promoter by FMR1 and FXR2 in the presence of mPER2.
(C) Upregulation of BMAL1-NPAS2-mediated transcription on
mPer1 promoter by FMR1 and FXR2 in the presence of mPER1.
HeLa cells were cotransfected with the reporter construct mPer1-
luc or mPer2-luc and control reporter construct Renilla luciferase
encoding plasmids PRL-TK and various combinations of expression
construct (Material and Methods). Luciferase activity in samples
transfected with reporter constructs only is adjusted as 1.0. Error
bars indicate the SD (n ¼ 4).
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circadian rhythms in the central nervous system.32 Interest-
ingly, it has been shown that the absence of FMRP causes ab-
normal neurotransmitter signaling, which could be respon-
sible forneurological deficiencies in fragileX syndrome.33,34
It is possible, therefore, that the loss of FMRP and FXR2P
results in arrhythmicity resulting from inappropriateneuro-
nal communication within the central nervous system.
A link between abnormal sleep patterns andmental retar-
dation has been suggested from several other mental retar-
dation disorders,35 including Smith-Magenis syndrome,36
where the RAI1 transcriptional activator appears to be ama-
jor contributor to phenotype. To our knowledge, our data
provide the first molecular evidence to connect a protein
involved in cognitive ability with the circadian system. Al-
though sleep abnormalities are a frequent feature in males
with fragile X syndrome, the level of severity varies signifi-
cantly in different patients.2,14 Our data that in the absence
of Fmr1, losinghalf normal levels of Fxr2 can result in loss of
light-dark entrainment suggest that genetic variation in
Fxr2 could be responsible for the variability of sleep prob-
lems in fragile X population. Sleep abnormality could add
to the phenotype; several lines of evidence suggest a role
for normal sleep in learning and memory.37 The close
association between the circadian system and the timing
of sleep and wakefulness together with the typical distur-
bances of circadian behavior and sleep in fragile X syn-
drome opens up a new perspective for the investigation
and treatment of patients suffering from this disorder.
Supplemental Data
Five figures are available at http://www.ajhg.org/.
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Figure S1. Distribution of Free-Running Period of Locomotor Activity Rhythm in DD of Wild-Type, Fmr1 
KO, and Fxr2 KO Mice 
The data on free-running period (tau) were averaged across different genotypes. Error bars indicate the 
standard error of the mean (SEM) 
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Figure S2. Representative Locomotor Activity Records of Fmr1/Fxr2 Double KO and Fmr1 KO/Fxr2 
Heterozygous Mice 
(A–D) Representative locomotor activity records of Fmr1/Fxr2 double KO mice. Activity records are 
double-plotted, so that 48 hr is shown on each horizontal trace with a 24 hr day presented both beneath and 
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to the right of the preceding day. Times of activity are indicated by black vertical marks. All records show 
activity in wheel running activity during exposure to a 12:12 light/dark cycle. The open and dark rectangles 
at the top of the figure indicate the LD cycle during entrainment.  
(E–H) Chi-square periodogram analysis over LD cycle shown in actograms, corresponding to the activity 
recording in (A)–(D), respectively.  
(I–L) Representative locomotor activity records of Fmr1 KO/Fxr2 heterozygous mice.  
(M–P) Chi-square periodogram analysis over LD cycle shown in actograms, corresponding to the activity 
recording in (I)–(L), respectively. 
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Figure S3. Expression Analysis of Wild-Type, Fmr1 KO, Fxr2 KO, and Fmr1/Fxr2 Double KO Mice 
under DD Conditions in Liver 
Amount of Bmal1 (A), Clock (B), Per1 (C), Per2 (D), Cry1 (E), and Npas2 (F) mRNA expression was 
quantified by real-time PCR and calibrated in reference to 18S RNA levels. The data on relative mRNA 
abundance were averaged across different time points. Error bars indicate the SEM. Graphs of (G) illustrate 
the relative transcript levels of these six genes. The largest value of wt is normalized to as 100%. *p < 0.05, 
**p < 0.01. 
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Figure S4. Regulation of BMAL1-NPAS2-Mediated Transcription by FMR1 and FXR2 in the Presence of 
CRY1 
Reporter assay studies used mPer1 promoter (A) or mPer2 promoter (B). HeLa cells were cotransfected 
with the reporter construct mPer1-luc (A) or mPer2-luc (B), and control reporter construct Renilla 
luciferase encoding plasmids PRL-TK and various combination of expression construct (Material and 
Methods). Luciferase activity in samples transfected with reporter constructs only is adjusted as 1.0. Error 
bars indicate the SD (n = 4). 
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Figure S5. Regulation of mPER1- or mPER2-Induced BMAL1-NPAS2-Mediated Transcription by 
Different Dose of FMR1 and FXR2 Based on mPer1 Promoter or mPer2 Promoter 
HeLa cells were cotransfected with the reporter construct mPer1-luc or mPer2-luc, control reporter 
construct PRL-TK and mPER2 (A) or mPER1 (B) and various combination of expression construct 
(Material and Methods). Luciferase activity in samples transfected with reporter constructs only is adjusted 
as 1.0. Error bars indicate the SD (n = 4). **p < 0.01. B, BMAL1; N, NPAS2; P1, mPER1; P2, mPER2. 
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Production of TNF-! and IL-1 in infectious and autoimmune dis-
eases is associated with fever, fatigue, and sleep disturbances,
which are collectively referred to as sickness behavior syndrome. In
mice TNF-! and IL-1 increase nonrapid eye movement sleep. Be-
cause clock genes regulate the circadian rhythm and thereby
locomotor activity and may alter sleep architecture we assessed
the influence of TNF-! on the circadian timing system. TNF-! is
shown here to suppress the expression of the PAR bZip clock-
controlled genes Dbp, Tef, and Hlf and of the period genes Per1,
Per2, and Per3 in fibroblasts in vitro and in vivo in the liver of mice
infused with the cytokine. The effect of TNF-! on clock genes is
shared by IL-1", but not by IFN-!, and IL-6. Furthermore, TNF-!
interferes with the expression of Dbp in the suprachiasmatic
nucleus and causes prolonged rest periods in the dark when mice
show spontaneous locomotor activity. Using clock reporter genes
TNF-! is found here to inhibit CLOCK-BMAL1-induced activation of
E-box regulatory elements-dependent clock gene promoters. We
suggest that the increase of TNF-! and IL-1", as seen in infectious
and autoimmune diseases, impairs clock gene functions and causes
fatigue.
behavior ! circadian rhythms ! cytokines ! innate immunity
In microbial infections, host defense mechanisms activate theinnate and adaptive arms of the immune response. Microbial
recognition byToll-like receptors (TLR) expressed bymacrophages
and dendritic cells leads to the activation of signal transduction
pathways with induction of various genes including IL-1, TNF-!,
IL-6, and IFN-!/" (1–3). These cytokines mediate the acute-phase
response, which is a systemic generalized reaction characterized by
fever, fatigue, and weight loss, an increase in the number of
neutrophils, and the induction of synthesis of acute-phase proteins
in the liver with increased haptoglobin, antiproteases, complement
components, fibrinogen, ceruloplasmin, and ferritin in the blood
(4). An acute phase response with a dose-dependent state of
lethargy and severe fatigue has been described in cancer patients
treated with TNF-! (5). A link between production of TNF-! and
daytime fatigue has also been suggested in rheumatoid arthritis
(RA) and in the obstruction sleep apnea syndrome (OSAS).
Inhibition of TNF-! by soluble TNF-receptor p75 improves dis-
abling fatigue in patients with RA (6). A TNF-!-308 (A-G)
single-nucleotide polymorphism and elevated TNF-! serum levels
have been described in OSAS (7, 8). Moreover, neutralization of
TNF-! reduces daytime sleepiness in sleep apneics (9). Direct
effects of TNF-! on spontaneous sleep are also shown in animal
studies. i.v., i.p., or intracerebroventricular injections of TNF-! or
IL-1 enhance nonrapid eye-movement (NREM) sleep (for reviews,
see refs. 10 and 11). This increase in NREM sleep is independent
of the fever-inducing capacity of these cytokines (12). Although
there is good evidence for TNF-! and IL-1 as mediators of altered
sleep–wake behavior, the underlying mechanisms remain elusive.
The regulation of sleep depends on a circadian control and a
homeostatic drive (13, 14). The circadian influence is provided
by the suprachiasmatic nuclei (SCN) of the hypothalamus being
entrained by light stimuli to the environment. This self-
sustaining circadian pacemaker uses a molecular mechanism
similar to the one used in subsidiary oscillators present in any
type of cell in the organism. The molecular clockwork involves
the transcriptional repressor genes Per1, Per2, Cry1, and Cry2, as
well as the transcriptional activators Bmal1 and Clock. The
heterodimerized transcription factor BMAL1:CLOCK activates
Per and Cry gene transcription by binding to E-box mo-
tives in their promoters. PER and CRY proteins inhibit
BMAL1:CLOCK complexes, thereby inhibiting their own gene
expression. This feedback-loop mechanism generates circadian
oscillations of Per and Cry expression. The same positive and
negative regulatory components also govern the rhythmic ex-
pression of the nuclear orphan receptor Rev-Erb!, which in turn
represses the transcription of Bmal1 through direct binding to a
REV-ERB! response element in the Bmal1 promoter. Thereby,
REV-ERB! interconnects the cyclic expression of positive- and
negative-loop members (for reviews, see refs. 15 and 16). The
targeted inactivation of Bmal1 showed that this gene is indis-
pensable for the maintenance of circadian functions (17). Clock-
deficient mice show robust circadian patterns of locomotor
activity with period lengths shortened by only 20 min; Dbp
mRNA rhythm, however, was severely blunted in both the SCN
and the liver (18). The deletion of the clock-controlled genes
(CCG) PAR bZip transcription factors Dbp, Tef, and Hlf only
moderately affects the circadian clock but leads to pronounced
disturbances of locomotor activity. In the present study, our
objective was to examine (i) whether and how TNF-! influences
the circadian timing system and modulates the expression of
clock genes and CCGs, and (ii) whether TNF-! affects locomo-
tor activity, rest time, and periodicity in mice.
Results
Suppressed Expression of Clock Genes in TNF-!-Treated Synchronized
Fibroblasts. To determine whether TNF-! interferes with circa-
dian gene expression, we used NIH 3T3 fibroblast cultures
synchronized by a 2-h serum shock; this system elicits a well
described circadian expression of central clock genes and CCGs
for at least three cycles (19). We analyzed serum shocked
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fibroblasts challenged over time with or without TNF-! (10
ng/ml). RNA was extracted every 4 h thereafter up to Zeitgeber
time (ZT) 36 and analyzed by using quantitative real-time
RT-PCR methods. Within the first 12 h, the course of the
examined clock gene expression was not altered by TNF-!
treatment. However, around the peak (ZT 20–28), TNF-!
strikingly suppressed the expression of the central clock genes
Per1, Per2, and Per3 and of the CCGs Dbp, Tef, and Hlf. Peak
expression of Rev-erb! mRNA at ZT 20 was slightly increased,
whereas Bmal1 expression was not affected by TNF-!. Clock
expression was slightly increased. For all genes, TNF-! did not
affect the phases but rather attenuated the amplitude of expres-
sion (Fig. 1A). Therefore, we assessed the extent of clock gene
expression at their main peak at ZT 24. TNF-! induced a
significant reduction of gene expression for Per1, Per2, Per3,Dbp,
Tef, and Hlf genes. Rev-Erb! expression, as assessed at its peak
of expression at ZT 20, remained unchanged by TNF-!, as did
Clock (Fig. 1B). We extended the time of observation over a
second circadian cycle and analyzed rhythmic expression up to
60 h. In this, emphasis was placed on Dbp expression, because its
amplitude was the most affected by TNF-!. Rhythmicity and
period length of Dbp expression were not changed by TNF-!, but
its amplitude was severely suppressed at both peaks (Fig. 1C). To
determine whether the TNF-!-mediated suppression is revers-
ible, we washed out TNF-! after the first cycle (at ZT 24) and
analyzed the second peak at ZT 48. By washing out TNF-!, the
second peak of expression of Per1 and Per2 was restored, and
Dbp expression increased compared with the control where
TNF-! still led to reduced peak expression. The expression of
Clock was not affected when extending the time of TNF-!
treatment to 48 h (Fig. 1D). Moreover, the suppression of Dbp,
Per1, and Per2 gene expression in synchronized NIH 3T3 fibro-
blasts is clearly dose-dependent, being most significantly af-
fected with concentrations !1 ng/ml TNF-!. The expression of
Clock remained unchanged irrespective of the dose of TNF-!
(Fig. 1E).
IL-1", but Neither IFN Nor IL-6, Shares with TNF-! the Effect to
Down-Regulate Clock Genes. Besides TNF-!, other cytokines are
produced by TLR-activated macrophages and dendritic cells that
have been implicated in the sickness behavior syndrome, namely
the proinflammatory cytokines IL-1, IL-6, and IFN-# and type
I IFN cytokines IFN-! and -" (20). Therefore, we examined
whether the effect of TNF-! on clock genes is a unique property
of TNF-! or is shared by other cytokines. Besides TNF-!, also
IL-1" suppressed the expression of both, Dbp and Per3 (Fig. 2).
The expression of Dbp, Per1, Per2, and Per3 was not inhibited by
treatment of synchronized fibroblasts with IL-6 and IFN-!.
IFN-# induced a significant, albeit minor, suppression of Dbp
expression.
TNF-! Interferes with E-Box-Dependent Transcription of Clock Genes.
Circadian transcriptional activation of Per genes and of the PAR
bZip transcription factor genes Dbp, Tef, and Hlf is thought to
depend on the binding of the heterodimer BMAL1:CLOCK to
the canonical or noncanonical E-box, a basic helix–loop–helix
transcription factor-binding site ideally harboring the sequence
CACGTG (21). In our study, TNF-! affected suppression only
of the transcription of those clock genes harboring an E-box
upstream of the transcription initiation site (Per genes and Dbp,
Tef, and Hlf ). No suppression was observed on Bmal1 and Clock
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Fig. 1. TNF-! impairs expression of clock genes in synchronized NIH 3T3
fibroblasts. (A) TNF-! attenuates circadian Per1/2/3 and PAR bZIP family (Dbp,
Tef, and Hlf ) gene expression. After serum shock (ZT 0–2), cells were kept in
serum-free medium with TNF-! (10 ng/ml; open circles) or without the cyto-
kine (filled circles) and analyzed every 4 h with quantitative real-time RT-PCR.
Results are shown as x-fold variations to nonsynchronized fibroblast cultures
at ZT 0; three independent experiments; mean values " SD. (B) Per and PAR
bZIP family genes are significantly down-regulated at the 24-h peak (TNF-!:
gray bars; controls: black bars), whereas Clock and RevErb! are not affected.
Expression of Rev-Erb! was assessed at its peak at ZT 20. Data show one
representativeexperimentdone in triplicate (mean" SD)of fourexperiments.
(C) The amplitudeofDbp expression in serum-shockedNIH3T3fibroblastswas
attenuated during 60 h in the presence of TNF-! (open circles) compared with
controls (filled circles). (D) Withdrawal of TNF-! after the first peak at ZT 24
shows that the suppression of Dbp, Per1, and Per2 at the second peak at ZT 48
is reversible. After serum shock, cells were treated with TNF-! for 24 h (gray
bars), or for 48 h with or without a withdrawal of TNF-! after 24 h (white and
black bars, respectively). Gene expression was compared with mock-treated
cells at the respective ZT (100% expression). Data show one representative
experiment done in triplicates (mean " SD) of three experiments. (E) The
suppression of the expression of Dbp, Per1, and Per2 in synchronized fibro-
blasts at ZT 24 is dose-dependent being significant (P# 0.005) at doses higher
than 1 ng/ml TNF-!. Data show the mean " SD of three independent exper-
iments performed in triplicates. For BDE, we used the independent-sample t
test; *, P $ 0,05; **, P $ 0,005; ***, P $ 0.0005.
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Fig. 2. Cytokine effects on Dbp, Per1, Per2, and Per3 in NIH 3T3 fibroblasts.
Confluent cells were synchronized with 50% horse serum for 2 h (ZT 0–2).
After serum shock, cells were kept in serum-free medium with TNF-! (10
ng/ml), IL-1" (10 ng/ml), IL-6 (10 ng/ml), IFN-! (10 ng/ml), IFN-# (20 ng/ml) or
without cytokines and analyzed at ZT 24 with quantitative real-time RT-PCR.
Results are shown as percent of expression to noncytokine-treated fibroblast
cultures; one representative experiment of three;mean values of triplicates"
SD; independent sample t test; *, P $ 0,05; **, P $ 0,005; ***, P $ 0.0005.
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expression, their transcription not being E-box-dependent. Thus,
TNF-! may interfere with E-box-mediated transcriptional acti-
vation. To test this hypothesis, we performed transient transfec-
tions of NIH 3T3 cells with luciferase reporter genes under the
control of the native 3- or 1.7-kB promoter sequences of mouse
Per1 and Per3, respectively, and of the 1-kB promoter of Bmal1
(Fig. 3A). Consistent with the gene expression studies, Per1 and
Per3 promoter activity was suppressed after TNF-! administra-
tion but not that of the Bmal1 promoter, which is devoid of E-box
elements (Fig. 3B). To specify the possible effect on E-boxes, we
performed assays using NIH 3T3 cells stably transfected with a
luciferase reporter plasmid consisting of three E-boxes within 2.0
kb of the 5$ f lanking region of the mouse Per1 gene with their
immediate flanking sequence linked together and joined to the
thymidine kinase promoter (22) (Fig. 3A). Again, treatment with
TNF-! reduced luciferase activity by 45%, corresponding to the
basal activity of the basic pGL3-TK vector without E-boxes (Fig.
3C). An E-box reporter construct of the Dbp gene (Dbp-E-
box857; Fig. 3A) that was cotransfected with plasmids expressing
CLOCK and BMAL1 proteins showed expression reduced by
67%, indicating that overexpressed CLOCK and BMAL1 are
still efficiently blocked. In contrast, with the mutated E-box
(ACCAGT instead of CACATG) reporter construct (Dbp-857
mut), the activity was significantly derepressed (Fig. 3D). We
suggest therefore that TNF-! suppresses E-box-mediated tran-
scription of clock genes. Thus, selective down-regulation of clock
genes or CCGs is likely to depend on the presence of E-box
elements in the respective genes.
Reduction of Clock Genes and CCGs in TNF-!-Treated Mice. To assess
the effect of TNF-! on the expression of clock genes in vivo,
C57BL/6 mice were constantly infused with TNF-! (1.5 %g/day
or 0.075 mg/kg per day) via an osmotic minipump inserted s.c. on
the back of the mice over a period of 7 days (see Materials and
Methods). The dose chosen is%10-fold lower than the dose used
to induce a septic shock-like disease in rats (0.7 mg/kg, admin-
istered intravenously) (23). Histopathology revealed no evidence
for TNF-!-induced vascular damage, hemorrhages, or inflam-
mation in the liver, lung, and kidney based on morphological
criteria and on the expression of heme oxygenase (HO-1), a
marker for oxidative stress. Macrophages of mice infused with
TNF-! showed signs of being activated in the liver and kidney
[supporting information (SI) Fig. 6]. We found TNF-! serum
concentrations at 43 ("10.9) pg/ml at day three in TNF-!-
treated mice compared with 10 ("0.8) pg/ml in controls (SI Fig.
7). In mice with experimental septic shock the respective value
for TNF-! exceeds 10 ng/ml (24). In controls, osmotic pumps
were filled with diluent (PBS, 0.1% BSA). Total RNA was
extracted from the liver of mice treated with TNF-! or control;
expression of clock genes was tested at day three at ZT 11.5 and
ZT 15.5 (ZT 0& 6 a.m. lights on, ZT 12& 6 p.m. lights off), when
we encountered maximal inhibition of locomotion (Fig. 5A). As
shown for fibroblasts in vitro, TNF-! also suppressed the ex-
pression of Dbp, Tef and Hlf, and Per3, but not of Bmal1 and
Clock (Fig. 4). Although Per1 and Per2were down-regulated, this
was not significant. However, at a later time point (ZT 15.5),
when Per2 normally reaches its peak of expression, significant
suppression of Per2 was observed (Fig. 4 Lower). In contrast to
the fibroblast data, we found that TNF-! suppressed the expres-
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Fig. 3. TNF-! suppresses E-box-mediated transcription of clock genes. (A)
Schematic representation of the luciferase reporter genes used. mPer1-luc
(3-kb promoter fragment) andmPer3-luc (1.7-kb promoter fragment) contain
promoter sequences upstreamof their genes in the pGL3basic vector. pBmal1-
luc is regulatedbya1-kbpromoter fragmentanda1-kb sequenceof the3$UTR
from mBmal1 gene. E54-TK consists of the three E-boxes of the mouse Per1
gene and their immediate flanking sequences in front of a TK promoter.
DBP-Ebox857-luc contains one of four E-boxes of the Dbp promoter regulat-
ing the activity of a SV40 promoter. (B) Native clock gene promoters bearing
an E-box are affected by TNF-!. Percent luciferase expression of mPer1-luc,
mPer3-luc, and pBmal1-luc transfected NIH 3T3 cells after treatment with 10
ng/ml TNF-! overnight compared with untreated controls (100% luciferase
expression) is shown. (C) E-boxes of mPer1 are affected by TNF-! treatment.
TNF-! significantly reduces E54-TK-dependent luciferase expression but not
pGL3-TK lacking E-boxes and flanking sequences as shown by raw data (RLU,
relative light units; Left) and percent inhibition (Right). (D) The E-box of Dbp
gene at position'857 is repressedby TNF-! evenwhenCLOCKandBMAL1 are
overexpressed. Cotransfection with CLOCK and BMAL1 leads to four to five
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E-box vector (857mut) indicating that the interaction of CLOCK:BMAL1 with
the E-box is functional. Luciferase activity is efficiently suppressed by over-
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Fig. 4. Impaired expression of clock genes in livers of TNF-!-infused mice.
Animals were entrained to a LD cycle during 2 weeks, and their locomotor
activity was constantly monitored via a passive infrared sensor and a running
wheel. Mice were then implanted with osmotic minipumps delivering TNF-!
(light gray bars) or saline as control (dark gray bars). On the third day after the
operation, mice were killed at ZT & 11.5 or & 15.5 (ZT & 0, light on; ZT & 12,
light off). Livers were extracted and gene expression assessed by real-time
PCR. (A) Per1/2/3, RevErb!, and PAR bZip family genes, Dbp, Hlf, and Tef, are
down-regulatedat both timepoints, the suppressionof PARbZip family genes
is highly significant. In contrast to fibroblast data, RevErb! is strongly down-
regulated. Results are shown as percentages relative to the mean of the
control group. One representative experiment of three is shown (n & 6 per
group; Mann–Whitney test. *, P $ 0,05; **, P $ 0,005.)
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sion of Rev-Erb!. TNF-! induced reduction of expression of the
Per genes and of PAR bZip transcription factor genes is likely to
influence the expression of clock output genes. Among the genes
that are positively regulated by DBP is the liver-specific albumin
gene (25). The capacity of TNF-! to interfere with Dbp mRNA
expression is congruent with the observation of a decrease in
albumin serum concentration by 41% in TNF-!-treated mice
compared with controls (SI Fig. 8). TNF-! has already been
described as inhibiting albumin synthesis in liver cells, but the
mechanisms remain elusive (26). Taken collectively, these data
provide evidence that the suppressive role of TNF-! on Dbp is
associated with impaired activation of their target gene. TNF-
!-treated mice also show higher endogenous expressions of
IL-1" and TNF-! in the liver [both genes are well known to be
induced by TNF-! (28)]; the level of expression of these cyto-
kines correlates with each other (SI Fig. 9). Furthermore, the
increased expression of the cytokines in the liver is associated
with a decrease of the CCG Dbp, Hlf, and Tef; the extent of the
decrease of these PAR bZip transcription factors fits to the
TNF-! expression in individual mice (SI Fig. 9).
TNF-! Reduces Dbp Expression in the SCN in the Hypothalamic Region.
To verify whether the effect of TNF-! is sustained across the
blood–brain barrier and reaches the SCN, the expression of Dbp
was quantified. As described above, mice were implanted with
minipumps releasing TNF-! or diluent; mice were killed after 3
days at ZT 6, when peak expression ofDbpwas expected. A slight
((15%) but statistically significant reduction of Dbp expression
(P & 0.003) can be seen by in situ hybridization in the SCN of
TNF-!-treated mice (SI Fig. 10). To verify the time point of the
rhythm, we used Bmal1, which, at peak expression of Dbp, is not
detectable. Indeed, unlike Dbp mRNA-positive cells, Bmal1
transcripts were not identified by in situ hybridization at ZT 6.
TNF-! Reduces Locomotor Activity and Promotes Increased Rest Time
in Mice. The function of TNF-! to interfere with the transcription
of distinct clock genes or CCGs prompted us to evaluate whether
TNF-! alters the circadian rhythm and/or the amount of loco-
motor activity in vivo. The timing and extent of locomotor
activity were assessed with infrared sensors as well as by mon-
itoring running-wheel activity in mice recorded under a 12-h
light/12-h dark (LD) schedule. The surgical procedure led to a
decrease in locomotor activity that lasted for 48 h (infrared; Fig.
5A Upper). However, beside the more pronounced impairment
of locomotor activity on days 1 and 2, TNF-! led also to a severe
suppression of locomotor activity on day 3; on this day, control
mice had attained baseline levels of activity. When running-
wheel activity was assessed, an analogous picture emerged with
maximum inhibition at day 3 (Fig. 5 A Lower and B). At later
time points, especially on days 5 and 6, TNF-! no longer exerted
any effect on locomotor activity. This is most likely due to a
failed release of TNF-! from the pump, because starting at day
4, hemorrhagic necrosis developed at the site of the pump. This
local side effect was noticed when pumps were filled with TNF-!
but not with control solution and has been described in areas of
s.c. injection of TNF-! in mice (3 %g for 5 days) (29). Our results
show that TNF-! leads to a decrease in the total amount of
locomotor activity as measured by a running-wheel and infrared
sensors until day 4 (Fig. 5A). The activity in both groups was still
restricted to the dark period, and highest loss of activity in
TNF-! treated animals can be observed during the second half
of the active period (Fig. 5B). Further, based on these observa-
tions, we chose day 3 to investigate the frequency and duration
of rest episodes during the LD period (SI Fig. 11A). During the
light period, no change was observed. But in the dark period,
when mice are usually active, a significant increase in rest
episodes lasting 6–60 min was detected. As a readout of the
endogenous circadian clock, we assessed locomotor activity in
constant darkness (‘‘free-running condition’’) after implantation
of the minipumps and calculated the period length (&). We
observed no changes in the periodicity of & (SI Fig. 11B). Taken
together, mice treated continuously with TNF-! show reduced
motor activity and more consolidated rest time but no change in
period length under free-running conditions. These findings are
consistent with experiments with fibroblasts showing that the
amplitude of the expression of clock genes and CCGs are
attenuated by TNF-!, rather than their circadian rhythm itself.
Discussion
Whereas the molecular mechanisms provided by clock genes to
maintain the circadian rhythm are becoming increasingly clear,
the potential influences of the immune system on the molecular
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Fig. 5. TNF-! reduces locomotor activity ofmice but does not alter their circadian rest-activity cycles in free running conditions. (A) Reduced locomotor activities
inmicewith constant TNF-! infusions are detected fromdays 1–4. Boxplot showing the changes of locomotor activity for each day afterminipump implantation
(TNF-!, 1.5 %g/day, for 6 days) or saline as control, compared with the baseline (mean of 3 days immediately before the operation). The TNF-!-treated group
is shown as light gray bars and the control group as dark gray bars; circles are outliers, and triangles are extreme values. Six mice per group were analyzed. Data
show one experiment (ANOVA for repeated measures, followed by independent-sample t tests; *, P $ 0.05). The effect of TNF-! to impair locomotor activity
was confirmed at day 3 in two independent experiments. (B) TNF-! reduces locomotor activity in the second half of the dark phase. Actograms (as measured by
infrared and running wheel) show data from six individual mice before and after the minipump insertion. Each line represents one individual mouse per
treatment, 1 day before the implantation of minipumps (baseline, BL) and 3 days after the operation (OP).
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clockwork remain to be explored. Here, we provide evidence
that TNF-! interferes with the expression of clock genes, namely
the Per genes and the PAR bZip genes Dbp, Tef, and Hlf. TNF-!
suppresses the expression of these genes in fibroblasts (and
attenuates their amplitudes) in vitro and in vivo in the liver of
mice infused with this cytokine. That the same genes (with the
exception of RevErb!) are prone to TNF-! stimulation in vitro
compared with in vivo speaks for a rather direct effect of TNF-!,
although we cannot exclude other intermediates involved leading
to the same response. In situ hybridization shows that the s.c.
administration of TNF-! also leads to reduction of Dbp expres-
sion in the central circadian pacemaker, the SCN. Thus, it is
tempting to speculate that TNF-! is likely to reach the SCN via
the blood and to bind to TNF receptor (TNF-R) on neurons. At
least in the hippocampus, both TNF-RI and -RII are expressed
(30). In the present study E-box regulatory elements of clock
genes are found here to play a pivotal role in the effect of TNF-!
to inhibit clock gene expression. First, only clock genes with
E-boxes in their promoter, the PAR bZip genes Dbp, Tef, and Hlf
and the Per genes, are affected by TNF-!, whereas clock genes
devoid of E-boxes such as Clock and Bmal1 are not affected by
TNF-!. Second, mutated E-boxes provide protection of TNF-
!-induced suppression of clock reporter genes. E-boxes are
functionally important components of DNA promoters that
guide the expression of clock genes and thereby influence the
circadian rhythm, including the sleep–wake cycle. Rhythmic
binding of CLOCK and BMAL1 depends on E-boxes and is a
prerequisite for robust waves of gene expression characteristic of
circadian transcription (31, 32).
The effects of TNF-! on clock gene expression also become
apparent when studying clock-dependent genes. Dbp has been
described to mediate transcription of the albumin gene in
hepatocytes (25). Albumin serum concentrations are found here
to be lowered by 41% in TNF-!-treated mice compared with
controls.
Recording of locomotor activity of TNF-!-treated mice shows
more rest episodes during spontaneous activity. In line with the
finding that TNF-! does not alter circadian rhythm in cultured
fibroblasts but rather lowers the extent of expression of distinct
clock genes, TNF-! did not influence period length of the
circadian rhythm under ‘‘free running’’ conditions. Of interest
for the findings presented here are data showing that the
deletion of the Dbp gene in mice results in only a slight reduction
of period length but in a striking impairment of spontaneous
locomotor activity and running-wheel activity (33, 34). Whereas
Tef and Hlf single-knockout mice show an increased period
length, the inactivation of all three genes, Dbp, Tef, and Hlf,
resulted in an unchanged circadian period length (27). Thus, a
normal period length may be due to opposite effects leading to
mutual neutralization of indirect clock gene dysfunction. Besides
lowering the expression of PAR bZip transcription factors,
TNF-! impaired Per1, Per2, and Per3 mRNA. Target disruption
of these genes results in slightly (Per3(/( mice) or more dra-
matically (Per1(/( mice) shortened period lengths or eventually
gives rise to arrhythmic behavior (Per2(/( mice). Taken collec-
tively, TNF-! interferes with the expression of E-box-dependent
clock genes and leads to prolonged rest episodes during spon-
taneous activity of mice.
Sleep architecture in humans is affected by the endogenous
circadian pacemaker, which regulates the timing of the sleep–
wake cycle, presumably by circadian expression of clock genes
(13, 35). Enhanced NREM sleep has been shown in mice treated
with muramyl dipeptides, which activate TLR2 and TLR4 on
macrophages (36, 37). TNF-!, as well as IL-1, is produced by
TLR2- and TLR4-activated macrophages and is well described to
enhance NREM sleep (11, 38, 39). In light of the overlapping
properties of TNF-! and IL-1 on NREM sleep, it is interesting
that our studies show IL-1 to share with TNF-! the inhibitory
effect on expression of the Dbp and Per3 genes in fibroblasts. As
recently outlined, the effects of IL-6 on sleep differs from IL-1
and TNF-!, in that it may also act on systems involved in NREM
sleep but not in REM sleep, which is suppressed by TNF-! and
IL-1 but not by IL-6 (40). In this context, it may be of relevance
that the expression of Dbp is found here not to be affected by
IL-6. Although the expression of Dbp and Per1 is also not
inhibited by IFN-!, IFN-# only slightly interfered with Dbp
expression. This is remarkable, because in mice, the daily
injection of IFN-! or -# has been reported to lower Per1, Per2,
Per3, and Clock after 6 days of treatment (41). The absence of
effects of IFN-! and -# on expression of the Per genes by
synchronized fibroblasts in vitro indicates that IFNs down-
regulate the Per and Clock genes by E-box-independent mech-
anisms or induce production of other clock gene-regulating
factors when mice are treated over a long time period with the
cytokines.
In infectious diseases, TNF-! serves to successfully eliminate the
infectious agent. The function of TNF-! to interfere with the
expression of clock genes, to impair locomotor activity, and to
enhance rest may provide the link between the activation of the
innate immunity and fatigue associated with infectious and auto-
immunediseases, such asmultiple sclerosis,RA, orCrohn’s disease.
In these disorders, both fatigue and elevated TNF-! concentrations
have been described (6, 42, 43). It is still debated whether sleep
changes in infections are beneficial to the host defense. Rabbits
infected with E. coli, Staphylococcus aureus, or Candida albicans
showed an improved prognosis when their sleep duration was
prolonged (44). In this context, it is to be noted that Per2(/( mice
are partially protected from LPS-induced shock (45). During the
TNF-!-induced ‘‘inflammatory clock gene response,’’ the expres-
sion ofPer1,Per2, andPer3 genes and of thePARbZip transcription
factors Dbp, Tef, and Hlf is down-regulated, the locomotor activity
reduced, and rest episodes prolonged. Although this pathway may
induce an adaptive state in infectious diseases, the ‘‘inflammatory
clock gene response’’ may, by inducing fatigue, diminish the quality
of life in autoimmune diseases. Our study will serve to lay an
important foundation for further exploration of the connection
between the TNF-!-induced ‘‘inflammatory clock gene response’’
and the TNF-!-triggered reduction of locomotor activity.
Materials and Methods
Cytokines. Recombinant murine (rm) TNF-!, rm IL-1", and rm
IL-6 were purchased either from Sigma (St. Louis, MO) (in vitro
time course assays) or from Peprotech (London, U.K.) (in vivo
assays); rm IFN-! from Immunotools (Friesoythe, Germany),
and rm IFN-# from Roche (Rotkreuz, Switzerland).
Synchronization of Fibroblasts by Serum Shock. NIH 3T3 fibroblasts
were grown in DMEM (Gibco, Basel, Switzerland) supple-
mented with 10% FBS (PAA Laboratories, Pasching, Austria)
and Glutamax (Gibco). For serum shock, cells were grown to
confluency in 6-cm tissue culture dishes. At time t & 0, the
medium was exchanged by 50% horse serum (Gibco) in DMEM/
Glutamax; after 2 h, the medium was replaced with serum-free
DMEM/Glutamax, with or without TNF-!. At the indicated time
points, tissue culture dishes were washed once with Hanks;
solution, frozen on a layer of liquid nitrogen, and kept at (70°C
until the extraction of whole-cell RNA.
Transfection and Luciferase Assays. Unsynchronized NIH 3T3 cells
were transfected with the following constructs by using Lipo-
fectamine Plus (Life Technologies, Basel, Switzerland) or Trans-
Fectin (Bio-Rad, Hercules, CA) according to the manufacturer’s
protocol: mPer1-luc (46), kindly provided by David Earnest
[Texas A&M, College Station, TX; E54-TK (22)], kindly pro-
vided by Sato Honma (Hokkaido University, Sapporo, Japan);
Bmal1-luc (19), DBP-Ebox-luc and mut Ebox, pCDNA3.1-Clock
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and pCDNA3.1-Bmal1 (47), kindly provided by U. Schibler
(University of Geneva, Geneva, Switzerland); mPer3-luc (48),
kindly provided by P. Sassone-Corsi (IGBMC, Illkirch, France).
As an internal control for transfection efficiency, a GFP con-
struct (pMax-GFP; Amaxa, Cologne, Germany) was cotrans-
fected 1:10.
Twenty-four hours after transfection, the medium was replaced
with serum-free DMEM/glutamax with or without TNF-! (10
ng/ml). After %15 h, cells were lysed by using Passive Lysis Buffer
(Promega, Wallisellen, Switzerland) and enzyme activity was mea-
sured by the Luciferase Assay System (Promega). Bioluminescence
was measured with a Luminometer (Berthold Technologies, Re-
gensdorf, Switzerland) and normalized to transfection efficiency or
protein concentration.
Animal Groups and Locomotor Activity Recording. Seven-week-old
C57BL/6 male mice (Harlan Breeding Laboratory, AD Horst,
The Netherlands) were housed in individual cages, equipped
with a running-wheel and a passive infrared sensor in a tem-
perature-controlled sound-proof light-tight room. Food and
water were available ad libitum. We allowed mice 10–15 days of
acclimatization to a LD cycle (light on at 0600, i.e., ZT 0; light
off at 1800, i.e., ZT 12). Mice were operated under deep
isoflurane anesthesia, and 30 %g of Temgesic anesthetic (bu-
prenorphine; Essex Chemie, Lucerne, Switzerland) was applied.
TNF-! (1.5%g/day, diluted in 0.1% BSA/PBS) or 0.1% BSA/PBS
as a control was administered s.c. by using osmotic minipumps
(Model 1007D; Alzet, Cupertino, CA) implanted on the back, for
6 days. Locomotor activity was continuously measured via
running-wheel and infrared sensors based on 1-min episodes by
using the Chronobiology Kit software (Stanford Software Sys-
tems, Santa Cruz, CA), as described (49, 50). Rest episodes were
defined as 1-min units with activity & zero. The free-running
period of locomotion was calculated by periodogram analysis for
days 2–6 after minipump implantation, when the mice were kept
in constant darkness. In gene expression studies, livers were
extracted 3 days after minipump insertion at two different ZTs
known to approximately represent the peak of expression of Dbp
(ZT & 11.5) or Per2 (ZT & 15.5). Livers were frozen in TRIzol
(Invitrogen, Basel, Switzerland) for subsequent RNA extraction.
All experimental procedures were approved by the local com-
mittee of the veterinary office and in strict accordance with Swiss
regulations on animal welfare.
RNA Isolation and Gene Expression Analysis. The method for RNA
extraction, RT-PCR, and quantification of gene expression is
described in SI Text.
In Situ Hybridization. The method for in situ hybridization was
published (51) and is described in SI Text.
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SI Figure 6 
Fig. 6. Photomicrographs of histological sections of liver, lung and kidney with 
(top row) and without (bottom row) TNF-a treatment: The liver shows an 
increase in HO-1 positive Kupffer cells. At high power magnification the cells 
appear also larger. No morphologically apparent liver cell damage is however 
detected. The lung shows unremarkable numbers of HO-1 positive 
macrophages in the bronchial mucus layer. No increase in HO-1 positive 
alveolar macrophages is seen. At high power magnification (hematoxylin eosin 
staining) increased numbers of megakaryocytes (indicated by arrows) are 
seen trapped within the alveolar vascular bed. There is, however, no evidence 
of pulmonary edema or acute pulmonary damage. Sections of the kidney 
(hematoxylin eosin staining) are unremarkable. The scale bar represents from 
left to right 400 mm, 50 mm, 200 mm, 50 mm, and 100 mm, respectively. 
 
SI Figure 7 
Fig. 7. At day 3 (ZT 15.5) after minipump insertion, serum was collected and 
TNF-a was measured by ELISA. Data are given as the mean ± SD of TNF-a 
serum concentrations measured in six animals per group. Independent 
samples t test, P = 0.001. 
 
SI Figure 8 
Fig. 8. Decreased concentrations of albumin in serum of TNF-a-treated mice. 
Serum was collected at day three after minipump implantation at ZT 15.5 and 
albumin concentrations were measured as described in materials and 
methods. Data show the mean ±SD of serum albumin concentrations in mice 
(six mice per group). 
 
SI Figure 9 
Fig. 9. IL1b expression correlates to TNF-a expression, both being increased 
in TNF-a treated animals (circles with different colors, each individual mouse 
representing one color) compared to animals infused with PBS (blue open 
circles) (day 3, at ZT 15.5; 6 mice per group). In contrary, Dbp, Hlf, and Tef 
are negatively correlated to the relative TNF-a expression. 
 
SI Figure 10 
Fig. 10. TNF-a impairs expression of the clock output genes, Dbp in the SCN. 
(A and B) Dbp and Bmal1 expression in the SCN at ZT 6 as determined by 
radioactive in situ hybridization. At the time point of peak expression of Dbp, 
when Bmal1 expression is lowest, TNF-a leads to a significant reduction by 
15% of the Dbp mRNA. (means ± SEM of six consecutive sections per mouse 
SCN; four mice; paired t test; * P = 0.003). 
 
SI Figure 11 
Fig. 11. (A) Mice treated with TNF-a show increased long rest epochs in the 
dark phase. Analysis of rest epochs was performed at day 3 of TNF-a and 
control infused mice; the analysis being performed separately for the light and 
dark period. The data show the differences in numbers of 1-min episodes 
with activity = 0 compared to baseline (mean of the three days before 
minipump insertion). The occurrence of rest was arbitrarily subdivided in 
episodes for durations with rest = 0 activity counts: up to 1 min rest, between 
2 and 5 min, 6 and 60 min, and more than 60 min. (ANOVA for repeated 
measures, followed by independent-samples t test; * P £0,05). (B) TNF-a 
does not affect the period length measured in constant darkness. On day 1 
after minipump insertion the lights were turned off and the mice were kept in 
constant darkness. The circadian period of locomotion and running-wheel 
activity was determined by periodogram analysis over the 5 days in constant 
darkness. Independent-sample t-tests were performed. TNF-a (1.5 mg/day; 
light gray bars) or saline as control (dark gray bars). 
 
SI Text 
RNA Isolation and Gene Expression Analysis 
Whole-cell RNA from cultured cells was extracted using the NucleoSpin-RNA II 
kit (Macherey-Nagel, Switzerland). RNA from mouse tissues was extracted by 
homogenization of the organ in TRIzol (Invitrogen) according to the 
manufacturer's instructions. Subsequently, RNA was reverse-transcribed using 
random hexamers (Promega, for the in vitro assays; Roche, for the in vivo 
assays) and AMV reverse transcriptase (Promega, for the in vitro assays) or 
M-MuLV reverse transcriptase (Roche, for the in vivo assays). The cDNA 
equivalent to 50 ng of total RNA was PCR-amplified in an ABI PRISM 7700 
detection system (PE-Applied Biosystems) using the TaqMan Universal PCR 
Master Mix (Applied Biosystems) and quantified as follows. Primers and 
probes for Taqman analysis were either purchased from Applied Biosystems 
or purchased from Microsynth, Balgach, Switzerland, as described in detail in 
SI Table 1. The relative levels of each RNA were calculated by the 2-DDCT 
method (CT standing for the cycle number at which the signal reaches the 
threshold of detection); 18s rRNA was used as a housekeeping gene. Each CT 
value used for these calculations is the mean of two duplicates of the same 
reaction. Relative RNA levels are expressed as x-fold variations compared to 
ZT = 0 (time course experiments) or as percentages of the average control 
groups (in the in vitro one-time-point experiments and in the in vivo 
experiments). 
 
In situ hybridization 
After infusion of mice with saline or TNF-a mice were killed at day three at ZT 
6. Brains were embedded in paraffin and sectioned at 7-mm-thickness and 
hybridized with 35S-rUTP labeled riboprobes as described (1). The Bmal1 
probe corresponded to nucleotides 654-1290 (accession no. AF015953) and 
the Dbp probe to nucleotides 2-951 (accession no. NM016974). 
Quantification was performed by densitometric analysis of autoradiograph 
films using the Molecular analyst program (Bio-Rad). Data from the SCN were 
normalized to the lateral hypothalamus next to the SCN. For each treatment 
three animals were used and six sections per SCN were analyzed. We 
assessed the relative mRNA abundance values by defining the highest value of 
each experiment in mock treated animals as 100%. 
 
ELISA 
The concentration of albumin and TNF-a in the serum of mice implanted with 
osmotic minipumps was determined by ELISA (Mouse Albumin ELISA 
Quantitation Kit, Bethyl Laboratories, TX, and mouse TNF-a ELISA kit, 
KMC3012, Biosource). 
1. Deboer T, Tobler I (2000) J Comp Physiol A 186:969-973. 
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Mutation of the Circadian Clock Gene Per2 Alters Vascular
Endothelial Function
Hema Viswambharan, PhD*; João M. Carvas, MSc*; Vladan Antic, MD, PhD; Ana Marecic, MSc;
Corinne Jud, MSc; Christian E. Zaugg, PhD; Xiu-Fen Ming, MD, PhD; Jean-Pierre Montani, MD;
Urs Albrecht, PhD; Zhihong Yang, MD
Background—The circadian clock regulates biological processes including cardiovascular function and metabolism. In the
present study, we investigated the role of the circadian clock gene Period2 (Per2) in endothelial function in a mouse
model.
Methods and Results—Compared with the wild-type littermates, mice with Per2 mutation exhibited impaired endothelium-
dependent relaxations to acetylcholine in aortic rings suspended in organ chambers. During transition from the inactive to
active phase, this response was further increased in the wild-type mice but further decreased in the Per2 mutants. The
endothelial dysfunction in the Per2 mutants was also observed with ionomycin, which was improved by the cyclooxygenase
inhibitor indomethacin. No changes in the expression of endothelial acetylcholine-M3 receptor or endothelial nitric oxide
synthase protein but increased cyclooxygenase-1 (not cyclooxygenase-2) protein levels were observed in the aortas of the
Per2 mutants. Compared with Per2 mutants, a greater endothelium-dependent relaxation to ATP was observed in the
wild-type mice, which was reduced by indomethacin. In quiescent aortic rings, ATP caused greater endothelium-dependent
contractions in the Per2 mutants than in the wild-type mice, contractions that were abolished by indomethacin. The endothelial
dysfunction in the Per2 mutant mice is not associated with hypertension or dyslipidemia.
Conclusions—Mutation in the Per2 gene in mice is associated with aortic endothelial dysfunction involving decreased
production of NO and vasodilatory prostaglandin(s) and increased release of cyclooxygenase-1–derived vasoconstric-
tor(s). The results suggest an important role of the Per2 gene in maintenance of normal cardiovascular functions.
(Circulation. 2007;115:2188-2195.)
Key Words: acetylcholine  circadian rhythm  cyclooxygenase 1  endothelium  nitric oxide  vasodilation
The master circadian clock in mammals, located in thesuprachiasmatic nuclei of the hypothalamus, regulates
many biochemical, physiological, and behavioral processes
and allows an organism to anticipate diurnal changes.1 In
mammals, a set of clock genes constitutes the molecular
machinery of the circadian clock.2 The 2 transcription factors
CLOCK and BMAL1 form heterodimers and induce expres-
sion of several genes by binding to E-box enhancer elements
in the promoters of target genes.2 Among these genes are the
Period genes (Per1/2/3) and Cryptochrome genes (Cry1/2),
whose protein products PER and CRY then negatively
regulate the activation of their own expression by inhibiting
the activity of the CLOCK/BMAL1 complex, thereby consti-
tuting a negative feedback loop.2 Genetic studies revealed
important roles of the circadian genes not only in the
regulation of behavior but also in metabolism. For
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example, an autosomal dominant mutation in the human Per2
gene results in familial advanced sleep phase syndrome,3 and
Per2 mutant mice display impaired clock resetting and loss of
circadian rhythmicity in constant darkness.4 Recent studies
suggest an important role of CLOCK and BMAL1 in glucose
homeostasis.5 Homozygous Clock mutant mice reveal not
only behavioral changes but also phenotypes resembling
metabolic syndrome, a cluster of cardiovascular risk factors
including obesity, dyslipidemia, hypertension, insulin resis-
tance, and hyperglycemia.6 These risk factors can cause
vascular injury, and in particular they promote endothelial
dysfunction leading to cardiovascular diseases.7
The endothelium regulates vascular function by releasing
vasoactive factors including relaxing and contracting factors.
An imbalance between the relaxing factors and contracting
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factors participates in pathogenesis of cardiovascular diseas-
es.8 Research from the past decades has provided firm
evidence for the vasoprotective role of endothelium-derived
nitric oxide (NO), which is produced from L-arginine via
endothelial NO synthase (eNOS). NO causes vasodilation and
inhibits smooth muscle cell proliferation, platelet aggrega-
tion, and inflammatory responses.9 Therefore, endothelial
dysfunction, reflected by impaired endothelium-dependent
relaxations in response to various agonists such as acetylcho-
line, ATP, histamine, and ionomycin, plays an essential role
in pathogenesis of cardiovascular diseases.10,11 The mecha-
nisms underlying endothelial dysfunction are attributable to
(1) a defect in eNOS gene expression; (2) eNOS enzymatic
activation; or (3) an increase in oxidative stress.12,13 Besides
these mechanisms, increased production of endothelium-
derived contracting factors from cyclooxygenase (COX) has
also been implicated in endothelial dysfunction under various
disease conditions by counteracting the vascular relaxing
effect of NO.14–16
Clinical studies have well documented the circadian pat-
tern of physiological cardiovascular functions and patholog-
ical cardiovascular events. The onset of unstable angina,
myocardial infarction, sudden cardiac death, and stroke oc-
curs usually at specific moments of the day.17–21 It has been
suggested that it is attributed primarily to the diurnal varia-
tions of cardiovascular parameters, such as sympathetic nerve
activity, blood pressure, and heart rate, in addition to varia-
tions in plasma lipid, platelets, coagulation factors, or endo-
thelial dysfunction.22–29 However, it is unknown whether the
diurnal variation of cardiovascular parameters is controlled
primarily by circadian clock genes or influenced secondarily
by external factors. The aim of the present study is to
investigate whether there are alterations in endothelial func-
tions in a mouse model with Per2 mutation and whether the
endothelial functional changes are associated with the meta-
bolic cardiovascular risk factors, the phenotype observed in
the CLOCK and BMAL1 mutant mice.
Methods
Materials
See the online-only Data Supplement.
Animals
The Per2 mutant mice were from Zheng et al30 and propagated in our
own facility. Adult 3-month-old male wild-type (WT) (C57Bl/6J)
and Per2 mutant littermates produced from heterozygote-
heterozygote crosses were fed ad libitum and euthanized by decap-
itation. Artificial light was provided daily from 6 AM (Zeitgeber time
[ZT0]) to 6 PM (ZT12) (12 hours of light/12 hours of darkness) with
room temperature and humidity kept constant (temperature,
221°C; humidity, 555%). Mice were euthanized at ZT3, ZT6,
ZT9, or ZT15. All the animal experimental protocols were approved
by the Ethical Committee of Veterinary Office of Fribourg,
Switzerland.
Vasomotor Responses
The descending thoracic aortas with intact endothelium were isolated
and dissected free from perivascular tissues and cut into rings (3 mm
in length). The rings were suspended in a Multi-Myograph System
(model 610M, Danish Myo Technology A/S, Denmark) filled with
Krebs-Ringer bicarbonate buffer (in mmol/L: 118 NaCl, 4.7 KCl, 2.5
CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 0.026 EDTA, and 11.1
glucose) at 37°C, aerated with 95% O2 and 5% CO2. Changes in
isometric tension were recorded with MyoData software as previ-
ously described.31
Aortic rings were allowed to equilibrate for 45 minutes and were
progressively stretched to a passive tension of 5.0 mN that gives the
optimal length-tension relationship. To study the effects of Per2 on
endothelium-dependent or -independent relaxations, aortic rings
from WT and Per2 mutant mice were precontracted with norepi-
nephrine (0.1 to 0.3 mol/L) to match the precontraction. Acetyl-
choline, ATP, or ionomycin, which release NO from endothelial
cells, or the NO donor sodium nitroprusside (0.1 nmol/L to 10
mol/L) was added to the precontracted aortic rings. To study
whether arginase and free radical formation are involved in the
regulation of endothelial function, the arterial rings were treated with
the arginase inhibitor L-norvaline (0.2 mmol/L, 60 minutes) in the
presence of L-arginine (10 mmol/L) or with superoxide dismutase
(150 U/mL) plus catalase (1000 U/mL; 15 minutes), respectively,
followed by the response to acetylcholine (1 nmol/L to 10 mol/L).
To study the role of cyclooxygenase in regulation of vascular
functions, the vascular rings were incubated with indomethacin (1
mol/L) for 30 minutes. The endothelium-dependent responses to
acetylcholine, ionomycin, or ATP were then performed.
Protein Expression of eNOS, COX, and
Acetylcholine-M3 Receptor in Mouse Aortas
Aortic segments with intact endothelium were snap-frozen and kept
at 80°C until use. Crude protein extracts were obtained by
homogenizing the aortic tissues in protein extraction buffer as
described previously.32 Protein concentrations were measured by the
Lowry method; 30 g of the extract was resolved by SDS-PAGE.
The separated proteins were transferred to polyvinylidene fluoride
membrane (Millipore). The proteins of interest were detected by
immunoblotting with the use of antibodies against eNOS (1:2500),
COX-1 (1:500), COX-2 (1:500), or acetylcholine-M3 receptor
(1:500) as primary antibodies followed by incubation with a corre-
sponding secondary fluorophore-conjugated goat (polyclonal) anti-
mouse or anti-rabbit antibody. The signals were visualized with the
use of the Odyssey Infrared Imaging System (LI-COR Biosciences).
Quantification of the signals was performed with the use of Odyssey
Application Software 1.2. Protein levels were expressed as the ratio
against tubulin.
In Vitro ECG
See the online-only Data Supplement.
Blood Pressure Measurement by Telemetry
All mice were instrumented with an arterial catheter connected to an
implantable transducer (model TA11PA-C20, Data Sciences Inter-
national) to monitor arterial pressure by telemetry. Through a
paratracheal incision with the use of stereomicroscopy, the left
carotid artery was exposed, briefly clamped, and punctured with a
26-gauge needle. The cannula was then inserted into the aortic arch
against the flow and secured in place with tissue adhesive. The body
of the implant was placed subcutaneously on the right flank. After
completion of the surgery, the mice were housed in individual
standard mouse cages (231714 cm high, Indulab AG, Switzer-
land) for blood pressure measurement.33 At least 12 days were given
to animals to recover from surgery and for blood pressure and heart
rate to stabilize.
Continuous arterial pressure monitoring was performed in unre-
strained conscious mice. Each animal cage was equipped with 1
RPC-1 plastic receiver (Data Sciences International) fixed on the
bottom of the cage and connected to an analog output device
(R11-CPA), allowing for the continuous recording of the analog
pulsatile arterial pressure signal. The analog pressure signal was then
fed to a 12-bit analog-to-digital converter (Dash-16, Metrabyte
Corp), sampled at 1 kHz, and processed with customized algo-
rithms34 for beat-to-beat analysis. To analyze only data from the
undisturbed periods, the 2-hour period of animal maintenance and
cage cleaning (8 to 10 AM) was excluded from the analysis.
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Statistical Analysis
Relaxations were expressed as percentage of decrease in tension of
the contraction to norepinephrine. Data are given as meanSEM. In
all experiments, n equals the number of animals from which the
blood vessels were dissected. Area under the curve or responses to
agents at each corresponding concentrations among the different
groups of animals were compared either by the Student t test for
unpaired observations or by ANOVA for multiple comparisons
followed by Bonferroni adjustment. A 2-tailed value of P0.05 is
considered to indicate a statistical difference.
The authors had full access to and take full responsibility for the
integrity of the data. All authors have read and agree to the
manuscript as written.
Results
Endothelium-Dependent Relaxations to
Acetylcholine in Per2 Mutant Mice
In aortic rings with intact endothelium precontracted with
norepinephrine (0.1 or 0.3 mol/L), acetylcholine (1 nmol/L
to 10 mol/L), which stimulates NO release from the endo-
thelium via activation of endothelial acetylcholine-M3 recep-
tor,35 evoked potent concentration-dependent relaxations in
WT mice at ZT3, the beginning of the inactive phase for the
rodents (Figure 1A; n9). The response was significantly
decreased in the Per2 mutant mice (Figure 1A; n9; P0.05
versus WT). The smooth muscle sensitivity to NO as dem-
onstrated by endothelium-independent relaxations to the NO
donor sodium nitroprusside (0.1 nmol/L to 1 mol/L) was
comparable between the 2 groups of animals (Figure 1B;
n9; PNS).
Western blots showed no difference in protein levels of
endothelial acetylcholine-M3 receptor or eNOS in the aortas
of the WT and Per2 mutant mice (Figure 2; n5 to 6).
Neither inhibition of oxidative stress by incubating aortic
rings with superoxide dismutase (150 U/mL) plus catalase
(1000 U/mL) nor inhibition of arginase by L-norvaline
(20 mmol/L, 1 hour, to increase L-arginine substrate avail-
ability for eNOS) improved endothelium-dependent relax-
ations to acetylcholine in Per2 mutant mice (Figure IA and IB
in the online-only Data Supplement; n6).
Furthermore, we showed that the decreased endothelium-
dependent relaxations in response to acetylcholine in Per2
mutant mice were consistently present during the inactive
phase as demonstrated in animals at ZT6 and ZT9 (Figure II
in the online-only Data Supplement). Interestingly, the endo-
thelium-dependent relaxations induced by acetylcholine were
further enhanced in the WT mice at ZT15, the beginning of
the active phase (Figure 1A; n7 to 9; P0.05 versus WT
Figure 1. Endothelium-dependent relaxations to acetylcholine in Per2 mutant mice. Endothelium-dependent relaxations to acetylcholine
(ACh) (A) and endothelium-independent relaxations to the NO donor sodium nitroprusside (B) in the aortas of WT and Per2 mutant mice
at ZT3 (open symbol) and ZT15 (solid symbol) are shown. *P0.05 for WT (ZT15) or Per2 (ZT3) vs WT (ZT3); †P0.05 for Per2 (ZT15)
vs Per2 (ZT3) at the indicated corresponding concentration between the compared groups. n7 to 9; ANOVA with Bonferroni adjust-
ment for ACh responses and Student unpaired t test for sodium nitroprusside responses. NE indicates norepinephrine; SNP, sodium
nitroprusside.
Figure 2. Acetylcholine-M3 receptor and eNOS expression in
Per2 mutant mice. A, Western blot demonstrates comparable
acetylcholine-M3 receptor (ACh-M3R) or eNOS protein levels in
the aortas of WT and Per2 mutant mice; B, Quantification of the
acetylcholine-M3 receptor or eNOS protein levels of the afore-
mentioned experiments. n5 to 6; Student unpaired t test for
comparison of the expression of acetylcholine-M3 receptor or
eNOS between WT and Per2 mutants.
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mice at ZT3), but decreased in the Per2 mutants (Figure 1A;
n7 to 9; P0.05 versus Per2 mutants at ZT3).
Endothelium-Dependent Relaxations to Ionomycin
in Per2 Mutant Mice
Moreover, the endothelium-dependent relaxations to ionomy-
cin (10 nmol/L to 1 mol/L), which stimulates eNOS
enzymatic activity via non–receptor-mediated increase in
intracellular Ca2 concentration, were also reduced signifi-
cantly in the Per2 mutant mice during the inactive phase
(maximum effect: 46.712.1%) compared with the WT
animals (maximum effect: 75.16.5%; P0.05; Figure 3;
n7). During transition of the animals from the inactive to
the active phase, the endothelium-dependent relaxations to
ionomycin were significantly enhanced in both groups of
animals (P0.05 between ZT9 and ZT15 in the WT or Per2
mutants). However, the relaxations remained weaker in the
Per2 mutants than the WT animals (Figure 3; n7 to 9;
P0.05) also in the presence of indomethacin (Figure III in
the online-only Data Supplement; n7; P0.05).
Role of COX in Endothelium-Dependent
Responses in Per2 Mutant Mice
We further analyzed whether COX-derived vasoactive pro-
stanoids play a role in the functional changes in endotheli-
um-dependent responses. Interestingly, a significantly higher
protein level of COX-1 in aortas was found in the Per2
mutant mice than in the WT animals by immunoblotting
(1.80.3-fold increase; Figure 4A; n9; P0.05). No
COX-2 signal could be detected in the aortas of the animals.
Inhibition of COX by indomethacin (1 mol/L, 30 minutes)
did not affect the endothelium-dependent relaxations to ace-
tylcholine in both WT and Per2 mutant mice (Figure 4B;
n5 to 6; ZT3), whereas it significantly enhanced the
relaxations to ionomycin in the Per2 mutants (Figure 4C).
The enhanced production of COX-derived vasoconstric-
tor(s) in the Per2 mutants was further demonstrated in the
quiescent aortic rings stimulated by ATP in the presence of
NG-nitro-L-arginine methyl ester (L-NAME) (to eliminate the
vasorelaxing effect of NO) (Figure 5A and 5B). ATP (0.1 to
10 mol/L) evoked a transient but more pronounced vaso-
constriction in the Per2 mutant (14.51.8% of KCl
100 mmol/L) than the WT mice (5.01.3%; n4; P0.05).
The contraction was abolished by the COX inhibitor indo-
methacin (Figure 5B; 1 mol/L, 30 minutes).
Further experiments in the precontracted aortic rings dem-
onstrated that ATP at 0.1 mol/L did not cause vascular
relaxation in both WT and Per2 mutant mice (Figure 5C),
whereas it caused an endothelium-dependent relaxation at 1
mol/L, which was more pronounced in the WT
(57.16.0%) than in the Per2 mutant mice (21.37.7%;
n6; P0.05) (Figure 5C). Incubation of the aortas with the
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COX inhibitor indomethacin (1 mol/L, 30 minutes) signif-
icantly reduced the relaxation to ATP at 1 mol/L in the WT
mice (Figure 5C; 35.45.6%; n7; P0.05) but was unable
to affect the response in the Per2 mutants. These relaxations
in both WT and Per2 mutant mice were fully inhibited by
incubation of the aortas with the eNOS inhibitor L-NAME
(0.1 mmol/L, 15 minutes; data not shown). Furthermore, the
endothelium-dependent relaxation induced by the highest
concentration of ATP (10 mol/L) was also significantly
reduced in the Per2 mutant mice, and indomethacin was
unable to significantly modulate the response in both groups
(Figure 5C). Approximately 30% of relaxations were still
present in the aortas incubated with indomethacin plus
L-NAME, which can be fully blocked by KCl 100 mmol/L
(data not shown), indicating the involvement of the endothe-
lium-derived hyperpolarizing factor in endothelium-
dependent relaxation to ATP at the highest concentration.
Metabolic and Hemodynamic Parameters
Mean arterial pressure for the whole-day period (22 hours) in
Per2 mutant animals (105.91.9 mm Hg; n10) was signif-
icantly lower than that in their WT counterparts
(116.52.1 mm Hg; n9; P0.05). Whole-day values for
heart rate were not different between Per2 mutant mice
(530.95.7 bpm; n10) and WT animals (535.711.3 bpm;
n9; PNS). In vitro ECG showed no difference in changes
of PP interval or PQ interval in response to increasing
concentrations of acetylcholine (1 nmol/L to 0.1 mmol/L)
between the 2 groups (Figure IV in the online-only Data
Supplement; n8).
There was no difference in plasma concentrations of total
cholesterol and triglyceride between the 2 groups of animals
(Figure V in the online-only Data Supplement; n4). Nota-
bly, a previous study showed no difference in plasma glucose
concentration between the WT and Per2 mutant mice and an
increased insulin sensitivity in the latter.36
Discussion
In the present study, we provided the first evidence for a role
of the circadian clock gene Per2 in the regulation of endo-
thelium-mediated vascular responses in a mouse model,
which is not associated with phenotypes resembling cardio-
vascular metabolic risk factors.
Endothelial Dysfunction in Per2 Mutant Mice
The endothelium controls vascular functions by releasing NO
from eNOS in response to various hormonal factors.37 In the
present study, we showed decreased endothelium-dependent
relaxations in the Per2 mutant mice on stimulation with
acetylcholine but endothelium-independent relaxations to the
NO donor sodium nitroprusside comparable to those in the
WT animals. Notably, the decreased endothelium-dependent
relaxation to acetylcholine persists throughout the daytime,
the inactive phase of the rodents (Figure I in the online-only
Data Supplement). This is not attributable to a differential
eNOS gene expression or acetylcholine receptor expression
between the 2 groups because the protein levels of eNOS and
acetylcholine-M3 receptor that mediate NO release from the
endothelial cells35 are comparable between the Per2 mutants
and WT littermates. Furthermore, impaired endothelium-
dependent relaxations in the Per2 mutants are also demon-
strated with ATP as well as ionomycin, which activates eNOS
by non–receptor-mediated increase in intracellular Ca2 con-
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centration, demonstrating endothelial dysfunction in the
mutants.
Studies in the past demonstrate that besides alterations in
eNOS gene expression, defective eNOS enzymatic activity
and increased oxidative stress are potential mechanisms for
the impairment of endothelial NO-mediated vascular relax-
ations.9 It is unlikely that increased oxidative stress is
responsible for the endothelial dysfunction in the Per2 mutant
mice because the decreased endothelium-dependent relax-
ations could not be reversed by scavenging reactive oxygen
species with superoxide dismutase and catalase. Furthermore,
inhibition of arginase to enhance L-arginine availability for
eNOS or supplementation of the eNOS cofactor BH4 had no
effects on endothelium-dependent relaxations to acetylcho-
line in the Per2 mutant mice (data not shown). It is notewor-
thy that Per2 mutant mice have decreased calmodulin expres-
sion in the liver, as demonstrated in a previous study.38
Because calmodulin is essential for the Ca2-dependent acti-
vation of eNOS by various agonists, it is conceivable that the
decrease in calmodulin expression could also occur in the
endothelial cells, which might be responsible for the impaired
endothelium-dependent relaxations in the Per2 mutant mice
in response to the various agonists. This hypothesis warrants
further investigation.
Diurnal Changes of Endothelial Function in Per2
Mutant Mice
Interestingly, during the transition from the inactive to the
active phase, the endothelium-dependent relaxation to acetyl-
choline is increased in the WT but decreased in the Per2
mutant mice. In contrast to acetylcholine, the endothelium-
dependent relaxation to ionomycin is enhanced in both
groups of the animals during the transition from the inactive
to the active phase, whereby the response still remains weaker
in the Per2 mutant mice. These results further demonstrate
endothelial dysfunction in the mutant mice in the inactive as
well as in the active phase. The increased response to
ionomycin in both groups of animals in the active phase may
be explained by the hemodynamic adaptation during this time
period, ie, the increase in blood flow in the circulation, that
increases NO release from the endothelium.39 The possibility
of different physical activity between WT and Per2 mutant
mice can be ruled out because a previous study showed
normal behavioral activity of the Per2 mutant mice under
normal light/dark cycles.30 The observation that the endothe-
lium-dependent relaxations in response to acetylcholine are
further decreased in the Per2 mutant mice in the active phase
might be due to opposite changes in the signal transduction
pathways mediated by acetylcholine receptor, which leads to
a further decrease in eNOS activation in the active phase of
the Per2 mutant mice. This conclusion is supported by the
following evidence: First, ionomycin-induced endothelium-
dependent relaxation is increased instead of decreased in the
active phase, as shown in the present study; second, a study
from another group showed that mouse aortic eNOS activity
does not display 24-hour rhythmicity under a normal light/
dark cycle.40 Increased endothelium-dependent relaxation in
healthy subjects in the morning hours has been reported in
humans,41 which is in agreement with the results from the WT
mice, although the results are controversial in clinical stud-
ies.28,29 The inconsistent results among the clinical studies are
not clear but might be related to the different vascular beds
investigated, ie, resistance vessels and conduit blood vessels,
or might be due to changes in sympathetic nerve activity in
vivo.22 Whether our results can explain the increased inci-
dence of cardiac events in the morning hours in certain patient
populations42 remains speculative.
Notably, the heart seems not to be affected by the defective
acetylcholine response in the Per2 mutant mice because the
responses to acetylcholine in the heart, ie, increases in PP
interval or PQ interval, that are mediated by acetylcholine-M2
receptor43 remain unchanged, as demonstrated by in vitro
ECG. In addition, the blood pressure is significantly lower
and heart rate is the same during 24 hours in the Per2 mice
compared with the WT animals, suggesting that the parasym-
pathetic nerve or acetylcholine-mediated signaling in the
heart of the Per2 mutant mice remains intact.
COX-1 Expression and COX-Derived Vasoactive
Prostanoids in Per2 Mutant Mice
Another important finding of our present study is the in-
creased expression of COX-1 (no signal of COX-2 detect-
able) in the aortas of the Per2 mutant mice. The mechanism
of the increased COX-1 expression in the Per2 mutants is
unknown. Whether COX-1 is a target gene of Per2, ie,
regulated directly by Per2, or regulated secondarily remains
to be investigated. Accordingly, the endothelium-dependent
relaxations induced by ionomycin (but not acetylcholine) are
enhanced by the COX inhibitor indomethacin in the Per2
mutant mice, demonstrating that COX-1–derived vasocon-
strictor(s) is stimulated by ionomycin but not by acetylcho-
line, which partly contributes to the endothelial dysfunction
in the Per2 mutant mice. The lack of the effect of indometh-
acin on acetylcholine-induced response in Per2 mutants
further indicates a defective acetylcholine receptor–mediated
signaling in the aortic endothelial cells of these animals. It is
possible that enhanced COX-1 expression could influence
endothelial function in the Per2 mutant mice if the defect in
endothelial acetylcholine signaling could be corrected.
The increased production of COX-1–derived vasoconstric-
tor(s) is also demonstrated in the quiescent rings incubated
with L-NAME (to inhibit eNOS and to unmask the contract-
ing effect of COX-derived vasoconstrictors). Under this
condition, ATP causes a more pronounced vasoconstriction in
the Per2 mutants than in WT mice, which is inhibited by
indomethacin. However, indomethacin cannot improve endo-
thelium-dependent relaxations to ATP (in contrast to iono-
mycin) in the Per2 mutants, but it reduces the relaxation
response to ATP (1 mol/L) in the WT mice. These results
suggest that ATP releases a vasodilator(s) produced from the
COX pathway, most likely prostaglandin I2, another well-
known endothelial vascular protective factor, in the WT mice
but not in the Per2 mutants. Notably, the increased produc-
tion of COX-1–derived vasoconstrictor(s) that was observed
in the quiescent aortic rings of Per2 mutant mice is appar-
ently not sufficient to counteract the effect of NO induced by
ATP (1 mol/L). Only 3% of the maximum contraction to
KCl 100 mmol/L was observed under this condition. Notably,
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ATP at a higher concentration of 10 mol/L also releases the
endothelium-derived hyperpolarizing factor, which in part
compensates the vasodilatory response to the agonist. Al-
though 15% contraction occurs in response to the higher
concentration of ATP of 10 mol/L, the relaxation effect
exerted by both NO and endothelium-derived hyperpolarizing
factor is dominant in the Per2 mutants. Nonetheless, the
results in the quiescent rings demonstrate an increased pro-
duction of COX-1–derived vasoconstrictor(s) in the aortas of
the Per2 mutant mice.
Vascular functions, including endothelial functions, can be
impaired by various risk factors that are clustered in the
metabolic syndrome.7 Recent studies demonstrate that mice
with disruption of the Clock gene are prone to develop a
phenotype resembling metabolic syndrome.6 In contrast to the
Clock mutant mice, our Per2 mutants have lower blood
pressure and do not develop dyslipidemia. It has been shown
recently that the Per2 mutant mice have faster glucose
clearance than the WT animals.36 These results imply that the
endothelial dysfunction in the Per2 mutant mice is not
associated with metabolic risk factors but rather is linked
directly to the Per2 gene. Whether the endothelial function is
regulated directly by the peripheral circadian clock44 or
indirectly by the master clock in suprachiasmatic nuclei
remains to be investigated.
In conclusion, mutation of circadian clock genes is not
necessarily associated with metabolic syndrome. Functional
loss of the Per2 gene impairs endothelial function in mouse
aortas involving decreased production of NO and a vasodi-
latory prostaglandin(s) as well as increased release of COX-
1–derived vasoconstrictor(s) (Figure 6). The results suggest
an important role of the Per2 gene in maintenance of normal
cardiovascular functions.
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CLINICAL PERSPECTIVE
Clinical studies document an increased frequency of cardiovascular events such as unstable angina, myocardial infarction,
sudden cardiac death, and thrombotic stroke during the morning hours, usually from 6 AM to noon. It is, however, not
known whether this is primarily related to the diurnal variation of cardiovascular parameters and physical activities or
controlled by the master clock that resides in the suprachiasmatic nuclei of the hypothalamus in mammals. In the present
study, we show that mice with the mutation of the clock gene Period2 (Per2) exhibit impaired endothelium-dependent
relaxations due to decreased endothelial nitric oxide synthase activity and a decreased production of vasodilatory
prostaglandin(s) in the aorta. The endothelium-dependent relaxation in response to acetylcholine is further decreased in the
Per2 mutant mice during transition from the inactive to the active phase, whereas it is increased in the wild-type littermates.
Furthermore, an increase in cyclooxygenase-1 protein level and cyclooxygenase-derived vasoconstrictor production is
observed in the Per2 mutant mouse aorta. The endothelial dysfunction in the Per2 mutant mice is not associated with
hypertension or dyslipidemia. The results of the present study demonstrate that mutation of the Per2 gene in mice is
associated with endothelial dysfunction involving decreased production of nitric oxide and vasodilatory prostaglandin(s)
as well as increased release of cyclooxygenase-1–derived vasoconstrictor(s). The results suggest a potential role of the
Per2 gene in maintenance of normal cardiovascular functions and may provide certain clues at the molecular level for the
circadian pattern of cardiac events in clinical settings.
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Appendix IV 
Corticosterone levels before and after stress in wild-type and Per2
Brdm1
 mice 
 
 
Fig. AIV-1: Serum corticosterone levels are significantly different between wild-type and 
Per2
Brdm1
 mice under normal conditions at ZT6. However, 30 min after a 10 min tube restraint 
the corticosterone levels are increased comparably in both genotypes. *** p<0.0001 
 
Materials and Methods 
Corticosterone determination 
3 to 4 month old male mice are kept individually with food and water ad libitum for at least 1 day 
prior to blood sampling. Serum samples are collected around noon (ZT6) before and 30 min after 
a 10 min tube restraint. Mice are anesthetized using isoflurane (Attane
TM
 isoflurane, Provet, ATC 
vet code QN01AB06). A small horizontal incision is made close to the tail base on the ventral 
part of the tail. Blood is collected using a Microvette 100 (Sarstedt, cat # 20.1280) for serum 
preparation. Tubes are kept on ice until they are centrifuged at 6000 rpm and 4°C for 10 min. The 
serum is stored at -20°C. Corticosterone levels are determined using a radioimmunassay kit from 
MP Biomedicals (Corticosterone 
3
H RIA kit for rats & mice, cat # 07-120002) according to the 
manufacturers instructions. 3 l of serum are diluted in 1.5 ml of steroid diluent. 
